{"id": 45397728, "time": "2025-05-14 00:40:47", "headline": "YouTube Scores NFL First: Chargers Game In Brazil To Stream Free Worldwide", "summary": "YouTube is set to broadcast the first NFL game on Sept. 5 from S\u00e3o Paulo. Mary Ellen Coe promises interactive viewing experience. More to come if successful.", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/tech/25/05/45397728/youtube-scores-nfl-first-chargers-game-in-brazil-to-stream-free-worldwide", "tags": []}
{"id": 45397758, "time": "2025-05-14 00:47:29", "headline": "Reported Earlier, Australia Wage Price Index (QoQ) For Q1 0.9% Vs. 0.8% Est.; 0.7% Prior", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45397758/reported-earlier-australia-wage-price-index-qoq-for-q1-0-9-vs-0-8-est-0-7-prior", "tags": []}
{"id": 45397896, "time": "2025-05-14 01:01:04", "headline": "Roger Federer-Backed On Holding Jumps 12% As DTC Sales Soar \u2014Sneaker Price Hikes Coming To Offset Tariffs And Fuel Premium Growth", "summary": "Swiss athletic footwear company On Holding AG saw its stock jump 12% following stellar first-quarter of 2025 results that handily beat analyst expectations, demonstrating the strength of its premium positioning strategy.", "symbols": ["ONON"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/05/45397896/roger-federer-backed-on-holding-jumps-12-as-dtc-sales-soar-sneaker-price-hikes-coming-to-offset-tariffs-and-fuel-premium-growth", "tags": []}
{"id": 45397930, "time": "2025-05-14 01:06:34", "headline": "Trump Memecoin Adopted By China-Linked Nasdaq Company As Treasury Reserve Asset", "summary": "Publicly-listed holding company GD Culture Group Ltd.", "symbols": ["BTC", "BTCUSD", "FRGT", "GDC", "TRUMPUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45397930/trump-memecoin-adopted-by-china-linked-nasdaq-company-as-treasury-reserve-asset", "tags": []}
{"id": 45398000, "time": "2025-05-14 01:21:45", "headline": "Nyxoah Q1 EPS $(0.63) Misses $(0.50) Estimate, Sales $1.10M Miss $1.64M Estimate", "summary": "", "symbols": ["NYXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398000/nyxoah-q1-eps-0-63-misses-0-50-estimate-sales-1-10m-miss-1-64m-estimate", "tags": ["earnings"]}
{"id": 45398081, "time": "2025-05-14 01:30:19", "headline": "IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate", "summary": "", "symbols": ["IGMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398081/igm-biosciences-q1-eps-0-50-misses-0-48-estimate-sales-499-00k-miss-3-10m-estimate", "tags": ["earnings"]}
{"id": 45398090, "time": "2025-05-14 01:31:50", "headline": "Sonnet BioTherapeutics Q2 EPS $(0.89) Misses $(0.79) Estimate", "summary": "", "symbols": ["SONN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398090/sonnet-biotherapeutics-q2-eps-0-89-misses-0-79-estimate", "tags": ["earnings"]}
{"id": 45398099, "time": "2025-05-14 01:33:51", "headline": "Pharvaris Q1 EPS $(0.89) Misses $(0.82) Estimate", "summary": "", "symbols": ["PHVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398099/pharvaris-q1-eps-0-89-misses-0-82-estimate", "tags": ["earnings"]}
{"id": 45398101, "time": "2025-05-14 01:34:51", "headline": "Microsoft To Cut 6,000 Jobs Globally Amid AI-Driven Shift, Says Changes Necessary To 'Best Position The Company For Success'", "summary": "Microsoft Corp. announced on Tuesday it will eliminate approximately 6,000 positions globally, representing 3% of its workforce, as the tech giant seeks to streamline operations and reduce middle management layers.", "symbols": ["AMZN", "META", "MSFT"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/05/45398101/microsoft-to-cut-6000-jobs-in-global-restructuring-joins-meta-and-amazon-in-trimming-workforce-amid-ai-driven-shift", "tags": []}
{"id": 45398102, "time": "2025-05-14 01:35:06", "headline": "Pluri Q3 EPS $(0.94) Up From $(1.01) YoY, Sales $427.00K Up From $71.00K YoY", "summary": "", "symbols": ["PLUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398102/pluri-q3-eps-0-94-up-from-1-01-yoy-sales-427-00k-up-from-71-00k-yoy", "tags": ["earnings"]}
{"id": 45398113, "time": "2025-05-14 01:36:34", "headline": "Avalon Globocare Q1 EPS $(1.43) Up From $(1.80) YoY, Sales $349.80K Up From $314.59K YoY", "summary": "", "symbols": ["ALBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398113/avalon-globocare-q1-eps-1-43-up-from-1-80-yoy-sales-349-80k-up-from-314-59k-yoy", "tags": ["earnings"]}
{"id": 45398126, "time": "2025-05-14 01:37:56", "headline": "Kezar Life Sciences Q1 EPS $(2.27) Beats $(2.61) Estimate", "summary": "", "symbols": ["KZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398126/kezar-life-sciences-q1-eps-2-27-beats-2-61-estimate", "tags": ["earnings"]}
{"id": 45398194, "time": "2025-05-14 01:41:48", "headline": "Reported Earlier, Uber Prices $1B In 0.0% Exchangeable Senior Notes Due 2028, Exchangeable Into Aurora Innovation Stock", "summary": "", "symbols": ["UBER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45398194/reported-earlier-uber-prices-1b-in-0-0-exchangeable-senior-notes-due-2028-exchangeable-into-aurora-i", "tags": []}
{"id": 45398200, "time": "2025-05-14 01:44:24", "headline": "Reported Earlier, Hewlett Packard Enterprise Selected By KISTI To Deliver South Korea's Sixth-Generation, AI-Powered Supercomputer", "summary": "", "symbols": ["HPE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45398200/reported-earlier-hewlett-packard-enterprise-selected-by-kisti-to-deliver-south-koreas-sixth-generati", "tags": []}
{"id": 45398208, "time": "2025-05-14 01:45:14", "headline": "Hall Of Fame Resort Q1 EPS $(2.30) Misses $(2.23) Estimate, Sales $2.94M Miss $3.75M Estimate", "summary": "", "symbols": ["HOFV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398208/hall-of-fame-resort-q1-eps-2-30-misses-2-23-estimate-sales-2-94m-miss-3-75m-estimate", "tags": ["earnings"]}
{"id": 45398210, "time": "2025-05-14 01:46:45", "headline": "Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY", "summary": "", "symbols": ["PTIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398210/protagenic-therapeutics-q1-eps-2-75-up-from-5-44-yoy", "tags": ["earnings"]}
{"id": 45398212, "time": "2025-05-14 01:47:01", "headline": "Reported Earlier, GreenPower Motor Announces $2M Term Loan Offering To Support Production And Working Capital", "summary": "", "symbols": ["GP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45398212/reported-earlier-greenpower-motor-announces-2m-term-loan-offering-to-support-production-and-working", "tags": ["offering"]}
{"id": 45398215, "time": "2025-05-14 01:48:54", "headline": "Tvardi Therapeutics Q1 EPS $(3.22) Misses $(0.31) Estimate, Sales $2.57M Up From $2.13M YoY", "summary": "", "symbols": ["TVRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398215/tvardi-therapeutics-q1-eps-3-22-misses-0-31-estimate-sales-2-57m-up-from-2-13m-yoy", "tags": ["earnings"]}
{"id": 45398216, "time": "2025-05-14 01:49:50", "headline": "Belite Bio Q1 EPS $(0.45) Misses $(0.35) Estimate", "summary": "", "symbols": ["BLTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398216/belite-bio-q1-eps-0-45-misses-0-35-estimate", "tags": ["earnings"]}
{"id": 45398300, "time": "2025-05-14 01:54:43", "headline": "Investcorp Credit Q3 EPS $0.05 Misses $0.11 Estimate, Sales $4.37M Miss $5.27M Estimate", "summary": "", "symbols": ["ICMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398300/investcorp-credit-q3-eps-0-05-misses-0-11-estimate-sales-4-37m-miss-5-27m-estimate", "tags": ["earnings"]}
{"id": 45398306, "time": "2025-05-14 01:59:22", "headline": "Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY", "summary": "", "symbols": ["BJDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398306/bluejay-diagnostics-q1-eps-3-37-up-from-394-76-yoy", "tags": ["earnings"]}
{"id": 45398341, "time": "2025-05-14 02:01:21", "headline": "How To Earn $500 A Month From Cisco Stock Ahead Of Q3 Earnings", "summary": "Cisco offers an annual dividend yield of 2.66%. To earn $500 monthly, start with the yearly target of $6,000 ($500 x 12 months).", "symbols": ["CSCO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/05/45398341/how-to-earn-500-a-month-from-cisco-stock-ahead-of-q3-earnings", "tags": ["earnings", "dividend"]}
{"id": 45398422, "time": "2025-05-14 02:03:17", "headline": "Sony Group FY 2024 GAAP EPS \u00a5187.92 Beats \u00a5180.09 Estimate, Sales \u00a512.957T Miss \u00a513.336T Estimate", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398422/sony-group-fy-2024-gaap-eps-187-92-beats-180-09-estimate-sales-12-957t-miss-13-336t-estimate", "tags": ["earnings"]}
{"id": 45398578, "time": "2025-05-14 02:12:31", "headline": "Germany Consumer Price Index (YoY) For April 2.1% Vs. 2.1% Est.; 2.2% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45398578/germany-consumer-price-index-yoy-for-april-2-1-vs-2-1-est-2-2-prior", "tags": []}
{"id": 45398579, "time": "2025-05-14 02:13:49", "headline": "Germany Consumer Price Index (MoM) For April 0.4% Vs. 0.4% Est.; 0.3% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45398579/germany-consumer-price-index-mom-for-april-0-4-vs-0-4-est-0-3-prior", "tags": []}
{"id": 45398586, "time": "2025-05-14 02:17:48", "headline": "Sony Group Q4 EPS $0.21 Beats $0.12 Estimate, Sales $17.25B Miss $20.40B Estimate", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398586/sony-group-q4-eps-0-21-beats-0-12-estimate-sales-17-25b-miss-20-40b-estimate", "tags": ["earnings"]}
{"id": 45398594, "time": "2025-05-14 02:22:19", "headline": "Sony's Forecast For Fiscal Year Ending March 31, 2026: Expects Sales From Continuing Operations Of \u00a511.7T (-2.9% YoY), Operating Income Of \u00a51.28T (+0.3% YoY), And Net Income Of \u00a5930B (-12.9% YoY)", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398594/sonys-forecast-for-fiscal-year-ending-march-31-2026-expects-sales-from-continuing-operations-of-11-", "tags": ["guidance"]}
{"id": 45398595, "time": "2025-05-14 02:22:25", "headline": "Trump Praises Nvidia CEO Jensen Huang At Saudi Summit: 'Tim Cook Isn't Here, But You Are' Controlling 99% Of The Chip Market: 'That's Not Easy To Beat'", "summary": "President Donald Trump singled out Nvidia Corp. CEO Jensen Huang for praise during a U.S.-Saudi Investment Forum on Tuesday, highlighting the chipmaker&#39;s planned $500 billion investment in U.S. artificial intelligence infrastructure.", "symbols": ["AAPL", "NVDA", "TSM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/05/45398595/trump-praises-nvidia-ceo-jensen-huang-at-saudi-summit-tim-cook-isnt-here-but-you-are-controlling-99-of-the-chip-market-thats-not-easy-to-beat", "tags": ["management"]}
{"id": 45398694, "time": "2025-05-14 02:26:20", "headline": "Sony's Forecast Factors In U.S. Tariffs As Of April But Excludes The May 12 China Tariff Changes; The Company Noted The Actual Impact May Vary With Future Policy Shifts", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45398694/sonys-forecast-factors-in-u-s-tariffs-as-of-april-but-excludes-the-may-12-china-tariff-changes-the-c", "tags": ["guidance"]}
{"id": 45398745, "time": "2025-05-14 02:31:03", "headline": "Dan Ives Says Tesla's Future Hinges On Autonomy As Europe Demand Craters\u2014xAI Acquisition Could Be Musk's Next Big Bet: 'Heavy Lifting Ahead'", "summary": "Tech analyst Dan Ives offers a candid assessment of Tesla Inc. (NASDAQ: TSLA) as demand pressures mount and investor attention shifts toward its autonomy and AI roadmap.", "symbols": ["BYDDF", "TSLA"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/25/05/45398745/heavy-lifting-ahead-dan-ives-says-teslas-future-hinges-on-autonomy-as-europe-demand-cratersxai-acquisition-could-be-musks-next-big-bet", "tags": []}
{"id": 45398819, "time": "2025-05-14 02:32:31", "headline": "Valeura Energy Q1 EPS $0.13 Misses $0.26 Estimate, Sales $148.08M Down From $149.41M YoY", "summary": "", "symbols": ["TSX:VLE", "VLERF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45398819/valeura-energy-q1-eps-0-13-misses-0-26-estimate-sales-148-08m-down-from-149-41m-yoy", "tags": ["earnings"]}
{"id": 45398821, "time": "2025-05-14 02:35:06", "headline": "Dynatrace Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["DT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45398821/dynatrace-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 45398822, "time": "2025-05-14 02:35:11", "headline": "GSK To Expand Liver Disease Portfolio With $1.2B Acquisition Of Boston Pharmaceuticals' Efimosfermin, Targeting 2029 Launch", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45398822/gsk-to-expand-liver-disease-portfolio-with-1-2b-acquisition-of-boston-pharmaceuticals-efimosfermin-t", "tags": []}
{"id": 45398849, "time": "2025-05-14 02:39:18", "headline": "FirstCash To Acquire H&T Group For $394M In UK Expansion Deal Expected To Deliver Meaningful EBITDA And EPS Accretion", "summary": "", "symbols": ["FCFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45398849/firstcash-to-acquire-h-t-group-for-394m-in-uk-expansion-deal-expected-to-deliver-meaningful-ebitda-a", "tags": ["earnings", "merger", "contract"]}
{"id": 45398856, "time": "2025-05-14 02:39:55", "headline": "India Wholesale Price Index (WPI) Inflation (YoY) For April 0.85% Vs. 1.76% Est.; 2.05% Prior", "summary": "", "symbols": ["INDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45398856/india-wholesale-price-index-wpi-inflation-yoy-for-april-0-85-vs-1-76-est-2-05-pri", "tags": []}
{"id": 45398946, "time": "2025-05-14 02:44:28", "headline": "Broadridge Secures U.S. Patent For Large Language Model Orchestration Powering BondGPT And Enterprise AI Trading Tools", "summary": "", "symbols": ["BR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45398946/broadridge-secures-u-s-patent-for-large-language-model-orchestration-powering-bondgpt-and-enterprise", "tags": []}
{"id": 45398963, "time": "2025-05-14 02:50:51", "headline": "Top Wall Street Forecasters Revamp Endava Expectations Ahead Of Q3 Earnings", "summary": " ", "symbols": ["DAVA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/05/45398963/top-wall-street-forecasters-revamp-endava-expectations-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 45399081, "time": "2025-05-14 02:54:50", "headline": "Alphabet's Value Could Skyrocket To $3.7 Trillion With Google's 'Big Bang Breakup' Over 'Isolated Spin-Offs,' Says Analyst", "summary": "DA Davidson analyst\u00a0Gil Luria\u00a0has proposed that\u00a0Alphabet Inc.\u00a0(NASDAQ: GOOGL) (NASDAQ: GOOG) should contemplate splitting up Google&#39;s various businesses to enhance its overall value. This recommendation comes amid Google&#39;s struggle to retain its supremacy in the search engine market due to the rise of AI chatbots.", "symbols": ["AAPL", "GOOG", "GOOGL", "NFLX", "NVDA", "SNOW", "UBER"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/05/45399081/alphabets-value-could-skyrocket-to-3-7-trillion-with-googles-big-bang-breakup-over-isolated-spin-offs-says-analyst", "tags": []}
{"id": 45368241, "time": "2025-05-14 02:54:49", "headline": "Jeff Bezos Called 'Chief Dark Arts Officer' In Secret Amazon Doc As FTC Says Company Hid Thousands Of Key Files In Antitrust Case (UPDATED)", "summary": "The FTC accuses Amazon of concealing evidence in an antitrust case. Thousands of documents were wrongly labeled as protected, showing a pattern of misleading tactics.", "symbols": ["AMZN"], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/legal/25/05/45368241/jeff-bezos-called-chief-dark-arts-officer-in-secret-amazon-doc-as-ftc-says-company-hid-thousands-of-key-files-in-antitrust-case", "tags": []}
{"id": 45399090, "time": "2025-05-14 02:56:32", "headline": "Reported Earlier, TrueBlue Adopts Limited Duration Shareholder Rights Plan Following Unsolicited $7.50 Per Share Offer From HireQuest", "summary": "", "symbols": ["HQI", "TBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399090/reported-earlier-trueblue-adopts-limited-duration-shareholder-rights-plan-following-unsolicited-7-50", "tags": []}
{"id": 45399095, "time": "2025-05-14 02:59:09", "headline": "Reported Earlier, HCW Biologics Announces $5M Offering of 671,140 Units At $7.45 Per Unit Under Nasdaq Rules", "summary": "", "symbols": ["HCWB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399095/reported-earlier-hcw-biologics-announces-5m-offering-of-671-140-units-at-7-45-per-unit-under-nasdaq", "tags": ["offering"]}
{"id": 45399127, "time": "2025-05-14 03:05:04", "headline": "Reported Earlier, Cboe Strengthens Asia Pacific Presence With Key Hires Amid Surging Demand For U.S. And European Market Access", "summary": "", "symbols": ["CBOE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399127/reported-earlier-cboe-strengthens-asia-pacific-presence-with-key-hires-amid-surging-demand-for-u-s-a", "tags": []}
{"id": 45399235, "time": "2025-05-14 03:10:56", "headline": "Reported Earlier, Telstra, Accenture Open First-of-Its-Kind AI Innovation Hub In Silicon Valley To Power Intelligent Systems And Agentic AI", "summary": "", "symbols": ["ACN", "TLGPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399235/reported-earlier-telstra-accenture-open-first-of-its-kind-ai-innovation-hub-in-silicon-valley-to-pow", "tags": []}
{"id": 45399287, "time": "2025-05-14 03:18:20", "headline": "Steel Partners Holdings Q1 EPS $1.41 Down From $1.50 YoY, Sales $499.22M Up From $476.35M YoY", "summary": "", "symbols": ["SPLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45399287/steel-partners-holdings-q1-eps-1-41-down-from-1-50-yoy-sales-499-22m-up-from-476-35m-yoy", "tags": ["earnings"]}
{"id": 45399288, "time": "2025-05-14 03:18:40", "headline": "Kevin O'Leary Lauds Robinhood's Acquisition Of WonderFi Will 'Transform Cross-Border Trading:' 'No More Outrageous Bank Fees'", "summary": "After Robinhood announced the acquisition of WonderFi, entrepreneur and investor Kevin O&#39;Leary expressed his excitement over the deal.", "symbols": ["HOOD", "QQQ", "WONDF"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/05/45399288/kevin-oleary-lauds-robinhoods-acquisition-of-wonderfi-will-transform-cross-border-trading-no-more-outrageous-bank-fees", "tags": ["contract"]}
{"id": 45399312, "time": "2025-05-14 03:23:52", "headline": "Dayforce Chosen By Hubexo To Standardize HR Operations And Power Workforce Across Europe, North America, And Asia Pacific", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399312/dayforce-chosen-by-hubexo-to-standardize-hr-operations-and-power-workforce-across-europe-north-ameri", "tags": []}
{"id": 45399408, "time": "2025-05-14 03:25:26", "headline": "Healthier Choices Mgmt Q1 Sales $1.78K Up From $119.00 YoY", "summary": "", "symbols": ["HCMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45399408/healthier-choices-mgmt-q1-sales-1-78k-up-from-119-00-yoy", "tags": []}
{"id": 45399409, "time": "2025-05-14 03:25:52", "headline": "Google Cloud And Philips Partner To Transform Global Marketing With AI-Powered Digital Asset Management", "summary": "", "symbols": ["GOOG", "PHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399409/google-cloud-and-philips-partner-to-transform-global-marketing-with-ai-powered-digital-asset-managem", "tags": []}
{"id": 45399435, "time": "2025-05-14 03:32:30", "headline": "Munchener Q1 EPS $0.88 Up From $0.35 YoY, Sales $16.63B Up From $16.36B YoY", "summary": "", "symbols": ["MURGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45399435/munchener-q1-eps-0-88-up-from-0-35-yoy-sales-16-63b-up-from-16-36b-yoy", "tags": ["earnings"]}
{"id": 45399438, "time": "2025-05-14 03:34:05", "headline": "SMCI Stock In 'Sweet Spot,' Says Raymond James \u2014 Sets $41 Price Target As AI Revenue Hits 70%", "summary": "Raymond James has initiated coverage on\u00a0Super Micro Computer\u00a0(NASDAQ:SMCI) with an Outperform rating. This move comes in light of Supermicro&#39;s strong standing in the AI-optimized infrastructure sector and its swift revenue growth.", "symbols": ["DELL", "HPE", "SMCI"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/05/45399438/smci-rated-outperform-by-raymond-james-amid-dominance-in-branded-ai-server-market", "tags": ["earnings"]}
{"id": 45399468, "time": "2025-05-14 03:40:28", "headline": "Elizabeth Warren Calls Out Trump-Linked Stablecoin As A National Security Risk: 'He's Cashing In On Foreign Crypto Deals'", "summary": "Senior Democratic lawmaker Sen.\u00a0Elizabeth Warren\u00a0(D-Mass.) called President Donald Trump-backed stablecoin a potential threat to national security and a conduit for corruption on Tuesday.", "symbols": ["BNBUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45399468/elizabeth-warren-calls-out-trump-linked-stablecoin-as-a-national-security-risk-hes-cashing-in-on-foreign-crypto-deals", "tags": []}
{"id": 45399583, "time": "2025-05-14 03:43:46", "headline": "Cryptocurrency Tycoon's Daughter Escapes Kidnapping Attempt: Viral Video Captures Terrifying Ordeal", "summary": "French authorities are on the hunt for armed men who attempted to kidnap a woman, believed to be the daughter of a cryptocurrency\u00a0tycoon, on Tuesday.", "symbols": ["BTCUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45399583/cryptocurrency-tycoons-daughter-escapes-kidnapping-attempt-viral-video-captures-terrifying-ordeal", "tags": []}
{"id": 45399602, "time": "2025-05-14 03:53:33", "headline": "Standard Chartered Partners With FalconX To Fuel Institutional Crypto Access As Bitcoin Soars Past $103K", "summary": "Institutional digital asset prime broker FalconX has formed a strategic partnership with Standard Chartered (OTC:SCBFF), strengthening connections between traditional banking and the rapidly expanding cryptocurrency market as Bitcoin (CRYPTO: ", "symbols": ["BTCUSD", "SCBFF"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45399602/standard-chartered-partners-with-falconx-to-fuel-institutional-crypto-access-as-bitcoin-soars-past-103k", "tags": ["contract"]}
{"id": 45399783, "time": "2025-05-14 04:05:35", "headline": "Gordon Johnson Warns Of Potential 'Liberation Day 2.0' As 30-Year Treasury Yields Approach 5% Amid Dollar Weakness", "summary": "Gordon Johnson has suggested that a potential &#34;Liberation Day 2.0&#34; \u2013 an event triggering equity market downturn \u2013 could be imminent.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness", "tags": []}
{"id": 45399802, "time": "2025-05-14 04:08:16", "headline": "Clarivate Announced The Incorporation Of Pathway Maps In OFF-X, A Cutting-edge Translational Safety Intelligence Solution", "summary": "", "symbols": ["CLVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45399802/clarivate-announced-the-incorporation-of-pathway-maps-in-off-x-a-cutting-edge-translational-safety-i", "tags": []}
{"id": 45399804, "time": "2025-05-14 04:08:43", "headline": "Robert Kennedy Jr. Cheers FDA Plan To Ban Fluoride Supplements For Children, Calls Move 'Long Overdue'", "summary": "U.S. Health Secretary Robert F. Kennedy Jr. praised the Food and Drug Administration&#39;s decision to begin removing fluoride supplements for children from the market, calling the move &#34;long overdue.&#34;", "symbols": [], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/government/regulations/25/05/45399804/robert-kennedy-jr-cheers-fda-plan-to-ban-fluoride-supplements-for-children-calls-move-long-overdue", "tags": ["fda"]}
{"id": 45399940, "time": "2025-05-14 04:18:48", "headline": "Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of 'Compound Interest'", "summary": "According to Creative Planning, Inc., the &#39;Oracle of Omaha,&#39; Warren Buffett earned 98% of his current net worth after turning 65 years old.", "symbols": ["AAPL", "AXP", "BAC", "BRK", "KO", "QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest", "tags": []}
{"id": 45400088, "time": "2025-05-14 04:32:23", "headline": "Earnings Scheduled For May 14, 2025", "summary": " ", "symbols": ["ADCT", "AEVA", "AFCG", "ALUR", "ARCO", "ATER", "AYTU", "BCDA", "BITF", "BLX", "BNGO", "BODI", "BOOT", "BRTX", "BYD", "BZAI", "CAAS", "CANG", "CCAP", "CDXS", "CELC", "CLBT", "CLSD", "CREX", "CSCO", "CSPI", "CSWC", "CTSO", "DAVA", "DERM", "DLO", "DRIO", "DT", "DXC", "DYAI", "ECO", "EGAN", "ELVA", "EPSN", "EWCZ", "FIHL", "FOSL", "FVR", "GAU", "GCTS", "GLBE", "GROV", "GWRS", "HWKN", "IBTA", "ICCC", "ICU", "INVZ", "IPM", "IREN", "ISSC", "ITRG", "JACK", "JOB", "KARO", "KITT", "KMDA", "KRNT", "LAR", "LAZR", "LDTC", "LIEN", "LIQT", "LOCL", "LPA", "LUCD", "LUXE", "LVLU", "MDXH", "MGRM", "MMYT", "NEXN", "NFE", "NOA", "NSYS", "NTWK", "NVGS", "NXT", "NYXH", "ONC", "ONCY", "PDSB", "PYPD", "RCAT", "RDCM", "REKR", "RELI", "RSKD", "SBLK", "SCPH", "SDHC", "SDOT", "SDST", "SGML", "SHIM", "SKYX", "SMTI", "SNAL", "SONY", "SOWG", "SPCB", "SPIR", "SPRU", "SPRY", "SRRK", "SSKN", "STE", "STN", "STRR", "TBN", "TLPH", "TMC", "TOI", "TSEM", "UHG", "USAR", "USIO", "XOS", "ZSPC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45400088/earnings-scheduled-for-may-14-2025", "tags": ["earnings"]}
{"id": 45400104, "time": "2025-05-14 04:34:28", "headline": "Elon Musk Says Mohammed Bin Salman And Trump Were 'Impressed' With Tesla Optimus As The Humanoid Robot Danced To 'YMCA'", "summary": "Tesla Inc. CEO Elon Musk revealed that both Saudi Crown Prince Mohammed bin Salman and former U.S. President Donald Trump were impressed by the company&#39;s Optimus humanoid robot during a demonstration in Riyadh where the robot danced to &#34;YMCA.&#34;", "symbols": ["TSLA"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/25/05/45400104/elon-musk-says-mohammed-bin-salman-and-trump-were-impressed-with-tesla-optimus-as-the-humanoid-robot-danced-to-ymca", "tags": ["management"]}
{"id": 45400462, "time": "2025-05-14 05:09:46", "headline": "The Wall Street Journal Reported Tuesday, Baidu To Start Testing Robotaxis in Switzerland by End-2025, Partnering With PostAuto; Turkey Robotaxi Tests Also Planned", "summary": "", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45400462/the-wall-street-journal-reported-tuesday-baidu-to-start-testing-robotaxis-in-switzerland-by-end-2025", "tags": []}
{"id": 45400599, "time": "2025-05-14 05:14:44", "headline": "'Only Reasonable Profits:' JD.com Takes Aim At Global Food Delivery Economics With Zero-Commission Model\u2014Revives Founder's '$0.35 Principle'", "summary": "Chinese e-commerce company, JD.com Inc. is shaking up China&#39;s food delivery market with its bold zero-commission model, while taking aim at the global meal delivery scene as well.", "symbols": ["DASH", "JD", "UBER"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/general/restaurants/25/05/45400599/only-reasonable-profits-jdcom-takes-aim-at-global-food-delivery-economics-with-zero-commission-modelrevives-founders-035-principle", "tags": []}
{"id": 45400617, "time": "2025-05-14 05:20:09", "headline": "Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["ABP", "ABSI", "AEO", "ALLT", "ALUR", "ASNS", "AUR", "AXDX", "DBVT", "DEVS", "ECG", "FNGR", "GRAL", "HWH", "LRHC", "LUCY", "PLRZ", "UBER", "WBUY", "XHLD", "XTKG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45400617/why-everus-construction-group-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 45400750, "time": "2025-05-14 05:29:44", "headline": "China Slams UK-US Trade Pact, Finds It 'Against' Its Interests: 'This Type Of Poison Pill Clause Is Actually Worse Than The Tariffs'", "summary": "The recent trade agreement between the\u00a0U.K.\u00a0and the\u00a0U.S.\u00a0has been met with disapproval from\u00a0China, potentially adding more complexity to London&#39;s ongoing efforts to rebuild its relations with Beijing.", "symbols": ["F", "GM", "STLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/05/45400750/china-slams-uk-us-trade-pact-finds-it-against-its-interests-this-type-of-poison-pill-clause-is-actually-worse-than-the-tariffs", "tags": ["contract"]}
{"id": 45400794, "time": "2025-05-14 05:34:51", "headline": "BlackRock Canada Declares May 2025 Cash Distributions for TSX- and Cboe-Listed Monthly iShares ETFs, Including XIU And  ETF XRB", "summary": "", "symbols": ["BLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45400794/blackrock-canada-declares-may-2025-cash-distributions-for-tsx-and-cboe-listed-monthly-ishares-etfs-i", "tags": []}
{"id": 45400798, "time": "2025-05-14 05:36:38", "headline": "Rocket Lab Completes Two Earth Return Missions in Two Months, Supports Varda Space's W-3 Capsule Recovery on May 14", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45400798/rocket-lab-completes-two-earth-return-missions-in-two-months-supports-varda-spaces-w-3-capsule-recov", "tags": []}
{"id": 45400804, "time": "2025-05-14 05:38:11", "headline": "Intuitive Machines Plans 'Higher-Margin Recurring Revenue Streams' By Putting Satellites Around The Moon\u2014Scores $18 Million NASA Task Order", "summary": "Astronautics company, Intuitive Machines Inc. (NASDAQ: LUNR), unveiled plans for its Near Space Network Services (NSNS) program, highlighting a strategic pivot toward recurring, high-margin revenue from lunar orbit infrastructure.", "symbols": ["GSAT", "IRDM", "LUNR"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/general/space/25/05/45400804/intuitive-machines-plans-higher-margin-recurring-revenue-streams-by-putting-satellites-around-the-moon-scores-18-million-nasa-task-order", "tags": ["earnings"]}
{"id": 45400944, "time": "2025-05-14 05:48:29", "headline": "As Nikki Haley Slams Trump's $400 Million Boeing Jet Gift From Qatar, Bill Ackman Cites National Security Implications: 'Only A Fool Would Not Accept This,' Says President", "summary": "President Donald Trump defended Qatar&#39;s offer of a Boeing Co. 747-8 jumbo jet valued at $400 million, dismissing critics and declaring that &#34;only a FOOL would not accept this gift on behalf of our Country.&#34;", "symbols": ["BA"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/news/25/05/45400944/as-nikki-haley-slams-trumps-400-million-boeing-jet-gift-from-qatar-bill-ackman-cites-national-security-implications-only-a-fool-would-not-accept-this-says-president", "tags": []}
{"id": 45401069, "time": "2025-05-14 05:59:49", "headline": "Solana Trades Higher Wednesday Morning \u2014 Is A $200 Breakout On The Horizon?", "summary": "Solana (CRYPTO: SOL) fell somewhat in the early hours of Wednesday, but not before reaching a nearly three-month high.\n\n\n\nWhat happened: The fifth-largest cryptocurrency by market capitalization soared to $184.72, the highest it has been since Feb. 18, before easing to around $180.", "symbols": ["SOLUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/05/45401069/solana-trades-in-the-green-wednesday-morning-should-you-brace-for-200", "tags": []}
{"id": 45401120, "time": "2025-05-14 06:01:11", "headline": "Ecolab Life Sciences Has Officially Opened Its New Us Bioprocessing Applications Laboratory In King Of Prussia, Pennsylvania", "summary": "", "symbols": ["ECL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401120/ecolab-life-sciences-has-officially-opened-its-new-us-bioprocessing-applications-laboratory-in-king", "tags": []}
{"id": 45401123, "time": "2025-05-14 06:01:45", "headline": "Boyd Group Services Q1 Adj. EPS $0.10 Down From $0.44 YoY, Sales $778.32M Miss $795.25M Estimate", "summary": "", "symbols": ["TSX:BYD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401123/boyd-group-services-q1-adj-eps-0-10-down-from-0-44-yoy-sales-778-32m-miss-795-25m-estimate", "tags": ["earnings"]}
{"id": 45401126, "time": "2025-05-14 06:02:11", "headline": "China Automotive Systems Q1 EPS $0.24 Down From $0.27 YoY, Sales $167.09M Up From $139.39M YoY", "summary": "", "symbols": ["CAAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401126/china-automotive-systems-q1-eps-0-24-down-from-0-27-yoy-sales-167-09m-up-from-139-39m-yoy", "tags": ["earnings"]}
{"id": 45401146, "time": "2025-05-14 06:03:04", "headline": "China Automotive Systems Affirms FY2025 Sales Guidance of $700.00M", "summary": "", "symbols": ["CAAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401146/china-automotive-systems-affirms-fy2025-sales-guidance-of-700-00m", "tags": ["guidance"]}
{"id": 45401148, "time": "2025-05-14 06:03:16", "headline": "European Wax Center Q1 Adj. EPS $0.13 Beats $0.05 Estimate, Sales $51.43M Beat $49.70M Estimate", "summary": "", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401148/european-wax-center-q1-adj-eps-0-13-beats-0-05-estimate-sales-51-43m-beat-49-70m-estimate", "tags": ["earnings"]}
{"id": 45401152, "time": "2025-05-14 06:04:13", "headline": "European Wax Center Affirms FY2025 Sales Guidance of $210.00M-$214.00M vs $211.88M Est", "summary": "", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401152/european-wax-center-affirms-fy2025-sales-guidance-of-210-00m-214-00m-vs-211-88m-est", "tags": ["guidance"]}
{"id": 45401153, "time": "2025-05-14 06:04:34", "headline": "Telus Announced A Strategic Partnership With GTCR To Support Last Week's Acquisition Of Workplace Options For Cash Of Approximately CAD500 Million ($350M), Net Of Assumed Debt Of Approximately CAD100 Million ($70M)", "summary": "", "symbols": ["TU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45401153/telus-announced-a-strategic-partnership-with-gtcr-to-support-last-weeks-acquisition-of-workplace-opt", "tags": ["contract"]}
{"id": 45401119, "time": "2025-05-14 06:01:09", "headline": "Bloomberg Reported Pony AI Is Said To Confidentially File For Hong Kong Listing", "summary": "", "symbols": ["PONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401119/bloomberg-reported-pony-ai-is-said-to-confidentially-file-for-hong-kong-listing", "tags": []}
{"id": 45401164, "time": "2025-05-14 06:05:25", "headline": "European Wax Center Q1 Net New Centers +1% To 1,062 Total Centers In 45 states, Same-store Sales +0.7%", "summary": "", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401164/european-wax-center-q1-net-new-centers-1-to-1-062-total-centers-in-45-states-same-store-sales-0-7", "tags": []}
{"id": 45401165, "time": "2025-05-14 06:05:28", "headline": "Tesla Gears Up To Restart Key Component Shipping From China For Cybercab, Semi Truck Production In US: Report", "summary": " ", "symbols": ["TSLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/tech/25/05/45401165/tesla-gears-up-to-restart-key-component-shipping-from-china-for-cybercab-semi-truck-production-in-us-report", "tags": []}
{"id": 45401210, "time": "2025-05-14 06:08:02", "headline": "LuxExperience Q3 Adj. EPS $0.06 Beats $(0.01) Estimate, Sales $255.01M Beat $246.70M Estimate", "summary": "", "symbols": ["LUXE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401210/luxexperience-q3-adj-eps-0-06-beats-0-01-estimate-sales-255-01m-beat-246-70m-estimate", "tags": ["earnings"]}
{"id": 45401453, "time": "2025-05-14 06:14:04", "headline": "Metagenomi Announced The Presentation Of Three Abstracts At The American Society Of Gene & Cell Therapy Annual Meeting", "summary": "", "symbols": ["MGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45401453/metagenomi-announced-the-presentation-of-three-abstracts-at-the-american-society-of-gene-cell-the", "tags": []}
{"id": 45401455, "time": "2025-05-14 06:14:24", "headline": "MakeMyTrip Q4 Adj. EPS $0.42 Beats $0.30 Estimate, Sales $261.19M Beat $255.93M Estimate", "summary": "", "symbols": ["MMYT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401455/makemytrip-q4-adj-eps-0-42-beats-0-30-estimate-sales-261-19m-beat-255-93m-estimate", "tags": ["earnings"]}
{"id": 45401636, "time": "2025-05-14 06:31:03", "headline": "Dynatrace Q4 Adj. EPS $0.33 Beats $0.30 Estimate, Sales $445.17M Beat $434.78M Estimate", "summary": "", "symbols": ["DT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401636/dynatrace-q4-adj-eps-0-33-beats-0-30-estimate-sales-445-17m-beat-434-78m-estimate", "tags": ["earnings"]}
{"id": 45401638, "time": "2025-05-14 06:31:19", "headline": "Howard Hughes Rises Nearly 3% In Pre-Market As Bill Ackman Exits From Universal Music Group's Board To Prioritize New Investments", "summary": "Non-Executive Director,\u00a0Bill Ackman, has stepped down from the Board of Directors of\u00a0Universal Music Group N.V.\u00a0(OTC: UMGNF). The decision comes in light of\u00a0new executive and board obligations\u00a0that Ackman has undertaken.", "symbols": ["BRK", "HHH", "UMGNF"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/05/45401638/howard-hughes-rises-nearly-3-in-pre-market-as-bill-ackman-exits-from-universal-music-groups-board-to-prioritize-new-investments", "tags": []}
{"id": 45401639, "time": "2025-05-14 06:31:26", "headline": "Red Cat Announced The Expansion Of Its Multi-domain Family Of Systems With A New Line Of Unmanned Surface Vessels", "summary": "", "symbols": ["RCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401639/red-cat-announced-the-expansion-of-its-multi-domain-family-of-systems-with-a-new-line-of-unmanned-su", "tags": []}
{"id": 45401648, "time": "2025-05-14 06:31:50", "headline": "Trimble Launched Trimble Forestry One, A Comprehensive Technology Platform Built To Connect And Streamline Forestry Operations", "summary": "", "symbols": ["TRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401648/trimble-launched-trimble-forestry-one-a-comprehensive-technology-platform-built-to-connect-and-strea", "tags": []}
{"id": 45401650, "time": "2025-05-14 06:32:05", "headline": "Dynatrace Sees Q1 Adj EPS $0.37-$0.38 vs $0.35 Est; Sees Sales $465.000M-$470.000M vs $454.51M Est", "summary": "", "symbols": ["DT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401650/dynatrace-sees-q1-adj-eps-0-37-0-38-vs-0-35-est-sees-sales-465-000m-470-000m-vs-454-51m-est", "tags": ["earnings"]}
{"id": 45401654, "time": "2025-05-14 06:32:18", "headline": "Dynatrace Sees FY2026 Adj EPS $1.56-$1.59 vs $1.54 Est; Sees Sales $1.950B-$1.965B vs $1.94B Est", "summary": "", "symbols": ["DT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401654/dynatrace-sees-fy2026-adj-eps-1-56-1-59-vs-1-54-est-sees-sales-1-950b-1-965b-vs-1-94b-est", "tags": ["earnings"]}
{"id": 45401659, "time": "2025-05-14 06:32:20", "headline": "DarioHealth Q1 Adj. EPS $(0.12), Inline, Sales $6.75M Miss $7.48M Estimate", "summary": "", "symbols": ["DRIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401659/dariohealth-q1-adj-eps-0-12-inline-sales-6-75m-miss-7-48m-estimate", "tags": ["earnings"]}
{"id": 45401670, "time": "2025-05-14 06:32:58", "headline": "The Board Of Directors Of Txnm Energy Announced The Transition Of Current Chief Executive Officer Pat Collawn To Executive Chair, Effective July 1, 2025", "summary": "", "symbols": ["TXNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401670/the-board-of-directors-of-txnm-energy-announced-the-transition-of-current-chief-executive-officer-pa", "tags": []}
{"id": 45401673, "time": "2025-05-14 06:33:39", "headline": "Franklin Street Properties Announced That Its Board Of Directors Has Initiated A Review Of Strategic Alternatives In Order To Explore Ways To Maximize Shareholder Value", "summary": "", "symbols": ["FSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401673/franklin-street-properties-announced-that-its-board-of-directors-has-initiated-a-review-of-strategic", "tags": []}
{"id": 45401674, "time": "2025-05-14 06:33:40", "headline": "Orezone Gold Q1 Adj. EPS $0.04 Up From $0.02 YoY, Sales $82.72M Up From $64.69M YoY", "summary": "", "symbols": ["TSX:ORE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401674/orezone-gold-q1-adj-eps-0-04-up-from-0-02-yoy-sales-82-72m-up-from-64-69m-yoy", "tags": ["earnings"]}
{"id": 45401675, "time": "2025-05-14 06:34:03", "headline": "Xenia Hotels Declares $0.14 Dividend, Adds $100M to Share Buyback Program", "summary": "", "symbols": ["XHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401675/xenia-hotels-declares-0-14-dividend-adds-100m-to-share-buyback-program", "tags": ["buyback", "dividend"]}
{"id": 45401678, "time": "2025-05-14 06:34:43", "headline": "Goldman Sachs, Barclays, JPM Walk Back US Recession Forecasts After 90-Day US-China Tariff Truce \u2014 Fewer Fed Cuts Expected In 2025", "summary": "\nMajor brokerages have reduced U.S. recession odds after tariff pause between U.S. and China. Goldman Sachs predicts 1% GDP growth and 3 Fed rate cuts. China holds firm against coercion.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/markets/25/05/45401678/goldman-sachs-barclays-jpm-walk-back-us-recession-forecasts-after-90-day-us-china-tariff-truce-fewer-fed-cuts-expected-in-2025", "tags": []}
{"id": 45401695, "time": "2025-05-14 06:37:10", "headline": "HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14", "summary": "", "symbols": ["ANNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401695/hc-wainwright-co-maintains-buy-on-annexon-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 45401702, "time": "2025-05-14 06:37:42", "headline": "Asia Markets Gain, Europe Dips, Dollar Pressured By Soft Inflation Data - Global Markets Today While US Slept", "summary": "US markets closed mixed, with S&amp;P 500 and Nasdaq up due to cooling inflation and US-China trade truce. Dow down on UnitedHealth shares drop.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/05/45401702/asia-markets-gain-europe-dips-oil-retreat-dollar-pressured-by-cooling-inflation-global-markets-today-while-us-slept", "tags": []}
{"id": 45401727, "time": "2025-05-14 06:40:53", "headline": "Trimble Unveils Forestry One To Connect And Streamline Forestry Operations", "summary": "", "symbols": ["TRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401727/trimble-unveils-forestry-one-to-connect-and-streamline-forestry-operations", "tags": []}
{"id": 45401856, "time": "2025-05-14 06:44:15", "headline": "HC Wainwright & Co. Maintains Buy on Blink Charging, Lowers Price Target to $5", "summary": "", "symbols": ["BLNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401856/hc-wainwright-co-maintains-buy-on-blink-charging-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45401868, "time": "2025-05-14 06:47:11", "headline": "Affimed Receives Nasdaq Delisting Notice; Trading To Be Suspended May 20", "summary": "", "symbols": ["AFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401868/affimed-receives-nasdaq-delisting-notice-trading-to-be-suspended-may-20", "tags": []}
{"id": 45401871, "time": "2025-05-14 06:48:58", "headline": "Needham Reiterates Buy on Cytokinetics, Maintains $72 Price Target", "summary": "", "symbols": ["CYTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401871/needham-reiterates-buy-on-cytokinetics-maintains-72-price-target", "tags": ["analyst_other"]}
{"id": 45401885, "time": "2025-05-14 06:50:46", "headline": "Kolibri Global Energy Q1 EPS $0.16 Beats $0.12 Estimate, Sales $16.37M Beat $14.77M Estimate", "summary": "", "symbols": ["KGEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401885/kolibri-global-energy-q1-eps-0-16-beats-0-12-estimate-sales-16-37m-beat-14-77m-estimate", "tags": ["earnings"]}
{"id": 45401890, "time": "2025-05-14 06:51:38", "headline": "Riskified Q1 Adj. EPS $0.03 Beats $0.01 Estimate, Sales $82.39M Beat $79.23M Estimate", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45401890/riskified-q1-adj-eps-0-03-beats-0-01-estimate-sales-82-39m-beat-79-23m-estimate", "tags": ["earnings"]}
{"id": 45401892, "time": "2025-05-14 06:52:20", "headline": "Riskified Affirms FY2025 Sales Guidance of $333.00M-$346.00M vs $339.97M Est", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401892/riskified-affirms-fy2025-sales-guidance-of-333-00m-346-00m-vs-339-97m-est", "tags": ["guidance"]}
{"id": 45401907, "time": "2025-05-14 06:53:33", "headline": "Northern Dynasty Minerals And Its 100%-owned U.S.-based Subsidiary Pebble Limited Partnership Have Informed The Court That They Do Not Object To A Motion From The Environmental Protection Agency And U.S. Army Corps Of Engineers To Hold The Litigation In Abeyance For A Further 30 Days", "summary": "", "symbols": ["NAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401907/northern-dynasty-minerals-and-its-100-owned-u-s-based-subsidiary-pebble-limited-partnership-have-inf", "tags": ["contract", "legal"]}
{"id": 45401923, "time": "2025-05-14 06:53:59", "headline": "CNBC Reported Pony.ai Reports First Robotaxi Fire, No Injuries", "summary": "", "symbols": ["PONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45401923/cnbc-reported-pony-ai-reports-first-robotaxi-fire-no-injuries", "tags": []}
{"id": 45402066, "time": "2025-05-14 06:55:45", "headline": "Needham Maintains Buy on On Holding, Raises Price Target to $62", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402066/needham-maintains-buy-on-on-holding-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 45402094, "time": "2025-05-14 06:57:05", "headline": "Global-e Online And Shopify Announces 3-Yr Strategic Partnership Agreement To Empower International Direct To Consumer E-Commerce On Shopify Platform", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402094/global-e-online-and-shopify-announces-3-yr-strategic-partnership-agreement-to-empower-international", "tags": ["contract"]}
{"id": 45402126, "time": "2025-05-14 06:59:00", "headline": "Mohammed Bin Salman Launches Saudi AI Firm 'Humain' Led By Ex-Aramco Digital CEO As Trump Hails 'Golden Era' With $600 Billion In US Deals", "summary": "Saudi Arabia launched Humain, a state-owned AI company led by Crown Prince Mohammed bin Salman with former Aramco Digital CEO Tareq Amin as CEO, coinciding with Trump&#39;s Middle East tour and a $600 billion investment commitment from Saudi Arabia to the US.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/tech/25/05/45402126/mohammed-bin-salman-launches-saudi-ai-firm-humain-led-by-ex-aramco-digital-ceo-as-trump-hails-golden-era-with-600-billion-in-us-deals", "tags": ["management"]}
{"id": 45402224, "time": "2025-05-14 07:00:23", "headline": "Short-Term Excess Cobalt Supply Masks Long-Term Trend, Study Says", "summary": " ", "symbols": ["CMCLF"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/news/guidance/25/05/45402224/short-term-excess-cobalt-supply-masks-long-term-trend-study-says", "tags": []}
{"id": 45402247, "time": "2025-05-14 07:00:24", "headline": "Bausch + Lomb Announced The U.S. Launch Of Zenlens Chroma Hoa Scleral Contact Lenses", "summary": "", "symbols": ["BLCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402247/bausch-lomb-announced-the-u-s-launch-of-zenlens-chroma-hoa-scleral-contact-lenses", "tags": []}
{"id": 45402253, "time": "2025-05-14 07:00:45", "headline": "Cellebrite DI Q1 Adj. EPS $0.10 Beats $0.08 Estimate, Sales $107.55M Miss $109.36M Estimate", "summary": "", "symbols": ["CLBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402253/cellebrite-di-q1-adj-eps-0-10-beats-0-08-estimate-sales-107-55m-miss-109-36m-estimate", "tags": ["earnings"]}
{"id": 45402265, "time": "2025-05-14 07:01:02", "headline": "PolyPid Q1 2025 EPS $(0.70) Beats $(0.80) Estimate", "summary": "", "symbols": ["PYPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402265/polypid-q1-2025-eps-0-70-beats-0-80-estimate", "tags": ["earnings"]}
{"id": 45402271, "time": "2025-05-14 07:01:04", "headline": "Innoviz Technologies Q1 EPS $(0.07) Beats $(0.27) Estimate, Sales $17.39M Beat $11.25M Estimate", "summary": "", "symbols": ["INVZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402271/innoviz-technologies-q1-eps-0-07-beats-0-27-estimate-sales-17-39m-beat-11-25m-estimate", "tags": ["earnings"]}
{"id": 45402275, "time": "2025-05-14 07:01:20", "headline": "Bitfarms Q1 GAAP EPS $(0.07) Misses $(0.02) Estimate, Sales $66.85M Miss $70.08M Estimate", "summary": "", "symbols": ["BITF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402275/bitfarms-q1-gaap-eps-0-07-misses-0-02-estimate-sales-66-85m-miss-70-08m-estimate", "tags": ["earnings"]}
{"id": 45402279, "time": "2025-05-14 07:01:33", "headline": "United Homes Gr Q1 EPS $0.31 Down From $0.44 YoY, Sales $87.00M Down From $100.84M YoY", "summary": "", "symbols": ["UHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402279/united-homes-gr-q1-eps-0-31-down-from-0-44-yoy-sales-87-00m-down-from-100-84m-yoy", "tags": ["earnings"]}
{"id": 45402280, "time": "2025-05-14 07:01:36", "headline": "Radcom Q1 Adj. EPS $0.25 Beats $0.20 Estimate, Sales $16.59M Beat $16.23M Estimate", "summary": "", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402280/radcom-q1-adj-eps-0-25-beats-0-20-estimate-sales-16-59m-beat-16-23m-estimate", "tags": ["earnings"]}
{"id": 45402281, "time": "2025-05-14 07:01:36", "headline": "Global E Online Q1 EPS $(0.11) Beats $(0.13) Estimate, Sales $189.90M Beat $187.87M Estimate", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402281/global-e-online-q1-eps-0-11-beats-0-13-estimate-sales-189-90m-beat-187-87m-estimate", "tags": ["earnings"]}
{"id": 45402283, "time": "2025-05-14 07:01:52", "headline": "Kamada Q1 EPS $0.07, Inline, Sales $44.02M Beat $42.23M Estimate", "summary": "", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402283/kamada-q1-eps-0-07-inline-sales-44-02m-beat-42-23m-estimate", "tags": ["earnings"]}
{"id": 45402285, "time": "2025-05-14 07:01:56", "headline": "Smith Douglas Homes Q1 EPS $0.30 Misses $0.31 Estimate, Sales $224.72M Beat $214.56M Estimate", "summary": "", "symbols": ["SDHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402285/smith-douglas-homes-q1-eps-0-30-misses-0-31-estimate-sales-224-72m-beat-214-56m-estimate", "tags": ["earnings"]}
{"id": 45402287, "time": "2025-05-14 07:01:58", "headline": "ARS Pharmaceuticals Q1 EPS $(0.35) Misses $(0.33) Estimate, Sales $7.97M Beat $7.48M Estimate", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402287/ars-pharmaceuticals-q1-eps-0-35-misses-0-33-estimate-sales-7-97m-beat-7-48m-estimate", "tags": ["earnings"]}
{"id": 45402291, "time": "2025-05-14 07:02:03", "headline": "KP Tissue Q1 EPS $0.17 Beats $0.09 Estimate, Sales $546.11M Beat $518.19M Estimate", "summary": "", "symbols": ["TSX:KPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402291/kp-tissue-q1-eps-0-17-beats-0-09-estimate-sales-546-11m-beat-518-19m-estimate", "tags": ["earnings"]}
{"id": 45402293, "time": "2025-05-14 07:02:12", "headline": "Kamada Affirms FY2025 Sales Guidance of $178.00M-$182.00M vs $179.90M Est", "summary": "", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402293/kamada-affirms-fy2025-sales-guidance-of-178-00m-182-00m-vs-179-90m-est", "tags": ["guidance"]}
{"id": 45402298, "time": "2025-05-14 07:02:15", "headline": "Needham Maintains Buy on Rigetti Computing, Lowers Price Target to $15", "summary": "", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402298/needham-maintains-buy-on-rigetti-computing-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 45402303, "time": "2025-05-14 07:02:20", "headline": "Telsey Advisory Group Maintains Outperform on Tapestry, Maintains $92 Price Target", "summary": "", "symbols": ["TPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402303/telsey-advisory-group-maintains-outperform-on-tapestry-maintains-92-price-target", "tags": ["analyst_other"]}
{"id": 45402306, "time": "2025-05-14 07:02:24", "headline": "Tower Semiconductor Q1 Adj. EPS $0.45 Beats $0.38 Estimate, Sales $358.17M Beat $358.15M Estimate", "summary": "", "symbols": ["TSEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402306/tower-semiconductor-q1-adj-eps-0-45-beats-0-38-estimate-sales-358-17m-beat-358-15m-estimate", "tags": ["earnings"]}
{"id": 45402308, "time": "2025-05-14 07:02:25", "headline": "Nasdaq Rises 300 Points Amid Surge In Nvidia Shares; Investor Sentiment Improves, Fear & Greed Index Remains In 'Greed' Zone", "summary": " ", "symbols": ["CSCO", "MMYT", "NVDA", "SONY", "UNH"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/05/45402308/nasdaq-rises-300-points-amid-surge-in-nvidia-shares-investor-sentiment-improves-fear-greed-index-remains-in-greed-zone", "tags": []}
{"id": 45402311, "time": "2025-05-14 07:02:28", "headline": "Cellebrite DI Lowers FY2025 Sales Guidance from $480.00M-$490.00M to $470.00M-$485.00M vs $484.17M Est", "summary": "", "symbols": ["CLBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402311/cellebrite-di-lowers-fy2025-sales-guidance-from-480-00m-490-00m-to-470-00m-485-00m-vs-484-17m-est", "tags": ["guidance"]}
{"id": 45402324, "time": "2025-05-14 07:02:39", "headline": "BioCryst Announces FDA Acceptance Of Its New Drug Application For Oral, Once Daily ORLADEYO In Hereditary Angioedema Patents Aged 2 To 11 Years", "summary": "", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402324/biocryst-announces-fda-acceptance-of-its-new-drug-application-for-oral-once-daily-orladeyo-in-heredi", "tags": ["fda"]}
{"id": 45402327, "time": "2025-05-14 07:02:42", "headline": "Cellebrite DI Sees Q2 Sales $110.000M-$116.000M vs $115.34M Est", "summary": "", "symbols": ["CLBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402327/cellebrite-di-sees-q2-sales-110-000m-116-000m-vs-115-34m-est", "tags": []}
{"id": 45402335, "time": "2025-05-14 07:02:45", "headline": "PolyPid Had Cash And Cash Equivalents And Short-term Deposits Of $8M, As of March 31, 2025, That Is Expected To Provide Cash Runway Into Q3 Of 2025", "summary": "", "symbols": ["PYPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45402335/polypid-had-cash-and-cash-equivalents-and-short-term-deposits-of-8m-as-of-march-31-2025-that-is-e", "tags": []}
{"id": 45402343, "time": "2025-05-14 07:02:52", "headline": "Chicago Atlantic BDC Q1 EPS $0.34, Inline", "summary": "", "symbols": ["LIEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402343/chicago-atlantic-bdc-q1-eps-0-34-inline", "tags": ["earnings"]}
{"id": 45402349, "time": "2025-05-14 07:03:01", "headline": "Innoviz Technologies Affirms FY2025 Sales Guidance of $50.00M-$60.00M vs $54.75M Est", "summary": "", "symbols": ["INVZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402349/innoviz-technologies-affirms-fy2025-sales-guidance-of-50-00m-60-00m-vs-54-75m-est", "tags": ["guidance"]}
{"id": 45402352, "time": "2025-05-14 07:03:17", "headline": "American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday", "summary": " ", "symbols": ["AEO", "ALC", "CSCO", "MMYT", "SONY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/05/45402352/american-eagle-cisco-systems-and-3-stocks-to-watch-heading-into-wednesday", "tags": []}
{"id": 45402362, "time": "2025-05-14 07:03:34", "headline": "Global E Online Sees Q2 Sales $204.000M-$211.000M vs $209.63M Est", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402362/global-e-online-sees-q2-sales-204-000m-211-000m-vs-209-63m-est", "tags": []}
{"id": 45402370, "time": "2025-05-14 07:03:43", "headline": "LeddarTech Launches LeddarSim Simulation Platform To Bridge Gap Between Virtual Testing And Real-World Deployment In ADAS And Autonomous Driving", "summary": "", "symbols": ["LDTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402370/leddartech-launches-leddarsim-simulation-platform-to-bridge-gap-between-virtual-testing-and-real-wor", "tags": []}
{"id": 45402372, "time": "2025-05-14 07:03:46", "headline": "Identiv Introduces A New Nfc-based Anti-counterfeiting Smart Packaging Solution For Luxury Wine Producers And Collectors In Collaboration With Zatap And Genuine-analytics", "summary": "", "symbols": ["INVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402372/identiv-introduces-a-new-nfc-based-anti-counterfeiting-smart-packaging-solution-for-luxury-wine-prod", "tags": []}
{"id": 45402375, "time": "2025-05-14 07:04:00", "headline": "Global E Online Affirms FY2025 Sales Guidance of $917.00M-$967.00M vs $931.39M Est", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402375/global-e-online-affirms-fy2025-sales-guidance-of-917-00m-967-00m-vs-931-39m-est", "tags": ["guidance"]}
{"id": 45402377, "time": "2025-05-14 07:04:07", "headline": "Tower Semiconductor Sees Q2 Sales $353.400M-$390.600M vs $371.26M Est", "summary": "", "symbols": ["TSEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402377/tower-semiconductor-sees-q2-sales-353-400m-390-600m-vs-371-26m-est", "tags": []}
{"id": 45402378, "time": "2025-05-14 07:04:08", "headline": "Telsey Advisory Group Maintains Outperform on On Holding, Maintains $65 Price Target", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402378/telsey-advisory-group-maintains-outperform-on-on-holding-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 45402381, "time": "2025-05-14 07:04:14", "headline": "Centessa Pharmaceuticals Q1 EPS $(0.20) Beats $(0.37) Estimate, Sales $15.00M", "summary": "", "symbols": ["CNTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402381/centessa-pharmaceuticals-q1-eps-0-20-beats-0-37-estimate-sales-15-00m", "tags": ["earnings"]}
{"id": 45402384, "time": "2025-05-14 07:04:24", "headline": "Boralex Q1 EPS $0.29 Misses $0.37 Estimate, Sales $226.00M Miss $242.70M Estimate", "summary": "", "symbols": ["TSX:BLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402384/boralex-q1-eps-0-29-misses-0-37-estimate-sales-226-00m-miss-242-70m-estimate", "tags": ["earnings"]}
{"id": 45402399, "time": "2025-05-14 07:04:56", "headline": "Pasithea Therapeutics Initiates Phase 1/1B Study Of PAS-004 In Adult NF1 Patients, First Patient Expected To Be Dosed In Q2 2025", "summary": "", "symbols": ["KTTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45402399/pasithea-therapeutics-initiates-phase-11b-study-of-pas-004-in-adult-nf1-patients-first-patient-ex", "tags": ["fda"]}
{"id": 45402400, "time": "2025-05-14 07:04:57", "headline": "Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases", "summary": "", "symbols": ["NVO", "SEPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402400/septerna-and-novo-nordisk-to-collaborate-on-oral-small-molecule-medicines-for-obesity-and-other-card", "tags": []}
{"id": 45402402, "time": "2025-05-14 07:05:02", "headline": "LeddarTech Holdings Q2 EPS $(0.42) Misses $(0.39) Estimate", "summary": "", "symbols": ["LDTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402402/leddartech-holdings-q2-eps-0-42-misses-0-39-estimate", "tags": ["earnings"]}
{"id": 45402412, "time": "2025-05-14 07:05:15", "headline": "Needham Reiterates Buy on Silicon Laboratories, Maintains $150 Price Target", "summary": "", "symbols": ["SLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402412/needham-reiterates-buy-on-silicon-laboratories-maintains-150-price-target", "tags": ["analyst_other"]}
{"id": 45402430, "time": "2025-05-14 07:05:46", "headline": "Telsey Advisory Group Maintains Market Perform on a.k.a. Brands Holding, Raises Price Target to $10", "summary": "", "symbols": ["AKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402430/telsey-advisory-group-maintains-market-perform-on-a-k-a-brands-holding-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 45402433, "time": "2025-05-14 07:05:52", "headline": "Invivyd Urges FDA To Reassess COVID-19 Vaccine Efficacy In Seropositive Populations And Prioritize Monoclonal Antibodies For Endemic-Era Prevention", "summary": "", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402433/invivyd-urges-fda-to-reassess-covid-19-vaccine-efficacy-in-seropositive-populations-and-prioritize-m", "tags": ["fda"]}
{"id": 45402435, "time": "2025-05-14 07:06:03", "headline": "Sanara MedTech Q1 EPS $(0.41) Beats $(0.48) Estimate, Sales $23.43M Inline", "summary": "", "symbols": ["SMTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402435/sanara-medtech-q1-eps-0-41-beats-0-48-estimate-sales-23-43m-inline", "tags": ["earnings"]}
{"id": 45402437, "time": "2025-05-14 07:06:18", "headline": "Tilray Subsidiary High Park Launches XMG Atomic Sours Line Of Cannabis Beverages And Gummies With 'Nostalgic Sour Flavours'", "summary": "", "symbols": ["TLRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402437/tilray-subsidiary-high-park-launches-xmg-atomic-sours-line-of-cannabis-beverages-and-gummies-with-no", "tags": []}
{"id": 45402446, "time": "2025-05-14 07:06:57", "headline": "ScaleReady, In Collaboration With Wilson Wolf Manufacturing, Bio-Techne And CellReady Announced Three G-rex Grants That Have Been Awarded To Faculty Members At The University Of Southern California And The Children's Hospital Of Los Angeles. The Funding Totaling $1.025M Will Support The Translation Of Various Cell And Gene Therapy Initiatives Into The Clinic", "summary": "", "symbols": ["TECH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402446/scaleready-in-collaboration-with-wilson-wolf-manufacturing-bio-techne-and-cellready-announced-three", "tags": ["contract"]}
{"id": 45402455, "time": "2025-05-14 07:07:14", "headline": "Editas Medicine Unveils New In Vivo Data Highlighting Potential of Editas' Gene Upregulation Strategy In HSCs At American Society of Gene and Cell Therapy Annual Meeting", "summary": "", "symbols": ["EDIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402455/editas-medicine-unveils-new-in-vivo-data-highlighting-potential-of-editas-gene-upregulation-strategy", "tags": []}
{"id": 45402487, "time": "2025-05-14 07:07:45", "headline": "Aeva Inks Strategic Collaboration With Global Tech Affiliate, Secures Up To $50M Investment Including Equity Stake", "summary": "", "symbols": ["AVEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402487/aeva-inks-strategic-collaboration-with-global-tech-affiliate-secures-up-to-50m-investment-including", "tags": []}
{"id": 45402488, "time": "2025-05-14 07:07:47", "headline": "Verve Therapeutics Q1 EPS $(0.35) Versus $(0.59) YoY, Sales $32.98M", "summary": "", "symbols": ["VERV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402488/verve-therapeutics-q1-eps-0-35-versus-0-59-yoy-sales-32-98m", "tags": ["earnings"]}
{"id": 45402497, "time": "2025-05-14 07:08:18", "headline": "Needham Maintains Buy on Camtek, Lowers Price Target to $80", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402497/needham-maintains-buy-on-camtek-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 45402499, "time": "2025-05-14 07:08:22", "headline": "Bruker And 10x Genomics Settle Patent Disputes And Enter Global Cross-License Agreement, Dismissing All Ongoing Litigations", "summary": "", "symbols": ["BRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402499/bruker-and-10x-genomics-settle-patent-disputes-and-enter-global-cross-license-agreement-dismissing-a", "tags": ["contract"]}
{"id": 45402502, "time": "2025-05-14 07:08:59", "headline": "Toyota Adds 20th Electrified Model With 2026 C-HR BEV: High Power, Long Range, Striking Looks", "summary": "", "symbols": ["TM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402502/toyota-adds-20th-electrified-model-with-2026-c-hr-bev-high-power-long-range-striking-looks", "tags": []}
{"id": 45402504, "time": "2025-05-14 07:09:07", "headline": "Telsey Advisory Group Maintains Market Perform on VF, Lowers Price Target to $17", "summary": "", "symbols": ["VFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402504/telsey-advisory-group-maintains-market-perform-on-vf-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 45402512, "time": "2025-05-14 07:09:49", "headline": "CalciMedica Q1 EPS $(0.36) Misses $(0.31) Estimate", "summary": "", "symbols": ["CALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402512/calcimedica-q1-eps-0-36-misses-0-31-estimate", "tags": ["earnings"]}
{"id": 45402513, "time": "2025-05-14 07:09:49", "headline": "Aeluma to Showcase Breakthrough AI and Quantum Tech at Key Semiconductor Conferences", "summary": "", "symbols": ["ALMU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402513/aeluma-to-showcase-breakthrough-ai-and-quantum-tech-at-key-semiconductor-conferences", "tags": []}
{"id": 45402517, "time": "2025-05-14 07:09:58", "headline": "Radcom Raises FY2025 Sales Guidance from $69.20M to $71.10M vs $68.75M Est", "summary": "", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402517/radcom-raises-fy2025-sales-guidance-from-69-20m-to-71-10m-vs-68-75m-est", "tags": ["guidance"]}
{"id": 45402525, "time": "2025-05-14 07:10:09", "headline": "Mercury Launches ROCK3 Mission Computer To Power AI, 5G-Enabled Military And Urban Air Platforms", "summary": "", "symbols": ["MRCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402525/mercury-launches-rock3-mission-computer-to-power-ai-5g-enabled-military-and-urban-air-platforms", "tags": []}
{"id": 45402537, "time": "2025-05-14 07:10:30", "headline": "Foghorn Therapeutics Q1 EPS $(0.30) Beats $(0.31) Estimate, Sales $5.95M Beat $5.82M Estimate", "summary": "", "symbols": ["FHTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402537/foghorn-therapeutics-q1-eps-0-30-beats-0-31-estimate-sales-5-95m-beat-5-82m-estimate", "tags": ["earnings"]}
{"id": 45402550, "time": "2025-05-14 07:10:42", "headline": "Endava And AlixPartners Form Strategic Partnership To Deliver End-To-End Technology-Driven Solutions And Accelerate Digital Transformation Globally", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402550/endava-and-alixpartners-form-strategic-partnership-to-deliver-end-to-end-technology-driven-solutions", "tags": ["contract"]}
{"id": 45402558, "time": "2025-05-14 07:11:13", "headline": "Live Nation To Anchor New 5,300-Seat Venue at Atlanta's $5B Centennial Yards District", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402558/live-nation-to-anchor-new-5-300-seat-venue-at-atlantas-5b-centennial-yards-district", "tags": []}
{"id": 45402567, "time": "2025-05-14 07:11:46", "headline": "Scholar Rock Holding Q1 EPS $(0.67) Misses $(0.65) Estimate", "summary": "", "symbols": ["SRRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402567/scholar-rock-holding-q1-eps-0-67-misses-0-65-estimate", "tags": ["earnings"]}
{"id": 45402672, "time": "2025-05-14 07:12:05", "headline": "Benchmark Reiterates Buy on Silicon Laboratories, Maintains $160 Price Target", "summary": "", "symbols": ["SLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402672/benchmark-reiterates-buy-on-silicon-laboratories-maintains-160-price-target", "tags": ["analyst_other"]}
{"id": 45402677, "time": "2025-05-14 07:12:12", "headline": "Climb Bio Q1 EPS $(0.31) Misses $(0.15) Estimate", "summary": "", "symbols": ["CLYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402677/climb-bio-q1-eps-0-31-misses-0-15-estimate", "tags": ["earnings"]}
{"id": 45402691, "time": "2025-05-14 07:13:14", "headline": "Milestone Pharmaceuticals Q1 EPS $(0.31) Misses $(0.18) Estimate", "summary": "", "symbols": ["MIST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402691/milestone-pharmaceuticals-q1-eps-0-31-misses-0-18-estimate", "tags": ["earnings"]}
{"id": 45402713, "time": "2025-05-14 07:14:38", "headline": "FDA Accepts Biologics License Application For Mucopolysaccharidosis II Treatment", "summary": "", "symbols": [], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402713/fda-accepts-biologics-license-application-for-mucopolysaccharidosis-ii-treatment", "tags": ["fda"]}
{"id": 45402723, "time": "2025-05-14 07:15:07", "headline": "Needham Reiterates Hold on Under Armourto Hold", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402723/needham-reiterates-hold-on-under-armourto-hold", "tags": ["analyst_other"]}
{"id": 45402727, "time": "2025-05-14 07:15:14", "headline": "Market-Moving News for May 14th", "summary": "", "symbols": ["LUCY", "SEPN", "SMCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45402727/market-moving-news-for-may-14th", "tags": []}
{"id": 45402732, "time": "2025-05-14 07:15:37", "headline": "LeddarTech Holdings Q2 Sales $238.91K Vs $$122.10K YoY", "summary": "", "symbols": ["LDTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402732/leddartech-holdings-q2-sales-238-91k-vs-122-10k-yoy", "tags": []}
{"id": 45402738, "time": "2025-05-14 07:16:42", "headline": "Needham Reiterates Hold on Perion Networkto Hold", "summary": "", "symbols": ["PERI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402738/needham-reiterates-hold-on-perion-networkto-hold", "tags": ["analyst_other"]}
{"id": 45402739, "time": "2025-05-14 07:16:42", "headline": "Rosenblatt Maintains Buy on Coinbase Global, Raises Price Target to $300", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402739/rosenblatt-maintains-buy-on-coinbase-global-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 45402740, "time": "2025-05-14 07:16:43", "headline": "Kornit Digital Q1 Adj. EPS $0.01 Beats $(0.04) Estimate, Sales $46.46M Miss $47.36M Estimate", "summary": "", "symbols": ["KRNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402740/kornit-digital-q1-adj-eps-0-01-beats-0-04-estimate-sales-46-46m-miss-47-36m-estimate", "tags": ["earnings"]}
{"id": 45402745, "time": "2025-05-14 07:17:18", "headline": "Unicycive Therapeutics Q1 EPS $(0.05) Beats $(0.07) Estimate", "summary": "", "symbols": ["UNCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402745/unicycive-therapeutics-q1-eps-0-05-beats-0-07-estimate", "tags": ["earnings"]}
{"id": 45402746, "time": "2025-05-14 07:17:28", "headline": "Kornit Digital Sees Q2 Sales $49.000M-$55.000M vs $52.74M Est", "summary": "", "symbols": ["KRNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402746/kornit-digital-sees-q2-sales-49-000m-55-000m-vs-52-74m-est", "tags": []}
{"id": 45402762, "time": "2025-05-14 07:18:52", "headline": "Bitcoin Steady As Ethereum, XRP, Dogecoin Climb On Wednesday Morning", "summary": "Major cryptocurrencies are slightly up on early Wednesday morning, with Bitcoin holding steady and altcoins like Ethereum, XRP, Dogecoin and Solana pushing higher.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45402762/bitcoin-steady-as-ethereum-xrp-dogecoin-climb-on-wednesday-morning", "tags": []}
{"id": 45402763, "time": "2025-05-14 07:19:00", "headline": "Local Bounti Q1 2025 GAAP EPS $(4.32) Down From $(2.89) YoY, Sales $11.605M Beat $11.300M Estimate", "summary": "", "symbols": ["LOCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402763/local-bounti-q1-2025-gaap-eps-4-32-down-from-2-89-yoy-sales-11-605m-beat-11-300m-estimate", "tags": ["earnings"]}
{"id": 45402774, "time": "2025-05-14 07:19:33", "headline": "Local Bounti Sees Q2 Sales $12.000M-$12.500M vs $12.65M Est", "summary": "", "symbols": ["LOCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402774/local-bounti-sees-q2-sales-12-000m-12-500m-vs-12-65m-est", "tags": []}
{"id": 45402775, "time": "2025-05-14 07:19:36", "headline": "Endava Q3 Adj. EPS $0.43 Beats $0.31 Estimate, Sales $245.25M Beat $197.84M Estimate", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45402775/endava-q3-adj-eps-0-43-beats-0-31-estimate-sales-245-25m-beat-197-84m-estimate", "tags": ["earnings"]}
{"id": 45402789, "time": "2025-05-14 07:20:50", "headline": "TD Securities Maintains Buy on Wingstop, Raises Price Target to $330", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402789/td-securities-maintains-buy-on-wingstop-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 45402790, "time": "2025-05-14 07:20:53", "headline": "Endava Sees Q4 Adj EPS $0.28-$0.30 vs $0.34 Est; Sees Sales $234.128M-$236.645M vs $202.55M Est", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402790/endava-sees-q4-adj-eps-0-28-0-30-vs-0-34-est-sees-sales-234-128m-236-645m-vs-202-55m-est", "tags": ["earnings"]}
{"id": 45402795, "time": "2025-05-14 07:22:09", "headline": "Top 3 Materials Stocks That Could Blast Off This Month", "summary": " ", "symbols": ["ACNT", "ITP", "TSE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45402795/top-3-materials-stocks-that-could-blast-off-this-month", "tags": []}
{"id": 45402833, "time": "2025-05-14 07:23:49", "headline": "Needham Reiterates Hold on 3D Systo Hold", "summary": "", "symbols": ["DDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402833/needham-reiterates-hold-on-3d-systo-hold", "tags": ["analyst_other"]}
{"id": 45402837, "time": "2025-05-14 07:24:58", "headline": "Endava Lowers FY2025 Adj EPS Guidance from $1.54-$1.58 to $1.40-$1.42; Lowers FY2025 Sales Guidance from $1.02B-$1.02B to $971.13M-$973.64M", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402837/endava-lowers-fy2025-adj-eps-guidance-from-1-54-1-58-to-1-40-1-42-lowers-fy2025-sales-guidance-from", "tags": ["earnings", "guidance"]}
{"id": 45402979, "time": "2025-05-14 07:28:59", "headline": "Needham Reiterates Buy on Alcon, Maintains $110 Price Target", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45402979/needham-reiterates-buy-on-alcon-maintains-110-price-target", "tags": ["analyst_other"]}
{"id": 45403040, "time": "2025-05-14 07:30:21", "headline": "Jeff Bezos Became A Billionaire After Taking This Leap Of Faith: Would You Have The Stomach For His 'Regret-Minimization' Strategy?", "summary": "Jeff Bezos left a secure job in 1994 to start Amazon after seeing the potential of the internet. Within 2 years, he became a billionaire and is now the 2nd richest person in the world.", "symbols": ["AMZN"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/news/25/05/45403040/jeff-bezos-became-a-billionaire-after-taking-this-leap-of-faith-would-you-have-the-stomach-for-his-regret-minimization-strategy", "tags": []}
{"id": 45403048, "time": "2025-05-14 07:30:41", "headline": "Jefferies Maintains Buy on Danaos, Raises Price Target to $105", "summary": "", "symbols": ["DAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403048/jefferies-maintains-buy-on-danaos-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 45403073, "time": "2025-05-14 07:31:55", "headline": "Needham Reiterates Hold on Fate Therapeuticsto Hold", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403073/needham-reiterates-hold-on-fate-therapeuticsto-hold", "tags": ["analyst_other"]}
{"id": 45403076, "time": "2025-05-14 07:32:00", "headline": "Plus Therapeutics: REYOBIQ Shows Clinical Benefit And Safety In ReSPECT-LM Clinical Trial For Patients With Leptomeningeal Metastases", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403076/plus-therapeutics-reyobiq-shows-clinical-benefit-and-safety-in-respect-lm-clinical-trial-for-patient", "tags": ["fda"]}
{"id": 45403078, "time": "2025-05-14 07:32:06", "headline": "Arcos Dorados Holdings Q1 EPS $0.07 Misses $0.13 Estimate, Sales $1.08B Beat $1.05B Estimate", "summary": "", "symbols": ["ARCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403078/arcos-dorados-holdings-q1-eps-0-07-misses-0-13-estimate-sales-1-08b-beat-1-05b-estimate", "tags": ["earnings"]}
{"id": 45403082, "time": "2025-05-14 07:32:15", "headline": "Quoin Reports Early Data for Rare Skin Disease Treatment With No Adverse Events", "summary": "", "symbols": ["QNRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403082/quoin-reports-early-data-for-rare-skin-disease-treatment-with-no-adverse-events", "tags": []}
{"id": 45403092, "time": "2025-05-14 07:32:17", "headline": "PDS Biotechnology Q1 EPS $(0.21) Beats $(0.25) Estimate", "summary": "", "symbols": ["PDSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403092/pds-biotechnology-q1-eps-0-21-beats-0-25-estimate", "tags": ["earnings"]}
{"id": 45403098, "time": "2025-05-14 07:33:15", "headline": "Abeona Therapeutics And Lurie Children's Open Center For ZEVASKYNTM Gene Therapy To Treat Wounds Associated With Recessive Dystrophic Epidermolysis Bullosa", "summary": "", "symbols": ["ABEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45403098/abeona-therapeutics-and-lurie-childrens-open-center-for-zevaskyntm-gene-therapy-to-treat-wounds-a", "tags": []}
{"id": 45403099, "time": "2025-05-14 07:33:19", "headline": "Owens Corning Board Approves New Share Repurchase Authorization For Up To 12M Shares", "summary": "", "symbols": ["OC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403099/owens-corning-board-approves-new-share-repurchase-authorization-for-up-to-12m-shares", "tags": ["buyback"]}
{"id": 45403100, "time": "2025-05-14 07:33:22", "headline": "'Bullish For Nvidia, Tesla, Palantir, Microsoft, Alphabet, Amazon:' AI 'Revolution Is Coming' To The Saudi Kingdom, Says Wedbush's Dan Ives", "summary": "Daniel Ives praised the upcoming &#39;AI Revolution&#39; in Saudi Arabia and the Middle East after the U.S.-Saudi Investment Forum on Tuesday.", "symbols": ["AMZN", "GOOG", "GOOGL", "MSFT", "PLTR", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/government/regulations/25/05/45403100/bullish-for-nvidia-tesla-palantir-microsoft-alphabet-amazon-ai-revolution-is-coming-to-the-saudi-kingdom-says-wedbushs-dan-ives", "tags": []}
{"id": 45403102, "time": "2025-05-14 07:33:34", "headline": "Chardan Capital Maintains Buy on MeiraGTx Hldgs, Lowers Price Target to $35", "summary": "", "symbols": ["MGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403102/chardan-capital-maintains-buy-on-meiragtx-hldgs-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 45403108, "time": "2025-05-14 07:33:59", "headline": "Pony.ai Co-Founders Extend Lock-Up on Nearly 23% of Shares, Signaling Long-Term Commitment", "summary": "", "symbols": ["PONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403108/pony-ai-co-founders-extend-lock-up-on-nearly-23-of-shares-signaling-long-term-commitment", "tags": []}
{"id": 45403122, "time": "2025-05-14 07:35:14", "headline": "Inozyme Pharma Q1 EPS $(0.44) Misses $(0.41) Estimate", "summary": "", "symbols": ["INZY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403122/inozyme-pharma-q1-eps-0-44-misses-0-41-estimate", "tags": ["earnings"]}
{"id": 45403123, "time": "2025-05-14 07:35:30", "headline": "Nexxen International Q1 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $78.33M Beat $76.60M Estimate", "summary": "", "symbols": ["NEXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403123/nexxen-international-q1-adj-eps-0-16-beats-0-05-estimate-sales-78-33m-beat-76-60m-estimate", "tags": ["earnings"]}
{"id": 45403138, "time": "2025-05-14 07:36:15", "headline": "Needham Reiterates Buy on Absci, Maintains $9 Price Target", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403138/needham-reiterates-buy-on-absci-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 45403139, "time": "2025-05-14 07:36:28", "headline": "Arbutus Biopharma Q1 EPS $(0.13) Misses $(0.10) Estimate, Sales $1.76M Miss $1.78M Estimate", "summary": "", "symbols": ["ABUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403139/arbutus-biopharma-q1-eps-0-13-misses-0-10-estimate-sales-1-76m-miss-1-78m-estimate", "tags": ["earnings"]}
{"id": 45403181, "time": "2025-05-14 07:37:56", "headline": "AFC Gamma Q1 Adj. EPS $0.21 Misses $0.25 Estimate", "summary": "", "symbols": ["AFCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403181/afc-gamma-q1-adj-eps-0-21-misses-0-25-estimate", "tags": ["earnings"]}
{"id": 45403183, "time": "2025-05-14 07:38:29", "headline": "Nexxen International Affirms FY2025 Contribution ex-TAC of approximately $380 million", "summary": "", "symbols": ["NEXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403183/nexxen-international-affirms-fy2025-contribution-ex-tac-of-approximately-380-million", "tags": []}
{"id": 45403184, "time": "2025-05-14 07:38:35", "headline": "Gain Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate", "summary": "", "symbols": ["GANX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403184/gain-therapeutics-q1-eps-0-16-beats-0-18-estimate", "tags": ["earnings"]}
{"id": 45403187, "time": "2025-05-14 07:38:41", "headline": "3 Key Drivers Behind Ethereum's 65% Rally: Bernstein", "summary": "Ethereum (CRYPTO: ETH) has surged 65% over the past month, sharply outperforming other digital assets after a prolonged stretch of underperformance relative to Bitcoin.", "symbols": ["BTCUSD", "ETHUSD", "HOOD", "SOLUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/25/05/45403187/bernstein-identifies-three-key-drivers-behind-ethereums-recent-rally", "tags": []}
{"id": 45403196, "time": "2025-05-14 07:39:03", "headline": "Needham Upgrades Establishment Labs Hldgs to Buy, Announces $48 Price Target", "summary": "", "symbols": ["ESTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403196/needham-upgrades-establishment-labs-hldgs-to-buy-announces-48-price-target", "tags": ["analyst_up"]}
{"id": 45403213, "time": "2025-05-14 07:40:29", "headline": "LAVA Therapeutics Q1 EPS $(0.13) Beats $(0.38) Estimate", "summary": "", "symbols": ["LVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403213/lava-therapeutics-q1-eps-0-13-beats-0-38-estimate", "tags": ["earnings"]}
{"id": 45403218, "time": "2025-05-14 07:41:39", "headline": "Needham Reiterates Buy on Pixelworks, Maintains $1.5 Price Target", "summary": "", "symbols": ["PXLW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403218/needham-reiterates-buy-on-pixelworks-maintains-1-5-price-target", "tags": ["analyst_other"]}
{"id": 45403219, "time": "2025-05-14 07:41:42", "headline": "Telesat And Arab Satellite Communications Organization Announced The Companies Have Successfully Negotiated And Signed A Term Sheet For A Multi-Gbps Capacity Pool Of Telesat Lightspeed Connectivity Services", "summary": "", "symbols": ["TSAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403219/telesat-and-arab-satellite-communications-organization-announced-the-companies-have-successfully-neg", "tags": []}
{"id": 45403345, "time": "2025-05-14 07:42:48", "headline": "Nissan To Cut 20,000 Jobs, Shut 7 Plants Globally In Major Restructuring After $4.5 Billion Annual Loss", "summary": "Nissan announced major steps to reconfigure global operations, including cutting thousands of jobs and closing half of production plants to stabilize finances.", "symbols": ["MSFT", "NSANF", "NSANY"], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/markets/asia/25/05/45403345/nissan-to-cut-20000-jobs-shut-7-plants-globally-in-major-restructuring-after-4-5-billion-annual-loss", "tags": []}
{"id": 45403356, "time": "2025-05-14 07:43:51", "headline": "Jefferies Upgrades PVH to Buy, Raises Price Target to $105", "summary": "", "symbols": ["PVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403356/jefferies-upgrades-pvh-to-buy-raises-price-target-to-105", "tags": ["analyst_up", "price_target_up"]}
{"id": 45403359, "time": "2025-05-14 07:44:38", "headline": "Needham Reiterates Hold on Airbnbto Hold", "summary": "", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403359/needham-reiterates-hold-on-airbnbto-hold", "tags": ["analyst_other"]}
{"id": 45403369, "time": "2025-05-14 07:46:27", "headline": "Jacobs Was Selected As The Integrated Delivery Partner For Marinus Link, An Approximately 214 Mile (345-kilometer) Undersea And Underground High-voltage Direct Current (Hvdc) Electricity And Data Interconnector", "summary": "", "symbols": ["J"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403369/jacobs-was-selected-as-the-integrated-delivery-partner-for-marinus-link-an-approximately-214-mile-34", "tags": []}
{"id": 45403371, "time": "2025-05-14 07:46:47", "headline": "Jefferies Downgrades Rivian Automotive to Hold, Maintains Price Target to $16", "summary": "", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403371/jefferies-downgrades-rivian-automotive-to-hold-maintains-price-target-to-16", "tags": ["analyst_down", "analyst_other"]}
{"id": 45403379, "time": "2025-05-14 07:47:37", "headline": "ADC Therapeutics Presents Data From LOTIS-7 Phase 1B Clinical Trial Evaluating ZYNLONTA In Combination With Glofitamab In Patients With r/r DLBCL", "summary": "", "symbols": ["ADCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403379/adc-therapeutics-presents-data-from-lotis-7-phase-1b-clinical-trial-evaluating-zynlonta-in-combinati", "tags": ["fda"]}
{"id": 45403427, "time": "2025-05-14 07:50:43", "headline": "EXCLUSIVE: Channel Therapeutics Tells Benzinga Co. Announces Results For The Treatment Of Eye Pain Using NaV1.7 Inhibitor In Multiple Preclinical In Vivo Models", "summary": "", "symbols": ["CHRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403427/exclusive-channel-therapeutics-tells-benzinga-co-announces-results-for-the-treatment-of-eye-pain-usi", "tags": []}
{"id": 45403447, "time": "2025-05-14 07:51:28", "headline": "MediPharm Labs Q1 Sales $7.53M Miss $10.54M Estimate", "summary": "", "symbols": ["MEDIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403447/medipharm-labs-q1-sales-7-53m-miss-10-54m-estimate", "tags": []}
{"id": 45403452, "time": "2025-05-14 07:51:34", "headline": "Brian Chesky Shares Promo For Airbnb's Biggest Change In Decades, Sam Altman Calls Him 'The Most Auteur Founder Of This Generation'", "summary": "Sam Altman praised Airbnb CEO Chesky&#39;s individuality and influence after Airbnb&#39;s major update on Tuesday which included the addition of new services and experiences.", "symbols": [], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/tech/25/05/45403452/brian-chesky-shares-promo-for-airbnbs-biggest-change-in-decades-sam-altman-calls-him-the-most-auteur-founder-of-this-generation", "tags": ["management"]}
{"id": 45403467, "time": "2025-05-14 07:52:15", "headline": "Avis Budget Announced That Its Wholly-owned Subsidiaries Intend, Subject To Market And Other Customary Conditions, To Offer $500M Aggregate Principal Amount Of Senior Notes Due 2032 In A Private Offering", "summary": "", "symbols": ["CAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403467/avis-budget-announced-that-its-wholly-owned-subsidiaries-intend-subject-to-market-and-other-customar", "tags": ["offering"]}
{"id": 45403487, "time": "2025-05-14 07:53:49", "headline": "JP Morgan Assumes Forge Global Holdings at Neutral, Announces Price Target of $18", "summary": "", "symbols": ["FRGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403487/jp-morgan-assumes-forge-global-holdings-at-neutral-announces-price-target-of-18", "tags": []}
{"id": 45403634, "time": "2025-05-14 07:57:52", "headline": "UPDATE: Alico Q2 Adj. EPS $(10.98), Sales $17.98M Miss $22.20M Estimate", "summary": "", "symbols": ["ALCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403634/update-alico-q2-adj-eps-10-98-sales-17-98m-miss-22-20m-estimate", "tags": ["earnings"]}
{"id": 45403640, "time": "2025-05-14 07:59:12", "headline": "EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models", "summary": "Channel Therapeutics reports CT2000 reduced eye pain in preclinical trials, with plans to enter human testing for acute and chronic indications.", "symbols": ["CHRO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45403640/exclusive-channel-therapeutics-touts-positive-efficacy-results-for-eye-treatment-potential-in-multiple-preclinical-in-vivo-models", "tags": []}
{"id": 45403658, "time": "2025-05-14 07:59:40", "headline": "Leerink Partners Downgrades ITeos Therapeutics to Market Perform, Lowers Price Target to $9", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403658/leerink-partners-downgrades-iteos-therapeutics-to-market-perform-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 45403671, "time": "2025-05-14 07:59:57", "headline": "Incyte And Novartis Settle Royalty Dispute With $280M Payment And 50% Reduction In Future JAKAFI U.S. Royalties, Resolving Litigation Over 2009 Collaboration Agreement And Releasing $242.2M In Accrued Liabilities", "summary": "", "symbols": ["INCY", "NVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403671/incyte-and-novartis-settle-royalty-dispute-with-280m-payment-and-50-reduction-in-future-jakafi-u-s-r", "tags": ["contract"]}
{"id": 45403814, "time": "2025-05-14 08:00:24", "headline": "Assessing Absci: Insights From 6 Financial Analysts", "summary": " ", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45403814/assessing-absci-insights-from-6-financial-analysts", "tags": []}
{"id": 45403818, "time": "2025-05-14 08:00:35", "headline": "Creative Realities Q1 Adj. EPS $(0.12), Inline, Sales $9.73M Miss $10.90M Estimate", "summary": "", "symbols": ["CREX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403818/creative-realities-q1-adj-eps-0-12-inline-sales-9-73m-miss-10-90m-estimate", "tags": ["earnings"]}
{"id": 45403821, "time": "2025-05-14 08:01:02", "headline": "What Analysts Are Saying About VF Stock", "summary": " ", "symbols": ["VFC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45403821/what-analysts-are-saying-about-vf-stock", "tags": []}
{"id": 45403835, "time": "2025-05-14 08:01:14", "headline": "Demystifying PVH: Insights From 16 Analyst Reviews", "summary": " ", "symbols": ["PVH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45403835/demystifying-pvh-insights-from-16-analyst-reviews", "tags": []}
{"id": 45403844, "time": "2025-05-14 08:01:26", "headline": "Leatt Q1 EPS $0.17 Up From $(0.13) YoY, Sales $15.37M Up From $10.61M YoY", "summary": "", "symbols": ["LEAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403844/leatt-q1-eps-0-17-up-from-0-13-yoy-sales-15-37m-up-from-10-61m-yoy", "tags": ["earnings"]}
{"id": 45403846, "time": "2025-05-14 08:01:30", "headline": "WeRide Unveils 8 Autonomous Robotaxi Pilot Operation Routes In Central Guangzhou, Establishing China's First 24-Hour Autonomous Ride-Hailing Network Covering Core Areas Of Tier 1 City", "summary": "", "symbols": ["WRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403846/weride-unveils-8-autonomous-robotaxi-pilot-operation-routes-in-central-guangzhou-establishing-chinas", "tags": []}
{"id": 45403847, "time": "2025-05-14 08:01:30", "headline": "Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday", "summary": " ", "symbols": ["ANNX", "CAMT", "COIN", "DAC", "ITOS", "MGTX", "NGNE", "ONON", "PVH", "VFC", "WING"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/05/45403847/coinbase-to-rally-around-17-here-are-10-top-analyst-forecasts-for-wednesday", "tags": []}
{"id": 45403848, "time": "2025-05-14 08:01:30", "headline": "LiqTech Intl Q1 EPS $(0.25) Misses $(0.18) Estimate, Sales $4.62M Beat $4.50M Estimate", "summary": "", "symbols": ["LIQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403848/liqtech-intl-q1-eps-0-25-misses-0-18-estimate-sales-4-62m-beat-4-50m-estimate", "tags": ["earnings"]}
{"id": 45403854, "time": "2025-05-14 08:01:39", "headline": "The Analyst Verdict: Silicon Laboratories In The Eyes Of 6 Experts", "summary": " ", "symbols": ["SLAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45403854/the-analyst-verdict-silicon-laboratories-in-the-eyes-of-6-experts", "tags": []}
{"id": 45403872, "time": "2025-05-14 08:02:02", "headline": "Deep Dive Into Rigetti Computing Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45403872/deep-dive-into-rigetti-computing-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 45403876, "time": "2025-05-14 08:02:09", "headline": "Sow Good Q1 GAAP EPS $(0.23) Misses $(0.11) Estimate, Sales $2.48M Miss $6.50M Estimate", "summary": "", "symbols": ["SOWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403876/sow-good-q1-gaap-eps-0-23-misses-0-11-estimate-sales-2-48m-miss-6-50m-estimate", "tags": ["earnings"]}
{"id": 45403894, "time": "2025-05-14 08:02:28", "headline": "LiqTech International Sees Q2 Sales $4.800M-$5.200M vs $4.70M Est", "summary": "", "symbols": ["LIQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403894/liqtech-international-sees-q2-sales-4-800m-5-200m-vs-4-70m-est", "tags": []}
{"id": 45403902, "time": "2025-05-14 08:02:38", "headline": "Cingulate Receives Formal Pre-NDA Meeting Minutes From FDA For CTx-1301 In ADHD", "summary": "", "symbols": ["CING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403902/cingulate-receives-formal-pre-nda-meeting-minutes-from-fda-for-ctx-1301-in-adhd", "tags": ["fda"]}
{"id": 45403912, "time": "2025-05-14 08:03:03", "headline": "Barclays Downgrades Lavoro to Underweight, Lowers Price Target to $1.5", "summary": "", "symbols": ["LVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403912/barclays-downgrades-lavoro-to-underweight-lowers-price-target-to-1-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 45403937, "time": "2025-05-14 08:03:47", "headline": "Curtiss-Wright Announces $400M Increase In Share Repurchase Authorization, Increases Dividend From $0.21 To $0.24 Per Share", "summary": "", "symbols": ["CW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403937/curtiss-wright-announces-400m-increase-in-share-repurchase-authorization-increases-dividend-from-0-2", "tags": ["buyback", "dividend"]}
{"id": 45403941, "time": "2025-05-14 08:03:55", "headline": "Revolution Medicines Announces First Patient Dosed In Phase 3 Clinical Trial, RASolve 301", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403941/revolution-medicines-announces-first-patient-dosed-in-phase-3-clinical-trial-rasolve-301", "tags": ["fda"]}
{"id": 45403942, "time": "2025-05-14 08:03:56", "headline": "Lucid Diagnostics Q1 Adj. EPS $(0.16), Inline, Sales $800.00K Miss $1.28M Estimate", "summary": "", "symbols": ["LUCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403942/lucid-diagnostics-q1-adj-eps-0-16-inline-sales-800-00k-miss-1-28m-estimate", "tags": ["earnings"]}
{"id": 45401873, "time": "2025-05-14 08:04:01", "headline": "US Stock Futures Trade Higher On Wednesday: S&P 500 Is Flashing 'Quite Rare And Rather Bullish' Signal, Says Expert (UPDATED)", "summary": "U.S. stock futures were slightly below the flatline on Wednesday after a mixed close on Tuesday. Futureswere trading lower in premarket.", "symbols": ["AEO", "ASNS", "BTCUSD", "CSCO", "DAVA", "DT", "KDLY", "LUCY", "NRG", "NVDA", "QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/government/regulations/25/05/45401873/us-stock-futures-trade-lower-on-wednesday-sp-500-is-flashing-quite-rare-and-rather-bullish-signal-says-expert", "tags": []}
{"id": 45403954, "time": "2025-05-14 08:04:24", "headline": "ADC Therapeutics Q1 Adj. EPS $(0.22) Beats $(0.40) Estimate, Sales $23.03M Beat $17.71M Estimate", "summary": "", "symbols": ["ADCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45403954/adc-therapeutics-q1-adj-eps-0-22-beats-0-40-estimate-sales-23-03m-beat-17-71m-estimate", "tags": ["earnings"]}
{"id": 45403962, "time": "2025-05-14 08:04:30", "headline": "Bitcoin Consolidates Before All-Time High Breakout As Altcoins Surge \u2014 'Signs Of A Bull Market,' Says Micha\u00ebl Van De Poppe", "summary": "Bitcoin (CRYPTO: BTC) is consolidating near record levels while altcoins show significant momentum, according to cryptocurrency analyst Micha\u00ebl van de Poppe.", "symbols": ["BTCUSD", "ETHUSD"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/25/05/45403962/bitcoin-consolidates-before-all-time-high-breakout-as-altcoins-surge-signs-of-a-bull-market-says-michael-van-de-poppe", "tags": []}
{"id": 45403988, "time": "2025-05-14 08:05:10", "headline": "Loop Capital Downgrades Wayfair to Sell, Announces $35 Price Target", "summary": "", "symbols": ["W"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45403988/loop-capital-downgrades-wayfair-to-sell-announces-35-price-target", "tags": ["analyst_down"]}
{"id": 45404028, "time": "2025-05-14 08:06:36", "headline": "Aethlon Medical Publishes Preclinical Data Showing Ability Of Hemopurifier To Remove Platelet-Derived Extracellular Vesicles From Plasma", "summary": "", "symbols": ["AEMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404028/aethlon-medical-publishes-preclinical-data-showing-ability-of-hemopurifier-to-remove-platelet-derive", "tags": []}
{"id": 45404035, "time": "2025-05-14 08:06:53", "headline": "Western Digital And Ingrasys Collaborate On Top-of-Rack Switch With Embedded Storage", "summary": "", "symbols": ["WDC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/05/45404035/western-digital-and-ingrasys-collaborate-on-top-of-rack-switch-with-embedded-storage", "tags": []}
{"id": 45404058, "time": "2025-05-14 08:07:57", "headline": "aTyr Pharma Advances ATYR0101 To IND Candidate Stage For Pulmonary Fibrosis; Preclinical Data Demonstrate ATYR0101's Unique Anti-fibrotic Mechanism Through Interaction With LTBP-1", "summary": "", "symbols": ["ATYR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45404058/atyr-pharma-advances-atyr0101-to-ind-candidate-stage-for-pulmonary-fibrosis-preclinical-data-demo", "tags": []}
{"id": 45404059, "time": "2025-05-14 08:08:06", "headline": "Viasat Selects Blue Origin As Launch Mission Partner To Support Viasat's Demonstration Of InRange Launch Telemetry Relay Service As Part Of Work With NASA's CSP", "summary": "", "symbols": ["VSAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404059/viasat-selects-blue-origin-as-launch-mission-partner-to-support-viasats-demonstration-of-inrange-lau", "tags": []}
{"id": 45404063, "time": "2025-05-14 08:08:19", "headline": "Diodes Incorporated Appoints Gary Yu As CEO", "summary": "", "symbols": ["DIOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404063/diodes-incorporated-appoints-gary-yu-as-ceo", "tags": ["management"]}
{"id": 45404067, "time": "2025-05-14 08:09:01", "headline": "Perplexity Selects PayPal To Power Agentic Commerce; Consumers Can Check Out Instantly With PayPal Or Venmo When They Ask Perplexity To Find Products, Book Travel, Or Buy Tickets", "summary": "", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404067/perplexity-selects-paypal-to-power-agentic-commerce-consumers-can-check-out-instantly-with-paypal-or", "tags": []}
{"id": 45404071, "time": "2025-05-14 08:09:20", "headline": "NWTN Appointed Benjamin Bin Zhai As CEO; Succeeds Alan Wu", "summary": "", "symbols": ["NWTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404071/nwtn-appointed-benjamin-bin-zhai-as-ceo-succeeds-alan-wu", "tags": ["management"]}
{"id": 45404072, "time": "2025-05-14 08:09:32", "headline": "12 Information Technology Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ASNS", "AUR", "DAVA", "DGLY", "DGNX", "GRYP", "ONDS", "RCAT", "RDCM", "SMCI", "TAOP", "XTKG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45404072/12-information-technology-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 45404074, "time": "2025-05-14 08:09:38", "headline": "12 Industrials Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["AQMS", "CTRI", "ECG", "HYFM", "KRMN", "KULR", "MCRP", "MSW", "NCL", "PGHL", "TIC", "WLGS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45404074/12-industrials-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 45404075, "time": "2025-05-14 08:09:44", "headline": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ABP", "ADVB", "APYX", "AXDX", "DBVT", "EUDA", "GRAL", "LUCY", "NUTX", "PLRZ", "QNRX", "SEPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45404075/12-health-care-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 45404076, "time": "2025-05-14 08:09:49", "headline": "12 Communication Services Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ASST", "BAOS", "BLMZ", "FNGR", "GITS", "HAO", "HWH", "IZEA", "LDWY", "SURG", "TNMG", "XHLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45404076/12-communication-services-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 45404082, "time": "2025-05-14 08:09:53", "headline": "Rhythm Pharmaceuticals Presents Data On Patients With Acquired Or Congenital Hypothalamic Obesity (N=35) Treated With Setmelanotide For Up To Nine Months In French Early-Access Program", "summary": "", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45404082/rhythm-pharmaceuticals-presents-data-on-patients-with-acquired-or-congenital-hypothalamic-obesity", "tags": ["merger"]}
{"id": 45404090, "time": "2025-05-14 08:10:09", "headline": "IN8bio Presents Preclinical Data From INB-619 Program", "summary": "", "symbols": ["INAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45404090/in8bio-presents-preclinical-data-from-inb-619-program", "tags": []}
{"id": 45404144, "time": "2025-05-14 08:10:54", "headline": "This Wayfair Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday", "summary": " ", "symbols": ["ITOS", "LVRO", "RIVN", "W"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/downgrades/25/05/45404144/this-wayfair-analyst-turns-bearish-here-are-top-4-downgrades-for-wednesday", "tags": ["analyst_down"]}
{"id": 45404160, "time": "2025-05-14 08:11:24", "headline": "Incannex Healthcare Completes Patient Dosing In Phase 2 Portion Of Phase 2/3 RePOSA Study Of IHL-42X In Obstructive Sleep Apnea", "summary": "", "symbols": ["IXHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45404160/incannex-healthcare-completes-patient-dosing-in-phase-2-portion-of-phase-23-reposa-study-of-ihl-4", "tags": ["fda"]}
{"id": 45404162, "time": "2025-05-14 08:11:30", "headline": "Indaptus Therapeutics Q1 EPS $(0.32) Misses $(0.18) Estimate", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404162/indaptus-therapeutics-q1-eps-0-32-misses-0-18-estimate", "tags": ["earnings"]}
{"id": 45404167, "time": "2025-05-14 08:11:45", "headline": "Kala Bio Q1 EPS $(1.41) Beats $(2.03) Estimate", "summary": "", "symbols": ["KALA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404167/kala-bio-q1-eps-1-41-beats-2-03-estimate", "tags": ["earnings"]}
{"id": 45404197, "time": "2025-05-14 08:12:04", "headline": "Gorilla Technology Group Appoints Bruce Bower As CFO", "summary": "", "symbols": ["GRRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404197/gorilla-technology-group-appoints-bruce-bower-as-cfo", "tags": ["management"]}
{"id": 45404279, "time": "2025-05-14 08:12:17", "headline": "Citigroup Downgrades Merck & Co to Neutral, Lowers Price Target to $84", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404279/citigroup-downgrades-merck-co-to-neutral-lowers-price-target-to-84", "tags": ["analyst_down", "price_target_down"]}
{"id": 45404107, "time": "2025-05-14 08:10:40", "headline": "UPDATE: Advanced Flower Capital Q1 Adj. EPS $0.21 Misses $0.25 Estimate, Net Interest Income $6.64M Miss $7.61M Estimate", "summary": "", "symbols": ["AFCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404107/updat-e-advanced-flower-capital-q1-adj-eps-0-21-misses-0-25-estimate-net-interest-income-6-64m-miss", "tags": ["earnings"]}
{"id": 45404297, "time": "2025-05-14 08:13:11", "headline": "Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["AEO", "ALC", "ALLT", "AUR", "GRAL", "PGY", "UBER", "W", "WBTN", "XHG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45404297/alcon-american-eagle-grail-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 45404298, "time": "2025-05-14 08:13:18", "headline": "Enphase Energy  Announces Homeowners In All Of New York's Major Investor-Owned Electric Utility Service Territories Who Install Enphase IQ Batteries Can Now Qualify To Enroll In The NYSERDA New York Battery Incentive Program", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404298/enphase-energy-announces-homeowners-in-all-of-new-yorks-major-investor-owned-electric-utility-servic", "tags": []}
{"id": 45404305, "time": "2025-05-14 08:13:32", "headline": "Kalaris Therapeutics Q1 EPS $(2.52) Misses $(1.17) Estimate", "summary": "", "symbols": ["KLRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404305/kalaris-therapeutics-q1-eps-2-52-misses-1-17-estimate", "tags": ["earnings"]}
{"id": 45404313, "time": "2025-05-14 08:13:51", "headline": "Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate", "summary": "", "symbols": ["BNTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404313/benitec-biopharma-q3-eps-0-24-beats-0-35-estimate", "tags": ["earnings"]}
{"id": 45404315, "time": "2025-05-14 08:14:08", "headline": "Aprea Therapeutics Q1 EPS $(0.66) Up From $(0.67) YoY, Sales $162.46K Down From $380.57K YoY", "summary": "", "symbols": ["APRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404315/aprea-therapeutics-q1-eps-0-66-up-from-0-67-yoy-sales-162-46k-down-from-380-57k-yoy", "tags": ["earnings"]}
{"id": 45404329, "time": "2025-05-14 08:14:47", "headline": "Allurion Technologies Affirms FY2025 Sales Guidance of $30.00M vs $40.20M Est", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404329/allurion-technologies-affirms-fy2025-sales-guidance-of-30-00m-vs-40-20m-est", "tags": ["guidance"]}
{"id": 45404338, "time": "2025-05-14 08:15:25", "headline": "Wall Street's Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["NXST", "SSTK", "VZ"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45404338/wall-streets-most-accurate-analysts-spotlight-on-3-tech-and-telecom-stocks-delivering-high-dividend-yields", "tags": ["dividend"]}
{"id": 45404339, "time": "2025-05-14 08:15:33", "headline": "IO Biotech Q1 EPS $(0.34) Beats $(0.38) Estimate", "summary": "", "symbols": ["IOBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404339/io-biotech-q1-eps-0-34-beats-0-38-estimate", "tags": ["earnings"]}
{"id": 45404346, "time": "2025-05-14 08:15:59", "headline": "Citigroup Downgrades UL Solutions to Neutral, Raises Price Target to $71", "summary": "", "symbols": ["ULS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404346/citigroup-downgrades-ul-solutions-to-neutral-raises-price-target-to-71", "tags": ["analyst_down", "price_target_up"]}
{"id": 45404354, "time": "2025-05-14 08:16:31", "headline": "Antalpha Announces Pricing Of Initial Public Offering Of 3.85M Shares At A Price Of $12.80 Per Share", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404354/antalpha-announces-pricing-of-initial-public-offering-of-3-85m-shares-at-a-price-of-12-80-per-share", "tags": ["offering"]}
{"id": 45404361, "time": "2025-05-14 08:18:51", "headline": "Millrose Properties Q1 EPS $0.39", "summary": "", "symbols": ["MRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404361/millrose-properties-q1-eps-0-39", "tags": ["earnings"]}
{"id": 45404362, "time": "2025-05-14 08:19:03", "headline": "Atossa Therapeutics Reports Full Results From Phase\u202f2 EOP Sub\u2011Study Within I\u2011SPY\u202f2 Trial Evaluating Low\u2011Dose Oral (Z)\u2011Endoxifen As Neoadjuvant Treatment In 20 Women With Stage\u202fII/III ER+, HER2\u2011Negative Breast Cancer", "summary": "", "symbols": ["ATOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404362/atossa-therapeutics-reports-full-results-from-phase-2-eop-sub-study-within-i-spy-2-trial-evaluating", "tags": ["fda"]}
{"id": 45404365, "time": "2025-05-14 08:19:47", "headline": "Raised Its FY25 Guidance For New Transaction Funding Outside Of The Lennar Master Program To $1.5B, Up From The Previously Announced $1B, Driven By Heightened Demand;  Increased Year-End Quarterly Earnings Per Share Run-Rate To A Range Of $0.69 To $0.71.", "summary": "", "symbols": ["MRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404365/raised-its-fy25-guidance-for-new-transaction-funding-outside-of-the-lennar-master-program-to-1-5b-up", "tags": ["earnings", "guidance"]}
{"id": 45404375, "time": "2025-05-14 08:19:55", "headline": "Citigroup Downgrades AbbVie to Neutral, Lowers Price Target to $205", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404375/citigroup-downgrades-abbvie-to-neutral-lowers-price-target-to-205", "tags": ["analyst_down", "price_target_down"]}
{"id": 45404379, "time": "2025-05-14 08:21:00", "headline": "ATAI Life Sciences Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $1.55M", "summary": "", "symbols": ["ATAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404379/atai-life-sciences-q1-eps-0-15-beats-0-18-estimate-sales-1-55m", "tags": ["earnings"]}
{"id": 45404380, "time": "2025-05-14 08:21:18", "headline": "Sen. Ted Cruz Wants To Give Americans $1,000 At Birth To Invest, Bill Ackman Says He's 'Been A Fan Of This Idea For Years'", "summary": "Billionaire Bill Ackman supports Sen. Cruz&#39;s $1,000 investment account proposal for newborn Americans.", "symbols": [], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/general/education/25/05/45404380/sen-ted-cruz-wants-to-give-americans-1000-at-birth-to-invest-bill-ackman-says-hes-been-a-fan-of-this-idea-for-years", "tags": []}
{"id": 45404381, "time": "2025-05-14 08:21:25", "headline": "Saudi Arabian Mining Agrees With MP Materials To Explore Opportunities To Establish Fully Integrated, End-To-End Rare Earth Supply Chain", "summary": "", "symbols": ["MP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404381/saudi-arabian-mining-agrees-with-mp-materials-to-explore-opportunities-to-establish-fully-integrated", "tags": []}
{"id": 45402695, "time": "2025-05-14 07:13:10", "headline": "Tesla's Robotaxi Plans Under Federal Scrutiny Ahead Of Austin Launch As Elon Musk Vows Nationwide Rollout By Year-End", "summary": "Federal regulators are pressing Tesla Inc. for details on how its driverless taxis will operate safely in challenging conditions as the electric vehicle maker prepares for a pivotal robotaxi launch in Austin next month.", "symbols": ["TSLA"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/markets/equities/25/05/45402695/teslas-robotaxi-plans-under-federal-scrutiny-ahead-ff-austin-launch-as-elon-musk-vows-nationwide-rollout-by-year-end", "tags": []}
{"id": 45404398, "time": "2025-05-14 08:22:21", "headline": "Citigroup Upgrades Regeneron Pharmaceuticals to Buy, Raises Price Target to $700", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404398/citigroup-upgrades-regeneron-pharmaceuticals-to-buy-raises-price-target-to-700", "tags": ["analyst_up", "price_target_up"]}
{"id": 45404403, "time": "2025-05-14 08:23:16", "headline": "Lockheed Martin Expands Industrial Cooperation In Spain With New PAC-3 MSE Agreement", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404403/lockheed-martin-expands-industrial-cooperation-in-spain-with-new-pac-3-mse-agreement", "tags": ["contract"]}
{"id": 45404421, "time": "2025-05-14 08:24:34", "headline": "TXO Partners, L.P. Announces Pricing Of $175M Public Offering Of 11.667M Common Units At A Price Of $15/Unit", "summary": "", "symbols": ["TXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404421/txo-partners-l-p-announces-pricing-of-175m-public-offering-of-11-667m-common-units-at-a-price-of-15u", "tags": ["offering"]}
{"id": 45404534, "time": "2025-05-14 08:25:49", "headline": "Scotiabank Downgrades Nutrien to Sector Perform, Maintains Price Target to $62", "summary": "", "symbols": ["NTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404534/scotiabank-downgrades-nutrien-to-sector-perform-maintains-price-target-to-62", "tags": ["analyst_down", "analyst_other"]}
{"id": 45404406, "time": "2025-05-14 08:23:29", "headline": "Safe & Green Holdings Provides Corporate Update; To Evaluate High-Value Partnerships And Acquisitions Across US Energy Production, Sustainable Technologies And Modular Construction Solutions", "summary": "", "symbols": ["SGBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404406/safe-green-holdings-provides-corporate-update-to-evaluate-high-value-partnerships-and-acquisitions-a", "tags": []}
{"id": 45404541, "time": "2025-05-14 08:27:14", "headline": "MediPharm Labs Q1 Sales $10.81M Beat $10.54M Estimate", "summary": "", "symbols": ["TSX:LABS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404541/medipharm-labs-q1-sales-10-81m-beat-10-54m-estimate", "tags": []}
{"id": 45404553, "time": "2025-05-14 08:27:19", "headline": "Mesa Air Gr Q4 Sales $115.26M Up From $114.37M YoY", "summary": "", "symbols": ["MESA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404553/mesa-air-gr-q4-sales-115-26m-up-from-114-37m-yoy", "tags": []}
{"id": 45404564, "time": "2025-05-14 08:29:27", "headline": "UBS Upgrades Chimera Investment to Buy, Raises Price Target to $15", "summary": "", "symbols": ["CIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404564/ubs-upgrades-chimera-investment-to-buy-raises-price-target-to-15", "tags": ["analyst_up", "price_target_up"]}
{"id": 45404651, "time": "2025-05-14 08:31:45", "headline": "HC Wainwright & Co. Reiterates Buy on Endeavour Silver, Maintains $7.25 Price Target", "summary": "", "symbols": ["EXK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404651/hc-wainwright-co-reiterates-buy-on-endeavour-silver-maintains-7-25-price-target", "tags": ["analyst_other"]}
{"id": 45404655, "time": "2025-05-14 08:31:52", "headline": "Alphabet, Uber, Leidos And A Financial Stock On CNBC's 'Final Trades'", "summary": " ", "symbols": ["GOOG", "GOOGL", "LDOS", "SAN", "UBER"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45404655/alphabet-uber-leidos-and-a-financial-stock-on-cnbcs-final-trades", "tags": []}
{"id": 45404667, "time": "2025-05-14 08:32:07", "headline": "Boehringer Will Have Access To Tempus' De-identified Database Containing Molecular, Clinical, And Imaging Data And Its Analytical Platform, Lens As Part Of Collaboration", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/05/45404667/boehringer-will-have-access-to-tempus-de-identified-database-containing-molecular-clinical-and-imagi", "tags": ["fda"]}
{"id": 45404692, "time": "2025-05-14 08:32:24", "headline": "Informatica Expands Partnership With Databricks To Enable Customers Migrate To Modern, AI-powered Cloud Data Management Platform", "summary": "", "symbols": ["INFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404692/informatica-expands-partnership-with-databricks-to-enable-customers-migrate-to-modern-ai-powered-clo", "tags": ["contract"]}
{"id": 45404696, "time": "2025-05-14 08:32:30", "headline": "Spruce Power Announces $50M Share Repurchase Program", "summary": "", "symbols": ["SPRU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404696/spruce-power-announces-50m-share-repurchase-program", "tags": ["buyback"]}
{"id": 45404697, "time": "2025-05-14 08:32:37", "headline": "William Blair Downgrades Biodesix to Market Perform", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404697/william-blair-downgrades-biodesix-to-market-perform", "tags": ["analyst_down"]}
{"id": 45404703, "time": "2025-05-14 08:33:50", "headline": "Vuzix And Himax Technologies Announce Joint Debut Of Next-Gen AR Optical Module At Display Week 2025", "summary": "", "symbols": ["HIMX", "VUZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404703/vuzix-and-himax-technologies-announce-joint-debut-of-next-gen-ar-optical-module-at-display-week-2025", "tags": []}
{"id": 45404704, "time": "2025-05-14 08:33:54", "headline": "Carlyle, SK Capital Partners And bluebird bio Amend Merger Agreement; Stockholders May Elect To Receive Either $3/Share Plus CVR Of $6.84/Share In Cash Payable Upon Achievement Of A Net Sales Milestone Or $5/Share With No CVR", "summary": "", "symbols": ["BLUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45404704/carlyle-sk-capital-partners-and-bluebird-bio-amend-merger-agreement-stockholders-may-elect-to-receiv", "tags": ["merger", "contract"]}
{"id": 45404707, "time": "2025-05-14 08:34:45", "headline": "DeFi Development Q1 EPS $(0.55) Up From $(0.70) YoY, Sales $287.17K Down From $411.14K YoY", "summary": "", "symbols": ["DFDV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404707/defi-development-q1-eps-0-55-up-from-0-70-yoy-sales-287-17k-down-from-411-14k-yoy", "tags": ["earnings"]}
{"id": 45404708, "time": "2025-05-14 08:34:51", "headline": "Trump's Qatar Jet Gift Could Cost Taxpayers $1 Billion \u2014 And He Still May Not Be Able To Use It This Term, Say Experts", "summary": "The conversion of a Qatari 747 jet into the\u00a0new Air Force One for\u00a0President Donald Trump could\u00a0cost over $1 billion and\u00a0take several years, according to aviation experts.", "symbols": ["BA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/05/45404708/trumps-boeing-jet-gift-from-qatar-could-cost-taxpayers-1-billion-and-he-still-may-not-be-able-to-use-it-this-term-say-experts", "tags": []}
{"id": 45404712, "time": "2025-05-14 08:35:06", "headline": "Star Equity Hldgs Q1 2025 Adj. EPS $(0.52) Misses $(0.25) Estimate, Sales $12.92M Miss $16.35M Estimate", "summary": "", "symbols": ["STRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404712/star-equity-hldgs-q1-2025-adj-eps-0-52-misses-0-25-estimate-sales-12-92m-miss-16-35m-estimate", "tags": ["earnings"]}
{"id": 45404717, "time": "2025-05-14 08:35:12", "headline": "SAIHEAT Receives Invention Patent Authorization Notice For Its 'Control Rod Drive Mechanism for Small Modular Pressurized Water Reactors (SMRs).'", "summary": "", "symbols": ["SAIH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404717/saiheat-receives-invention-patent-authorization-notice-for-its-control-rod-drive-mechanism-for-small", "tags": []}
{"id": 45404722, "time": "2025-05-14 08:35:15", "headline": "Ernexa Therapeutics Establishes Texas Subsidiary To Support Ongoing Development Of ERNA-101 And Future Clinical Operations", "summary": "", "symbols": ["ERNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45404722/ernexa-therapeutics-establishes-texas-subsidiary-to-support-ongoing-development-of-erna-101-and-f", "tags": ["fda"]}
{"id": 45404730, "time": "2025-05-14 08:35:45", "headline": "CSP Q2 EPS $(0.01) Down From $0.16 YoY, Sales $13.15M Down From $13.71M YoY", "summary": "", "symbols": ["CSPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404730/csp-q2-eps-0-01-down-from-0-16-yoy-sales-13-15m-down-from-13-71m-yoy", "tags": ["earnings"]}
{"id": 45404731, "time": "2025-05-14 08:35:51", "headline": "Wells Fargo Downgrades Magnera to Equal-Weight, Lowers Price Target to $16", "summary": "", "symbols": ["MAGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404731/wells-fargo-downgrades-magnera-to-equal-weight-lowers-price-target-to-16", "tags": ["analyst_down", "price_target_down"]}
{"id": 45404742, "time": "2025-05-14 08:36:37", "headline": "Tivic Health Advances Entolimod Toward FDA BLA Filing With GMP Manufacturing Validation", "summary": "", "symbols": ["SCPX", "TIVC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404742/tivic-health-advances-entolimod-toward-fda-bla-filing-with-gmp-manufacturing-validation", "tags": ["fda"]}
{"id": 45404748, "time": "2025-05-14 08:37:07", "headline": "Brag House Launches Investigation Into Suspected Illegal Naked Short Selling, Cites Preliminary Evidence Of Abusive Trading Activity And Urges SEC, FINRA, And Nasdaq To Initiate Immediate Probe Into Unusual Volume, Stock Borrowing Rates, And Price Pressure", "summary": "", "symbols": ["TBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404748/brag-house-launches-investigation-into-suspected-illegal-naked-short-selling-cites-preliminary-evide", "tags": ["legal"]}
{"id": 45404763, "time": "2025-05-14 08:37:47", "headline": "Wells Fargo Upgrades Omnicell to Overweight, Raises Price Target to $35", "summary": "", "symbols": ["OMCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404763/wells-fargo-upgrades-omnicell-to-overweight-raises-price-target-to-35", "tags": ["analyst_up", "price_target_up"]}
{"id": 45404766, "time": "2025-05-14 08:38:28", "headline": "Surrozen Granted US Patent To Antibody-Based Molecules Targeting Key Receptors In Wnt Pathway", "summary": "", "symbols": ["SRZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404766/surrozen-granted-us-patent-to-antibody-based-molecules-targeting-key-receptors-in-wnt-pathway", "tags": []}
{"id": 45404769, "time": "2025-05-14 08:38:47", "headline": "Informatica Enters Into New Strategic Agreement With Microsoft To Accelerate Customer Adoption, Continuing Innovation And Customer Adoption On The Microsoft Azure Cloud Platform", "summary": "", "symbols": ["INFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404769/informatica-enters-into-new-strategic-agreement-with-microsoft-to-accelerate-customer-adoption-conti", "tags": ["contract"]}
{"id": 45404771, "time": "2025-05-14 08:38:52", "headline": "NETSOL Technologies Q3 EPS $0.12 Up From $0.03 YoY, Sales $17.53M Up From $15.46M YoY", "summary": "", "symbols": ["NTWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404771/netsol-technologies-q3-eps-0-12-up-from-0-03-yoy-sales-17-53m-up-from-15-46m-yoy", "tags": ["earnings"]}
{"id": 45404774, "time": "2025-05-14 08:39:26", "headline": "How To Earn $500 A Month From Deere Stock Ahead Of Q2 Earnings", "summary": "With the recent buzz around Deere, some investors may be eyeing potential gains from the company&#39;s dividends.", "symbols": ["DE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/05/45404774/how-to-earn-500-a-month-from-deere-stock-ahead-of-q2-earnings", "tags": ["earnings"]}
{"id": 45404777, "time": "2025-05-14 08:39:44", "headline": "Allurion Technologies Q1 Adj. EPS $0.24 Beats $(8.58) Estimate, Sales $5.58M Beat $5.50M Estimate", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404777/allurion-technologies-q1-adj-eps-0-24-beats-8-58-estimate-sales-5-58m-beat-5-50m-estimate", "tags": ["earnings"]}
{"id": 45404798, "time": "2025-05-14 08:40:14", "headline": "Foresight Autonomous Holdings Agrees For POC Project With Global Tier One Automotive Supplier To Improve Urban Transit Safety Through Precision Curb Detection System", "summary": "", "symbols": ["FRSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404798/foresight-autonomous-holdings-agrees-for-poc-project-with-global-tier-one-automotive-supplier-to-imp", "tags": []}
{"id": 45404821, "time": "2025-05-14 08:41:05", "headline": "Peter Schiff Warns Only Major Dollar Decline Or High Tariffs Can Cut US Trade Deficit \u2014 But Inflation And Rates Will Soar", "summary": "Peter Schiff has warned that without the implementation of high tariffs, the only path to reduce trade deficit is through dollar decline.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/25/05/45404821/dollar-correction-imminent-sans-tariffs-to-reduce-the-us-trade-deficit-says-peter-schiff-minor-decline-would-make-trade-deficit-larger", "tags": []}
{"id": 45404825, "time": "2025-05-14 08:41:20", "headline": "Reborn Coffee Signs MoU With Tori AI To Implement Smart Retail Technology", "summary": "", "symbols": ["REBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404825/reborn-coffee-signs-mou-with-tori-ai-to-implement-smart-retail-technology", "tags": []}
{"id": 45404950, "time": "2025-05-14 08:42:21", "headline": "Silo Pharma Agrees With Frontage Laboratories For FDA Requested 7-Day Safety And Toxicology Large Animal Study Of Lead Asset SPC-15, Intranasal Prophylactic Treatment For PTSD", "summary": "", "symbols": ["SILO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404950/silo-pharma-agrees-with-frontage-laboratories-for-fda-requested-7-day-safety-and-toxicology-large-an", "tags": ["fda"]}
{"id": 45404982, "time": "2025-05-14 08:44:57", "headline": "Theriva Biologics Q1 EPS $(1.55) Up From $(7.53) YoY", "summary": "", "symbols": ["TOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45404982/theriva-biologics-q1-eps-1-55-up-from-7-53-yoy", "tags": ["earnings"]}
{"id": 45404993, "time": "2025-05-14 08:45:33", "headline": "Keybanc Upgrades Ameren to Overweight, Announces $103 Price Target", "summary": "", "symbols": ["AEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45404993/keybanc-upgrades-ameren-to-overweight-announces-103-price-target", "tags": ["analyst_up"]}
{"id": 45405004, "time": "2025-05-14 08:45:57", "headline": "Jim Cramer: SoFi Goes To 'New Highs,' Recommends Not Buying This Health Care Stock", "summary": " ", "symbols": ["GEHC", "ROKU", "SOFI", "STZ"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock", "tags": []}
{"id": 45405019, "time": "2025-05-14 08:47:13", "headline": "Keybanc Downgrades Consolidated Edison to Underweight, Announces $90 Price Target", "summary": "", "symbols": ["ED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405019/keybanc-downgrades-consolidated-edison-to-underweight-announces-90-price-target", "tags": ["analyst_down"]}
{"id": 45405024, "time": "2025-05-14 08:47:38", "headline": "Schwab Monthly Highlights: Total Client Assets Equaled $9.89T At Month-End Apr, Up 12% YoY; Core Net New Assets Brought To Co Totaled $2.7B", "summary": "", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405024/schwab-monthly-highlights-total-client-assets-equaled-9-89t-at-month-end-apr-up-12-yoy-core-net-new", "tags": []}
{"id": 45405041, "time": "2025-05-14 08:48:08", "headline": "Cisco's Partners With AIP In Latest AI Push", "summary": "Cisco unveils collaborations and initiatives related to AI advancements, including partnerships with BlackRock, Microsoft, NVIDIA, xAI, GE Vernova, and NextEra Energy.", "symbols": ["CSCO", "GEV", "MSFT", "NEE", "NVDA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/05/45405041/ciscos-partners-with-aip-in-latest-ai-push", "tags": ["contract"]}
{"id": 45405067, "time": "2025-05-14 08:50:24", "headline": "Saudi Arabia Bets Big On AI, Teams Up With AWS And NVIDIA", "summary": "Amazon&#39;s AWS and HUMAIN partner to invest $5 billion for AI Zone in Saudi Arabia, aiming to advance AI leadership goals and expand global demand.", "symbols": ["AMZN", "NVDA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/05/45405067/saudi-arabia-bets-big-on-ai-teams-up-with-aws-and-nvidia", "tags": []}
{"id": 45405077, "time": "2025-05-14 08:50:53", "headline": "Keybanc Upgrades Entergy to Overweight, Announces $85 Price Target", "summary": "", "symbols": ["ETR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405077/keybanc-upgrades-entergy-to-overweight-announces-85-price-target", "tags": ["analyst_up"]}
{"id": 45405123, "time": "2025-05-14 08:52:34", "headline": "Top 2 Real Estate Stocks That May Collapse In Q2", "summary": " ", "symbols": ["DHC", "DOUG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45405123/top-2-real-estate-stocks-that-may-collapse-in-q2", "tags": []}
{"id": 45405124, "time": "2025-05-14 08:52:36", "headline": "Keybanc Downgrades Exelon to Underweight, Announces $39 Price Target", "summary": "", "symbols": ["EXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405124/keybanc-downgrades-exelon-to-underweight-announces-39-price-target", "tags": ["analyst_down"]}
{"id": 45405176, "time": "2025-05-14 08:54:34", "headline": "Be Fearful When Others Have FOMO", "summary": " ", "symbols": [], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/markets/equities/25/05/45405176/be-fearful-when-others-have-fomo", "tags": []}
{"id": 45405180, "time": "2025-05-14 08:55:01", "headline": "'Roche Warns US Investments at Risk From Trump Drug Price Plans' - Bloomberg News", "summary": "", "symbols": ["RHHBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45405180/roche-warns-us-investments-at-risk-from-trump-drug-price-plans-bloomberg-news", "tags": []}
{"id": 45405187, "time": "2025-05-14 08:55:06", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["MLEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45405187/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45405195, "time": "2025-05-14 08:55:17", "headline": "Keybanc Maintains Overweight on On Holding, Raises Price Target to $68", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405195/keybanc-maintains-overweight-on-on-holding-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 45405199, "time": "2025-05-14 08:55:33", "headline": "Mainz Biomed Files For Offer Of 2.,448,980 Ordinary Units And 2,488,988 Pre-Funded Units", "summary": "", "symbols": ["MYNZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405199/mainz-biomed-files-for-offer-of-2-448-980-ordinary-units-and-2-488-988-pre-funded-units", "tags": []}
{"id": 45404099, "time": "2025-05-14 08:10:19", "headline": "Coinbase Global Rises 8.2% After Key Signal", "summary": "A significant trading signal occurred for\u00a0CoinBase Global, as it demonstrated a power inflow at $240.74, after which COIN rose up to 8.2%.", "symbols": [], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/markets/equities/25/05/45404099/coinbase-global-rises-8-2-after-key-signal", "tags": []}
{"id": 45405299, "time": "2025-05-14 08:56:48", "headline": "Genprex Files For Offering Of 27,586,206 Shares Together With Warrants At $0.29 Per Share And Warrant", "summary": "", "symbols": ["GNPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405299/genprex-files-for-offering-of-27-586-206-shares-together-with-warrants-at-0-29-per-share-and-warrant", "tags": ["offering"]}
{"id": 45405301, "time": "2025-05-14 08:56:57", "headline": "What's Going On With Innovative Eyewear Stock On Wednesday?", "summary": "Innovative Eyewear shares surge premarket after narrower-than-expected loss and strong growth in smart glasses product lines", "symbols": ["LUCY"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/25/05/45405301/whats-going-on-with-innovative-eyewear-stock-on-wednesday", "tags": ["why_moving"]}
{"id": 45405313, "time": "2025-05-14 08:57:13", "headline": "AbbVie And ADARx Pharma Announce Collaboration And License Option Agreement To Develop siRNA Therapeutics Across Multiple Disease Areas, Including Neuroscience, Immunology And Oncology", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405313/abbvie-and-adarx-pharma-announce-collaboration-and-license-option-agreement-to-develop-sirna-therape", "tags": ["contract"]}
{"id": 45405337, "time": "2025-05-14 08:57:24", "headline": "US-China Tariff Truce May Not Revive Imports, Says Port Of LA Chief: 'You're Not Going To Be Frontloading At 30%'", "summary": "The Port of Los Angeles, one of the largest import gateways in the U.S., has issued a warning that the recent reduction in tariffs on Chinese goods may not be enough to reverse the declining cargo volume.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/05/45405337/us-china-tariff-truce-may-not-revive-imports-says-port-of-la-chief-youre-not-going-to-be-frontloading-at-30", "tags": []}
{"id": 45405339, "time": "2025-05-14 08:57:33", "headline": "Cyclacel Pharmaceuticals Announces Majority Stockholder And Board Approval Of Reverse Stock Split At A Ratio Between 1-For-3 And 1-For-100", "summary": "", "symbols": ["CYCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405339/cyclacel-pharmaceuticals-announces-majority-stockholder-and-board-approval-of-reverse-stock-split-at", "tags": []}
{"id": 45405343, "time": "2025-05-14 08:57:41", "headline": "Keybanc Downgrades Portland Gen Electric to Sector Weight, Maintains Price Target to $51", "summary": "", "symbols": ["POR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405343/keybanc-downgrades-portland-gen-electric-to-sector-weight-maintains-price-target-to-51", "tags": ["analyst_down", "analyst_other"]}
{"id": 45405366, "time": "2025-05-14 08:58:51", "headline": "This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday", "summary": " ", "symbols": ["AEE", "ESTA", "OMCL", "PVH", "REGN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45405366/this-pvh-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday", "tags": ["analyst_up"]}
{"id": 45405405, "time": "2025-05-14 08:59:57", "headline": "Keybanc Downgrades Southern to Underweight, Announces $78 Price Target", "summary": "", "symbols": ["SO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405405/keybanc-downgrades-southern-to-underweight-announces-78-price-target", "tags": ["analyst_down"]}
{"id": 45405436, "time": "2025-05-14 09:00:06", "headline": "Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["XAGEW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45405436/trading-halt-halt-status-updated-at-9-00-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45405536, "time": "2025-05-14 09:00:23", "headline": "How Is The Market Feeling About Idacorp?", "summary": " ", "symbols": ["IDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45405536/how-is-the-market-feeling-about-idacorp", "tags": []}
{"id": 45405563, "time": "2025-05-14 09:00:29", "headline": "Looking Into Intercontinental Exchange's Recent Short Interest", "summary": " ", "symbols": ["ICE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45405563/looking-into-intercontinental-exchanges-recent-short-interest", "tags": []}
{"id": 45405569, "time": "2025-05-14 09:00:30", "headline": "Deep Dive Into Consolidated Edison Stock: Analyst Perspectives (11 Ratings)", "summary": " ", "symbols": ["ED"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45405569/deep-dive-into-consolidated-edison-stock-analyst-perspectives-11-ratings", "tags": []}
{"id": 45405597, "time": "2025-05-14 09:00:34", "headline": "Is SkyWest Gaining or Losing Market Support?", "summary": " ", "symbols": ["SKYW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45405597/is-skywest-gaining-or-losing-market-support", "tags": []}
{"id": 45405622, "time": "2025-05-14 09:01:03", "headline": "Assessing Merck & Co: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45405622/assessing-merck-co-insights-from-4-financial-analysts", "tags": []}
{"id": 45405636, "time": "2025-05-14 09:01:11", "headline": "Expert Outlook: AbbVie Through The Eyes Of 10 Analysts", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45405636/expert-outlook-abbvie-through-the-eyes-of-10-analysts", "tags": ["guidance"]}
{"id": 45405646, "time": "2025-05-14 09:01:19", "headline": "AMD Announces New $6B Share Repurchase Authorization; New Authorization Is In Addition To The Remaining Balance, As Of March 29, 2025, Of \n ~$4B Of Its Existing Share Repurchase Program, Increasing The Total Current Repurchase Authority To ~$10B", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405646/amd-announces-new-6b-share-repurchase-authorization-new-authorization-is-in-addition-to-the-remainin", "tags": ["buyback"]}
{"id": 45405649, "time": "2025-05-14 09:01:37", "headline": "The Curious Story Behind The Melania Trump Meme Coin Launch", "summary": "The launch of the Melania (CRYPTO: MELANIA) meme coin, tied to former First Lady Melania Trump, has stirred controversy following a series of unusually timed trades that suggest some investors had early access ", "symbols": ["MELANIAUSD", "TRUMPUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/25/05/45405649/the-curious-story-behind-the-melania-trump-meme-coin-launch", "tags": []}
{"id": 45405663, "time": "2025-05-14 09:01:57", "headline": "Affirm Named Pay-Over-Time Provider For Costco.com In The US", "summary": "", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405663/affirm-named-pay-over-time-provider-for-costco-com-in-the-us", "tags": []}
{"id": 45405669, "time": "2025-05-14 09:02:04", "headline": "Palantir Storms Past $300 Billion Valuation, CEO Karp Champions Saudi AI Over Europe", "summary": "Palantir Technologies Inc (NASDAQ:PLTR) hits $300B market cap, up from $20B in 2 years. CEO praises Saudi engineers, criticizes Europe&#39;s AI adoption.", "symbols": ["PLTR"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/05/45405669/palantir-storms-past-300b-valuation-as-karp-champions-saudi-ai-over-hopeless-europe", "tags": ["management"]}
{"id": 45405716, "time": "2025-05-14 09:03:07", "headline": "FirstCash Enters UK Market With $394 Million Acquisition Of H&T Group", "summary": "FirstCash Holdings Inc. expands into U.K. by acquiring H&amp;T Group plc, largest pawnbroker chain. Deal worth $394 million adds 285 stores and boosts global presence.", "symbols": ["FCFS"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45405716/firstcash-enters-uk-market-with-394-million-acquisition-of-ht-group", "tags": ["merger", "contract"]}
{"id": 45405753, "time": "2025-05-14 09:03:59", "headline": "AGRIForce Announces Delivery Of 500 Bitmain S19j Pro 100T Bitcoin Mining Machines To Its EPCM Contractor For Installation At East Palestine, Ohio Bitcoin Mining Site", "summary": "", "symbols": ["AGRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45405753/agriforce-announces-delivery-of-500-bitmain-s19j-pro-100t-bitcoin-mining-machines-to-its-e", "tags": []}
{"id": 45405793, "time": "2025-05-14 09:04:55", "headline": "Red Cat Holdings Stock Is Ripping Higher Wednesday: What's Going On?", "summary": "Red Cat Holdings Inc (NASDAQ:RCAT) shares are surging Wednesday after the company announced an expansion of its multi-domain Family of Systems to maritime platforms. Red Cat is due to report earnings after the bell. Here&#39;s what you need to know.", "symbols": ["RCAT"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45405793/red-cat-holdings-stock-is-ripping-higher-wednesday-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 45405825, "time": "2025-05-14 09:05:28", "headline": "Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Following Written Agreement On Final Study Protocol From FDA; Expects To Report Topline Data In 1H 2026", "summary": "", "symbols": ["CNTB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405825/connect-biopharma-initiates-phase-2-seabreeze-stat-copd-study-following-written-agreement-on-final-s", "tags": ["fda", "contract"]}
{"id": 45405846, "time": "2025-05-14 09:06:13", "headline": "Shyft Group Advances Merger Process With Aebi Schmidt As SEC Declares Registration Statement Effective To Trade On NASDAQ As \"AEBI\"", "summary": "", "symbols": ["SHYF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45405846/shyft-group-advances-merger-process-with-aebi-schmidt-as-sec-declares-registration-statement-effecti", "tags": ["merger"]}
{"id": 45405857, "time": "2025-05-14 09:06:45", "headline": "Baird Maintains Outperform on e.l.f. Beauty, Raises Price Target to $100", "summary": "", "symbols": ["ELF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405857/baird-maintains-outperform-on-e-l-f-beauty-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 45405878, "time": "2025-05-14 09:07:21", "headline": "Twilio Announces Multi-Year Strategic Partnership With Microsoft To Accelerate Adoption Of Conversational AI Solutions For Customer Engagement", "summary": "", "symbols": ["MSFT", "TWLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405878/twilio-announces-multi-year-strategic-partnership-with-microsoft-to-accelerate-adoption-of-conversat", "tags": ["contract"]}
{"id": 45405881, "time": "2025-05-14 09:07:26", "headline": "Euronet Announces A Collaboration With Visa To Make Visa Direct Available To Its Customers", "summary": "", "symbols": ["EEFT", "V"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405881/euronet-announces-a-collaboration-with-visa-to-make-visa-direct-available-to-its-customers", "tags": []}
{"id": 45405882, "time": "2025-05-14 09:07:38", "headline": "Baird Maintains Neutral on Harley-Davidson, Raises Price Target to $28", "summary": "", "symbols": ["HOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405882/baird-maintains-neutral-on-harley-davidson-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 45405905, "time": "2025-05-14 09:07:56", "headline": "Keybanc Maintains Overweight on UnitedHealth Group, Lowers Price Target to $450", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405905/keybanc-maintains-overweight-on-unitedhealth-group-lowers-price-target-to-450", "tags": ["analyst_other", "price_target_down"]}
{"id": 45405906, "time": "2025-05-14 09:08:02", "headline": "Supermicro Announces Improvements To Its Direct Liquid Cooling  Solutions Including Up To 40% Power Savings Of Data Center", "summary": "", "symbols": ["SMCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405906/supermicro-announces-improvements-to-its-direct-liquid-cooling-solutions-including-up-to-40-power-sa", "tags": []}
{"id": 45405914, "time": "2025-05-14 09:08:37", "headline": "First Busey Prices Public Offering Of 8M Depositary Shares Representing 8.25% Fixed Rate Series B Preferred Stock At $25 Each, With Proceeds To Redeem 5.25% Subordinated Notes Due 2030 And Support Busey Bank's Balance Sheet Growth", "summary": "", "symbols": ["BUSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405914/first-busey-prices-public-offering-of-8m-depositary-shares-representing-8-25-fixed-rate-series-b-pre", "tags": ["offering"]}
{"id": 45405916, "time": "2025-05-14 09:09:10", "headline": "Baird Maintains Outperform on On Holding, Raises Price Target to $70", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405916/baird-maintains-outperform-on-on-holding-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 45405917, "time": "2025-05-14 09:09:15", "headline": "Alibaba's 55% Rally Gets Goldman's $1 Billion Boost - Will Q4 Earnings Justify The Bet?", "summary": "Alibaba (BABA) will report Q4 earnings on Thursday. Wall Street expects $1.37 EPS and $33.21B revenue. Stock is up 54.9% YTD with bullish momentum.", "symbols": ["BABA", "BABAF"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/25/05/45405917/alibabas-55-rally-gets-goldmans-1-billion-boost-will-q4-earnings-justify-the-bet", "tags": ["earnings"]}
{"id": 45405919, "time": "2025-05-14 09:09:20", "headline": "AgEagle Aerial Systems Announces Sale Of 20 High-Performance RedEdge-P Cameras To Wingtr", "summary": "", "symbols": ["UAVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405919/ageagle-aerial-systems-announces-sale-of-20-high-performance-rededge-p-cameras-to-wingtr", "tags": []}
{"id": 45405935, "time": "2025-05-14 09:09:52", "headline": "DoorDash Expands Drone Delivery Partnership With Wing In Charlotte", "summary": "", "symbols": ["DASH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405935/doordash-expands-drone-delivery-partnership-with-wing-in-charlotte", "tags": ["contract"]}
{"id": 45405941, "time": "2025-05-14 09:10:09", "headline": "Leading And Lagging Sectors For May 14, 2025", "summary": " ", "symbols": ["XLB", "XLC", "XLE", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/25/05/45405941/leading-and-lagging-sectors-for-may-14-2025", "tags": []}
{"id": 45405944, "time": "2025-05-14 09:10:23", "headline": "Baird Maintains Neutral on Under Armour, Raises Price Target to $7", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45405944/baird-maintains-neutral-on-under-armour-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 45405964, "time": "2025-05-14 09:10:53", "headline": "PagBank Q1 2025 Net Revenue Totaled R$4.9 Billion, A 13% YoY Increase", "summary": "", "symbols": ["PAGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45405964/pagbank-q1-2025-net-revenue-totaled-r-4-9-billion-a-13-yoy-increase", "tags": ["earnings"]}
{"id": 45406014, "time": "2025-05-14 09:11:56", "headline": "Scotiabank Maintains Sector Outperform on Mosaic, Raises Price Target to $42", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406014/scotiabank-maintains-sector-outperform-on-mosaic-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406073, "time": "2025-05-14 09:12:19", "headline": "Keybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $55", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406073/keybanc-maintains-overweight-on-acadia-healthcare-co-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406152, "time": "2025-05-14 09:12:58", "headline": "Baird Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $9", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406152/baird-maintains-outperform-on-allogene-therapeutics-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406154, "time": "2025-05-14 09:13:26", "headline": "SEALSQ Intends To Invest $10M In WISeSat.Space And Join Parent Company, WISeKey As Strategic Investor In WISeSat Satellite Constellation", "summary": "", "symbols": ["LAES", "WKEY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406154/sealsq-intends-to-invest-10m-in-wisesat-space-and-join-parent-company-wisekey-as-strategic-investor", "tags": []}
{"id": 45406162, "time": "2025-05-14 09:14:28", "headline": "Baird Maintains Neutral on Fate Therapeutics, Lowers Price Target to $4", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406162/baird-maintains-neutral-on-fate-therapeutics-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406180, "time": "2025-05-14 09:15:32", "headline": "Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?", "summary": "Only about 50% of S&amp;P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April.", "symbols": ["ALB", "ARE", "BDX", "BIIB", "DOW", "EIX", "ENPH", "HAL", "IQV", "LEN", "LYB", "MRK", "ON", "REGN", "TECH", "TER", "TGT", "UNH", "WST"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/25/05/45406180/only-half-of-sp-500-stocks-joined-the-tariff-relief-rally-time-to-buy-the-laggards", "tags": []}
{"id": 45406192, "time": "2025-05-14 09:16:15", "headline": "Baird Maintains Outperform on UnitedHealth Group, Lowers Price Target to $356", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406192/baird-maintains-outperform-on-unitedhealth-group-lowers-price-target-to-356", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406235, "time": "2025-05-14 09:17:38", "headline": "Scotiabank Maintains Sector Outperform on Arizona Sonoran Copper, Raises Price Target to C$3.35", "summary": "", "symbols": ["TSX:ASCU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406235/scotiabank-maintains-sector-outperform-on-arizona-sonoran-copper-raises-price-target-to-c-3-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406262, "time": "2025-05-14 09:18:09", "headline": "Baird Maintains Outperform on Karman Holdings, Raises Price Target to $50", "summary": "", "symbols": ["KRMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406262/baird-maintains-outperform-on-karman-holdings-raises-price-target-to-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406265, "time": "2025-05-14 09:18:26", "headline": "Silynxcom FY24 EPS $(0.4505) Up From $(0.8916) YoY, Sales $9.09M Up From $7.63M YoY", "summary": "", "symbols": ["SYNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406265/silynxcom-fy24-eps-0-4505-up-from-0-8916-yoy-sales-9-09m-up-from-7-63m-yoy", "tags": ["earnings"]}
{"id": 45406266, "time": "2025-05-14 09:18:34", "headline": "Angel Oak Mortgage REIT Commences Underwritten Public Offering Of Senior Notes Due 2030", "summary": "", "symbols": ["AOMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406266/angel-oak-mortgage-reit-commences-underwritten-public-offering-of-senior-notes-due-2030", "tags": ["offering"]}
{"id": 45406164, "time": "2025-05-14 09:14:47", "headline": "Fed Vice Chair Jefferson Says Current Moderately Restrictive Policy Rate In A Good Place To Respond To Economic Developments; Recent Inflation Data Consistent With Further Progress Toward 2% Goal, But Future Path Uncertain Due To Tariffs; Watching Closely For Signs In Hard Data Of Weaker Activity; Tariffs Could Lead To Higher Inflation, Still Uncertain If Impact Would Be Temporary Or Persistent; Expect Lower Growth Due To Trade Policy But Expect Economy To Still Expand Over The Year", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45406164/fed-vice-chair-jefferson-reportedly-says-current-moderately-restrictive-policy-ra", "tags": []}
{"id": 45406271, "time": "2025-05-14 09:19:10", "headline": "Ethereum Rallies 42% In 7 Days: What Is Driving The Surge?", "summary": "Ethereum (CRYPTO: ETH) has surged 42% over the past seven days, driven by the announcement of the Pectra upgrade, a pivotal step in Ethereum&#39;s network evolution, and heavy institutional accumulation.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45406271/ethereum-rallies-42-in-7-days-what-is-driving-the-surge", "tags": ["analyst_up"]}
{"id": 45406165, "time": "2025-05-14 09:14:53", "headline": "Fed Vice Chair Jefferson Says First Quarter GDP Data Overstated Deceleration In Activity; Labor Market Still Solid; Whether Tariffs Create Persistent Inflation Depends On Implementation, Response Of Supply Chains, Other Factors", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45406165/fed-vice-chair-jefferson-reportedly-says-first-quarter-gdp-data-overstated-decele", "tags": []}
{"id": 45406288, "time": "2025-05-14 09:19:43", "headline": "Scotiabank Maintains Sector Outperform on Cameco, Lowers Price Target to C$80", "summary": "", "symbols": ["TSX:CCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406288/scotiabank-maintains-sector-outperform-on-cameco-lowers-price-target-to-c-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406319, "time": "2025-05-14 09:20:37", "headline": "Baird Maintains Outperform on CyberArk Software, Raises Price Target to $460", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406319/baird-maintains-outperform-on-cyberark-software-raises-price-target-to-460", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406327, "time": "2025-05-14 09:20:54", "headline": "Renovaro Launches Augusta Precision Neurology Platform Integrating Multiomics, AI, Phenoclustering, And CRISPR For Rapid, Interpretable Drug Discovery And Biomarker Identification In Neurological Disorders", "summary": "", "symbols": ["RENB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406327/renovaro-launches-augusta-precision-neurology-platform-integrating-multiomics-ai-phenoclustering-", "tags": []}
{"id": 45406329, "time": "2025-05-14 09:20:54", "headline": "Meta Faces Potential $200 Billion Legal Blow As Austrian Privacy Group Challenges EU Data Use For AI: '...Making Money Is More Important Than The Rights Of Its Users'", "summary": "Austrian advocacy group,\u00a0NOYB, is gearing up to seek an injunction against\u00a0Meta Platforms\u00a0(NASDAQ: META), potentially leading to billion-euro damages claims. This action comes as a response to Meta&#39;s plans to use Europeans&#39; personal data for AI training.", "symbols": ["AAPL", "GOOG", "GOOGL", "META", "MSFT"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/05/45406329/austrian-group-questions-metas-legitimate-interest-in-using-eu-data-for-ai-threatens-legal-action-over-200-billion-making-money-is-more-important-than-the-rights-of-its-users", "tags": []}
{"id": 45406397, "time": "2025-05-14 09:22:40", "headline": "Scotiabank Maintains Sector Perform on Dream Office REIT, Lowers Price Target to C$17.5", "summary": "", "symbols": ["TSX:D", "TSX:D/UN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406397/scotiabank-maintains-sector-perform-on-dream-office-reit-lowers-price-target-to-c-17-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406399, "time": "2025-05-14 09:22:52", "headline": "Baird Maintains Outperform on KinderCare Learning, Lowers Price Target to $20", "summary": "", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406399/baird-maintains-outperform-on-kindercare-learning-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406402, "time": "2025-05-14 09:23:20", "headline": "How To Trade SPY And Top Tech Stocks After a Softer Inflation Print", "summary": "How to trade the SPY and Top tech stocks, as the market assesses softer-than-expected US inflation numbers for April.", "symbols": ["MSFT"], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/markets/equities/25/05/45406402/how-to-trade-spy-and-top-tech-stocks-after-a-softer-inflation-print", "tags": []}
{"id": 45406332, "time": "2025-05-14 09:20:59", "headline": "Sony Q4 Earnings: Financial Unit Spin-Off, Stock Buyback, Cautious Outlook Amid Tariffs", "summary": "\nSONY reported lower quarterly sales and higher EPS than expected. It also announced plans for a partial spin-off of its financial services group.", "symbols": ["SONY"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/buybacks/25/05/45406332/sony-q4-earnings-financial-unit-spin-off-stock-buyback-cautious-outlook-amid-tariffs", "tags": ["earnings", "guidance", "buyback"]}
{"id": 45406430, "time": "2025-05-14 09:24:24", "headline": "What's Going On With Tilray Brands Stock On Wednesday?", "summary": "Tilray shares trade flat as company expands cannabis lineup with XMG Atomic Sours drinks and gummies.\n\n\n\n\n\n\n\n\n", "symbols": ["TLRY", "YOLO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45406430/whats-going-on-with-tilray-brands-stock-on-wednesday", "tags": ["why_moving"]}
{"id": 45406431, "time": "2025-05-14 09:24:30", "headline": "Scotiabank Maintains Sector Outperform on Ero Copper, Raises Price Target to C$24", "summary": "", "symbols": ["TSX:ERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406431/scotiabank-maintains-sector-outperform-on-ero-copper-raises-price-target-to-c-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406568, "time": "2025-05-14 09:26:49", "headline": "Ford Issues Recall Of Over 270,000 Vehicles As Safety Concerns Mount", "summary": "Ford (NYSE: F) recalls 274,000 SUVs due to brake line defect affecting certain Expedition and Navigator models built between 2022 and 2024.", "symbols": ["DRIV", "F", "GM", "IYK", "STLA"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/05/45406568/fords-brake-line-issue-spurs-recall-of-over-270k-vehicles-as-safety-concerns-mount", "tags": []}
{"id": 45406569, "time": "2025-05-14 09:26:51", "headline": "Top 10 Trending Stocks On WallStreetBets As Of May 14, 2025 (Via Swaggy Stocks)", "summary": "", "symbols": ["AMD", "BULL", "GLD", "GOOGL", "HIMS", "NVDA", "PLTR", "SMCI", "TSLA", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45406569/top-10-trending-stocks-on-wallstreetbets-as-of-may-14-2025-via-swaggy-stocks", "tags": []}
{"id": 45406595, "time": "2025-05-14 09:27:51", "headline": "SuperCom Q1 Adj. EPS $1.50 Beats $(0.09) Estimate, Sales $7.05M Beat $6.74M Estimate", "summary": "", "symbols": ["SPCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406595/supercom-q1-adj-eps-1-50-beats-0-09-estimate-sales-7-05m-beat-6-74m-estimate", "tags": ["earnings"]}
{"id": 45406600, "time": "2025-05-14 09:27:58", "headline": "On Holding Analysts Raise Their Forecasts After Upbeat Results", "summary": " ", "symbols": ["ONON"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45406600/on-holding-analysts-raise-their-forecasts-after-upbeat-results", "tags": []}
{"id": 45406623, "time": "2025-05-14 09:28:46", "headline": "Scotiabank Maintains Sector Outperform on Exchange Income, Raises Price Target to C$66", "summary": "", "symbols": ["TSX:EIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406623/scotiabank-maintains-sector-outperform-on-exchange-income-raises-price-target-to-c-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406625, "time": "2025-05-14 09:29:14", "headline": "Zoned Properties Q1 EPS $0.01, Same YoY, Sales $974.55K Up From $837.05K YoY", "summary": "", "symbols": ["ZDPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406625/zoned-properties-q1-eps-0-01-same-yoy-sales-974-55k-up-from-837-05k-yoy", "tags": ["earnings"]}
{"id": 45406646, "time": "2025-05-14 09:30:03", "headline": "Scotiabank Maintains Sector Outperform on Finning International, Raises Price Target to C$55", "summary": "", "symbols": ["TSX:FTT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406646/scotiabank-maintains-sector-outperform-on-finning-international-raises-price-target-to-c-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406673, "time": "2025-05-14 09:30:18", "headline": "GSK To Buy Phase-3 Ready Liver Disease Drug For Up To $2 Billion", "summary": "GSK acquires Boston Pharmaceuticals&#39; efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.", "symbols": ["GSK"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45406673/gsk-to-buy-phase-3-ready-liver-disease-drug-for-up-to-2-billion", "tags": ["merger"]}
{"id": 45406682, "time": "2025-05-14 09:30:41", "headline": "Greenpro Capital Q1 EPS $(0.08) Down From $(0.04) YoY, Sales $352.75K Down From $658.40K YoY", "summary": "", "symbols": ["GRNQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406682/greenpro-capital-q1-eps-0-08-down-from-0-04-yoy-sales-352-75k-down-from-658-40k-yoy", "tags": ["earnings"]}
{"id": 45406690, "time": "2025-05-14 09:30:59", "headline": "Beam Therapeutics To Present New Data From BEAM-101 Program iI Sickle Cell Disease At European Hematology Association 2025 Congress", "summary": "", "symbols": ["BEAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406690/beam-therapeutics-to-present-new-data-from-beam-101-program-ii-sickle-cell-disease-at-european-he", "tags": []}
{"id": 45406694, "time": "2025-05-14 09:31:09", "headline": "B of A Securities Initiates Coverage On EHang Holdings with Buy Rating, Announces Price Target of $26", "summary": "", "symbols": ["EH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406694/b-of-a-securities-initiates-coverage-on-ehang-holdings-with-buy-rating-announces-price-target-of-26", "tags": ["analyst_init"]}
{"id": 45406701, "time": "2025-05-14 09:31:50", "headline": "Super Micro Computer Stock Is Surging Again: What's Going On?", "summary": "Super Micro Computer Inc (NASDAQ:SMCI) shares are soaring again Wednesday after rising 16% on Tuesday. Here&#39;s a look at what&#39;s going on.", "symbols": ["SMCI"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45406701/super-micro-computer-stock-is-surging-again-whats-going-on", "tags": ["why_moving"]}
{"id": 45406702, "time": "2025-05-14 09:31:52", "headline": "This Hong Kong IPO Candidate May Benefit From Policy Tailwinds", "summary": "This digital payment services provider is likely to get a lift from China&#39;s initiatives to boost domestic consumption.", "symbols": [], "source": "benzinga", "author": "Bamboo Works", "url": "https://www.benzinga.com/markets/asia/25/05/45406702/this-hong-kong-ipo-candidate-may-benefit-from-policy-tailwinds", "tags": []}
{"id": 45406705, "time": "2025-05-14 09:32:03", "headline": "Scotiabank Maintains Sector Perform on First Quantum Minerals, Raises Price Target to C$22.5", "summary": "", "symbols": ["TSX:FM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406705/scotiabank-maintains-sector-perform-on-first-quantum-minerals-raises-price-target-to-c-22-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 45406742, "time": "2025-05-14 09:33:05", "headline": "Kairos Pharma Q1 EPS $(0.08) Misses $(0.05) Estimate", "summary": "", "symbols": ["KAPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406742/kairos-pharma-q1-eps-0-08-misses-0-05-estimate", "tags": ["earnings"]}
{"id": 45406745, "time": "2025-05-14 09:33:16", "headline": "Arcellx Announces New Data For Its iMMagine-1 Study In Patients With Relapsed And/Or Refractory Multiple Myeloma;  Results From All 117 Patients Dosed In The Pivotal Phase 2 iMMagine-1 Study Of Anito-Cel Demonstrated 97% ORR And 68% CR/sCR At A Median Follow-Up Of 12.6 Months", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406745/arcellx-announces-new-data-for-its-immagine-1-study-in-patients-with-relapsed-andor-refractory-mu", "tags": ["fda"]}
{"id": 45406750, "time": "2025-05-14 09:33:45", "headline": "B of A Securities Downgrades UnitedHealth Group to Neutral, Lowers Price Target to $350", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406750/b-of-a-securities-downgrades-unitedhealth-group-to-neutral-lowers-price-target-to-350", "tags": ["analyst_down", "price_target_down"]}
{"id": 45406751, "time": "2025-05-14 09:33:52", "headline": "Disc Medicine Announces Multiple Presentations Across Portfolio At The EHA 2025 Congress", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406751/disc-medicine-announces-multiple-presentations-across-portfolio-at-the-eha-2025-congress", "tags": []}
{"id": 45406752, "time": "2025-05-14 09:34:07", "headline": "Nurix Therapeutics Prersents Data From Ongoing Phase 1a/b Clinical Trial Of Bexobrutideg In Patients With r/r CLL And Waldenstr\u00f6m Macroglobulinemia At EHA Congress 2025 And 18-ICML", "summary": "", "symbols": ["NRIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406752/nurix-therapeutics-prersents-data-from-ongoing-phase-1ab-clinical-trial-of-bexobrutideg-in-patients", "tags": ["fda"]}
{"id": 45406753, "time": "2025-05-14 09:34:26", "headline": "Syndax Presents Data Showcasing Revuforj And Niktimvo At EHA 2025", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406753/syndax-presents-data-showcasing-revuforj-and-niktimvo-at-eha-2025", "tags": []}
{"id": 45406754, "time": "2025-05-14 09:34:37", "headline": "Schr\u00f6dinger To Present Phase 1 Clinical Data On MALT1 Inhibitor SGR-1505 At EHA Annual Congress And International Conference On Malignant Lymphoma", "summary": "", "symbols": ["SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406754/schr-dinger-to-present-phase-1-clinical-data-on-malt1-inhibitor-sgr-1505-at-eha-annual-congress-a", "tags": ["fda"]}
{"id": 45406757, "time": "2025-05-14 09:35:00", "headline": "Scotiabank Maintains Sector Outperform on Foran Mining, Lowers Price Target to C$4", "summary": "", "symbols": ["TSX:FOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406757/scotiabank-maintains-sector-outperform-on-foran-mining-lowers-price-target-to-c-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 45406773, "time": "2025-05-14 09:35:10", "headline": "Autolus Therapeutics Presents Clinical Data Updates At 2025 European Hematology Association Congress", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406773/autolus-therapeutics-presents-clinical-data-updates-at-2025-european-hematology-association-congr", "tags": ["fda"]}
{"id": 45406777, "time": "2025-05-14 09:35:11", "headline": "Karyopharm Announces Poster Presentation On Selinexor In Myelofibrosis At The 2025 EHA Annual Meeting", "summary": "", "symbols": ["KPTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45406777/karyopharm-announces-poster-presentation-on-selinexor-in-myelofibrosis-at-the-2025-eha-annual-mee", "tags": []}
{"id": 45406799, "time": "2025-05-14 09:35:20", "headline": "Sumitomo Chemical Q4 EPS $0.20 Up From $(4.16) YoY, Sales $4.60B Up From $4.31B YoY", "summary": "", "symbols": ["SOMMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406799/sumitomo-chemical-q4-eps-0-20-up-from-4-16-yoy-sales-4-60b-up-from-4-31b-yoy", "tags": ["earnings"]}
{"id": 45406800, "time": "2025-05-14 09:35:26", "headline": "These Analysts Slash Their Forecasts On UnitedHealth", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45406800/these-analysts-slash-their-forecasts-on-unitedhealth", "tags": []}
{"id": 45406809, "time": "2025-05-14 09:35:38", "headline": "Primech Regains Compliance With Nasdaq's Minimum Bid Price Requirement", "summary": "", "symbols": ["PMEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406809/primech-regains-compliance-with-nasdaqs-minimum-bid-price-requirement", "tags": []}
{"id": 45406818, "time": "2025-05-14 09:35:46", "headline": "Syndax Pharma: Multiple Abstracts Showcasing Clinical Data For Revuforj Accepted For Presentation At EHA Annual Congress Meeting", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45406818/syndax-pharma-multiple-abstracts-showcasing-clinical-data-for-revuforj-accepted-for-presentation-at", "tags": ["fda"]}
{"id": 45406896, "time": "2025-05-14 09:36:44", "headline": "Neonode Q1 EPS $(0.10) Misses $(0.08) Estimate, Sales $513.00K Miss $654.00K Estimate", "summary": "", "symbols": ["NEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45406896/neonode-q1-eps-0-10-misses-0-08-estimate-sales-513-00k-miss-654-00k-estimate", "tags": ["earnings"]}
{"id": 45407004, "time": "2025-05-14 09:38:36", "headline": "Scotiabank Maintains Sector Perform on Freeport-McMoRan, Raises Price Target to $43", "summary": "", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407004/scotiabank-maintains-sector-perform-on-freeport-mcmoran-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407129, "time": "2025-05-14 09:40:07", "headline": "Scotiabank Maintains Sector Outperform on Hudbay Minerals, Raises Price Target to C$14", "summary": "", "symbols": ["TSX:HBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407129/scotiabank-maintains-sector-outperform-on-hudbay-minerals-raises-price-target-to-c-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407150, "time": "2025-05-14 09:40:18", "headline": "Trading Halt: Halt status updated at 9:40:00 AM ET: Quotation Resumption: New Issue Available", "summary": "", "symbols": ["KWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45407150/trading-halt-halt-status-updated-at-9-40-00-am-et-quotation-resumption-new-issue-available", "tags": []}
{"id": 45407194, "time": "2025-05-14 09:40:42", "headline": "Subaru Q4 Earnings Per ADS of $0.10 Down From $0.39 YoY, Sales $7.54B Down From $8.13B YoY", "summary": "", "symbols": ["FUJHY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407194/subaru-q4-earnings-per-ads-of-0-10-down-from-0-39-yoy-sales-7-54b-down-from-8-13b-yoy", "tags": ["earnings"]}
{"id": 45407220, "time": "2025-05-14 09:40:49", "headline": "Benchmark Maintains Buy on Sea, Raises Price Target to $180", "summary": "", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407220/benchmark-maintains-buy-on-sea-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407264, "time": "2025-05-14 09:41:25", "headline": "Brenntag Q1 EPS $0.20 Down From $0.21 YoY, Sales $4.28B Down From $4.35B YoY", "summary": "", "symbols": ["BNTGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407264/brenntag-q1-eps-0-20-down-from-0-21-yoy-sales-4-28b-down-from-4-35b-yoy", "tags": ["earnings"]}
{"id": 45407280, "time": "2025-05-14 09:41:45", "headline": "Scotiabank Maintains Sector Perform on Killam Apartment REIT, Raises Price Target to C$20.75", "summary": "", "symbols": ["TSX:KMP", "TSX:KMP/UN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407280/scotiabank-maintains-sector-perform-on-killam-apartment-reit-raises-price-target-to-c-20-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407454, "time": "2025-05-14 09:42:48", "headline": "Zijin Mining Seeks Hong Kong IPO For Offshore Assets", "summary": "\u00a0Zijin Mining plans to spin off its offshore gold assets in a Hong Kong IPO.", "symbols": [], "source": "benzinga", "author": "Bamboo Works", "url": "https://www.benzinga.com/markets/asia/25/05/45407454/zijin-mining-seeks-hong-kong-ipo-for-offshore-assets", "tags": []}
{"id": 45407458, "time": "2025-05-14 09:42:50", "headline": "Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings", "summary": " ", "symbols": ["AXDX", "HWH", "IXHL", "PLRZ", "SEPN", "SONY", "XHLD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45407458/nasdaq-gains-over-100-points-sony-group-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 45407469, "time": "2025-05-14 09:43:03", "headline": "Scotiabank Maintains Sector Outperform on Lundin Mining, Raises Price Target to C$14.5", "summary": "", "symbols": ["TSX:LUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407469/scotiabank-maintains-sector-outperform-on-lundin-mining-raises-price-target-to-c-14-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407470, "time": "2025-05-14 09:43:05", "headline": "Dupont Unveils Branding Of Qnity, Planned Independent Electronics Public Company To Be Created Through Intended Spin-off Of Electronics Business", "summary": "", "symbols": ["DD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407470/dupont-unveils-branding-of-qnity-planned-independent-electronics-public-company-to-be-created-throug", "tags": []}
{"id": 45407481, "time": "2025-05-14 09:43:17", "headline": "Cisco Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45407481/cisco-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 45407486, "time": "2025-05-14 09:43:23", "headline": "Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs", "summary": "Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases.", "symbols": ["NVO", "SEPN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45407486/novo-nordisk-inks-22-billion-deal-with-septerna-to-develop-oral-weight-loss-and-diabetes-drugs", "tags": ["contract"]}
{"id": 45407570, "time": "2025-05-14 09:44:39", "headline": "Terns Pharmaceuticals Selected For Oral Presentation At EHA Congress For Preclinical Data On Novel Allosteric BCR-ABL Inhibitor TERN-701", "summary": "", "symbols": ["TERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45407570/terns-pharmaceuticals-selected-for-oral-presentation-at-eha-congress-for-preclinical-data-on-nove", "tags": []}
{"id": 45407596, "time": "2025-05-14 09:45:13", "headline": "Scotiabank Maintains Sector Underperform on Nexa Res, Raises Price Target to $5", "summary": "", "symbols": ["NEXA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407596/scotiabank-maintains-sector-underperform-on-nexa-res-raises-price-target-to-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407612, "time": "2025-05-14 09:45:48", "headline": "Benchmark Maintains Buy on JD.com, Lowers Price Target to $53", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407612/benchmark-maintains-buy-on-jd-com-lowers-price-target-to-53", "tags": ["analyst_other", "price_target_down"]}
{"id": 45407621, "time": "2025-05-14 09:45:55", "headline": "Telefonica Q1 Adj. EPS $0.08 Down From $0.11 YoY, Sales $9.70B Down From $11.01B YoY", "summary": "", "symbols": ["TEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407621/telefonica-q1-adj-eps-0-08-down-from-0-11-yoy-sales-9-70b-down-from-11-01b-yoy", "tags": ["earnings"]}
{"id": 45407634, "time": "2025-05-14 09:46:30", "headline": "SMC Q4 EPS $0.19 Down From $0.22 YoY, Sales $1.32B Up From $1.31B YoY", "summary": "", "symbols": ["SMCAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407634/smc-q4-eps-0-19-down-from-0-22-yoy-sales-1-32b-up-from-1-31b-yoy", "tags": ["earnings"]}
{"id": 45407712, "time": "2025-05-14 09:48:11", "headline": "B of A Securities Maintains Buy on NVIDIA, Raises Price Target to $160", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407712/b-of-a-securities-maintains-buy-on-nvidia-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407736, "time": "2025-05-14 09:48:25", "headline": "Benchmark Maintains Buy on Humacyte, Lowers Price Target to $14", "summary": "", "symbols": ["HUMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407736/benchmark-maintains-buy-on-humacyte-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 45407770, "time": "2025-05-14 09:49:13", "headline": "WELL Health Technologies Q1 Adj. EPS $0.03 Misses $0.07 Estimate, Sales $294.14M Beat $276.35M Estimate", "summary": "", "symbols": ["TSX:WELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407770/well-health-technologies-q1-adj-eps-0-03-misses-0-07-estimate-sales-294-14m-beat-276-35m-estimate", "tags": ["earnings"]}
{"id": 45407779, "time": "2025-05-14 09:49:31", "headline": "Rakuten Group Q1 EPS $(0.22) Down From $(0.13) YoY, Sales $3.69B Up From $3.46B YoY", "summary": "", "symbols": ["RKUNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407779/rakuten-group-q1-eps-0-22-down-from-0-13-yoy-sales-3-69b-up-from-3-46b-yoy", "tags": ["earnings"]}
{"id": 45407791, "time": "2025-05-14 09:49:46", "headline": "Scotiabank Maintains Sector Outperform on Power Corp of Canada, Lowers Price Target to C$57", "summary": "", "symbols": ["TSX:POW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407791/scotiabank-maintains-sector-outperform-on-power-corp-of-canada-lowers-price-target-to-c-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 45407795, "time": "2025-05-14 09:49:53", "headline": "Mowi Q1 Adj. EPS $0.30 Up From $0.23 YoY, Sales $1.43B Down From $1.45B YoY", "summary": "", "symbols": ["MHGVY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407795/mowi-q1-adj-eps-0-30-up-from-0-23-yoy-sales-1-43b-down-from-1-45b-yoy", "tags": ["earnings"]}
{"id": 45407809, "time": "2025-05-14 09:50:11", "headline": "B of A Securities Maintains Buy on Advanced Micro Devices, Raises Price Target to $130", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407809/b-of-a-securities-maintains-buy-on-advanced-micro-devices-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407822, "time": "2025-05-14 09:50:22", "headline": "Benchmark Maintains Buy on Quipt Home Medical, Lowers Price Target to $4", "summary": "", "symbols": ["QIPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407822/benchmark-maintains-buy-on-quipt-home-medical-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 45407824, "time": "2025-05-14 09:50:26", "headline": "Charlottes Web Holdings Q1 EPS $(0.04) Up From $(0.06) YoY, Sales $12.26M Up From $12.12M YoY", "summary": "", "symbols": ["TSX:CWEB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407824/charlottes-web-holdings-q1-eps-0-04-up-from-0-06-yoy-sales-12-26m-up-from-12-12m-yoy", "tags": ["earnings"]}
{"id": 45407895, "time": "2025-05-14 09:51:42", "headline": "Sysmex Q4 EPS $0.06 Up From $(0.29) YoY, Sales $929.63M Up From $909.66M YoY", "summary": "", "symbols": ["SSMXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407895/sysmex-q4-eps-0-06-up-from-0-29-yoy-sales-929-63m-up-from-909-66m-yoy", "tags": ["earnings"]}
{"id": 45407912, "time": "2025-05-14 09:52:14", "headline": "Toray Industries Q4 EPS $0.03 Up From $(0.20) YoY, Sales $4.19B Down From $4.28B YoY", "summary": "", "symbols": ["TRYIY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407912/toray-industries-q4-eps-0-03-up-from-0-20-yoy-sales-4-19b-down-from-4-28b-yoy", "tags": ["earnings"]}
{"id": 45407915, "time": "2025-05-14 09:52:18", "headline": "Firefly Neuroscience Q1 EPS $(1.74) Down From $(0.22) YoY, Sales $43.00K Up From $12.00K YoY", "summary": "", "symbols": ["AIFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407915/firefly-neuroscience-q1-eps-1-74-down-from-0-22-yoy-sales-43-00k-up-from-12-00k-yoy", "tags": ["earnings"]}
{"id": 45407949, "time": "2025-05-14 09:53:15", "headline": "B of A Securities Maintains Underperform on RH, Raises Price Target to $172", "summary": "", "symbols": ["RH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45407949/b-of-a-securities-maintains-underperform-on-rh-raises-price-target-to-172", "tags": ["analyst_other", "price_target_up"]}
{"id": 45407970, "time": "2025-05-14 09:53:45", "headline": "TerraVest Industries Q2 EPS $1.39 Beats $0.81 Estimate, Sales $311.45M Beat $300.63M Estimate", "summary": "", "symbols": ["TSX:TVK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45407970/terravest-industries-q2-eps-1-39-beats-0-81-estimate-sales-311-45m-beat-300-63m-estimate", "tags": ["earnings"]}
{"id": 45408015, "time": "2025-05-14 09:55:18", "headline": "B of A Securities Maintains Neutral on Wayfair, Raises Price Target to $43", "summary": "", "symbols": ["W"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408015/b-of-a-securities-maintains-neutral-on-wayfair-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408017, "time": "2025-05-14 09:55:27", "headline": "Crescita Therapeutics Q1 EPS $(0.05) Down From $(0.03) YoY, Sales $3.54M Down From $5.00M YoY", "summary": "", "symbols": ["TSX:CTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45408017/crescita-therapeutics-q1-eps-0-05-down-from-0-03-yoy-sales-3-54m-down-from-5-00m-yoy", "tags": ["earnings"]}
{"id": 45408108, "time": "2025-05-14 09:56:09", "headline": "XRP Up 416% Over The Past Year: How High Can It Go?", "summary": "XRP (CRYPTO: XRP) has surged 416% over the past year, with recent market data pointing to a strong undercurrent of accumulation despite heightened speculation.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45408108/xrp-up-416-over-the-past-year-how-high-can-it-go", "tags": []}
{"id": 45408146, "time": "2025-05-14 09:56:58", "headline": "Wells Fargo Maintains Equal-Weight on Academy Sports, Raises Price Target to $43", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408146/wells-fargo-maintains-equal-weight-on-academy-sports-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408149, "time": "2025-05-14 09:57:06", "headline": "Big Rock Brewery Q1 Sales $11.20M Up From $8.58M YoY", "summary": "", "symbols": ["TSX:BR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45408149/big-rock-brewery-q1-sales-11-20m-up-from-8-58m-yoy", "tags": []}
{"id": 45408177, "time": "2025-05-14 09:58:07", "headline": "Wells Fargo Maintains Equal-Weight on Amer Sports, Raises Price Target to $25", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408177/wells-fargo-maintains-equal-weight-on-amer-sports-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408195, "time": "2025-05-14 09:58:46", "headline": "B of A Securities Maintains Buy on Nutrien, Raises Price Target to $63", "summary": "", "symbols": ["NTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408195/b-of-a-securities-maintains-buy-on-nutrien-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408200, "time": "2025-05-14 09:58:53", "headline": "Wells Fargo Maintains Overweight on Bath & Body Works, Raises Price Target to $44", "summary": "", "symbols": ["BBWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408200/wells-fargo-maintains-overweight-on-bath-body-works-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408209, "time": "2025-05-14 09:59:11", "headline": "SFL Corp Q1 EPS $(0.24) Misses $(0.03) Estimate, Sales $186.74M Beat $186.23M Estimate", "summary": "", "symbols": ["SFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45408209/sfl-corp-q1-eps-0-24-misses-0-03-estimate-sales-186-74m-beat-186-23m-estimate", "tags": ["earnings"]}
{"id": 45408211, "time": "2025-05-14 09:59:13", "headline": "Enliven Therapeutics Announces Updated Data From Phase 1 ENABLE Clinical Trial Evaluating ELVN-001 In Patients With CML In Abstract Accepted For Oral Presentation At EHA 2025 Congress", "summary": "", "symbols": ["ELVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408211/enliven-therapeutics-announces-updated-data-from-phase-1-enable-clinical-trial-evaluating-elvn-001-i", "tags": ["fda"]}
{"id": 45408229, "time": "2025-05-14 09:59:52", "headline": "Wells Fargo Maintains Underweight on Carter's, Raises Price Target to $28", "summary": "", "symbols": ["CRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408229/wells-fargo-maintains-underweight-on-carters-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408306, "time": "2025-05-14 10:00:19", "headline": "Here's How Much You Would Have Made Owning LPL Finl Hldgs Stock In The Last 10 Years", "summary": " ", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45408306/heres-how-much-you-would-have-made-owning-lpl-finl-hldgs-stock-in-the-last-10-years", "tags": []}
{"id": 45408309, "time": "2025-05-14 10:00:21", "headline": "What Analysts Are Saying About JD.com Stock", "summary": " ", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408309/what-analysts-are-saying-about-jd-com-stock", "tags": []}
{"id": 45408311, "time": "2025-05-14 10:00:24", "headline": "Looking Into Seagate Tech Hldgs's Recent Short Interest", "summary": " ", "symbols": ["STX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45408311/looking-into-seagate-tech-hldgss-recent-short-interest", "tags": []}
{"id": 45408320, "time": "2025-05-14 10:00:29", "headline": "How Is The Market Feeling About AECOM?", "summary": " ", "symbols": ["ACM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45408320/how-is-the-market-feeling-about-aecom", "tags": []}
{"id": 45408321, "time": "2025-05-14 10:00:31", "headline": "P/E Ratio Insights for APi Group", "summary": " ", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45408321/pe-ratio-insights-for-api-group", "tags": []}
{"id": 45408327, "time": "2025-05-14 10:00:35", "headline": "Is Kratos Defense & Security Gaining or Losing Market Support?", "summary": " ", "symbols": ["KTOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45408327/is-kratos-defense-security-gaining-or-losing-market-support", "tags": []}
{"id": 45408331, "time": "2025-05-14 10:00:41", "headline": "4 Analysts Assess Fate Therapeutics: What You Need To Know", "summary": " ", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408331/4-analysts-assess-fate-therapeutics-what-you-need-to-know", "tags": []}
{"id": 45408334, "time": "2025-05-14 10:00:49", "headline": "Breaking Down Advanced Micro Devices: 26 Analysts Share Their Views", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408334/breaking-down-advanced-micro-devices-26-analysts-share-their-views", "tags": []}
{"id": 45408336, "time": "2025-05-14 10:00:56", "headline": "Unpacking the Latest Options Trading Trends in Palantir Technologies", "summary": " ", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45408336/unpacking-the-latest-options-trading-trends-in-palantir-technologies", "tags": []}
{"id": 45408337, "time": "2025-05-14 10:00:56", "headline": "Walmart's Earnings: A Preview", "summary": " ", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408337/walmarts-earnings-a-preview", "tags": ["earnings"]}
{"id": 45408338, "time": "2025-05-14 10:00:57", "headline": "Where Harley-Davidson Stands With Analysts", "summary": " ", "symbols": ["HOG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408338/where-harley-davidson-stands-with-analysts", "tags": []}
{"id": 45408341, "time": "2025-05-14 10:00:59", "headline": "B of A Securities Maintains Buy on OneStream, Raises Price Target to $33", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408341/b-of-a-securities-maintains-buy-on-onestream-raises-price-target-to-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408344, "time": "2025-05-14 10:01:01", "headline": "Smart Money Is Betting Big In AMD Options", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45408344/smart-money-is-betting-big-in-amd-options", "tags": []}
{"id": 45408345, "time": "2025-05-14 10:01:04", "headline": "Wells Fargo Maintains Equal-Weight on Deckers Outdoor, Raises Price Target to $120", "summary": "", "symbols": ["DECK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408345/wells-fargo-maintains-equal-weight-on-deckers-outdoor-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408356, "time": "2025-05-14 10:01:10", "headline": "The Analyst Verdict: KinderCare Learning In The Eyes Of 7 Experts", "summary": " ", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408356/the-analyst-verdict-kindercare-learning-in-the-eyes-of-7-experts", "tags": []}
{"id": 45408368, "time": "2025-05-14 10:01:15", "headline": "An Overview of Globant's Earnings", "summary": " ", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408368/an-overview-of-globants-earnings", "tags": ["earnings"]}
{"id": 45408375, "time": "2025-05-14 10:01:23", "headline": "Earnings Outlook For VEON", "summary": " ", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408375/earnings-outlook-for-veon", "tags": ["earnings", "guidance"]}
{"id": 45408376, "time": "2025-05-14 10:01:24", "headline": "Where UnitedHealth Group Stands With Analysts", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45408376/where-unitedhealth-group-stands-with-analysts", "tags": []}
{"id": 45408381, "time": "2025-05-14 10:01:28", "headline": "Cantor Fitzgerald Reiterates Overweight on NeuroPace, Maintains $17 Price Target", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408381/cantor-fitzgerald-reiterates-overweight-on-neuropace-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 45408384, "time": "2025-05-14 10:01:32", "headline": "Earnings Preview: KeyCorp", "summary": " ", "symbols": ["KEY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408384/earnings-preview-keycorp", "tags": ["earnings"]}
{"id": 45408391, "time": "2025-05-14 10:01:41", "headline": "Kura Oncology And Kyowa Kirin Announce Combination Data For Ziftomenib In Oral Presentation At The 2025 EHA Congress", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45408391/kura-oncology-and-kyowa-kirin-announce-combination-data-for-ziftomenib-in-oral-presentation-at-th", "tags": []}
{"id": 45408395, "time": "2025-05-14 10:01:43", "headline": "Kyocera Q4 EPS $0.03 Down From $0.05 YoY, Sales $3.42B Down From $3.45B YoY", "summary": "", "symbols": ["KYOCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45408395/kyocera-q4-eps-0-03-down-from-0-05-yoy-sales-3-42b-down-from-3-45b-yoy", "tags": ["earnings"]}
{"id": 45408408, "time": "2025-05-14 10:01:51", "headline": "A Glimpse of Canadian Solar's Earnings Potential", "summary": " ", "symbols": ["CSIQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408408/a-glimpse-of-canadian-solars-earnings-potential", "tags": ["earnings"]}
{"id": 45408420, "time": "2025-05-14 10:02:03", "headline": "KULR Tech Gr Earnings Preview", "summary": " ", "symbols": ["KULR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408420/kulr-tech-gr-earnings-preview", "tags": ["earnings"]}
{"id": 45408427, "time": "2025-05-14 10:02:10", "headline": "Agios Pharma: New Data On PK Activators, Mitapivat And Tebapivat, To Be Featured In Oral And Poster Presentations During EHA Congress 2025", "summary": "", "symbols": ["AGIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408427/agios-pharma-new-data-on-pk-activators-mitapivat-and-tebapivat-to-be-featured-in-oral-and-poster-pre", "tags": []}
{"id": 45408429, "time": "2025-05-14 10:02:12", "headline": "Earnings Preview: Bit Digital", "summary": " ", "symbols": ["BTBT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408429/earnings-preview-bit-digital", "tags": ["earnings"]}
{"id": 45408451, "time": "2025-05-14 10:02:22", "headline": "Examining the Future: Omeros's Earnings Outlook", "summary": " ", "symbols": ["OMER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408451/examining-the-future-omeross-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45408452, "time": "2025-05-14 10:02:23", "headline": "Stock Of The Day: Palantir Breaks Out As Classic 'Sell the News' Sets Up Rally", "summary": "Shares of Palantir Technologies are trending higher as the stock has been in a strong uptrend since it reversed after heading lower.", "symbols": ["PLTR"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/trading-ideas/technicals/25/05/45408452/stock-of-the-day-palantir-breaks-out-sell-news-rally", "tags": []}
{"id": 45408458, "time": "2025-05-14 10:02:32", "headline": "Exploring Sensus Healthcare's Earnings Expectations", "summary": " ", "symbols": ["SRTS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408458/exploring-sensus-healthcares-earnings-expectations", "tags": ["earnings"]}
{"id": 45408464, "time": "2025-05-14 10:02:38", "headline": "Wells Fargo Maintains Equal-Weight on Dick's Sporting Goods, Raises Price Target to $187", "summary": "", "symbols": ["DKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408464/wells-fargo-maintains-equal-weight-on-dicks-sporting-goods-raises-price-target-to-187", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408478, "time": "2025-05-14 10:02:46", "headline": "Insights into Expion360's Upcoming Earnings", "summary": " ", "symbols": ["XPON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408478/insights-into-expion360s-upcoming-earnings", "tags": ["earnings"]}
{"id": 45408481, "time": "2025-05-14 10:02:53", "headline": "B of A Securities Maintains Buy on Wingstop, Raises Price Target to $360", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408481/b-of-a-securities-maintains-buy-on-wingstop-raises-price-target-to-360", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408482, "time": "2025-05-14 10:02:53", "headline": "Earnings Outlook For Banzai International", "summary": " ", "symbols": ["BNZI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45408482/earnings-outlook-for-banzai-international", "tags": ["earnings", "guidance"]}
{"id": 45408522, "time": "2025-05-14 10:03:46", "headline": "Wells Fargo Maintains Underweight on Hanesbrands, Raises Price Target to $4", "summary": "", "symbols": ["HBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408522/wells-fargo-maintains-underweight-on-hanesbrands-raises-price-target-to-4", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408553, "time": "2025-05-14 10:04:26", "headline": "Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13", "summary": "", "symbols": ["VNDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408553/cantor-fitzgerald-assumes-vanda-pharmaceuticals-at-overweight-announces-price-target-of-13", "tags": []}
{"id": 45408576, "time": "2025-05-14 10:04:56", "headline": "Wells Fargo Maintains Overweight on Kontoor Brands, Raises Price Target to $90", "summary": "", "symbols": ["KTB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408576/wells-fargo-maintains-overweight-on-kontoor-brands-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408610, "time": "2025-05-14 10:05:18", "headline": "'Qatar Airways Expected To Order 150 Boeing Jets During Donald Trump's Doha Visit' - AeroTime", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408610/qatar-airways-expected-to-order-150-boeing-jets-during-donald-trumps-doha-visit-aerotime", "tags": []}
{"id": 45408603, "time": "2025-05-14 10:04:59", "headline": "Why Quoin Pharmaceuticals (QNRX) Stock Is Exploding Higher Wednesday", "summary": "Shares of Quoin Pharmaceuticals surged 47.5% Wednesday morning. The stock is higher following the release of promising initial data from its ongoing clinical study of QRX003.", "symbols": ["QNRX"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45408603/why-quoin-pharmaceuticals-qnrx-stock-is-exploding-higher-wednesday", "tags": ["fda"]}
{"id": 45408620, "time": "2025-05-14 10:05:36", "headline": "Guardian Pharmacy Services Acquires Senior Care Pharmacy in Wichita, Kan, Expanding Midwest Long-Term Care Footprint; Terms Not Disclosed", "summary": "", "symbols": ["GRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408620/guardian-pharmacy-services-acquires-senior-care-pharmacy-in-wichita-kan-expanding-midwest-long-term", "tags": ["merger"]}
{"id": 45408627, "time": "2025-05-14 10:05:41", "headline": "B of A Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $180", "summary": "", "symbols": ["THC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408627/b-of-a-securities-maintains-buy-on-tenet-healthcare-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408683, "time": "2025-05-14 10:07:03", "headline": "Wells Fargo Maintains Overweight on Levi Strauss, Raises Price Target to $22", "summary": "", "symbols": ["LEVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408683/wells-fargo-maintains-overweight-on-levi-strauss-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408715, "time": "2025-05-14 10:07:21", "headline": "B of A Securities Maintains Neutral on Under Armour, Lowers Price Target to $8", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408715/b-of-a-securities-maintains-neutral-on-under-armour-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 45408760, "time": "2025-05-14 10:08:13", "headline": "Wells Fargo Maintains Equal-Weight on Nike, Raises Price Target to $60", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408760/wells-fargo-maintains-equal-weight-on-nike-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408724, "time": "2025-05-14 10:07:16", "headline": "Tower Semiconductor Stock Dips Despite Q1 Revenue Growth As Margins Squeeze", "summary": "Tower Semiconductor reported 9% Y/Y revenue growth and beat EPS estimates. Despite stock decline, CEO expects further growth in RF and sensors business.", "symbols": ["TSEM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/25/05/45408724/tower-semiconductor-stock-dips-despite-q1-revenue-growth-as-margins-squeeze", "tags": ["earnings", "management"]}
{"id": 45408806, "time": "2025-05-14 10:09:09", "headline": "Zevra Therapeutics (ZVRA) Stock Jumps on Strong Q1 Results: What's Going On?", "summary": "Zevra Therapeutics shares are trading higher by 6.7% Wednesday morning. The company reported better-than-expected Q1 financial results.", "symbols": ["ZVRA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45408806/zevra-therapeutics-zvra-stock-jumps-on-strong-q1-results-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 45408816, "time": "2025-05-14 10:09:23", "headline": "Wells Fargo Maintains Equal-Weight on PVH, Raises Price Target to $100", "summary": "", "symbols": ["PVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408816/wells-fargo-maintains-equal-weight-on-pvh-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408822, "time": "2025-05-14 10:09:35", "headline": "President Trump Says Discussed Russia And Ukraine With Qatar Emir, Iran Too; Says Iran Situation Will Work Out; Says Boeing Agreement Is For Over $200B", "summary": "", "symbols": ["BA", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408822/president-trump-says-discussed-russia-and-ukraine-with-qatar-emir-iran-too-says-iran-situation-will", "tags": ["contract"]}
{"id": 45408840, "time": "2025-05-14 10:10:07", "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45408840/trading-halt-halt-status-updated-at-10-10-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 45408878, "time": "2025-05-14 10:10:43", "headline": "Wells Fargo Maintains Overweight on Ralph Lauren, Raises Price Target to $275", "summary": "", "symbols": ["RL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45408878/wells-fargo-maintains-overweight-on-ralph-lauren-raises-price-target-to-275", "tags": ["analyst_other", "price_target_up"]}
{"id": 45408999, "time": "2025-05-14 10:11:54", "headline": "Adapting to an Unstable World: Gold, Dollar, and Investor Strategies", "summary": "Geopolitical tensions in Yemen and South Asia drive gold and strengthen the dollar. Explore investor strategies on Benzinga.", "symbols": [], "source": "benzinga", "author": "Julia Khandoshko", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/05/45408999/adapting-to-an-unstable-world-gold-dollar-and-investor-strategies", "tags": []}
{"id": 45409051, "time": "2025-05-14 10:12:24", "headline": "Wells Fargo Maintains Overweight on Ross Stores, Raises Price Target to $155", "summary": "", "symbols": ["ROST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409051/wells-fargo-maintains-overweight-on-ross-stores-raises-price-target-to-155", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409055, "time": "2025-05-14 10:12:30", "headline": "Morgan Stanley Downgrades Halozyme Therapeutics to Equal-Weight, Lowers Price Target to $62", "summary": "", "symbols": ["HALO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409055/morgan-stanley-downgrades-halozyme-therapeutics-to-equal-weight-lowers-price-target-to-62", "tags": ["analyst_down", "price_target_down"]}
{"id": 45407792, "time": "2025-05-14 09:49:37", "headline": "'I Thought He Wanted To Be A Drug Dealer,' How Cannabis Healed A Father-Son Rift And Sparked Two Thriving Businesses", "summary": "After cannabis healed their rift, Los Arias and his father launched Flostar Group. Now he&#39;s speaking at Benzinga&#39;s June conference.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/news/events/25/05/45407792/i-thought-he-wanted-to-be-a-drug-dealer-how-cannabis-healed-a-father-son-rift-and-sparked-two-thriving-businesses", "tags": []}
{"id": 45409202, "time": "2025-05-14 10:13:25", "headline": "FatPipe Launches VMware VeloCloud Replacement Program To Help Enterprises Upgrade To Advanced SD-WAN Solutions; Sales Growth To Be Funded With IPO Proceeds And Internally Generated Funds", "summary": "", "symbols": ["FATN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409202/fatpipe-launches-vmware-velocloud-replacement-program-to-help-enterprises-upgrade-to-advanced-sd-wan", "tags": ["analyst_up"]}
{"id": 45409225, "time": "2025-05-14 10:13:47", "headline": "Wells Fargo Maintains Equal-Weight on Signet Jewelers, Raises Price Target to $70", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409225/wells-fargo-maintains-equal-weight-on-signet-jewelers-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409274, "time": "2025-05-14 10:14:37", "headline": "Wells Fargo Maintains Overweight on Tapestry, Raises Price Target to $100", "summary": "", "symbols": ["TPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409274/wells-fargo-maintains-overweight-on-tapestry-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409311, "time": "2025-05-14 10:15:18", "headline": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["WELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45409311/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45409332, "time": "2025-05-14 10:15:43", "headline": "Wells Fargo Maintains Equal-Weight on TJX Companies, Raises Price Target to $120", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409332/wells-fargo-maintains-equal-weight-on-tjx-companies-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409339, "time": "2025-05-14 10:15:53", "headline": "JPMorgan Completes First Public Trade Of Tokenized Treasuries", "summary": "JPMorgan&#39;s (NYSE:JPM) blockchain division, Kinexys, on Wednesday announced it has executed its first public transaction involving tokenized U.S.", "symbols": ["JPM", "LINKUSD", "ONDOUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45409339/jpmorgan-completes-first-public-trade-of-tokenized-treasuries", "tags": []}
{"id": 45409372, "time": "2025-05-14 10:16:44", "headline": "Wells Fargo Maintains Underweight on Ulta Beauty, Raises Price Target to $315", "summary": "", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409372/wells-fargo-maintains-underweight-on-ulta-beauty-raises-price-target-to-315", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409393, "time": "2025-05-14 10:17:06", "headline": "Morgan Stanley Upgrades KKR to Overweight, Raises Price Target to $150", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409393/morgan-stanley-upgrades-kkr-to-overweight-raises-price-target-to-150", "tags": ["analyst_up", "price_target_up"]}
{"id": 45409397, "time": "2025-05-14 10:17:09", "headline": "Genmab To Present 14 Abstracts Evaluating Epcoritamab As Monotherapy And In Combination Across Disease Settings In Patients With DLBCL And FL At EHA Congress 2025", "summary": "", "symbols": ["GMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409397/genmab-to-present-14-abstracts-evaluating-epcoritamab-as-monotherapy-and-in-combination-across-disea", "tags": []}
{"id": 45409401, "time": "2025-05-14 10:17:15", "headline": "MicroAlgo Unveils Quantum Information Recursive Optimization Algorithm To Revolutionize Combinatorial Optimization Using Quantum Computing", "summary": "", "symbols": ["MLGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409401/microalgo-unveils-quantum-information-recursive-optimization-algorithm-to-revolutionize-combinatoria", "tags": []}
{"id": 45409425, "time": "2025-05-14 10:17:38", "headline": "Wells Fargo Maintains Equal-Weight on Under Armour, Raises Price Target to $5", "summary": "", "symbols": ["UA", "UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409425/wells-fargo-maintains-equal-weight-on-under-armour-raises-price-target-to-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409436, "time": "2025-05-14 10:17:55", "headline": "Finanz Informatik And IBM  Expand Collaboration; IBM To Support Finanz Informatik In Its Strategic Initiatives With AI, Automation, And Hybrid Cloud Technology", "summary": "", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409436/finanz-informatik-and-ibm-expand-collaboration-ibm-to-support-finanz-informatik-in-its-strategic-ini", "tags": []}
{"id": 45409455, "time": "2025-05-14 10:18:18", "headline": "Wells Fargo Maintains Equal-Weight on VF, Raises Price Target to $13", "summary": "", "symbols": ["VFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409455/wells-fargo-maintains-equal-weight-on-vf-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409457, "time": "2025-05-14 10:18:22", "headline": "Etoro Group IPO Price Indicating $59.50 On 505K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409457/etoro-group-ipo-price-indicating-59-50-on-505k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45409502, "time": "2025-05-14 10:19:27", "headline": "Cantor Fitzgerald Reiterates Underweight on Airbnb, Maintains $100 Price Target", "summary": "", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409502/cantor-fitzgerald-reiterates-underweight-on-airbnb-maintains-100-price-target", "tags": ["analyst_other"]}
{"id": 45409503, "time": "2025-05-14 10:19:31", "headline": "Wells Fargo Maintains Underweight on Victoria's Secret, Raises Price Target to $15", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409503/wells-fargo-maintains-underweight-on-victorias-secret-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409509, "time": "2025-05-14 10:19:40", "headline": "Samsung's $1.7 Billion Cooling Spree - Buys Fl\u00e4ktGroup To Target Data Center Boom", "summary": "Samsung Electronics Co acquires Fl\u00e4ktGroup for $1.7B, expanding its HVAC business. The deal is expected to capitalize on growing demand for advanced technologies.", "symbols": ["SSNLF"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/05/45409509/samsungs-1-7-billion-cooling-spree-buys-flaktgroup-to-target-data-center-boom", "tags": ["merger", "contract"]}
{"id": 45409525, "time": "2025-05-14 10:20:01", "headline": "Morgan Stanley Downgrades Cboe Global Markets to Underweight, Lowers Price Target to $215", "summary": "", "symbols": ["CBOE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409525/morgan-stanley-downgrades-cboe-global-markets-to-underweight-lowers-price-target-to-215", "tags": ["analyst_down", "price_target_down"]}
{"id": 45409586, "time": "2025-05-14 10:21:15", "headline": "Wells Fargo Maintains Overweight on Wingstop, Raises Price Target to $320", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409586/wells-fargo-maintains-overweight-on-wingstop-raises-price-target-to-320", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409601, "time": "2025-05-14 10:21:52", "headline": "Wells Fargo Maintains Equal-Weight on Plug Power, Lowers Price Target to $1", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409601/wells-fargo-maintains-equal-weight-on-plug-power-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409638, "time": "2025-05-14 10:22:28", "headline": "Wells Fargo Maintains Equal-Weight on Venture Global, Raises Price Target to $12", "summary": "", "symbols": ["VG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409638/wells-fargo-maintains-equal-weight-on-venture-global-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409650, "time": "2025-05-14 10:22:50", "headline": "Morgan Stanley Maintains Overweight on UnitedHealth Group, Lowers Price Target to $374", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409650/morgan-stanley-maintains-overweight-on-unitedhealth-group-lowers-price-target-to-374", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409657, "time": "2025-05-14 10:22:59", "headline": "Cantor Fitzgerald Reiterates Overweight on Astria Therapeutics, Maintains $47 Price Target", "summary": "", "symbols": ["ATXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409657/cantor-fitzgerald-reiterates-overweight-on-astria-therapeutics-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 45409663, "time": "2025-05-14 10:23:16", "headline": "Wells Fargo Maintains Overweight on Ameren, Raises Price Target to $112", "summary": "", "symbols": ["AEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409663/wells-fargo-maintains-overweight-on-ameren-raises-price-target-to-112", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409703, "time": "2025-05-14 10:24:16", "headline": "Wells Fargo Maintains Overweight on Devon Energy, Raises Price Target to $46", "summary": "", "symbols": ["DVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409703/wells-fargo-maintains-overweight-on-devon-energy-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409706, "time": "2025-05-14 10:24:22", "headline": "Morgan Stanley Maintains Overweight on KinderCare Learning, Lowers Price Target to $19", "summary": "", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409706/morgan-stanley-maintains-overweight-on-kindercare-learning-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409738, "time": "2025-05-14 10:25:06", "headline": "Cantor Fitzgerald Reiterates Overweight on Zevra Therapeutics, Maintains $25 Price Target", "summary": "", "symbols": ["ZVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409738/cantor-fitzgerald-reiterates-overweight-on-zevra-therapeutics-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 45409743, "time": "2025-05-14 10:25:26", "headline": "Wells Fargo Maintains Overweight on Calumet, Lowers Price Target to $21", "summary": "", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409743/wells-fargo-maintains-overweight-on-calumet-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409762, "time": "2025-05-14 10:25:55", "headline": "Morgan Stanley Maintains Overweight on Exelixis, Raises Price Target to $47", "summary": "", "symbols": ["EXEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409762/morgan-stanley-maintains-overweight-on-exelixis-raises-price-target-to-47", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409804, "time": "2025-05-14 10:26:08", "headline": "Wells Fargo Maintains Overweight on ConocoPhillips, Lowers Price Target to $113", "summary": "", "symbols": ["COP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409804/wells-fargo-maintains-overweight-on-conocophillips-lowers-price-target-to-113", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409856, "time": "2025-05-14 10:26:48", "headline": "What's Going On With WeRide Stock?", "summary": "WeRide Inc (NASDAQ:WRD) shares are seeing increased attention in recent weeks, especially from retail investors. The company on Wednesday announced eight new autonomous robotaxi routes in China.", "symbols": ["WRD"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/global/25/05/45409856/whats-going-on-with-weride-stock", "tags": ["why_moving"]}
{"id": 45409859, "time": "2025-05-14 10:26:56", "headline": "Wells Fargo Maintains Equal-Weight on Murphy Oil, Lowers Price Target to $26", "summary": "", "symbols": ["MUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409859/wells-fargo-maintains-equal-weight-on-murphy-oil-lowers-price-target-to-26", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409904, "time": "2025-05-14 10:27:50", "headline": "Shiba Inu Burns 46 Million SHIB In Single Day: What Is Going On?", "summary": "Shiba Inu (CRYPTO: SHIB) is showing renewed bullish momentum as consistent token burns and growing adoption of the Shibarium Layer 2 network fuel speculation of an explosive leg higher.", "symbols": ["DOGEUSD", "PEPEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45409904/shiba-inu-burns-46-million-shib-in-single-day-what-is-going-on", "tags": []}
{"id": 45409907, "time": "2025-05-14 10:27:52", "headline": "Wells Fargo Maintains Overweight on SLM, Raises Price Target to $38", "summary": "", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409907/wells-fargo-maintains-overweight-on-slm-raises-price-target-to-38", "tags": ["analyst_other", "price_target_up"]}
{"id": 45409916, "time": "2025-05-14 10:28:03", "headline": "Oppenheimer Maintains Outperform on Olema Pharmaceuticals, Lowers Price Target to $22", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409916/oppenheimer-maintains-outperform-on-olema-pharmaceuticals-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409966, "time": "2025-05-14 10:29:20", "headline": "Etoro Group IPO Price Indicating $60.50 On 690K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409966/etoro-group-ipo-price-indicating-60-50-on-690k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45409975, "time": "2025-05-14 10:29:42", "headline": "Oppenheimer Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $9", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409975/oppenheimer-maintains-outperform-on-allogene-therapeutics-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 45409992, "time": "2025-05-14 10:30:00", "headline": "Wells Fargo Maintains Overweight on UnitedHealth Group, Lowers Price Target to $351", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45409992/wells-fargo-maintains-overweight-on-unitedhealth-group-lowers-price-target-to-351", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410009, "time": "2025-05-14 10:30:15", "headline": "USA Crude Oil Inventories 3.454M Barrel Build Vs 2.000M Barrel Draw Est.; 2.032M Barrel Draw Prior", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45410009/usa-crude-oil-inventories-3-454m-barrel-build-vs-2-000m-barrel-draw-est-2-032m-ba", "tags": []}
{"id": 45410011, "time": "2025-05-14 10:30:15", "headline": "Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ZTS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45410011/heres-how-much-100-invested-in-zoetis-10-years-ago-would-be-worth-today", "tags": []}
{"id": 45410012, "time": "2025-05-14 10:30:16", "headline": "Cantor Fitzgerald Reiterates Overweight on SoundThinking, Maintains $20 Price Target", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410012/cantor-fitzgerald-reiterates-overweight-on-soundthinking-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 45410016, "time": "2025-05-14 10:30:23", "headline": "EIA Weekly Distillates Stocks 3.155M Barrel Draw Vs 0.100M Barrel Build Est.; 1.107M Barrel Draw Prior", "summary": "", "symbols": ["SPY", "UNG", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45410016/eia-weekly-distillates-stocks-3-155m-barrel-draw-vs-0-100m-barrel-build-est-1-107", "tags": []}
{"id": 45410032, "time": "2025-05-14 10:30:34", "headline": "USA Gasoline Inventories 1.022M Barrel Draw Vs 0.600M Barrel Draw Est.; 0.188M Barrel Build Prior", "summary": "", "symbols": ["SPY", "UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45410032/usa-gasoline-inventories-1-022m-barrel-draw-vs-0-600m-barrel-draw-est-0-188m-barr", "tags": []}
{"id": 45410079, "time": "2025-05-14 10:31:34", "headline": "Oppenheimer Initiates Coverage On Digital Realty Trust with Outperform Rating, Announces Price Target of $200", "summary": "", "symbols": ["DLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410079/oppenheimer-initiates-coverage-on-digital-realty-trust-with-outperform-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 45410084, "time": "2025-05-14 10:31:59", "headline": "Legal Cannabis, 10 Years Later: Real Data From The First Country To Do It", "summary": "10 years after legalizing cannabis, Uruguay shows positive public health outcomes\u2014but the system faces growing pressure to modernize. The data reveals...", "symbols": [], "source": "benzinga", "author": "El Planteo", "url": "https://www.benzinga.com/markets/cannabis/25/05/45410084/legal-cannabis-10-years-later-real-data-from-the-first-country-to-do-it", "tags": []}
{"id": 45410089, "time": "2025-05-14 10:32:12", "headline": "Tampa Bay Lightning Enters Into Multi-year Media Rights Agreement With Scripps Sports", "summary": "", "symbols": ["SSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410089/tampa-bay-lightning-enters-into-multi-year-media-rights-agreement-with-scripps-sports", "tags": ["contract"]}
{"id": 45410111, "time": "2025-05-14 10:32:36", "headline": "Wells Fargo Maintains Equal-Weight on Hyperfine, Lowers Price Target to $0.68", "summary": "", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410111/wells-fargo-maintains-equal-weight-on-hyperfine-lowers-price-target-to-0-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410147, "time": "2025-05-14 10:33:37", "headline": "Oppenheimer Initiates Coverage On Core Scientific with Outperform Rating, Announces Price Target of $15", "summary": "", "symbols": ["CORZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410147/oppenheimer-initiates-coverage-on-core-scientific-with-outperform-rating-announces-price-target-of-1", "tags": ["analyst_init"]}
{"id": 45410169, "time": "2025-05-14 10:33:52", "headline": "Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $13", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410169/wells-fargo-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410202, "time": "2025-05-14 10:34:51", "headline": "Wells Fargo Maintains Equal-Weight on Adaptimmune Therapeutics, Lowers Price Target to $1", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410202/wells-fargo-maintains-equal-weight-on-adaptimmune-therapeutics-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410212, "time": "2025-05-14 10:35:13", "headline": "Oppenheimer Maintains Outperform on Inovio Pharmaceuticals, Lowers Price Target to $13", "summary": "", "symbols": ["INO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410212/oppenheimer-maintains-outperform-on-inovio-pharmaceuticals-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410216, "time": "2025-05-14 10:35:19", "headline": "Cruises Set Sail Ahead Of Summer Boom: These 3 S&P 500 Stocks Show Strongest Late-May Seasonality", "summary": " ", "symbols": ["BA", "CCL", "CZR", "ENPH", "NCLH", "RCL"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/25/05/45410216/cruises-set-sail-ahead-of-summer-boom-these-3-sp-500-stocks-show-strongest-late-may-seasonality", "tags": []}
{"id": 45410278, "time": "2025-05-14 10:36:42", "headline": "Oppenheimer Maintains Outperform on UnitedHealth Group, Lowers Price Target to $400", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410278/oppenheimer-maintains-outperform-on-unitedhealth-group-lowers-price-target-to-400", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410281, "time": "2025-05-14 10:36:51", "headline": "Wells Fargo Maintains Overweight on Arcturus Therapeutics, Lowers Price Target to $45", "summary": "", "symbols": ["ARCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410281/wells-fargo-maintains-overweight-on-arcturus-therapeutics-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410285, "time": "2025-05-14 10:36:53", "headline": "Charles Gasparino Posts On X \"Scoop: Trade-tariff deals with Japan and South Korea said to be \"close,\" according to me Wall Street sources close to the White House. Timing unclear. India deal as well though it has been throttled by the tensions with Pakistan....\"", "summary": "", "symbols": ["EWJ", "EWQ", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410285/charles-gasparino-posts-on-x-scoop-trade-tariff-deals-with-japan-and-south-korea-said-to-be-close-ac", "tags": ["contract"]}
{"id": 45410330, "time": "2025-05-14 10:37:40", "headline": "Charles Gasparino Posts On X \"Scoop: Trade-tariff deals with Japan and South Korea said to be \"close,\" according to me Wall Street sources close to the White House. Timing unclear. India deal as well though it has been throttled by the tensions with Pakistan...\"", "summary": "", "symbols": ["EWJ", "EWY", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45410330/charles-gasparino-posts-on-x-scoop-trade-tariff-deals-with-japan-and-south-korea-", "tags": ["contract"]}
{"id": 45410338, "time": "2025-05-14 10:37:54", "headline": "Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16", "summary": "", "symbols": ["MGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410338/wells-fargo-maintains-overweight-on-metagenomi-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410349, "time": "2025-05-14 10:38:13", "headline": "Benzinga Market Summary: S&P Roughly Flat At Open, AMD Rises On Buyback", "summary": "", "symbols": ["SPY", "VTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45410349/benzinga-market-summary-s-p-roughly-flat-at-open-amd-rises-on-buyback", "tags": ["buyback"]}
{"id": 45410350, "time": "2025-05-14 10:38:19", "headline": "Oppenheimer Maintains Outperform on Y-mAbs Therapeutics, Lowers Price Target to $20", "summary": "", "symbols": ["YMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410350/oppenheimer-maintains-outperform-on-y-mabs-therapeutics-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410384, "time": "2025-05-14 10:39:22", "headline": "Wells Fargo Maintains Equal-Weight on Masco, Raises Price Target to $73", "summary": "", "symbols": ["MAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410384/wells-fargo-maintains-equal-weight-on-masco-raises-price-target-to-73", "tags": ["analyst_other", "price_target_up"]}
{"id": 45410428, "time": "2025-05-14 10:40:36", "headline": "Oppenheimer Maintains Outperform on QuickLogic, Lowers Price Target to $11", "summary": "", "symbols": ["QUIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410428/oppenheimer-maintains-outperform-on-quicklogic-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410442, "time": "2025-05-14 10:41:16", "headline": "TMD Energy Shares Halted, News Pending", "summary": "", "symbols": ["TMDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410442/tmd-energy-shares-halted-news-pending", "tags": ["halt"]}
{"id": 45410636, "time": "2025-05-14 10:44:16", "headline": "Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $8", "summary": "", "symbols": ["AMLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410636/mizuho-maintains-outperform-on-amylyx-pharmaceuticals-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 45410638, "time": "2025-05-14 10:44:18", "headline": "Barclays Maintains Equal-Weight on Acadia Healthcare Co, Lowers Price Target to $28", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410638/barclays-maintains-equal-weight-on-acadia-healthcare-co-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410642, "time": "2025-05-14 10:44:27", "headline": "Exelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue Guidance", "summary": "Exelixis beats Q1 estimates with strong Cabometyx sales, raises 2025 guidance, and begins Phase 1 trial of its novel NK cell engager, XB628.", "symbols": ["EXEL"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45410642/exelixis-crushes-q1-earnings-estimates-with-strong-cabometyx-sales-raises-2025-revenue-guidance", "tags": ["earnings", "guidance", "fda"]}
{"id": 45410652, "time": "2025-05-14 10:44:46", "headline": "Cantor Fitzgerald Maintains Overweight on Pharvaris, Lowers Price Target to $25", "summary": "", "symbols": ["PHVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410652/cantor-fitzgerald-maintains-overweight-on-pharvaris-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410682, "time": "2025-05-14 10:45:17", "headline": "Here's How Much You Would Have Made Owning Chemed Stock In The Last 10 Years", "summary": " ", "symbols": ["CHE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45410682/heres-how-much-you-would-have-made-owning-chemed-stock-in-the-last-10-years", "tags": []}
{"id": 45410689, "time": "2025-05-14 10:45:26", "headline": "Mizuho Maintains Neutral on Apellis Pharmaceuticals, Lowers Price Target to $20", "summary": "", "symbols": ["APLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410689/mizuho-maintains-neutral-on-apellis-pharmaceuticals-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410707, "time": "2025-05-14 10:45:43", "headline": "Barclays Maintains Underweight on Adaptimmune Therapeutics, Lowers Price Target to $0.46", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410707/barclays-maintains-underweight-on-adaptimmune-therapeutics-lowers-price-target-to-0-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410714, "time": "2025-05-14 10:45:55", "headline": "'Uber Targets Commuters With Cheaper Pooled Rides, Price-Lock Pass'- Bloomberg", "summary": "", "symbols": ["UBER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410714/uber-targets-commuters-with-cheaper-pooled-rides-price-lock-pass-bloomberg", "tags": []}
{"id": 45410749, "time": "2025-05-14 10:46:17", "headline": "Etoro Group IPO Price Indicating $61.50 On 621K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45410749/etoro-group-ipo-price-indicating-61-50-on-621k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45410790, "time": "2025-05-14 10:46:33", "headline": "Mizuho Maintains Neutral on Fortrea Holdings, Lowers Price Target to $8", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410790/mizuho-maintains-neutral-on-fortrea-holdings-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410815, "time": "2025-05-14 10:47:20", "headline": "Barclays Maintains Equal-Weight on Ball, Lowers Price Target to $57", "summary": "", "symbols": ["BALL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410815/barclays-maintains-equal-weight-on-ball-lowers-price-target-to-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410816, "time": "2025-05-14 10:47:28", "headline": "Cantor Fitzgerald Reiterates Overweight on Capricor Therapeutics, Maintains $30 Price Target", "summary": "", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410816/cantor-fitzgerald-reiterates-overweight-on-capricor-therapeutics-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 45410843, "time": "2025-05-14 10:47:55", "headline": "Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $32", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410843/mizuho-maintains-neutral-on-acadia-healthcare-co-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410902, "time": "2025-05-14 10:48:28", "headline": "Etoro Group IPO Price Indicating $62.50 On 500K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410902/etoro-group-ipo-price-indicating-62-50-on-500k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45410939, "time": "2025-05-14 10:49:22", "headline": "AMD Stock Pops On $6 Billion Buyback Plan, US Tariff Ease", "summary": "AMD approves new $6 billion buyback, lifting total repurchase capacity to $10 billion as shares rebound on policy and trade news.", "symbols": ["AMD", "AMZN", "NVDA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/buybacks/25/05/45410939/amd-stock-pops-on-6-billion-buyback-plan-us-tariff-ease", "tags": ["buyback"]}
{"id": 45410946, "time": "2025-05-14 10:49:43", "headline": "Barclays Maintains Equal-Weight on Celanese, Raises Price Target to $62", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410946/barclays-maintains-equal-weight-on-celanese-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 45410949, "time": "2025-05-14 10:49:44", "headline": "Mizuho Maintains Outperform on JD.com, Lowers Price Target to $48", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410949/mizuho-maintains-outperform-on-jd-com-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 45410962, "time": "2025-05-14 10:49:59", "headline": "Cantor Fitzgerald Reiterates Overweight on Legend Biotech, Maintains $55 Price Target", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45410962/cantor-fitzgerald-reiterates-overweight-on-legend-biotech-maintains-55-price-target", "tags": ["analyst_other"]}
{"id": 45410991, "time": "2025-05-14 10:51:39", "headline": "Global-e Q1: Sales Up 30%, GMV Soars 34%, Extends Strategic Partnership With Shopify", "summary": "Global-E (GLBE) shares dropped 14.60% after reporting strong Q1 results, with sales of $189.9 million (+30% Y/Y) and GMV of $1.24 billion. The company also announced a new partnership with Shopify.", "symbols": ["GLBE", "ITEQ", "RJMG", "SHOP"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/05/45410991/global-e-q1-sales-up-30-gmv-soars-34-extends-strategic-partnership-with-shopify", "tags": ["earnings", "contract"]}
{"id": 45411039, "time": "2025-05-14 10:52:52", "headline": "Shiba Inu Price Breaks Out: Can Soaring Burn Rate Sustain the Bullish Momentum?", "summary": "Currently trading at $0.00001630, Shiba Inu (CRYPTO: SHIB) has marked a substantial 27.5% gain on the weekly chart.", "symbols": ["BTCUSD", "SHIBUSD"], "source": "benzinga", "author": "AJ Fabino", "url": "https://www.benzinga.com/25/05/45411039/shiba-inu-price-breaks-out-can-soaring-burn-rate-sustain-the-bullish-momentum", "tags": []}
{"id": 45411124, "time": "2025-05-14 10:54:09", "headline": "Goldman Sachs Maintains Buy on Axalta Coating Systems, Lowers Price Target to $40", "summary": "", "symbols": ["AXTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411124/goldman-sachs-maintains-buy-on-axalta-coating-systems-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411128, "time": "2025-05-14 10:54:18", "headline": "Barclays Maintains Equal-Weight on CF Industries Holdings, Raises Price Target to $91", "summary": "", "symbols": ["CF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411128/barclays-maintains-equal-weight-on-cf-industries-holdings-raises-price-target-to-91", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411142, "time": "2025-05-14 10:55:03", "headline": "Cantor Fitzgerald Maintains Overweight on CyberArk Software, Raises Price Target to $420", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411142/cantor-fitzgerald-maintains-overweight-on-cyberark-software-raises-price-target-to-420", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411148, "time": "2025-05-14 10:55:15", "headline": "Taiwan Semiconductor Commits $15 Billion To Chip Expansion, Approves Dividend", "summary": "Taiwan Semiconductor announced $15.25B for expansion and $5 cash dividend. Stock up 0.21% amid US-China trade deal and plan to repeal AI chip export restriction", "symbols": ["NVDA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/05/45411148/taiwan-semiconductor-commits-15-billion-to-chip-expansion-approves-dividend-amid-rising-global-demand", "tags": ["contract", "dividend"]}
{"id": 45411149, "time": "2025-05-14 10:55:20", "headline": "Goldman Sachs Maintains Buy on Axon Enterprise, Raises Price Target to $830", "summary": "", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411149/goldman-sachs-maintains-buy-on-axon-enterprise-raises-price-target-to-830", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411152, "time": "2025-05-14 10:55:25", "headline": "Barclays Maintains Equal-Weight on Corteva, Raises Price Target to $70", "summary": "", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411152/barclays-maintains-equal-weight-on-corteva-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411293, "time": "2025-05-14 10:56:18", "headline": "Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $14", "summary": "", "symbols": ["CC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411293/goldman-sachs-maintains-neutral-on-chemours-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411304, "time": "2025-05-14 10:56:43", "headline": "Barclays Maintains Overweight on Fate Therapeutics, Lowers Price Target to $2", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411304/barclays-maintains-overweight-on-fate-therapeutics-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411332, "time": "2025-05-14 10:57:48", "headline": "Goldman Sachs Maintains Neutral on Fortrea Holdings, Lowers Price Target to $5", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411332/goldman-sachs-maintains-neutral-on-fortrea-holdings-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411341, "time": "2025-05-14 10:57:58", "headline": "Barclays Maintains Overweight on Gauzy, Lowers Price Target to $13", "summary": "", "symbols": ["GAUZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411341/barclays-maintains-overweight-on-gauzy-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411370, "time": "2025-05-14 10:58:59", "headline": "Cantor Fitzgerald Maintains Overweight on Intuitive Machines, Raises Price Target to $16", "summary": "", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411370/cantor-fitzgerald-maintains-overweight-on-intuitive-machines-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411384, "time": "2025-05-14 10:59:22", "headline": "Goldman Sachs Upgrades Funko to Neutral, Lowers Price Target to $5.5", "summary": "", "symbols": ["FNKO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411384/goldman-sachs-upgrades-funko-to-neutral-lowers-price-target-to-5-5", "tags": ["analyst_up", "price_target_down"]}
{"id": 45411389, "time": "2025-05-14 10:59:26", "headline": "Barclays Maintains Equal-Weight on Helmerich & Payne, Lowers Price Target to $20", "summary": "", "symbols": ["HP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411389/barclays-maintains-equal-weight-on-helmerich-payne-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411396, "time": "2025-05-14 10:59:48", "headline": "Etoro Group IPO Price Indicating $63.50 On 694K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411396/etoro-group-ipo-price-indicating-63-50-on-694k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45411412, "time": "2025-05-14 11:00:06", "headline": "Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45411412/trading-halt-halt-status-updated-at-11-00-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 45411421, "time": "2025-05-14 11:00:07", "headline": "Barclays Maintains Equal-Weight on Johnson Controls Intl, Raises Price Target to $90", "summary": "", "symbols": ["JCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411421/barclays-maintains-equal-weight-on-johnson-controls-intl-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411444, "time": "2025-05-14 11:00:17", "headline": "Illinois Rep. Jonathan Jackson Sold Up to $265K Worth of Microsoft Stock", "summary": " ", "symbols": ["GOOGL", "MSFT", "NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/05/45411444/illinois-rep-jonathan-jackson-sold-up-to-265k-worth-of-microsoft-stock", "tags": []}
{"id": 45411445, "time": "2025-05-14 11:00:18", "headline": "$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45411445/1000-invested-in-veeva-systems-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45411448, "time": "2025-05-14 11:00:22", "headline": "Exploring The Competitive Space: Microsoft Versus Industry Peers In Software", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45411448/exploring-the-competitive-space-microsoft-versus-industry-peers-in-software", "tags": []}
{"id": 45411450, "time": "2025-05-14 11:00:22", "headline": "Rep. Greg Landsman Has Sold Up to $500K Worth Of Kroger Stock: Here's What You Should Know", "summary": " ", "symbols": ["AAPL", "GOOGL", "KR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/05/45411450/rep-greg-landsman-has-sold-up-to-500k-worth-of-kroger-stock-heres-what-you-should-know", "tags": []}
{"id": 45411451, "time": "2025-05-14 11:00:24", "headline": "Price Over Earnings Overview: Booking Holdings", "summary": " ", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45411451/price-over-earnings-overview-booking-holdings", "tags": ["earnings"]}
{"id": 45411452, "time": "2025-05-14 11:00:24", "headline": "How Is The Market Feeling About ASML Holding?", "summary": " ", "symbols": ["ASML"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45411452/how-is-the-market-feeling-about-asml-holding", "tags": []}
{"id": 45411455, "time": "2025-05-14 11:00:27", "headline": "Rep. Kelly Morrison Has Bought Up to $160K Worth Of Broadcom Stock: Here's What You Should Know", "summary": " ", "symbols": ["AVGO", "META", "TGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/05/45411455/rep-kelly-morrison-has-bought-up-to-160k-worth-of-broadcom-stock-heres-what-you-should-know", "tags": []}
{"id": 45411457, "time": "2025-05-14 11:00:28", "headline": "Goldman Sachs Maintains Neutral on iHeartMedia, Raises Price Target to $1.25", "summary": "", "symbols": ["IHRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411457/goldman-sachs-maintains-neutral-on-iheartmedia-raises-price-target-to-1-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411460, "time": "2025-05-14 11:00:30", "headline": "Is the Market Bullish or Bearish on Old National?", "summary": " ", "symbols": ["ONB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45411460/is-the-market-bullish-or-bearish-on-old-national", "tags": []}
{"id": 45411461, "time": "2025-05-14 11:00:30", "headline": "Analyzing Meta Platforms In Comparison To Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45411461/analyzing-meta-platforms-in-comparison-to-competitors-in-interactive-media-amp-services-industry", "tags": []}
{"id": 45411463, "time": "2025-05-14 11:00:32", "headline": "Sen. Sheldon Whitehouse Has Sold Up to $245K Worth Of Honeywell Intl Stock: Here's What You Should Know", "summary": " ", "symbols": ["AAPL", "HON", "NVDA", "SBUX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/05/45411463/sen-sheldon-whitehouse-has-sold-up-to-245k-worth-of-honeywell-intl-stock-heres-what-you-shoul", "tags": []}
{"id": 45411466, "time": "2025-05-14 11:00:35", "headline": "How Is The Market Feeling About UnitedHealth Group?", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45411466/how-is-the-market-feeling-about-unitedhealth-group", "tags": []}
{"id": 45411474, "time": "2025-05-14 11:00:37", "headline": "This Senator Just Sold Up To $700K In Thermo Fisher Scientific Stock", "summary": " ", "symbols": ["TMO", "VAW", "VLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/05/45411474/this-senator-just-sold-up-to-700k-in-thermo-fisher-scientific-stock", "tags": []}
{"id": 45411478, "time": "2025-05-14 11:00:39", "headline": "Insights Into Apple's Performance Versus Peers In Technology Hardware, Storage &amp; Peripherals Sector", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45411478/insights-into-apples-performance-versus-peers-in-technology-hardware-storage-amp-peripherals-sector", "tags": []}
{"id": 45411498, "time": "2025-05-14 11:00:54", "headline": "Spotlight on Apple: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45411498/spotlight-on-apple-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 45411503, "time": "2025-05-14 11:00:59", "headline": "Decoding Cisco Systems's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45411503/decoding-cisco-systemss-options-activity-whats-the-big-picture", "tags": []}
{"id": 45411504, "time": "2025-05-14 11:01:00", "headline": "Earnings Preview For Credicorp", "summary": " ", "symbols": ["BAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411504/earnings-preview-for-credicorp", "tags": ["earnings"]}
{"id": 45411510, "time": "2025-05-14 11:01:12", "headline": "NICE Earnings Preview", "summary": " ", "symbols": ["NICE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411510/nice-earnings-preview", "tags": ["earnings"]}
{"id": 45411511, "time": "2025-05-14 11:01:16", "headline": "Barclays Maintains Overweight on Macrogenics, Lowers Price Target to $3", "summary": "", "symbols": ["MGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411511/barclays-maintains-overweight-on-macrogenics-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411513, "time": "2025-05-14 11:01:20", "headline": "Kraft Heinz Bets $3 Billion On US Factory Overhaul To Offset Tariff Impact: Report", "summary": "Kraft Heinz investing $3 billion to upgrade US factories, improve efficiency &amp; offset tariffs, expects faster product development &amp; 60-day notice for price increases.", "symbols": ["KHC"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/25/05/45411513/kraft-heinz-bets-3-billion-on-us-factory-overhaul-to-offset-tariff-impact-report", "tags": ["analyst_up"]}
{"id": 45411521, "time": "2025-05-14 11:01:33", "headline": "Exploring 374Water's Earnings Expectations", "summary": " ", "symbols": ["SCWO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411521/exploring-374waters-earnings-expectations", "tags": ["earnings"]}
{"id": 45411531, "time": "2025-05-14 11:01:47", "headline": "Earnings Preview For RenovoRx", "summary": " ", "symbols": ["RNXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411531/earnings-preview-for-renovorx", "tags": ["earnings"]}
{"id": 45411546, "time": "2025-05-14 11:01:59", "headline": "Earnings Outlook For WidePoint", "summary": " ", "symbols": ["WYY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411546/earnings-outlook-for-widepoint", "tags": ["earnings", "guidance"]}
{"id": 45411566, "time": "2025-05-14 11:02:19", "headline": "Uncovering Potential: PLBY Group's Earnings Preview", "summary": " ", "symbols": ["PLBY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411566/uncovering-potential-plby-groups-earnings-preview", "tags": ["earnings"]}
{"id": 45411579, "time": "2025-05-14 11:02:22", "headline": "Etoro Group IPO Price Indicating $64.50 On 706K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411579/etoro-group-ipo-price-indicating-64-50-on-706k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45411584, "time": "2025-05-14 11:02:27", "headline": "A Glimpse of Workhorse Gr's Earnings Potential", "summary": " ", "symbols": ["WKHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411584/a-glimpse-of-workhorse-grs-earnings-potential", "tags": ["earnings"]}
{"id": 45411599, "time": "2025-05-14 11:02:35", "headline": "Barclays Maintains Overweight on Mosaic, Raises Price Target to $40", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411599/barclays-maintains-overweight-on-mosaic-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411603, "time": "2025-05-14 11:02:37", "headline": "Insights into FitLife Brands's Upcoming Earnings", "summary": " ", "symbols": ["FTLF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411603/insights-into-fitlife-brandss-upcoming-earnings", "tags": ["earnings"]}
{"id": 45411605, "time": "2025-05-14 11:02:38", "headline": "Goldman Sachs Maintains Buy on KinderCare Learning, Lowers Price Target to $26", "summary": "", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411605/goldman-sachs-maintains-buy-on-kindercare-learning-lowers-price-target-to-26", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411617, "time": "2025-05-14 11:02:48", "headline": "A Look at MiNK Therapeutics's Upcoming Earnings Report", "summary": " ", "symbols": ["INKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411617/a-look-at-mink-therapeuticss-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 45411618, "time": "2025-05-14 11:02:48", "headline": "Basel Medical Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -29.3%", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45411618/basel-medical-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-29-3", "tags": ["halt"]}
{"id": 45411629, "time": "2025-05-14 11:02:56", "headline": "Exploring Kore Group Holdings's Earnings Expectations", "summary": " ", "symbols": ["KORE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411629/exploring-kore-group-holdingss-earnings-expectations", "tags": ["earnings"]}
{"id": 45411636, "time": "2025-05-14 11:03:02", "headline": "Preview: IM Cannabis's Earnings", "summary": " ", "symbols": ["IMCC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45411636/preview-im-cannabiss-earnings", "tags": ["earnings"]}
{"id": 45411653, "time": "2025-05-14 11:03:24", "headline": "Goldman Sachs Maintains Sell on Kronos Worldwide, Lowers Price Target to $8.5", "summary": "", "symbols": ["KRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411653/goldman-sachs-maintains-sell-on-kronos-worldwide-lowers-price-target-to-8-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411658, "time": "2025-05-14 11:03:29", "headline": "Barclays Maintains Equal-Weight on Nutrien, Raises Price Target to $61", "summary": "", "symbols": ["NTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411658/barclays-maintains-equal-weight-on-nutrien-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411675, "time": "2025-05-14 11:03:41", "headline": "RBC Capital Initiates Coverage On Dutch Bros with Outperform Rating, Announces Price Target of $83", "summary": "", "symbols": ["BROS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411675/rbc-capital-initiates-coverage-on-dutch-bros-with-outperform-rating-announces-price-target-of-83", "tags": ["analyst_init"]}
{"id": 45411721, "time": "2025-05-14 11:04:22", "headline": "Watching Ensysce Biosciences; Zacks Small-Cap Research Gives Stock $18.45 Price Valuation", "summary": "", "symbols": ["ENSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411721/watching-ensysce-biosciences-zacks-small-cap-research-gives-stock-18-45-price-valuation", "tags": []}
{"id": 45411725, "time": "2025-05-14 11:04:26", "headline": "Barclays Maintains Overweight on On Holding, Raises Price Target to $68", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411725/barclays-maintains-overweight-on-on-holding-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411738, "time": "2025-05-14 11:04:46", "headline": "Goldman Sachs Maintains Buy on Lineage, Lowers Price Target to $63", "summary": "", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411738/goldman-sachs-maintains-buy-on-lineage-lowers-price-target-to-63", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411783, "time": "2025-05-14 11:05:29", "headline": "From Mine To Magnet: MP Materials, Maaden Plan Rare Earth Chain In Saudi Arabia", "summary": "MP Materials Corp. (NYSE: MP) has partnered with Maaden to explore creating a full rare earth supply chain in Saudi Arabia, boosting industrial growth.", "symbols": ["MP", "REMX", "SETM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/05/45411783/from-mine-to-magnet-mp-materials-and-maaden-plan-integrated-rare-earth-chain-in-saudi-arabia", "tags": []}
{"id": 45411797, "time": "2025-05-14 11:05:41", "headline": "Goldman Sachs Maintains Buy on MercadoLibre, Raises Price Target to $3000", "summary": "", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411797/goldman-sachs-maintains-buy-on-mercadolibre-raises-price-target-to-3000", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411838, "time": "2025-05-14 11:06:37", "headline": "Goldman Sachs Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $18", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411838/goldman-sachs-maintains-buy-on-olema-pharmaceuticals-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411885, "time": "2025-05-14 11:07:31", "headline": "Goldman Sachs Maintains Buy on Robinhood Markets, Raises Price Target to $64", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411885/goldman-sachs-maintains-buy-on-robinhood-markets-raises-price-target-to-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411896, "time": "2025-05-14 11:07:44", "headline": "Barclays Maintains Overweight on Sangamo Therapeutics, Lowers Price Target to $5", "summary": "", "symbols": ["SGMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411896/barclays-maintains-overweight-on-sangamo-therapeutics-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45411919, "time": "2025-05-14 11:08:05", "headline": "RBC Capital Reiterates Outperform on Allogene Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411919/rbc-capital-reiterates-outperform-on-allogene-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 45411923, "time": "2025-05-14 11:08:16", "headline": "Goldman Sachs Maintains Neutral on Roblox, Raises Price Target to $80", "summary": "", "symbols": ["RBLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411923/goldman-sachs-maintains-neutral-on-roblox-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 45411966, "time": "2025-05-14 11:09:16", "headline": "Goldman Sachs Maintains Buy on Safehold, Lowers Price Target to $25", "summary": "", "symbols": ["SAFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45411966/goldman-sachs-maintains-buy-on-safehold-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 45412015, "time": "2025-05-14 11:10:32", "headline": "Goldman Sachs Maintains Buy on Venture Global, Lowers Price Target to $17.5", "summary": "", "symbols": ["VG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412015/goldman-sachs-maintains-buy-on-venture-global-lowers-price-target-to-17-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45412162, "time": "2025-05-14 11:11:27", "headline": "Antalpha Platform IPO Opens For Trade At $15.01/Share; IPO Priced At $12.80/Share On 3.85M Shares", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412162/antalpha-platform-ipo-opens-for-trade-at-15-01share-ipo-priced-at-12-80share-on-3-85m-shares", "tags": []}
{"id": 45412212, "time": "2025-05-14 11:12:05", "headline": "RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target", "summary": "", "symbols": ["APLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412212/rbc-capital-reiterates-sector-perform-on-applied-therapeutics-maintains-1-5-price-target", "tags": ["analyst_other"]}
{"id": 45412262, "time": "2025-05-14 11:12:37", "headline": "Antalpha Platform Shares Halted On Circuit Breaker To The Upside At $16.51/Share", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45412262/antalpha-platform-shares-halted-on-circuit-breaker-to-the-upside-at-16-51share", "tags": ["halt"]}
{"id": 45412360, "time": "2025-05-14 11:13:28", "headline": "Dynatrace Delivers Double Beat, Raises The Bar For 2026", "summary": "Dynatrace (DT) reports Q4 2025 results, with revenue up 17% YoY to $445.17M and adjusted EPS at $0.33, beating estimates. Q1 outlook also strong.", "symbols": ["DT"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/25/05/45412360/dynatrace-delivers-double-beat-raises-the-bar-for-2026", "tags": ["earnings", "guidance"]}
{"id": 45412383, "time": "2025-05-14 11:14:00", "headline": "Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month", "summary": "Hims &amp; Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month.", "symbols": ["HIMS"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45412383/hims-hers-stock-pulls-back-after-strong-q1-earnings-115-gain-over-past-month", "tags": ["earnings"]}
{"id": 45412410, "time": "2025-05-14 11:14:45", "headline": "RBC Capital Reiterates Outperform on Aramark, Maintains $47 Price Target", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412410/rbc-capital-reiterates-outperform-on-aramark-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 45412420, "time": "2025-05-14 11:15:03", "headline": "TMD Energy Shares Resumed Trade", "summary": "", "symbols": ["TMDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45412420/tmd-energy-shares-resumed-trade", "tags": []}
{"id": 45412429, "time": "2025-05-14 11:15:15", "headline": "Here's How Much You Would Have Made Owning Carpenter Tech Stock In The Last 15 Years", "summary": " ", "symbols": ["CRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45412429/heres-how-much-you-would-have-made-owning-carpenter-tech-stock-in-the-last-15-years", "tags": []}
{"id": 45411731, "time": "2025-05-14 11:04:26", "headline": "Trump Bypasses Europe, Blocks China's Middle East Ambitions With Preemptive Gulf Strategy", "summary": " ", "symbols": [], "source": "benzinga", "author": "European Capital Insights", "url": "https://www.benzinga.com/markets/eurozone/25/05/45411731/trump-bypasses-europe-blocks-chinas-middle-east-ambitions-with-preemptive-gulf-strategy", "tags": []}
{"id": 45412459, "time": "2025-05-14 11:16:04", "headline": "Ethereum Pushes Towards $3000 Breakout Amid Institutional Surge", "summary": "Ethereum (CRYPTO: ETH) is on an upswing, now trading at approximately $2665.70, following a gain of over 44% in the past seven days, according to CoinMarketCap.", "symbols": ["BABA", "ETHUSD", "KO"], "source": "benzinga", "author": "AJ Fabino", "url": "https://www.benzinga.com/25/05/45412459/ethereum-pushes-towards-3000-breakout-amid-institutional-surge", "tags": []}
{"id": 45412551, "time": "2025-05-14 11:18:10", "headline": "RBC Capital Reiterates Sector Perform on BCE, Maintains $35 Price Target", "summary": "", "symbols": ["BCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412551/rbc-capital-reiterates-sector-perform-on-bce-maintains-35-price-target", "tags": ["analyst_other"]}
{"id": 45412576, "time": "2025-05-14 11:18:39", "headline": "TMD Energy FY EPS $0.09 Down From $0.10 YoY, Sales $688.61M Up From $633.08M YoY", "summary": "", "symbols": ["TMDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45412576/tmd-energy-fy-eps-0-09-down-from-0-10-yoy-sales-688-61m-up-from-633-08m-yoy", "tags": ["earnings"]}
{"id": 45412664, "time": "2025-05-14 11:20:50", "headline": "RBC Capital Reiterates Sector Perform on BCE, Maintains C$35 Price Target", "summary": "", "symbols": ["TSX:BCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412664/rbc-capital-reiterates-sector-perform-on-bce-maintains-c-35-price-target", "tags": ["analyst_other"]}
{"id": 45412668, "time": "2025-05-14 11:20:54", "headline": "Antalpha Platform Shares Resume Trade", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45412668/antalpha-platform-shares-resume-trade", "tags": []}
{"id": 45412690, "time": "2025-05-14 11:21:27", "headline": "Antalpha Platform Shares Halted On Circuit Breaker To The Upside At $20.35/Share", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45412690/antalpha-platform-shares-halted-on-circuit-breaker-to-the-upside-at-20-35share", "tags": ["halt"]}
{"id": 45412743, "time": "2025-05-14 11:22:30", "headline": "Watching Rocket Companies; Shares See Volume To The Upside, Citron Research Posts On X \"Just bought more $RKT Rocket is about to Rocket- and we have already seen a \"turning point\".  ...\"", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412743/watching-rocket-companies-shares-see-volume-to-the-upside-citron-research-posts-on-x-just-bought-mor", "tags": []}
{"id": 45412770, "time": "2025-05-14 11:23:14", "headline": "Oklo Stock Jumps On New CTO, Improved Q1 And Nuclear Plant Progress", "summary": "Oklo shares are trading higher by 14.4% during Wednesday&#39;s session. The stock is gaining following a series of strategic and financial updates.", "symbols": ["OKLO"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45412770/oklo-stock-jumps-on-new-cto-improved-q1-and-nuclear-plant-progress", "tags": ["why_moving"]}
{"id": 45412786, "time": "2025-05-14 11:23:29", "headline": "RBC Capital Reiterates Outperform on Cannae Holdings, Maintains $22 Price Target", "summary": "", "symbols": ["CNNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412786/rbc-capital-reiterates-outperform-on-cannae-holdings-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 45412844, "time": "2025-05-14 11:24:13", "headline": "DA Davidson Maintains Neutral on Intellicheck, Raises Price Target to $3", "summary": "", "symbols": ["IDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45412844/da-davidson-maintains-neutral-on-intellicheck-raises-price-target-to-3", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413028, "time": "2025-05-14 11:26:21", "headline": "Antalpha Platform Shares Resume Trading", "summary": "", "symbols": ["ANTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45413028/antalpha-platform-shares-resume-trading", "tags": []}
{"id": 45413050, "time": "2025-05-14 11:26:49", "headline": "RBC Capital Reiterates Sector Perform on CarParts.com, Maintains $0.8 Price Target", "summary": "", "symbols": ["PRTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413050/rbc-capital-reiterates-sector-perform-on-carparts-com-maintains-0-8-price-target", "tags": ["analyst_other"]}
{"id": 45413096, "time": "2025-05-14 11:27:41", "headline": "DA Davidson Maintains Buy on PaySign, Raises Price Target to $6", "summary": "", "symbols": ["PAYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413096/da-davidson-maintains-buy-on-paysign-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413153, "time": "2025-05-14 11:29:24", "headline": "RBC Capital Reiterates Outperform on CyberArk Software, Maintains $420 Price Target", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413153/rbc-capital-reiterates-outperform-on-cyberark-software-maintains-420-price-target", "tags": ["analyst_other"]}
{"id": 45413247, "time": "2025-05-14 11:31:32", "headline": "RBC Capital Reiterates Outperform on Exelixis, Maintains $40 Price Target", "summary": "", "symbols": ["EXEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413247/rbc-capital-reiterates-outperform-on-exelixis-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 45413258, "time": "2025-05-14 11:31:57", "headline": "Watching Capital One Financial; Reuters Reports Court Filing Saying New York Attorney General Sues Capital One For Misleading Consumers About Savings Accounts", "summary": "", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413258/watching-capital-one-financial-reuters-reports-court-filing-saying-new-york-attorney-general-sues-ca", "tags": ["legal"]}
{"id": 45413278, "time": "2025-05-14 11:32:25", "headline": "Susquehanna Maintains Positive on Boeing, Raises Price Target to $240", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413278/susquehanna-maintains-positive-on-boeing-raises-price-target-to-240", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413357, "time": "2025-05-14 11:34:11", "headline": "Susquehanna Maintains Positive on GE Vernova, Raises Price Target to $499", "summary": "", "symbols": ["GEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413357/susquehanna-maintains-positive-on-ge-vernova-raises-price-target-to-499", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413378, "time": "2025-05-14 11:34:39", "headline": "RBC Capital Reiterates Sector Perform on Inovio Pharmaceuticals, Maintains $5 Price Target", "summary": "", "symbols": ["INO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413378/rbc-capital-reiterates-sector-perform-on-inovio-pharmaceuticals-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 45413395, "time": "2025-05-14 11:35:11", "headline": "Susquehanna Maintains Positive on Intl Game Tech, Lowers Price Target to $25", "summary": "", "symbols": ["IGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413395/susquehanna-maintains-positive-on-intl-game-tech-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413412, "time": "2025-05-14 11:35:26", "headline": "Reported Earlier: Swvl Holdings Q1 Sales $4.91M Up From $4.37M YoY", "summary": "", "symbols": ["SWVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45413412/reported-earlier-swvl-holdings-q1-sales-4-91m-up-from-4-37m-yoy", "tags": []}
{"id": 45413424, "time": "2025-05-14 11:36:08", "headline": "Health In Tech Shares Halted On Circuit Breaker To The Downside, Stock Now Down -5.05%", "summary": "", "symbols": ["HIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45413424/health-in-tech-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-5-05", "tags": ["halt"]}
{"id": 45413440, "time": "2025-05-14 11:36:16", "headline": "Susquehanna Maintains Positive on Nu Holdings, Raises Price Target to $15", "summary": "", "symbols": ["NU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413440/susquehanna-maintains-positive-on-nu-holdings-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413456, "time": "2025-05-14 11:36:38", "headline": "Etoro Group IPO Price Indicating $70 On 770K Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413456/etoro-group-ipo-price-indicating-70-on-770k-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45413465, "time": "2025-05-14 11:37:01", "headline": "Susquehanna Maintains Positive on PagSeguro Digital, Lowers Price Target to $14", "summary": "", "symbols": ["PAGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413465/susquehanna-maintains-positive-on-pagseguro-digital-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413501, "time": "2025-05-14 11:37:55", "headline": "RBC Capital Maintains Outperform on Karman Holdings, Raises Price Target to $44", "summary": "", "symbols": ["KRMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413501/rbc-capital-maintains-outperform-on-karman-holdings-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413508, "time": "2025-05-14 11:38:06", "headline": "Susquehanna Maintains Neutral on Silicon Laboratories, Raises Price Target to $110", "summary": "", "symbols": ["SLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413508/susquehanna-maintains-neutral-on-silicon-laboratories-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413542, "time": "2025-05-14 11:39:52", "headline": "Trump Secures Historic $1.2T Economic Commitment In Qatar; Deals With Qatar Include More Than $243B, Including Sale Of Boeing Aircraft And GE Aerospace Engines To Qatar Airways; Qatar Airways To Acquire 210 Boeing 787 Dreamliner And 777x Aircraft Powered By GE Aerospace Engines; Raytheon Secures $1B Agreement For Qatar Acquisition Of Counter-Drone Capabilities; General Atomics Secured A Nearly $2B Agreement For Qatar's Acquisition Of The MQ-9B Remotely Piloted Aircraft System", "summary": "", "symbols": ["BA", "GE", "RTX", "SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413542/trump-secures-historic-1-2t-economic-commitment-in-qatar-deals-with-qatar-include-more-than-243b-inc", "tags": ["merger", "contract"]}
{"id": 45413578, "time": "2025-05-14 11:40:49", "headline": "Health In Tech Shares Resume Trade", "summary": "", "symbols": ["HIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45413578/health-in-tech-shares-resume-trade", "tags": []}
{"id": 45413589, "time": "2025-05-14 11:41:22", "headline": "Canaccord Genuity Maintains Buy on Biodesix, Lowers Price Target to $1.5", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413589/canaccord-genuity-maintains-buy-on-biodesix-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413628, "time": "2025-05-14 11:42:32", "headline": "Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $70", "summary": "", "symbols": ["ENOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413628/canaccord-genuity-maintains-buy-on-enovis-lowers-price-target-to-70", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413680, "time": "2025-05-14 11:43:12", "headline": "Stifel Maintains Hold on Landstar System, Lowers Price Target to $140", "summary": "", "symbols": ["LSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413680/stifel-maintains-hold-on-landstar-system-lowers-price-target-to-140", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413681, "time": "2025-05-14 11:43:26", "headline": "RBC Capital Maintains Outperform on Trican Well Service, Raises Price Target to C$6", "summary": "", "symbols": ["TSX:TCW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413681/rbc-capital-maintains-outperform-on-trican-well-service-raises-price-target-to-c-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413710, "time": "2025-05-14 11:45:11", "headline": "Canaccord Genuity Maintains Buy on GRAIL, Raises Price Target to $43", "summary": "", "symbols": ["GRAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413710/canaccord-genuity-maintains-buy-on-grail-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413712, "time": "2025-05-14 11:45:18", "headline": "Stifel Maintains Hold on Macrogenics, Lowers Price Target to $5", "summary": "", "symbols": ["MGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413712/stifel-maintains-hold-on-macrogenics-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413713, "time": "2025-05-14 11:45:22", "headline": "If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["COR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45413713/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45413723, "time": "2025-05-14 11:45:44", "headline": "Garden Stage Shares Halted On Circuit Breaker To The Upside, Stock Now Up 69%", "summary": "", "symbols": ["GSIW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45413723/garden-stage-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-69", "tags": ["halt"]}
{"id": 45413726, "time": "2025-05-14 11:46:07", "headline": "Canaccord Genuity Maintains Buy on Intuitive Machines, Raises Price Target to $21.5", "summary": "", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413726/canaccord-genuity-maintains-buy-on-intuitive-machines-raises-price-target-to-21-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413727, "time": "2025-05-14 11:46:13", "headline": "Stifel Maintains Buy on On Holding, Raises Price Target to $66", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413727/stifel-maintains-buy-on-on-holding-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413749, "time": "2025-05-14 11:47:05", "headline": "EXCLUSIVE: Apple Stock Could Benefit From Smartphone Upgrade Cycle, Poll Ranks Top Reason For Trade In (It's Not The Camera)", "summary": "Benzinga readers tell us where they stand in the upgrade cycle: 53.5% say they have not upgraded their smartphones in over 12 months.", "symbols": ["AAPL"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/tech/25/05/45413749/exclusive-apple-stock-could-benefit-from-smartphone-upgrade-cycle", "tags": ["analyst_up"]}
{"id": 45413775, "time": "2025-05-14 11:47:54", "headline": "Stifel Maintains Buy on Under Armour, Lowers Price Target to $10", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413775/stifel-maintains-buy-on-under-armour-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413781, "time": "2025-05-14 11:48:12", "headline": "Canaccord Genuity Maintains Hold on Rapid7, Lowers Price Target to $39", "summary": "", "symbols": ["RPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413781/canaccord-genuity-maintains-hold-on-rapid7-lowers-price-target-to-39", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413808, "time": "2025-05-14 11:50:07", "headline": "Evercore ISI Group Initiates Coverage On Centrus Energy with Outperform Rating, Announces Price Target of $145", "summary": "", "symbols": ["LEU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413808/evercore-isi-group-initiates-coverage-on-centrus-energy-with-outperform-rating-announces-price-targe", "tags": ["analyst_init"]}
{"id": 45413809, "time": "2025-05-14 11:50:09", "headline": "On Holding AG Posts Strong Q1 Beat, 'Strong Traction' Among Footwear Brands, Analysts Raise Price Target", "summary": "On Holding (ONON) stock climbs after strong Q1 results, with analysts raising price targets. DTC and wholesale growth expected to continue.", "symbols": ["ONON"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/25/05/45413809/on-holding-posts-strong-q1-beat-witnessing-more-traction-than-other-footwear-brands-analysts-raise-price-target", "tags": ["earnings"]}
{"id": 45413850, "time": "2025-05-14 11:50:58", "headline": "Seaport Global Initiates Coverage On Enova International with Buy Rating, Announces Price Target of $124", "summary": "", "symbols": ["ENVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413850/seaport-global-initiates-coverage-on-enova-international-with-buy-rating-announces-price-target-of-1", "tags": ["analyst_init"]}
{"id": 45413856, "time": "2025-05-14 11:51:27", "headline": "Evercore ISI Group Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating, Announces Price Target of $55", "summary": "", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413856/evercore-isi-group-initiates-coverage-on-xenon-pharmaceuticals-with-outperform-rating-announces-pric", "tags": ["analyst_init"]}
{"id": 45413868, "time": "2025-05-14 11:52:21", "headline": "Evercore ISI Group Maintains Outperform on Camtek, Lowers Price Target to $82", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413868/evercore-isi-group-maintains-outperform-on-camtek-lowers-price-target-to-82", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413880, "time": "2025-05-14 11:52:52", "headline": "Graphex Group Shares Halted, News Pending", "summary": "", "symbols": ["GRFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413880/graphex-group-shares-halted-news-pending", "tags": ["halt"]}
{"id": 45413887, "time": "2025-05-14 11:53:31", "headline": "Evercore ISI Group Maintains Outperform on Flowco Holdings, Lowers Price Target to $32", "summary": "", "symbols": ["FLOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413887/evercore-isi-group-maintains-outperform-on-flowco-holdings-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413888, "time": "2025-05-14 11:53:31", "headline": "Needham Maintains Buy on Robinhood Markets, Raises Price Target to $71", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413888/needham-maintains-buy-on-robinhood-markets-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413918, "time": "2025-05-14 11:54:27", "headline": "Evercore ISI Group Maintains In-Line on Landstar System, Lowers Price Target to $136", "summary": "", "symbols": ["LSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413918/evercore-isi-group-maintains-in-line-on-landstar-system-lowers-price-target-to-136", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413930, "time": "2025-05-14 11:55:11", "headline": "Evercore ISI Group Maintains Outperform on On Holding, Raises Price Target to $70", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413930/evercore-isi-group-maintains-outperform-on-on-holding-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 45413931, "time": "2025-05-14 11:55:30", "headline": "Garden Stage Shares Resume Trade", "summary": "", "symbols": ["GSIW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45413931/garden-stage-shares-resume-trade", "tags": []}
{"id": 45413934, "time": "2025-05-14 11:55:52", "headline": "Evercore ISI Group Maintains Underperform on Under Armour, Lowers Price Target to $6", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413934/evercore-isi-group-maintains-underperform-on-under-armour-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413978, "time": "2025-05-14 11:56:39", "headline": "Evercore ISI Group Maintains Outperform on Webtoon Entertainment, Lowers Price Target to $20", "summary": "", "symbols": ["WBTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413978/evercore-isi-group-maintains-outperform-on-webtoon-entertainment-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45413979, "time": "2025-05-14 11:56:50", "headline": "Stephens & Co. Reiterates Overweight on Wingstop, Maintains $385 Price Target", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413979/stephens-co-reiterates-overweight-on-wingstop-maintains-385-price-target", "tags": ["analyst_other"]}
{"id": 45413980, "time": "2025-05-14 11:57:12", "headline": "Etoro Group IPO Price Indicating $67.60 On 1M Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45413980/etoro-group-ipo-price-indicating-67-60-on-1m-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45414009, "time": "2025-05-14 11:58:46", "headline": "Piper Sandler Maintains Overweight on Samsara, Raises Price Target to $53", "summary": "", "symbols": ["IOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414009/piper-sandler-maintains-overweight-on-samsara-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414021, "time": "2025-05-14 11:59:49", "headline": "Why Is TotalEnergies Stock Trading Lower On Wednesday?", "summary": "TotalEnergies (NYSE: TTE) to sell 50% stake in PGB to HitecVision for \u20ac190M. PGB is a leading biogas producer in Poland with plans for expansion and decarbonization.", "symbols": ["EIPI", "EIPX", "TTE"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/asset-sales/25/05/45414021/why-is-totalenergies-stock-trading-lower-on-wednesday", "tags": ["why_moving"]}
{"id": 45414023, "time": "2025-05-14 12:00:00", "headline": "Magnificent Seven Add $3.6 Trillion Since April Lows: Is This Rally Just Beginning?", "summary": "The Magnificent Seven surged $3.57 trillion since April 8, fueled by tariff relief and trade optimism, as the Nasdaq 100 jumps 24.5% in 25 sessions.", "symbols": ["AAPL", "AMZN", "GOOGL", "META", "MSFT", "NVDA", "QQQ", "TSLA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/government/regulations/25/05/45414023/magnificent-seven-add-36-trillion-since-april-lows-is-this-rally-just-beginning", "tags": []}
{"id": 45414064, "time": "2025-05-14 12:00:11", "headline": "Piper Sandler Maintains Overweight on Flowco Holdings, Lowers Price Target to $33", "summary": "", "symbols": ["FLOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414064/piper-sandler-maintains-overweight-on-flowco-holdings-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414089, "time": "2025-05-14 12:00:31", "headline": "How Do Investors Really Feel About Workday?", "summary": " ", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45414089/how-do-investors-really-feel-about-workday", "tags": []}
{"id": 45414091, "time": "2025-05-14 12:00:32", "headline": "P/E Ratio Insights for Chemed", "summary": " ", "symbols": ["CHE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45414091/pe-ratio-insights-for-chemed", "tags": []}
{"id": 45414094, "time": "2025-05-14 12:00:36", "headline": "How Do Investors Really Feel About CACI International?", "summary": " ", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45414094/how-do-investors-really-feel-about-caci-international", "tags": []}
{"id": 45414101, "time": "2025-05-14 12:00:41", "headline": "Is the Market Bullish or Bearish on MongoDB?", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45414101/is-the-market-bullish-or-bearish-on-mongodb", "tags": []}
{"id": 45414245, "time": "2025-05-14 12:01:48", "headline": "Piper Sandler Maintains Underweight on Plug Power, Lowers Price Target to $0.8", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414245/piper-sandler-maintains-underweight-on-plug-power-lowers-price-target-to-0-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414265, "time": "2025-05-14 12:02:50", "headline": "Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue", "summary": "Biden restricted the export of U.S. semiconductor chips to Saudi Arabia over national security concerns. Trump rescinded those restrictions.", "symbols": ["NVDA"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/large-cap/25/05/45414265/nvidia-climbs-on-saudi-ai-investments-analyst-estimates-15-billion-to-20-billion-in-revenue", "tags": ["earnings"]}
{"id": 45414270, "time": "2025-05-14 12:02:50", "headline": "Unpacking the Latest Options Trading Trends in Eli Lilly", "summary": " ", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45414270/unpacking-the-latest-options-trading-trends-in-eli-lilly", "tags": []}
{"id": 45414271, "time": "2025-05-14 12:02:56", "headline": "Unpacking the Latest Options Trading Trends in AppLovin", "summary": " ", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45414271/unpacking-the-latest-options-trading-trends-in-applovin", "tags": []}
{"id": 45414272, "time": "2025-05-14 12:03:01", "headline": "Vistra Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45414272/vistra-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 45414276, "time": "2025-05-14 12:03:14", "headline": "Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $100", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414276/piper-sandler-maintains-neutral-on-westlake-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414311, "time": "2025-05-14 12:04:29", "headline": "Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday", "summary": " ", "symbols": ["AFRM", "ECG", "KRNT", "LBTYA", "LUXE", "NPCE", "NUTX", "OKLO", "PVH", "RDDT", "RGC", "RGTI", "RKLB", "SMCI", "SOUN", "TME", "TSEM", "TSLA", "WING"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45414311/tower-semiconductor-posts-upbeat-earnings-joins-nutex-health-kornit-digital-tencent-music-entertainment-and-other-big-stocks-moving-higher-on-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 45414315, "time": "2025-05-14 12:04:34", "headline": "Piper Sandler Maintains Overweight on Allogene Therapeutics, Lowers Price Target to $7", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414315/piper-sandler-maintains-overweight-on-allogene-therapeutics-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414352, "time": "2025-05-14 12:05:46", "headline": "Piper Sandler Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $12", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414352/piper-sandler-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414353, "time": "2025-05-14 12:05:48", "headline": "Uncovering Potential: Precision BioSciences's Earnings Preview", "summary": " ", "symbols": ["DTIL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45414353/uncovering-potential-precision-biosciencess-earnings-preview", "tags": ["earnings"]}
{"id": 45414358, "time": "2025-05-14 12:06:01", "headline": "3 Airbnb Initiatives That Could Unleash Growth Opportunities", "summary": "Airbnb issued its 2025 Summer Release, announcing new services/experiences and app redesign. Analysts have mixed views on growth potential.", "symbols": ["ABNB"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/general/travel/25/05/45414358/3-airbnb-initiatives-that-could-unleash-growth-opportunities", "tags": []}
{"id": 45414383, "time": "2025-05-14 12:06:49", "headline": "Live On CNBC, Steve Weiss Announces Bought Nvidia; Bought Amazon", "summary": "", "symbols": ["AMZN", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414383/live-on-cnbc-steve-weiss-announces-bought-nvidia-bought-amazon", "tags": []}
{"id": 45414387, "time": "2025-05-14 12:07:05", "headline": "American Eagle Stock Is Sliding Today: Here's Why", "summary": "American Eagle Outfitters Inc. (NYSE: AEO) shares are trading lower Wednesday after the company issued a profit warning and withdrew its full-year 2025 guidance.", "symbols": ["AEO"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/earnings/25/05/45414387/american-eagle-stock-is-sliding-today-heres-why", "tags": ["guidance", "why_moving"]}
{"id": 45414410, "time": "2025-05-14 12:07:38", "headline": "Truist Securities Maintains Buy on Allogene Therapeutics, Lowers Price Target to $10", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414410/truist-securities-maintains-buy-on-allogene-therapeutics-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414422, "time": "2025-05-14 12:08:18", "headline": "Rocket Lab Stock Is Rallying Wednesday: What's Going On?", "summary": "Rocket Lab USA Inc (NASDAQ:RKLB) shares are trading higher. The company on Wednesday announced the successful return of its Pioneer spacecraft for Varda Space Industries.", "symbols": ["RKLB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/25/05/45414422/rocket-lab-stock-is-rallying-wednesday-whats-going-on", "tags": ["why_moving"]}
{"id": 45414427, "time": "2025-05-14 12:08:35", "headline": "Truist Securities Maintains Hold on American Public Education, Raises Price Target to $30", "summary": "", "symbols": ["APEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414427/truist-securities-maintains-hold-on-american-public-education-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414447, "time": "2025-05-14 12:09:41", "headline": "Truist Securities Maintains Buy on Fox Factory Holding, Raises Price Target to $34", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414447/truist-securities-maintains-buy-on-fox-factory-holding-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414457, "time": "2025-05-14 12:10:46", "headline": "Truist Securities Maintains Buy on Legend Biotech, Lowers Price Target to $71", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414457/truist-securities-maintains-buy-on-legend-biotech-lowers-price-target-to-71", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414466, "time": "2025-05-14 12:11:38", "headline": "Truist Securities Maintains Buy on MidCap Financial, Lowers Price Target to $15", "summary": "", "symbols": ["MFIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414466/truist-securities-maintains-buy-on-midcap-financial-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414503, "time": "2025-05-14 12:12:23", "headline": "Truist Securities Maintains Buy on On Holding, Raises Price Target to $69", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414503/truist-securities-maintains-buy-on-on-holding-raises-price-target-to-69", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414504, "time": "2025-05-14 12:12:34", "headline": "Affirm Brings 'Buy Now, Pay Later' To Costco Shoppers", "summary": "Affirm partners with Costco to offer $500+ online purchases in installments amid rising summer demand.", "symbols": ["AFRM", "COST"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45414504/affirm-brings-buy-now-pay-later-to-costco-shoppers", "tags": ["contract"]}
{"id": 45414557, "time": "2025-05-14 12:12:55", "headline": "Why LEEF Brands' Stock Is Up 25% Today And A Look At Cannabis Earnings: Glass House, Charlotte's Web, AFC Gamma", "summary": "LEEF soared 25% on a new deal with Glass House. Here&#39;s what else moved markets in cannabis after earnings from CWBHF, AFCG, and GLASF.", "symbols": ["AFCG", "CWBHF", "GLASF", "LEEEF"], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/25/05/45414557/why-leef-brands-stock-is-up-25-today-and-a-look-at-cannabis-earnings-glass-house-charlottes-web-afc-gamma", "tags": ["earnings", "contract"]}
{"id": 45414573, "time": "2025-05-14 12:13:27", "headline": "Truist Securities Maintains Buy on PennantPark Floating Rate, Lowers Price Target to $11", "summary": "", "symbols": ["PFLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414573/truist-securities-maintains-buy-on-pennantpark-floating-rate-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414583, "time": "2025-05-14 12:13:59", "headline": "Etoro Group IPO Price Indicating $69.50 On 1.2M Shares; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414583/etoro-group-ipo-price-indicating-69-50-on-1-2m-shares-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45414586, "time": "2025-05-14 12:14:20", "headline": "Truist Securities Maintains Buy on Perspective Therapeutics, Lowers Price Target to $8", "summary": "", "symbols": ["CATX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414586/truist-securities-maintains-buy-on-perspective-therapeutics-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414597, "time": "2025-05-14 12:15:12", "headline": "Truist Securities Maintains Hold on Under Armour, Lowers Price Target to $7", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414597/truist-securities-maintains-hold-on-under-armour-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414603, "time": "2025-05-14 12:15:42", "headline": "Dow Edges Higher; US Crude Oil Inventories Increase", "summary": " ", "symbols": ["CLBT", "GLBE", "IXHL", "LOAR", "NUTX", "SEPN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45414603/dow-edges-higher-us-crude-oil-inventories-increase", "tags": []}
{"id": 45414619, "time": "2025-05-14 12:16:39", "headline": "Truist Securities Maintains Buy on Y-mAbs Therapeutics, Lowers Price Target to $14", "summary": "", "symbols": ["YMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414619/truist-securities-maintains-buy-on-y-mabs-therapeutics-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414625, "time": "2025-05-14 12:17:04", "headline": "Aurora Innovation Shares Fall As Uber Announces $1B Note Offering: What's Going On?", "summary": "Shares of Aurora Innovation are trading lower by 9.6% during Wednesday&#39;s session. Uber will monetize part of its Aurora stake using a $1 billion convertible note offering.", "symbols": ["AUR", "UBER"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45414625/aurora-innovation-shares-fall-as-uber-announces-1b-note-offering-whats-going-on", "tags": ["why_moving", "offering"]}
{"id": 45414638, "time": "2025-05-14 12:18:01", "headline": "B. Riley Securities Maintains Buy on Camtek, Raises Price Target to $95", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414638/b-riley-securities-maintains-buy-on-camtek-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414639, "time": "2025-05-14 12:18:03", "headline": "Here's How Much You Would Have Made Owning CyberArk Software Stock In The Last 10 Years", "summary": " ", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45414639/heres-how-much-you-would-have-made-owning-cyberark-software-stock-in-the-last-10-years", "tags": []}
{"id": 45414660, "time": "2025-05-14 12:18:52", "headline": "B. Riley Securities Maintains Buy on DoubleDown Interactive Co, Lowers Price Target to $22", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414660/b-riley-securities-maintains-buy-on-doubledown-interactive-co-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414664, "time": "2025-05-14 12:19:40", "headline": "B. Riley Securities Maintains Buy on 8x8, Lowers Price Target to $3", "summary": "", "symbols": ["EGHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414664/b-riley-securities-maintains-buy-on-8x8-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414670, "time": "2025-05-14 12:20:23", "headline": "B. Riley Securities Maintains Buy on Nayax, Raises Price Target to $47", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414670/b-riley-securities-maintains-buy-on-nayax-raises-price-target-to-47", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414678, "time": "2025-05-14 12:21:07", "headline": "Etoro Group IPO Opens For Trade At $69.69/Share; IPO Priced At $52/Share On 11,923,018 Shares", "summary": "", "symbols": ["ETOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414678/etoro-group-ipo-opens-for-trade-at-69-69share-ipo-priced-at-52share-on-11-923-018-shares", "tags": []}
{"id": 45414681, "time": "2025-05-14 12:21:29", "headline": "Under Armour Finds No Major Surprises In Q4, Analysts Cut Price Target", "summary": "Under Armour financial results were marginally better than expected, although its revenues are yet to bottom.", "symbols": ["UAA"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45414681/under-armour-finds-no-major-surprises-in-q4-analysts-cut-price-target", "tags": []}
{"id": 45414728, "time": "2025-05-14 12:23:55", "headline": "Live On CNBC, Joe Terranova Announces Sold Entire iShares 20+ Year Treasury Bond ETF Position", "summary": "", "symbols": ["JOET", "TLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414728/live-on-cnbc-joe-terranova-announces-sold-entire-ishares-20-year-treasury-bond-etf-position", "tags": []}
{"id": 45414748, "time": "2025-05-14 12:24:39", "headline": "BMO Capital Maintains Outperform on ServiceNow, Raises Price Target to $1150", "summary": "", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414748/bmo-capital-maintains-outperform-on-servicenow-raises-price-target-to-1150", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414768, "time": "2025-05-14 12:25:29", "headline": "BMO Capital Maintains Market Perform on NRG Energy, Raises Price Target to $167", "summary": "", "symbols": ["NRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414768/bmo-capital-maintains-market-perform-on-nrg-energy-raises-price-target-to-167", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414779, "time": "2025-05-14 12:26:17", "headline": "BMO Capital Maintains Market Perform on Okta, Raises Price Target to $135", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414779/bmo-capital-maintains-market-perform-on-okta-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414854, "time": "2025-05-14 12:27:05", "headline": "BMO Capital Maintains Market Perform on American Eagle Outfitters, Lowers Price Target to $11", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414854/bmo-capital-maintains-market-perform-on-american-eagle-outfitters-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414859, "time": "2025-05-14 12:27:16", "headline": "Watching Aurora Innovation; Bleecker Street Research Issues Report On Co", "summary": "", "symbols": ["AUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/short-sellers/25/05/45414859/watching-aurora-innovation-bleecker-street-research-issues-report-on-co", "tags": []}
{"id": 45414905, "time": "2025-05-14 12:28:44", "headline": "BMO Capital Maintains Outperform on Under Armour, Lowers Price Target to $9", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414905/bmo-capital-maintains-outperform-on-under-armour-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 45414926, "time": "2025-05-14 12:29:54", "headline": "Reported Earlier: 'FDA Approves Belzutifan For Pheochromocytoma Or Paraganglioma' - FDA", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45414926/reported-earlier-fda-approves-belzutifan-for-pheochromocytoma-or-paraganglioma-fda", "tags": ["fda"]}
{"id": 45414950, "time": "2025-05-14 12:30:31", "headline": "Live On CNBC, Steve Weiss Announces Bought More UnitedHealth Group", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414950/live-on-cnbc-steve-weiss-announces-bought-more-unitedhealth-group", "tags": []}
{"id": 45414951, "time": "2025-05-14 12:30:47", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Nayax, Raises Price Target to $40", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414951/keefe-bruyette-woods-maintains-market-perform-on-nayax-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 45414963, "time": "2025-05-14 12:31:27", "headline": "Live On CNBC, Steve Weiss Announces Sold Vertex Pharmaceuticals", "summary": "", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414963/live-on-cnbc-steve-weiss-announces-sold-vertex-pharmaceuticals", "tags": []}
{"id": 45414968, "time": "2025-05-14 12:31:54", "headline": "Here's How Much $100 Invested In Fidelity National Finl 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["FNF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45414968/heres-how-much-100-invested-in-fidelity-national-finl-5-years-ago-would-be-worth-today", "tags": []}
{"id": 45414971, "time": "2025-05-14 12:31:59", "headline": "V2X Collaborates With Bell Textron To Begin Strategic Planning For U.S. Army's Flight School Next Program", "summary": "", "symbols": ["TXT", "VVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45414971/v2x-collaborates-with-bell-textron-to-begin-strategic-planning-for-u-s-armys-flight-school-next-prog", "tags": []}
{"id": 45415002, "time": "2025-05-14 12:33:09", "headline": "Needham Reiterates Buy on Planet Labs, Maintains $8 Price Target", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415002/needham-reiterates-buy-on-planet-labs-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 45415017, "time": "2025-05-14 12:33:55", "headline": "Arrive AI Receives Approval To List Its Shares On Nasdaq Under Symbol ARAI; To Begin Trading On May 15, 2025", "summary": "", "symbols": ["ARAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415017/arrive-ai-receives-approval-to-list-its-shares-on-nasdaq-under-symbol-arai-to-begin-trading-on-may-1", "tags": []}
{"id": 45415029, "time": "2025-05-14 12:35:34", "headline": "Sanofi Intends To Invest At Least $20B In US Through 2030, Growing Investments In Science And Expanding Domestic Manufacturing", "summary": "", "symbols": ["SNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415029/sanofi-intends-to-invest-at-least-20b-in-us-through-2030-growing-investments-in-science-and-expandin", "tags": []}
{"id": 45415085, "time": "2025-05-14 12:37:59", "headline": "HC Wainwright & Co. Downgrades WonderFi Techs to Neutral", "summary": "", "symbols": ["TSX:WNDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415085/hc-wainwright-co-downgrades-wonderfi-techs-to-neutral", "tags": ["analyst_down"]}
{"id": 45415237, "time": "2025-05-14 12:43:13", "headline": "HC Wainwright & Co. Reiterates Buy on Mogo, Maintains $4 Price Target", "summary": "", "symbols": ["MOGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415237/hc-wainwright-co-reiterates-buy-on-mogo-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 45415261, "time": "2025-05-14 12:46:56", "headline": "$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["AIT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45415261/100-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45415288, "time": "2025-05-14 12:48:42", "headline": "Coinbase CEO Brian Armstrong Invites DOGE Staff To 'Create A More Efficient Financial System'", "summary": "Coinbase CEO Brian Armstrong seeks Department of Government Efficiency contractors to join the team and help create a more efficient financial system.", "symbols": ["COIN"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45415288/coinbase-ceo-brian-armstrong-invites-doge-staff-to-create-a-more-efficient-financial-system", "tags": ["management"]}
{"id": 45415290, "time": "2025-05-14 12:48:47", "headline": "'U.S. Not Seeking To Weaken Dollar As Part Of Trade Deals' - Bloomberg", "summary": "", "symbols": ["EWJ", "EWY", "SPY", "UUP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45415290/u-s-not-seeking-to-weaken-dollar-as-part-of-trade-deals-bloomberg", "tags": []}
{"id": 45415303, "time": "2025-05-14 12:49:06", "headline": "Needham Reiterates Hold on Verrica Pharmaceuticalsto Hold", "summary": "", "symbols": ["VRCA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415303/needham-reiterates-hold-on-verrica-pharmaceuticalsto-hold", "tags": ["analyst_other"]}
{"id": 45415306, "time": "2025-05-14 12:49:44", "headline": "Jefferies Maintains Hold on Hertz Global Holdings, Lowers Price Target to $6", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415306/jefferies-maintains-hold-on-hertz-global-holdings-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 45415352, "time": "2025-05-14 12:53:35", "headline": "This Digital Realty Trust Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday", "summary": " ", "symbols": ["BROS", "DLR", "EH", "ENVA", "LEU"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45415352/this-digital-realty-trust-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday", "tags": ["analyst_init"]}
{"id": 45415381, "time": "2025-05-14 12:54:54", "headline": "Sony Could See $680 Million Tariff Impact, Considers Moving PlayStation 5 Production To US", "summary": "Sony says it expects a $680 million impact from tariffs going forward. Here&#39;s why the company is considering moving production of the PlayStation 5.", "symbols": ["MSFT", "SONY"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/gaming/25/05/45415381/sony-could-see-680-million-tariff-impact-considers-moving-playstation-5-production-to-us", "tags": []}
{"id": 45415398, "time": "2025-05-14 12:55:20", "headline": "JP Morgan Downgrades Krispy Kreme to Neutral", "summary": "", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415398/jp-morgan-downgrades-krispy-kreme-to-neutral", "tags": ["analyst_down"]}
{"id": 45415476, "time": "2025-05-14 12:56:58", "headline": "HC Wainwright & Co. Assumes SAB Biotherapeutics at Buy, Announces Price Target of $10", "summary": "", "symbols": ["SABS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415476/hc-wainwright-co-assumes-sab-biotherapeutics-at-buy-announces-price-target-of-10", "tags": []}
{"id": 45415493, "time": "2025-05-14 12:58:08", "headline": "JP Morgan Maintains Neutral on American Eagle Outfitters, Lowers Price Target to $9", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415493/jp-morgan-maintains-neutral-on-american-eagle-outfitters-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 45415543, "time": "2025-05-14 13:00:27", "headline": "P/E Ratio Insights for AstraZeneca", "summary": " ", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45415543/pe-ratio-insights-for-astrazeneca", "tags": []}
{"id": 45415549, "time": "2025-05-14 13:00:39", "headline": "Looking Into Micron Technology's Recent Short Interest", "summary": " ", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45415549/looking-into-micron-technologys-recent-short-interest", "tags": []}
{"id": 45415550, "time": "2025-05-14 13:00:39", "headline": "An Opportunity To Invest In The $1.8 Trillion Space Economy", "summary": "Most companies in the space industry are private. Here&#39;s how you can get your feet wet in the $1.8 trillion space economy.", "symbols": [], "source": "benzinga", "author": "Gav Blaxberg", "url": "https://www.benzinga.com/markets/equities/25/05/45415550/an-opportunity-to-invest-in-the-1-8-trillion-space-economy", "tags": []}
{"id": 45415556, "time": "2025-05-14 13:00:44", "headline": "What Does the Market Think About Blackstone?", "summary": " ", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45415556/what-does-the-market-think-about-blackstone", "tags": []}
{"id": 45415559, "time": "2025-05-14 13:00:46", "headline": "JP Morgan Maintains Overweight on Trimble, Raises Price Target to $88", "summary": "", "symbols": ["TRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415559/jp-morgan-maintains-overweight-on-trimble-raises-price-target-to-88", "tags": ["analyst_other", "price_target_up"]}
{"id": 45415561, "time": "2025-05-14 13:00:49", "headline": "How Do Investors Really Feel About Discover Financial servs?", "summary": " ", "symbols": ["DFS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45415561/how-do-investors-really-feel-about-discover-financial-servs", "tags": []}
{"id": 45415568, "time": "2025-05-14 13:00:59", "headline": "HC Wainwright & Co. Downgrades ITeos Therapeutics to Neutral", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415568/hc-wainwright-co-downgrades-iteos-therapeutics-to-neutral", "tags": ["analyst_down"]}
{"id": 45415571, "time": "2025-05-14 13:01:05", "headline": "Nayax Analysts Raise Their Forecasts After Q1 Results", "summary": " ", "symbols": ["NYAX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45415571/nayax-analysts-raise-their-forecasts-after-q1-results", "tags": ["earnings"]}
{"id": 45415596, "time": "2025-05-14 13:01:55", "headline": "CNBC Halftime Report Final Trades: Apollo Global Management, Goldman Sachs Group, Taiwan Semiconductor Manufacturing, Zoom Communications", "summary": "", "symbols": ["APO", "GS", "TSM", "ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/analyst-ratings/25/05/45415596/cnbc-halftime-report-final-trades-apollo-global-management-goldman-sachs-group-taiwan-semiconduct", "tags": []}
{"id": 45415610, "time": "2025-05-14 13:02:21", "headline": "Walmart's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45415610/walmarts-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 45415628, "time": "2025-05-14 13:02:26", "headline": "Decoding IBM's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45415628/decoding-ibms-options-activity-whats-the-big-picture", "tags": []}
{"id": 45415632, "time": "2025-05-14 13:02:41", "headline": "Data Storage's Earnings: A Preview", "summary": " ", "symbols": ["DTST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45415632/data-storages-earnings-a-preview", "tags": ["earnings"]}
{"id": 45415661, "time": "2025-05-14 13:03:38", "headline": "JP Morgan Maintains Overweight on NeuroPace, Raises Price Target to $16", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415661/jp-morgan-maintains-overweight-on-neuropace-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 45415675, "time": "2025-05-14 13:03:51", "headline": "HC Wainwright & Co. Downgrades Affimed to Neutral", "summary": "", "symbols": ["AFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415675/hc-wainwright-co-downgrades-affimed-to-neutral", "tags": ["analyst_down"]}
{"id": 45415708, "time": "2025-05-14 13:06:10", "headline": "These Analysts Slash Their Forecasts On American Eagle Outfitters", "summary": " ", "symbols": ["AEO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45415708/these-analysts-slash-their-forecasts-on-american-eagle-outfitters", "tags": []}
{"id": 45415709, "time": "2025-05-14 13:06:11", "headline": "12 Information Technology Stocks Moving In Wednesday's Intraday Session", "summary": " ", "symbols": ["DAVA", "DVLT", "GCTS", "GRYP", "LDTC", "NTWK", "NXTT", "RGTI", "SMCI", "SMTK", "XTKG", "YXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45415709/12-information-technology-stocks-moving-in-wednesdays-intraday-session", "tags": ["why_moving"]}
{"id": 45415710, "time": "2025-05-14 13:06:17", "headline": "12 Industrials Stocks Moving In Wednesday's Intraday Session", "summary": " ", "symbols": ["ECG", "ELWS", "HTCO", "HYLN", "MCRP", "MSW", "NVVE", "PGHL", "SGLY", "SPCE", "SWVL", "WLGS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45415710/12-industrials-stocks-moving-in-wednesdays-intraday-session", "tags": ["why_moving"]}
{"id": 45415730, "time": "2025-05-14 13:06:23", "headline": "12 Health Care Stocks Moving In Wednesday's Intraday Session", "summary": " ", "symbols": ["ASBP", "AXDX", "BDSX", "BLUE", "BMGL", "GRAL", "KLTO", "LUCY", "LYRA", "PLRZ", "SEPN", "SILO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45415730/12-health-care-stocks-moving-in-wednesdays-intraday-session", "tags": ["why_moving"]}
{"id": 45415735, "time": "2025-05-14 13:06:28", "headline": "12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session", "summary": " ", "symbols": ["AKA", "ALUR", "BQ", "ECDA", "GENK", "GLBE", "LOBO", "NEGG", "NWTN", "RYET", "SUP", "TOPW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45415735/12-consumer-discretionary-stocks-moving-in-wednesdays-intraday-session", "tags": ["why_moving"]}
{"id": 45415767, "time": "2025-05-14 13:07:14", "headline": "Loop Capital Maintains Buy on Porch Group, Raises Price Target to $13", "summary": "", "symbols": ["PRCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415767/loop-capital-maintains-buy-on-porch-group-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 45415824, "time": "2025-05-14 13:09:15", "headline": "What's Going On With Airbnb Stock Today?", "summary": "Airbnb Inc. (NASDAQ: ABNB) shares are trending Wednesday following the company&#39;s announcement of a major platform expansion.", "symbols": ["ABNB"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45415824/whats-going-on-with-airbnb-stock-today", "tags": ["why_moving"]}
{"id": 45415837, "time": "2025-05-14 13:09:38", "headline": "An Overview of cbdMD's Earnings", "summary": " ", "symbols": ["YCBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45415837/an-overview-of-cbdmds-earnings", "tags": ["earnings"]}
{"id": 45415850, "time": "2025-05-14 13:09:59", "headline": "Uncovering Potential: NRX Pharmaceuticals's Earnings Preview", "summary": " ", "symbols": ["NRXP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45415850/uncovering-potential-nrx-pharmaceuticalss-earnings-preview", "tags": ["earnings"]}
{"id": 45415867, "time": "2025-05-14 13:10:30", "headline": "HC Wainwright & Co. Maintains Buy on Aclaris Therapeutics, Lowers Price Target to $16", "summary": "", "symbols": ["ACRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415867/hc-wainwright-co-maintains-buy-on-aclaris-therapeutics-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 45415873, "time": "2025-05-14 13:11:06", "headline": "Lake Street Maintains Buy on Perion Network, Raises Price Target to $13", "summary": "", "symbols": ["PERI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45415873/lake-street-maintains-buy-on-perion-network-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416068, "time": "2025-05-14 13:13:10", "headline": "AbbVie Announces That EMRELIS Has Been Granted Accelerated Approval By The FDA For The Treatment Of Adult Patients With Locally Advanced Or Metastatic, Non-Squamous Non-Small Cell Lung Cancer With High C-Met Protein Overexpression  Who Have Received A Prior Systemic Therapy", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416068/abbvie-announces-that-emrelis-has-been-granted-accelerated-approval-by-the-fda-for-the-treatment-of", "tags": ["fda"]}
{"id": 45416084, "time": "2025-05-14 13:14:52", "headline": "Lake Street Maintains Buy on BK Technologies, Raises Price Target to $55", "summary": "", "symbols": ["BKTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416084/lake-street-maintains-buy-on-bk-technologies-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416093, "time": "2025-05-14 13:15:58", "headline": "Roth MKM Upgrades Perion Network to Buy, Raises Price Target to $14", "summary": "", "symbols": ["PERI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416093/roth-mkm-upgrades-perion-network-to-buy-raises-price-target-to-14", "tags": ["analyst_up", "price_target_up"]}
{"id": 45416100, "time": "2025-05-14 13:16:50", "headline": "Cisco Stock Roars Back On AI Firepower, Saudi Pact \u2014 Bullish Breakout Faces Q3 Earnings Test", "summary": "Cisco stock (CSCO) expected to report Q3 earnings with EPS of 92 cents and revenue of $14.08 billion.", "symbols": ["CSCO"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/25/05/45416100/cisco-stock-roars-back-on-ai-firepower-saudi-pact-bullish-breakout-faces-q3-earnings-test", "tags": ["earnings"]}
{"id": 45416111, "time": "2025-05-14 13:17:19", "headline": "Lake Street Maintains Buy on SoundThinking, Raises Price Target to $20", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416111/lake-street-maintains-buy-on-soundthinking-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416130, "time": "2025-05-14 13:18:23", "headline": "Roth MKM Maintains Buy on Transact Technologies, Lowers Price Target to $5", "summary": "", "symbols": ["TACT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416130/roth-mkm-maintains-buy-on-transact-technologies-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416148, "time": "2025-05-14 13:20:27", "headline": "Robotaxi Service Pony AI Stock Falls Despite IPO Buzz - Here's Why", "summary": "Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for the first time.", "symbols": ["PONY", "UBER"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion", "tags": []}
{"id": 45416150, "time": "2025-05-14 13:20:37", "headline": "Roth MKM Reiterates Buy on EnerSys, Maintains $120 Price Target", "summary": "", "symbols": ["ENS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416150/roth-mkm-reiterates-buy-on-enersys-maintains-120-price-target", "tags": ["analyst_other"]}
{"id": 45416159, "time": "2025-05-14 13:20:56", "headline": "Lake Street Maintains Buy on Biodesix, Lowers Price Target to $2", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416159/lake-street-maintains-buy-on-biodesix-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416171, "time": "2025-05-14 13:22:15", "headline": "HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $134", "summary": "", "symbols": ["BNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416171/hc-wainwright-co-maintains-buy-on-biontech-lowers-price-target-to-134", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416186, "time": "2025-05-14 13:23:04", "headline": "Roth MKM Reiterates Buy on SoundThinking, Maintains $30 Price Target", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416186/roth-mkm-reiterates-buy-on-soundthinking-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 45416193, "time": "2025-05-14 13:23:55", "headline": "Ladenburg Thalmann Downgrades Gladstone Inv to Neutral", "summary": "", "symbols": ["GAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416193/ladenburg-thalmann-downgrades-gladstone-inv-to-neutral", "tags": ["analyst_down"]}
{"id": 45416194, "time": "2025-05-14 13:23:56", "headline": "Bitcoin's Volatility Makes It Unfit As A Benchmark For Liquid Funds: Report", "summary": "Bitcoin&#39;s (CRYPTO: BTC) extreme volatility makes it unsuitable as a benchmark for liquid funds, according to a new report from RedStone Oracles", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45416194/bitcoins-volatility-makes-it-unfit-as-a-benchmark-for-liquid-funds-report", "tags": []}
{"id": 45416225, "time": "2025-05-14 13:25:43", "headline": "Roth Capital Reiterates Buy on CyberArk Software, Maintains $415 Price Target", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416225/roth-capital-reiterates-buy-on-cyberark-software-maintains-415-price-target", "tags": ["analyst_other"]}
{"id": 45416286, "time": "2025-05-14 13:27:17", "headline": "Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity", "summary": "Bluebird Bio revised its agreement with Carlyle and SK Capital, adding a $5 per share cash option for stockholders ahead of deal completion.", "symbols": ["BLUE"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45416286/bluebird-bio-shareholders-get-new-all-cash-offer-from-private-equity", "tags": ["contract"]}
{"id": 45416304, "time": "2025-05-14 13:27:53", "headline": "Maxim Group Downgrades Cellectar Biosciences to Hold", "summary": "", "symbols": ["CLRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416304/maxim-group-downgrades-cellectar-biosciences-to-hold", "tags": ["analyst_down"]}
{"id": 45416305, "time": "2025-05-14 13:27:53", "headline": "Roth MKM Maintains Buy on Pixelworks, Lowers Price Target to $1", "summary": "", "symbols": ["PXLW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416305/roth-mkm-maintains-buy-on-pixelworks-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416326, "time": "2025-05-14 13:29:08", "headline": "HC Wainwright & Co. Maintains Buy on ArriVent BioPharma, Raises Price Target to $40", "summary": "", "symbols": ["AVBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416326/hc-wainwright-co-maintains-buy-on-arrivent-biopharma-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416478, "time": "2025-05-14 13:31:39", "headline": "Roth MKM Maintains Neutral on Monster Beverage, Raises Price Target to $56", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416478/roth-mkm-maintains-neutral-on-monster-beverage-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416482, "time": "2025-05-14 13:31:58", "headline": "Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results", "summary": " ", "symbols": ["BDSX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/05/45416482/biodesix-analysts-lower-their-forecasts-after-downbeat-q1-results", "tags": ["earnings"]}
{"id": 45416507, "time": "2025-05-14 13:32:39", "headline": "Maxim Group Maintains Buy on VerifyMe, Lowers Price Target to $1.5", "summary": "", "symbols": ["VRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416507/maxim-group-maintains-buy-on-verifyme-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416521, "time": "2025-05-14 13:34:12", "headline": "Maxim Group Maintains Buy on PennantPark Floating Rate, Lowers Price Target to $11.5", "summary": "", "symbols": ["PFLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416521/maxim-group-maintains-buy-on-pennantpark-floating-rate-lowers-price-target-to-11-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416530, "time": "2025-05-14 13:35:10", "headline": "10 Information Technology Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AAPL", "AVGO", "ENPH", "MSFT", "MSTR", "NVDA", "PATH", "PLTR", "SMCI", "SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45416530/10-information-technology-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 45416531, "time": "2025-05-14 13:35:15", "headline": "9 Consumer Discretionary Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AMZN", "BABA", "CMG", "DHI", "GCT", "MCD", "TSLA", "W", "WYNN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45416531/9-consumer-discretionary-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 45416534, "time": "2025-05-14 13:35:20", "headline": "9 Industrials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["CAT", "DE", "FDX", "GE", "PAYC", "POWL", "RKLB", "UBER", "UPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45416534/9-industrials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 45416561, "time": "2025-05-14 13:36:24", "headline": "What's Going On With DoorDash Stock On Wednesday?", "summary": "DoorDash shares edge higher as it launches drone delivery in Charlotte with Wing.", "symbols": ["DASH"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45416561/whats-going-on-with-doordash-stock-on-wednesday", "tags": ["why_moving"]}
{"id": 45416562, "time": "2025-05-14 13:36:24", "headline": "Maxim Group Maintains Buy on Caledonia Mining, Raises Price Target to $21", "summary": "", "symbols": ["CMCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416562/maxim-group-maintains-buy-on-caledonia-mining-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416627, "time": "2025-05-14 13:39:07", "headline": "Citigroup Maintains Neutral on Target, Raises Price Target to $97", "summary": "", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416627/citigroup-maintains-neutral-on-target-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416648, "time": "2025-05-14 13:41:15", "headline": "Citigroup Maintains Neutral on Lowe's Companies, Lowers Price Target to $253", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416648/citigroup-maintains-neutral-on-lowes-companies-lowers-price-target-to-253", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416650, "time": "2025-05-14 13:41:22", "headline": "\"EU Antitrust Regulators Set To Accept Microsoft's Revised Offer To End Investigation Into Its Video App Team; EU Regulators Likely To Seek Market Feedback In Coming Months Before Making Final Decision\"- Reuters Exclusive", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416650/eu-antitrust-regulators-set-to-accept-microsofts-revised-offer-to-end-investigation-into-its-video-a", "tags": ["legal"]}
{"id": 45416651, "time": "2025-05-14 13:41:23", "headline": "HC Wainwright & Co. Maintains Buy on Revolution Medicines, Lowers Price Target to $72", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416651/hc-wainwright-co-maintains-buy-on-revolution-medicines-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416744, "time": "2025-05-14 13:43:40", "headline": "Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $28", "summary": "", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416744/craig-hallum-maintains-buy-on-eton-pharmaceuticals-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416753, "time": "2025-05-14 13:45:00", "headline": "Craig-Hallum Maintains Buy on Biodesix, Lowers Price Target to $1.5", "summary": "", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416753/craig-hallum-maintains-buy-on-biodesix-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416757, "time": "2025-05-14 13:45:19", "headline": "Small Cap Consumer Research Reiterates Buy on a.k.a. Brands Holding, Maintains $30 Price Target", "summary": "", "symbols": ["AKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416757/small-cap-consumer-research-reiterates-buy-on-a-k-a-brands-holding-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 45416789, "time": "2025-05-14 13:48:12", "headline": "Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $13", "summary": "", "symbols": ["FENC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416789/craig-hallum-maintains-buy-on-fennec-pharmaceuticals-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416837, "time": "2025-05-14 13:50:44", "headline": "Lockheed Martin CFO During Conference Call Reportedly Says F35 Lot 19 Award Has The Potential To Accelerate Compared To Previous Expectation Of H2 Of The Year; What Our Customer Is Telling Us Now Is To Expect Lot 18 And Lot 19 To Be Combined Into A Single Award; We'Ve Seen International Demand For F35 Tick Up A Bit In The Last Few Lots", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416837/lockheed-martin-cfo-during-conference-call-reportedly-says-f35-lot-19-award-has-the-potential-to-acc", "tags": ["management"]}
{"id": 45416843, "time": "2025-05-14 13:51:21", "headline": "HC Wainwright & Co. Maintains Buy on Stoke Therapeutics, Lowers Price Target to $35", "summary": "", "symbols": ["STOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416843/hc-wainwright-co-maintains-buy-on-stoke-therapeutics-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416849, "time": "2025-05-14 13:51:46", "headline": "Deutsche Bank Maintains Buy on Robinhood Markets, Raises Price Target to $64", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416849/deutsche-bank-maintains-buy-on-robinhood-markets-raises-price-target-to-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 45416873, "time": "2025-05-14 13:53:02", "headline": "Deutsche Bank Maintains Buy on UnitedHealth Group, Lowers Price Target to $362", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416873/deutsche-bank-maintains-buy-on-unitedhealth-group-lowers-price-target-to-362", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416897, "time": "2025-05-14 13:55:24", "headline": "Neogen Estimates Negative Impact Of Tariffs On Ebitda Of $5M", "summary": "", "symbols": ["NEOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416897/neogen-estimates-negative-impact-of-tariffs-on-ebitda-of-5m", "tags": []}
{"id": 45416953, "time": "2025-05-14 13:56:43", "headline": "Piper Sandler Maintains Overweight on Global E Online, Maintains $42 Price Target", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416953/piper-sandler-maintains-overweight-on-global-e-online-maintains-42-price-target", "tags": ["analyst_other"]}
{"id": 45416966, "time": "2025-05-14 13:57:38", "headline": "Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $24", "summary": "", "symbols": ["CLBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45416966/needham-maintains-buy-on-cellebrite-di-lowers-price-target-to-24", "tags": ["analyst_other", "price_target_down"]}
{"id": 45416971, "time": "2025-05-14 13:57:56", "headline": "Coinbase Becomes First Pure-Play Crypto Stock In S&P 500, Analyst Sees Major Institutional Upside", "summary": "Rosenblatt analyst maintains Buy rating for Coinbase Global, raises price target to $300. Recent gains driven by S&amp;P 500 addition and Deribit acquisition.", "symbols": ["COIN"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/05/45416971/coinbase-becomes-first-pure-play-crypto-stock-in-sp-500-analyst-sees-major-institutional-upside", "tags": ["analyst_other", "price_target_up"]}
{"id": 45417006, "time": "2025-05-14 14:00:18", "headline": "Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417006/hyperfine-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 45417020, "time": "2025-05-14 14:00:24", "headline": "How Do Investors Really Feel About EQT?", "summary": " ", "symbols": ["EQT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45417020/how-do-investors-really-feel-about-eqt", "tags": []}
{"id": 45417021, "time": "2025-05-14 14:00:30", "headline": "How Is The Market Feeling About Adobe?", "summary": " ", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45417021/how-is-the-market-feeling-about-adobe", "tags": []}
{"id": 45417024, "time": "2025-05-14 14:00:32", "headline": "A Glimpse Into The Expert Outlook On Samsara Through 10 Analysts", "summary": " ", "symbols": ["IOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417024/a-glimpse-into-the-expert-outlook-on-samsara-through-10-analysts", "tags": ["guidance"]}
{"id": 45417026, "time": "2025-05-14 14:00:35", "headline": "What Does the Market Think About GoDaddy?", "summary": " ", "symbols": ["GDDY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45417026/what-does-the-market-think-about-godaddy", "tags": []}
{"id": 45417027, "time": "2025-05-14 14:00:41", "headline": "Breaking Down Zevra Therapeutics: 6 Analysts Share Their Views", "summary": " ", "symbols": ["ZVRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417027/breaking-down-zevra-therapeutics-6-analysts-share-their-views", "tags": []}
{"id": 45417032, "time": "2025-05-14 14:00:50", "headline": "10 Analysts Have This To Say About Freeport-McMoRan", "summary": " ", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417032/10-analysts-have-this-to-say-about-freeport-mcmoran", "tags": []}
{"id": 45417036, "time": "2025-05-14 14:00:57", "headline": "What Analysts Are Saying About Helmerich & Payne Stock", "summary": " ", "symbols": ["HP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417036/what-analysts-are-saying-about-helmerich-payne-stock", "tags": []}
{"id": 45417038, "time": "2025-05-14 14:00:57", "headline": "P/E Ratio Insights for Portland Gen Electric", "summary": " ", "symbols": ["POR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45417038/pe-ratio-insights-for-portland-gen-electric", "tags": []}
{"id": 45417048, "time": "2025-05-14 14:01:09", "headline": "A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts", "summary": " ", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45417048/a-glimpse-into-the-expert-outlook-on-eton-pharmaceuticals-through-4-analysts", "tags": ["guidance"]}
{"id": 45417055, "time": "2025-05-14 14:01:15", "headline": "Spotlight on Super Micro Computer: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["SMCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45417055/spotlight-on-super-micro-computer-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 45417056, "time": "2025-05-14 14:01:21", "headline": "Spotlight on DoorDash: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["DASH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45417056/spotlight-on-doordash-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 45417060, "time": "2025-05-14 14:01:26", "headline": "Check Out What Whales Are Doing With AXON", "summary": " ", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45417060/check-out-what-whales-are-doing-with-axon", "tags": []}
{"id": 45417105, "time": "2025-05-14 14:02:48", "headline": "Tesla Stock Continues To Climb: What's Going On?", "summary": "Tesla Inc (NASDAQ: TSLA) shares are trading higher by more than 4% on Wednesday, extending its recent rally to approximately 24% over the past week and about 37% over the past month.", "symbols": ["TSLA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45417105/tesla-stock-continues-to-climb-whats-going-on", "tags": ["why_moving"]}
{"id": 45417121, "time": "2025-05-14 14:03:28", "headline": "HC Wainwright & Co. Assumes Humacyte at Buy, Announces Price Target of $4", "summary": "", "symbols": ["HUMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417121/hc-wainwright-co-assumes-humacyte-at-buy-announces-price-target-of-4", "tags": []}
{"id": 45417156, "time": "2025-05-14 14:04:51", "headline": "Nvidia, AMD And Other Chip Stocks Gain As Trump Plans To Ease AI Chip Export Rules", "summary": "Nvidia Corp (NVDA) and Advanced Micro Devices (AMD) stocks rise after Trump plans to repeal Biden&#39;s AI restrictions. Huawei faces penalties for violating US sanctions, while US seeks individual deals with countries. Trump&#39;s government blacklisted Huawei in 2019 and Biden imposed semiconductor sanctions. Trump showcases Saudi Arabia&#39;s $600B investment commitment, including deals with Amazon, Oracle, and AMD. NVDA up 2.96%, AMD up 3.25% premarket. Can Corning-Broadcom deal transform AI", "symbols": ["AMD", "AMZN", "NVDA", "ORCL"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/05/45417156/nvidia-amd-stocks-climb-as-trump-plans-to-ease-ai-chip-export-rules", "tags": ["contract"]}
{"id": 45417306, "time": "2025-05-14 14:09:03", "headline": "Michael Saylor's Bitcoin Strategy\u2014'Infinite Money Glitch' Or A Reflexive Leverage Bet?", "summary": "Michael Saylor&#39;s Strategy (NASDAQ:MSTR) has engineered a financial mechanism that transforms market enthusiasm for Bitcoin (CRYPTO: BTC) into a self-reinforcing growth engine, according to the ", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet", "tags": []}
{"id": 45417323, "time": "2025-05-14 14:09:48", "headline": "Lockheed Martin CFO During Conference Call Reportedly Says We Still See Tariffs Not As A Cost Of Profit Risk For Us, But Potentially A Cash Timing Risk", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417323/lockheed-martin-cfo-during-conference-call-reportedly-says-we-still-see-tariffs-not-as-a-cost-of-pro", "tags": ["management"]}
{"id": 45417346, "time": "2025-05-14 14:11:42", "headline": "Needham Reiterates Buy on Lucid Diagnostics, Maintains $3 Price Target", "summary": "", "symbols": ["LUCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417346/needham-reiterates-buy-on-lucid-diagnostics-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 45417354, "time": "2025-05-14 14:12:16", "headline": "'Coinbase's Armstrong Looks to Make More Acquisitions After Deribit Purchase'- Bloomberg", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417354/coinbases-armstrong-looks-to-make-more-acquisitions-after-deribit-purchase-bloomberg", "tags": []}
{"id": 45417403, "time": "2025-05-14 14:12:36", "headline": "Insights into ESS Tech's Upcoming Earnings", "summary": " ", "symbols": ["GWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45417403/insights-into-ess-techs-upcoming-earnings", "tags": ["earnings"]}
{"id": 45417455, "time": "2025-05-14 14:13:55", "headline": "JD.com Gains Traction In Retail, Delivery As Analyst Flags Margin Risks", "summary": "\nJD.com (NASDAQ: JD) stock down on Wednesday due to lower than expected revenue, but analysts remain bullish with a $53 price target.", "symbols": ["JD"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/05/45417455/jd-com-gains-traction-in-retail-delivery-as-analyst-flags-margin-risks", "tags": ["earnings"]}
{"id": 45417482, "time": "2025-05-14 14:15:22", "headline": "Needham Maintains Buy on Inozyme Pharma, Lowers Price Target to $12", "summary": "", "symbols": ["INZY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417482/needham-maintains-buy-on-inozyme-pharma-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 45417534, "time": "2025-05-14 14:22:08", "headline": "Caught Off Guard, Institutions Chase Stock Market Rally", "summary": " ", "symbols": ["SPY"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/equities/25/05/45417534/caught-off-guard-institutions-chase-stock-market-rally", "tags": []}
{"id": 45417576, "time": "2025-05-14 14:25:01", "headline": "Nu Holdings Stock Bounces Back From Q1 Earnings Sell-Off: What's Going On?", "summary": "Nu Holdings Ltd. (NYSE: NU) shares are trading higher Wednesday, reversing earlier losses following the release of weaker-than-expected first-quarter financial results.", "symbols": ["NU"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/earnings/25/05/45417576/nu-holdings-stock-bounces-back-from-q1-earnings-sell-off-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 45417599, "time": "2025-05-14 14:25:36", "headline": "'Battery Maker With 720% Stock Gain Signs Early Data-Center Deal'- Bloomberg", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417599/battery-maker-with-720-stock-gain-signs-early-data-center-deal-bloomberg", "tags": ["contract"]}
{"id": 45417676, "time": "2025-05-14 14:30:07", "headline": "Hertz Faces Tough Road Ahead, Analyst Says Earnings Recovery Unlikely Before 2026", "summary": "Hertz stock dips as analyst flags fading tailwinds and delayed earnings recovery.", "symbols": ["HTZ"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/general/travel/25/05/45417676/hertz-faces-tough-road-ahead-analyst-says-earnings-recovery-unlikely-before-2026", "tags": ["earnings"]}
{"id": 45417710, "time": "2025-05-14 14:32:47", "headline": "TowneBank Hikes Quarterly Cash Dividend From $0.25 To $0.27 Per Share", "summary": "", "symbols": ["TOWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417710/townebank-hikes-quarterly-cash-dividend-from-0-25-to-0-27-per-share", "tags": ["dividend"]}
{"id": 45417761, "time": "2025-05-14 14:37:32", "headline": "Watching Criteo S.A.; Shares See Volume To The Upside; Company Presenting At JPM Tech Conference", "summary": "", "symbols": ["CRTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417761/watching-criteo-s-a-shares-see-volume-to-the-upside-company-presenting-at-jpm-tech-conference", "tags": []}
{"id": 45417777, "time": "2025-05-14 14:38:27", "headline": "Lobster Life: Sibling Entrepreneurs See Trade Turmoil As A Business Edge", "summary": "Lobsterboys founder Justin Maderia says the U.S. has depended on foreign markets and broken supply chains &#34;for too long.&#34;", "symbols": [], "source": "benzinga", "author": "Anthony Noto", "url": "https://www.benzinga.com/general/restaurants/25/05/45417777/lobster-life-sibling-entrepreneurs-see-trade-turmoil-as-a-business-edge", "tags": []}
{"id": 45417887, "time": "2025-05-14 14:43:37", "headline": "Tech Stocks Edge Up, AMD Rallies 5%, 30-Year Yields Eye Danger Zone: What's Driving Markets Wednesday?", "summary": "Nasdaq 100 rises further as Nvidia and AMD rally on Middle East investment hopes, while gold tumbles and Treasury yields surge.", "symbols": ["AMD", "BA", "CPRT", "CSCO", "DIA", "ETOR", "EXEL", "IWM", "NVDA", "QQQ", "SMCI", "SPY", "STE", "XLV", "XLY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/25/05/45417887/tech-stocks-edge-up-amd-rallies-5-30-year-yields-eye-danger-zone-whats-driving-markets-wednesday", "tags": []}
{"id": 45417888, "time": "2025-05-14 14:43:53", "headline": "'Netflix Ad Tier Hits 94 Million Global Monthly Active Users'- Adweek", "summary": "", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45417888/netflix-ad-tier-hits-94-million-global-monthly-active-users-adweek", "tags": []}
{"id": 45417895, "time": "2025-05-14 14:44:12", "headline": "JP Morgan Signals Caution On Plug Power's Near-Term Challenges, Withdraws Price Forecast", "summary": "\nJP Morgan analyst reiterated Neutral rating on Plug Power but has withdrawn price forecast. Q1 revenue and earnings beat estimates, Q2 guidance shows confidence in demand growth. Analyst lowered revenue estimates for year, citing potential deal delays and need for additional funding. Company faces near-term challenges, but has potential for future growth. Investors can gain exposure through Global X Hydrogen ETF. PLUG shares down 0.09% at $0.8110. ", "symbols": ["HYDR", "PLUG"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45417895/jp-morgan-signals-caution-on-plug-powers-near-term-challenges-withdraws-price-forecast", "tags": ["earnings", "guidance", "contract"]}
{"id": 45417914, "time": "2025-05-14 14:45:20", "headline": "Blink's Bumpy Road: Analyst Flags Sluggish Product Sales As Key Concern, Trims Estimates", "summary": "H.C. Wainwright analyst trims BLNK&#39;s price forecast to $5, cites product sales weakness. 2025 revenue estimate lowered to $95.1M, EBITDA to -$24.7M.", "symbols": ["BLNK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/05/45417914/blinks-bumpy-road-analyst-flags-sluggish-product-sales-as-key-concern-trims-estimates", "tags": ["earnings", "guidance"]}
{"id": 45418036, "time": "2025-05-14 14:55:10", "headline": "Exelixis Stock Soars As Analysts Applaud Raised 2025 Guidance, Q1 Earnings Beat", "summary": "Exelixis lifts 2025 revenue outlook after strong Q1 driven by Cabometyx sales surge and early traction in the neuroendocrine tumor market.", "symbols": ["EXEL"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45418036/exelixis-stock-soars-as-analysts-applaud-raised-2025-guidance-q1-earnings-beat", "tags": ["earnings", "guidance"]}
{"id": 45417980, "time": "2025-05-14 14:51:56", "headline": "Why Is McDonald's Franchisee Arcos Dorados Stock Falling On Wednesday?", "summary": "Arcos Dorados shares fall after Q1 earnings miss and margin decline.", "symbols": ["ARCO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/general/restaurants/25/05/45417980/why-is-mcdonalds-franchise-arcos-dorados-stock-falling-on-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 45418151, "time": "2025-05-14 15:00:19", "headline": "Forecasting The Future: 5 Analyst Projections For 8x8", "summary": " ", "symbols": ["EGHT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418151/forecasting-the-future-5-analyst-projections-for-8x8", "tags": []}
{"id": 45418153, "time": "2025-05-14 15:00:34", "headline": "Forecasting The Future: 5 Analyst Projections For Capricor Therapeutics", "summary": " ", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418153/forecasting-the-future-5-analyst-projections-for-capricor-therapeutics", "tags": []}
{"id": 45418154, "time": "2025-05-14 15:00:44", "headline": "Beyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock", "summary": " ", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418154/beyond-the-numbers-16-analysts-discuss-regeneron-pharmaceuticals-stock", "tags": []}
{"id": 45418158, "time": "2025-05-14 15:00:49", "headline": "Looking Into Post Holdings's Recent Short Interest", "summary": " ", "symbols": ["POST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45418158/looking-into-post-holdingss-recent-short-interest", "tags": []}
{"id": 45418159, "time": "2025-05-14 15:00:54", "headline": "Is the Market Bullish or Bearish on Archer-Daniels-Midland?", "summary": " ", "symbols": ["ADM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45418159/is-the-market-bullish-or-bearish-on-archer-daniels-midland", "tags": []}
{"id": 45418160, "time": "2025-05-14 15:00:55", "headline": "Assessing Aramark: Insights From 5 Financial Analysts", "summary": " ", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418160/assessing-aramark-insights-from-5-financial-analysts", "tags": []}
{"id": 45418165, "time": "2025-05-14 15:01:00", "headline": "Peering Into Hess's Recent Short Interest", "summary": " ", "symbols": ["HES"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45418165/peering-into-hesss-recent-short-interest", "tags": []}
{"id": 45418168, "time": "2025-05-14 15:01:03", "headline": "A Glimpse Into The Expert Outlook On Amer Sports Through 8 Analysts", "summary": " ", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418168/a-glimpse-into-the-expert-outlook-on-amer-sports-through-8-analysts", "tags": ["guidance"]}
{"id": 45418170, "time": "2025-05-14 15:01:11", "headline": "Price Over Earnings Overview: Murphy USA", "summary": " ", "symbols": ["MUSA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45418170/price-over-earnings-overview-murphy-usa", "tags": ["earnings"]}
{"id": 45418171, "time": "2025-05-14 15:01:12", "headline": "Demystifying Webtoon Entertainment: Insights From 6 Analyst Reviews", "summary": " ", "symbols": ["WBTN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45418171/demystifying-webtoon-entertainment-insights-from-6-analyst-reviews", "tags": []}
{"id": 45418210, "time": "2025-05-14 15:02:56", "headline": "PAVmed's Earnings: A Preview", "summary": " ", "symbols": ["PAVM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45418210/pavmeds-earnings-a-preview", "tags": ["earnings"]}
{"id": 45418275, "time": "2025-05-14 15:04:53", "headline": "An Overview of Biofrontera's Earnings", "summary": " ", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45418275/an-overview-of-biofronteras-earnings", "tags": ["earnings"]}
{"id": 45418316, "time": "2025-05-14 15:05:51", "headline": "An Overview of Ondas Holdings's Earnings", "summary": " ", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45418316/an-overview-of-ondas-holdingss-earnings", "tags": ["earnings"]}
{"id": 45418342, "time": "2025-05-14 15:06:46", "headline": "Katapult Holdings Earnings Preview", "summary": " ", "symbols": ["KPLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45418342/katapult-holdings-earnings-preview", "tags": ["earnings"]}
{"id": 45418360, "time": "2025-05-14 15:07:10", "headline": "What to Expect from Invivyd's Earnings", "summary": " ", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45418360/what-to-expect-from-invivyds-earnings", "tags": ["earnings"]}
{"id": 45418361, "time": "2025-05-14 15:07:14", "headline": "Uber Technologies And iFood Partner To Enhance Mobility And Delivery In Brazil", "summary": "", "symbols": ["UBER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45418361/uber-technologies-and-ifood-partner-to-enhance-mobility-and-delivery-in-brazil", "tags": []}
{"id": 45418430, "time": "2025-05-14 15:09:29", "headline": "Why Did Rigetti Computing Analyst Cut His Price Forecast?", "summary": "Rigetti Computing&#39;s shares surge after reporting lower-than-expected revenue and higher earnings, as analyst maintains Buy rating.", "symbols": ["RGTI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45418430/why-did-rigetti-computing-analyst-cut-his-price-forecast", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 45418446, "time": "2025-05-14 15:10:51", "headline": "This Week's Best Short Squeeze Options Trade", "summary": " ", "symbols": ["FSLR"], "source": "benzinga", "author": "Anne-Marie Baiynd", "url": "https://www.benzinga.com/25/05/45418446/this-weeks-best-short-squeeze-options-trade", "tags": []}
{"id": 45418458, "time": "2025-05-14 15:11:23", "headline": "Rigetti Stock Is Soaring Wednesday: What's Going On?", "summary": "Rigetti reported first-quarter earnings on Monday after the market closed.", "symbols": ["RGTI"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45418458/rigetti-stock-is-soaring-wednesday-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 45418474, "time": "2025-05-14 15:12:02", "headline": "Carvana (CVNA) Stock Is Up 52% Over The Past Month: What's Going On?", "summary": "Carvana shares have surged 52% over the past month, driven by strong earnings. Record Q1 revenue and sales beat estimates, boosting profit and future outlook expectations.", "symbols": ["CVNA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45418474/carvana-cvna-stock-is-up-52-over-the-past-month-whats-going-on", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 45418498, "time": "2025-05-14 15:12:29", "headline": "Reddit (RDDT) Stock Is Up 25% Over The Past Month: What's Going On?", "summary": "Reddit shares are surging 9.2% Wednesday afternoon. The stock&#39;s recent, sharp rise follows the company&#39;s stronger-than-expected Q1 earnings.", "symbols": ["RDDT"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/05/45418498/reddit-rddt-stock-is-up-25-over-the-past-month-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 45418556, "time": "2025-05-14 15:14:00", "headline": "Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds", "summary": "Weight loss drugs like semaglutide could add \u00a34.5 billion to the UK economy annually, boosting productivity and reducing alcohol use, though high costs may limit broad access.", "symbols": ["NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45418556/novo-nordisks-ozempic-weight-loss-jabs-could-boost-uk-economy-by-6-billion-study-finds", "tags": []}
{"id": 45418566, "time": "2025-05-14 15:14:31", "headline": "Silicon Labs Revenue Beats Estimates, Analysts Highlight Inventory Recovery", "summary": "Silicon Laboratories reported Q1 results, with revenues of $178 million, as inventory levels are being well-managed, analysts say.", "symbols": ["SLAB"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/05/45418566/silicon-labs-revenue-beats-estimates-analysts-highlight-inventory-recovery", "tags": ["earnings"]}
{"id": 45418567, "time": "2025-05-14 15:14:31", "headline": "What's Going On With Newegg Shares Wednesday?", "summary": " ", "symbols": ["NEGG"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45418567/whats-going-on-with-newegg-shares-wednesday", "tags": ["why_moving"]}
{"id": 45418609, "time": "2025-05-14 15:17:45", "headline": "FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors", "summary": "Merck&#39;s Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase.", "symbols": ["MRK"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45418609/fda-approves-mercks-kidney-cancer-drug-for-rare-type-of-neuroendocrine-tumors", "tags": ["fda"]}
{"id": 45418628, "time": "2025-05-14 15:18:47", "headline": "Bitcoin, Ethereum, XRP, Dogecoin Flat As Traders Hope For Altcoin Outperformance", "summary": "Major cryptocurrencies are trading sideways amid stagnating Bitcoin dominance, potentially signaling increased capital rotation into altcoins.", "symbols": ["BTCUSD", "DOGEUSD", "EOSUSD", "ETHUSD", "FLOKIUSD", "PIUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45418628/bitcoin-ethereum-xrp-dogecoin-flat-as-traders-hope-for-altcoin-outperformance", "tags": []}
{"id": 45418687, "time": "2025-05-14 15:25:05", "headline": "FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases", "summary": "FDA grants accelerated approval to AbbVie&#39;s Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront.", "symbols": ["ABBV", "RHHBY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/05/45418687/fda-fast-tracks-abbvies-new-lung-cancer-therapy-emrelis-for-tough-lung-cancer-cases", "tags": ["fda", "contract"]}
{"id": 45418724, "time": "2025-05-14 15:26:48", "headline": "CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up", "summary": "CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.", "symbols": ["BMY", "JNJ", "MRK"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/05/45418724/new-cms-guidance-raises-concerns-over-subcutaneous-drug-inclusion-goldman-sachs-sees-as-another-aspect-of-policy-uncertainty", "tags": []}
{"id": 45418896, "time": "2025-05-14 15:39:51", "headline": "Basel Medical Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -58.7%", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/05/45418896/basel-medical-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-58-7", "tags": ["halt"]}
{"id": 45419064, "time": "2025-05-14 15:48:44", "headline": "Coinbase Explodes 47% Ahead Of S&P 500 Debut - Charts Flash Bullish Breakout", "summary": "Coinbase (COIN) experiencing breakout moment, soaring 47% in past month due to S&amp;P 500 inclusion and acquisition of Deribit. Technicals also strong.", "symbols": ["COIN"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45419064/coinbase-explodes-47-ahead-of-sp-500-debut-charts-flash-bullish-breakout", "tags": []}
{"id": 45419116, "time": "2025-05-14 15:52:15", "headline": "Musk, Bezos Gain Billions After US-China Trade Deal, But The Wealthiest 10 Are Still Down $67B In 2025", "summary": "The top 10 richest people in the world are worth less than they were in 2024. Here&#39;s a look at the gains and losses for top billionaires year-to-date.", "symbols": ["SPY", "TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/management/25/05/45419116/musk-bezos-gain-billions-after-us-china-trade-deal-but-the-wealthiest-10-are-still-down-67b-in-2025", "tags": ["contract"]}
{"id": 45419166, "time": "2025-05-14 15:55:03", "headline": "American Eagle Slumps After Weak Q1 Preview, Analyst Cuts Forecasts On Demand Concerns", "summary": "American Eagle shares tumble as analyst cuts FY25 outlook after weak Q1 update.\n\n\n\n\n\n\n\n\n", "symbols": ["AEO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/25/05/45419166/american-eagle-slumps-after-weak-q1-preview-analyst-cuts-forecasts-on-demand-concerns", "tags": ["guidance"]}
{"id": 45419235, "time": "2025-05-14 15:58:29", "headline": "Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030", "summary": "Sanofi plans $20 billion US investment by 2030 to expand R&amp;D and manufacturing, aiming to boost medicine production and job creation across states.", "symbols": ["BDX", "BMY", "JNJ", "LLY", "NVS", "PFE", "REGN", "RHHBY", "SNY", "TMO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/05/45419235/sanofi-joins-other-big-pharma-to-navigate-potential-tariff-impact-with-at-least-20-billion-in-investments-through-2030", "tags": []}
{"id": 45419284, "time": "2025-05-14 16:00:32", "headline": "Is the Market Bullish or Bearish on Selective Insurance Gr?", "summary": " ", "symbols": ["SIGI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45419284/is-the-market-bullish-or-bearish-on-selective-insurance-gr", "tags": []}
{"id": 45419287, "time": "2025-05-14 16:00:32", "headline": "4 Analysts Have This To Say About PennantPark Floating Rate", "summary": " ", "symbols": ["PFLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419287/4-analysts-have-this-to-say-about-pennantpark-floating-rate", "tags": []}
{"id": 45419290, "time": "2025-05-14 16:00:37", "headline": "How Do Investors Really Feel About Freeport-McMoRan?", "summary": " ", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45419290/how-do-investors-really-feel-about-freeport-mcmoran", "tags": []}
{"id": 45419291, "time": "2025-05-14 16:00:37", "headline": "Xos Q1 EPS $(1.26) Misses $(1.11) Estimate, Sales $5.88M Miss $10.17M Estimate", "summary": "", "symbols": ["XOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419291/xos-q1-eps-1-26-misses-1-11-estimate-sales-5-88m-miss-10-17m-estimate", "tags": ["earnings"]}
{"id": 45419292, "time": "2025-05-14 16:00:43", "headline": "Peering Into MidCap Financial's Recent Short Interest", "summary": " ", "symbols": ["MFIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/05/45419292/peering-into-midcap-financials-recent-short-interest", "tags": []}
{"id": 45419293, "time": "2025-05-14 16:00:44", "headline": "Analyst Expectations For Deckers Outdoor's Future", "summary": " ", "symbols": ["DECK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419293/analyst-expectations-for-deckers-outdoors-future", "tags": []}
{"id": 45419294, "time": "2025-05-14 16:00:45", "headline": "A Look Into Lennox Intl Inc's Price Over Earnings", "summary": " ", "symbols": ["LII"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45419294/a-look-into-lennox-intl-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 45419314, "time": "2025-05-14 16:00:56", "headline": "A Glimpse Into The Expert Outlook On Fox Factory Holding Through 6 Analysts", "summary": " ", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419314/a-glimpse-into-the-expert-outlook-on-fox-factory-holding-through-6-analysts", "tags": ["guidance"]}
{"id": 45419348, "time": "2025-05-14 16:01:14", "headline": "Analyst Expectations For Kontoor Brands's Future", "summary": " ", "symbols": ["KTB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419348/analyst-expectations-for-kontoor-brandss-future", "tags": []}
{"id": 45419352, "time": "2025-05-14 16:01:21", "headline": "Xos Affirms FY2025 Sales Guidance of $50.20M-$65.80M vs $79.47M Est", "summary": "", "symbols": ["XOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419352/xos-affirms-fy2025-sales-guidance-of-50-20m-65-80m-vs-79-47m-est", "tags": ["guidance"]}
{"id": 45419353, "time": "2025-05-14 16:01:23", "headline": "MDxHealth Q1 EPS $(0.19) Misses $(0.13) Estimate, Sales $24.30M Beat $24.11M Estimate", "summary": "", "symbols": ["MDXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419353/mdxhealth-q1-eps-0-19-misses-0-13-estimate-sales-24-30m-beat-24-11m-estimate", "tags": ["earnings"]}
{"id": 45419358, "time": "2025-05-14 16:01:27", "headline": "A Glimpse Into The Expert Outlook On Ross Stores Through 15 Analysts", "summary": " ", "symbols": ["ROST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419358/a-glimpse-into-the-expert-outlook-on-ross-stores-through-15-analysts", "tags": ["guidance"]}
{"id": 45419370, "time": "2025-05-14 16:01:34", "headline": "Ibotta Q1 Adj. EPS $0.36 Beats $0.01 Estimate, Sales $84.57M Beat $82.07M Estimate", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419370/ibotta-q1-adj-eps-0-36-beats-0-01-estimate-sales-84-57m-beat-82-07m-estimate", "tags": ["earnings"]}
{"id": 45419373, "time": "2025-05-14 16:01:35", "headline": "A Glimpse Into The Expert Outlook On MidCap Financial Through 5 Analysts", "summary": " ", "symbols": ["MFIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45419373/a-glimpse-into-the-expert-outlook-on-midcap-financial-through-5-analysts", "tags": ["guidance"]}
{"id": 45419395, "time": "2025-05-14 16:01:50", "headline": "MDxHealth Affirms FY2025 Sales Guidance of $108.00M-$110.00M", "summary": "", "symbols": ["MDXH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419395/mdxhealth-affirms-fy2025-sales-guidance-of-108-00m-110-00m", "tags": ["guidance"]}
{"id": 45419397, "time": "2025-05-14 16:01:51", "headline": "Monogram Technologies Q1 EPS $(0.10) Beats $(0.12) Estimate", "summary": "", "symbols": ["MGRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419397/monogram-technologies-q1-eps-0-10-beats-0-12-estimate", "tags": ["earnings"]}
{"id": 45419398, "time": "2025-05-14 16:01:52", "headline": "Here's How Much $100 Invested In Sea 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45419398/heres-how-much-100-invested-in-sea-10-years-ago-would-be-worth-today", "tags": []}
{"id": 45419404, "time": "2025-05-14 16:01:55", "headline": "Decoding Citigroup's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["C"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/05/45419404/decoding-citigroups-options-activity-whats-the-big-picture", "tags": []}
{"id": 45419426, "time": "2025-05-14 16:02:09", "headline": "Red Cat Holdings Q1 EPS $(0.27) Misses $(0.08) Estimate, Sales $1.63M Miss $3.85M Estimate", "summary": "", "symbols": ["RCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419426/red-cat-holdings-q1-eps-0-27-misses-0-08-estimate-sales-1-63m-miss-3-85m-estimate", "tags": ["earnings"]}
{"id": 45419434, "time": "2025-05-14 16:02:14", "headline": "Celcuity Q1 Adj. EPS $(0.81) Beats $(0.86) Estimate", "summary": "", "symbols": ["CELC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419434/celcuity-q1-adj-eps-0-81-beats-0-86-estimate", "tags": ["earnings"]}
{"id": 45419442, "time": "2025-05-14 16:02:23", "headline": "Bionano Genomics Q1 Sales $6.50M Beat $6.23M Estimate", "summary": "", "symbols": ["BNGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419442/bionano-genomics-q1-sales-6-50m-beat-6-23m-estimate", "tags": []}
{"id": 45419451, "time": "2025-05-14 16:02:33", "headline": "Ibotta Sees Q2 Sales $86.500M-$92.500M vs $89.15M Est", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419451/ibotta-sees-q2-sales-86-500m-92-500m-vs-89-15m-est", "tags": []}
{"id": 45419488, "time": "2025-05-14 16:02:56", "headline": "Quantum Computing's Earnings Outlook", "summary": " ", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419488/quantum-computings-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45419490, "time": "2025-05-14 16:02:56", "headline": "Red Cat Holdings Affirms FY2025 Sales Guidance of $80.00M-$120.00M vs $80.17M Est", "summary": "", "symbols": ["RCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419490/red-cat-holdings-affirms-fy2025-sales-guidance-of-80-00m-120-00m-vs-80-17m-est", "tags": ["guidance"]}
{"id": 45419498, "time": "2025-05-14 16:03:03", "headline": "Jack In The Box Q2 Adj. EPS $1.20 Beats $1.11 Estimate, Sales $336.70M Miss $343.08M Estimate", "summary": "", "symbols": ["JACK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419498/jack-in-the-box-q2-adj-eps-1-20-beats-1-11-estimate-sales-336-70m-miss-343-08m-estimate", "tags": ["earnings"]}
{"id": 45419504, "time": "2025-05-14 16:03:08", "headline": "Oncolytics Biotech Q1 EPS $(0.06) Beats $(0.09) Estimate", "summary": "", "symbols": ["ONCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419504/oncolytics-biotech-q1-eps-0-06-beats-0-09-estimate", "tags": ["earnings"]}
{"id": 45419511, "time": "2025-05-14 16:03:15", "headline": "TriLink and IVI Collaborate To Advance Research And Development Of mRNA-Based Vaccines And Promote Equitable Access To Essential Vaccines And Health Technologies", "summary": "", "symbols": ["MRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419511/trilink-and-ivi-collaborate-to-advance-research-and-development-of-mrna-based-vaccines-and-promote-e", "tags": []}
{"id": 45419536, "time": "2025-05-14 16:03:37", "headline": "TMC Metals Q1 EPS $(0.06) Misses $(0.03) Estimate", "summary": "", "symbols": ["TMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419536/tmc-metals-q1-eps-0-06-misses-0-03-estimate", "tags": ["earnings"]}
{"id": 45419543, "time": "2025-05-14 16:03:51", "headline": "CORRECTION: Excelerate Energy Did Not Report Earnings Today", "summary": "", "symbols": ["EE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419543/correction-excelerate-energy-did-not-report-earnings-today", "tags": ["earnings"]}
{"id": 45419547, "time": "2025-05-14 16:03:55", "headline": "Usio Q1 EPS $(0.01) Misses $0.02 Estimate, Sales $22.01M Beat $21.99M Estimate", "summary": "", "symbols": ["USIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419547/usio-q1-eps-0-01-misses-0-02-estimate-sales-22-01m-beat-21-99m-estimate", "tags": ["earnings"]}
{"id": 45419549, "time": "2025-05-14 16:03:55", "headline": "A Look at BiomX's Upcoming Earnings Report", "summary": " ", "symbols": ["PHGE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419549/a-look-at-biomxs-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 45419559, "time": "2025-05-14 16:04:13", "headline": "A Preview Of CaliberCos's Earnings", "summary": " ", "symbols": ["CWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419559/a-preview-of-calibercoss-earnings", "tags": ["earnings"]}
{"id": 45419562, "time": "2025-05-14 16:04:18", "headline": "eGain Q3 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $21.00M Miss $21.24M Estimate", "summary": "", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419562/egain-q3-adj-eps-0-03-misses-0-04-estimate-sales-21-00m-miss-21-24m-estimate", "tags": ["earnings"]}
{"id": 45419575, "time": "2025-05-14 16:04:39", "headline": "Capital One Sued By New York Over Hidden Interest Rate Scheme That Cost Consumers Millions", "summary": "NY AG accuses Capital One of deceptive practices, freezing older savings account rates while offering higher yields to new customers.", "symbols": ["COF"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/government/regulations/25/05/45419575/capital-one-sued-by-new-york-over-hidden-interest-rate-scheme-that-cost-consumers-millions", "tags": ["offering"]}
{"id": 45419584, "time": "2025-05-14 16:04:54", "headline": "scPharmaceuticals Q1 EPS $(0.37) Misses $(0.30) Estimate, Sales $11.75M Beat $11.63M Estimate", "summary": "", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419584/scpharmaceuticals-q1-eps-0-37-misses-0-30-estimate-sales-11-75m-beat-11-63m-estimate", "tags": ["earnings"]}
{"id": 45419599, "time": "2025-05-14 16:05:06", "headline": "Preview: LightPath Technologies's Earnings", "summary": " ", "symbols": ["LPTH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419599/preview-lightpath-technologiess-earnings", "tags": ["earnings"]}
{"id": 45419610, "time": "2025-05-14 16:05:07", "headline": "Galapagos Announces New Data From ATALANTA-1 Study Of Investigational CAR-T Candidate GLPG5101", "summary": "", "symbols": ["GLPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45419610/galapagos-announces-new-data-from-atalanta-1-study-of-investigational-car-t-candidate-glpg5101", "tags": []}
{"id": 45419646, "time": "2025-05-14 16:05:09", "headline": "The Perfect Stocks Portfolio: May 2025 Update", "summary": " ", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/opinion/25/05/45419646/the-perfect-stocks-portfolio-may-2025-update", "tags": []}
{"id": 45419684, "time": "2025-05-14 16:05:16", "headline": "New Fortress Energy Q1 Adj. EPS $(0.73) May Not Compare To $(0.06) Estimate, Sales $609.50M Miss $620.51M Estimate", "summary": "", "symbols": ["NFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419684/new-fortress-energy-q1-adj-eps-0-73-may-not-compare-to-0-06-estimate-sales-609-50m-miss-620-51m-est", "tags": ["earnings"]}
{"id": 45419706, "time": "2025-05-14 16:05:34", "headline": "eGain Raises FY2025 Adj EPS Guidance from $0.14-$0.16 to $0.18-$0.20 vs $0.21 Est; Lowers FY2025 Sales Guidance from $88.50M-$90.00M to $88.00M-$88.50M vs $88.87M Est", "summary": "", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419706/egain-raises-fy2025-adj-eps-guidance-from-0-14-0-16-to-0-18-0-20-vs-0-21-est-lowers-fy2025-sales-gui", "tags": ["earnings", "guidance"]}
{"id": 45419715, "time": "2025-05-14 16:05:46", "headline": "Artivion Enters Into Separate, Privately Negotiated Exchange Agreements With Certain Holders Of 4.250% Convertible Senior Notes Due 2025", "summary": "", "symbols": ["AORT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419715/artivion-enters-into-separate-privately-negotiated-exchange-agreements-with-certain-holders-of-4-250", "tags": []}
{"id": 45419726, "time": "2025-05-14 16:05:52", "headline": "Karooooo Q4 Adj. EPS $0.51 Beats $0.37 Estimate, Sales $65.56M Beat $62.90M Estimate", "summary": "", "symbols": ["KARO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419726/karooooo-q4-adj-eps-0-51-beats-0-37-estimate-sales-65-56m-beat-62-90m-estimate", "tags": ["earnings"]}
{"id": 45419740, "time": "2025-05-14 16:05:58", "headline": "CV Sciences Q1 Sales $3.61M Down From $4.00M YoY", "summary": "", "symbols": ["CVSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419740/cv-sciences-q1-sales-3-61m-down-from-4-00m-yoy", "tags": []}
{"id": 45419753, "time": "2025-05-14 16:06:06", "headline": "Rekor Systems Q1 EPS $(0.10) Misses $(0.07) Estimate, Sales $9.20M Miss $10.90M Estimate", "summary": "", "symbols": ["REKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419753/rekor-systems-q1-eps-0-10-misses-0-07-estimate-sales-9-20m-miss-10-90m-estimate", "tags": ["earnings"]}
{"id": 45419762, "time": "2025-05-14 16:06:10", "headline": "ImmuCell Q1 EPS $0.16 Up From $(0.06) YoY, Sales $8.07M Up From $7.26M YoY", "summary": "", "symbols": ["ICCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419762/immucell-q1-eps-0-16-up-from-0-06-yoy-sales-8-07m-up-from-7-26m-yoy", "tags": ["earnings"]}
{"id": 45419772, "time": "2025-05-14 16:06:14", "headline": "CoreWeave Q1 GAAP EPS $(1.49), Sales $981.63M Beat $859.77M Estimate", "summary": "", "symbols": ["CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419772/coreweave-q1-gaap-eps-1-49-sales-981-63m-beat-859-77m-estimate", "tags": ["earnings"]}
{"id": 45419785, "time": "2025-05-14 16:06:25", "headline": "Codexis Q1 EPS $(0.25) Misses $(0.23) Estimate, Sales $7.54M Miss $9.66M Estimate", "summary": "", "symbols": ["CDXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419785/codexis-q1-eps-0-25-misses-0-23-estimate-sales-7-54m-miss-9-66m-estimate", "tags": ["earnings"]}
{"id": 45419825, "time": "2025-05-14 16:06:47", "headline": "Cisco Systems Q3 Adj. EPS $0.96 Beats $0.92 Estimate, Sales $14.15B Beat $14.08B Estimate", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419825/cisco-systems-q3-adj-eps-0-96-beats-0-92-estimate-sales-14-15b-beat-14-08b-estimate", "tags": ["earnings"]}
{"id": 45419832, "time": "2025-05-14 16:06:51", "headline": "Aeva Technologies Q1 Adj. EPS $(0.45) Beats $(0.48) Estimate, Sales $3.37M Beat $2.33M Estimate", "summary": "", "symbols": ["AEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419832/aeva-technologies-q1-adj-eps-0-45-beats-0-48-estimate-sales-3-37m-beat-2-33m-estimate", "tags": ["earnings"]}
{"id": 45419836, "time": "2025-05-14 16:06:54", "headline": "BioRestorative Therapies Q1 EPS $(0.64) Misses $(0.33) Estimate, Sales $25.00K Miss $380.00K Estimate", "summary": "", "symbols": ["BRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419836/biorestorative-therapies-q1-eps-0-64-misses-0-33-estimate-sales-25-00k-miss-380-00k-estimate", "tags": ["earnings"]}
{"id": 45419873, "time": "2025-05-14 16:07:13", "headline": "Codexis Affirms FY2025 Sales Guidance of $64.00M-$68.00M vs $65.67M Est", "summary": "", "symbols": ["CDXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419873/codexis-affirms-fy2025-sales-guidance-of-64-00m-68-00m-vs-65-67m-est", "tags": ["guidance"]}
{"id": 45419881, "time": "2025-05-14 16:07:20", "headline": "Nkarta Q1 EPS $(0.43) Beats $(0.44) Estimate", "summary": "", "symbols": ["NKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419881/nkarta-q1-eps-0-43-beats-0-44-estimate", "tags": ["earnings"]}
{"id": 45419883, "time": "2025-05-14 16:07:20", "headline": "DLocal Q1 EPS $0.15 Beats $0.11 Estimate, Sales $216.80M Beat $210.08M Estimate", "summary": "", "symbols": ["DLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419883/dlocal-q1-eps-0-15-beats-0-11-estimate-sales-216-80m-beat-210-08m-estimate", "tags": ["earnings"]}
{"id": 45419918, "time": "2025-05-14 16:07:36", "headline": "Epsilon Energy Q1 EPS $0.18 Beats $0.14 Estimate, Sales $16.16M Beat $11.71M Estimate", "summary": "", "symbols": ["EPSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419918/epsilon-energy-q1-eps-0-18-beats-0-14-estimate-sales-16-16m-beat-11-71m-estimate", "tags": ["earnings"]}
{"id": 45419928, "time": "2025-05-14 16:07:42", "headline": "Karooooo Sees FY2026 Adj EPS $1.75-$1.91 vs $1.70 Est", "summary": "", "symbols": ["KARO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45419928/karooooo-sees-fy2026-adj-eps-1-75-1-91-vs-1-70-est", "tags": ["earnings"]}
{"id": 45419931, "time": "2025-05-14 16:07:43", "headline": "Exploring Gossamer Bio's Earnings Expectations", "summary": " ", "symbols": ["GOSS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419931/exploring-gossamer-bios-earnings-expectations", "tags": ["earnings"]}
{"id": 45419941, "time": "2025-05-14 16:07:49", "headline": "Intelligent Protection Q1 EPS $0.06 Beats $(0.08) Estimate, Sales $5.52M Miss $5.77M Estimate", "summary": "", "symbols": ["IPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419941/intelligent-protection-q1-eps-0-06-beats-0-08-estimate-sales-5-52m-miss-5-77m-estimate", "tags": ["earnings"]}
{"id": 45419964, "time": "2025-05-14 16:08:01", "headline": "Examining the Future: Worksport's Earnings Outlook", "summary": " ", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45419964/examining-the-future-worksports-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45419968, "time": "2025-05-14 16:08:03", "headline": "ZSPACE Q1 Sales $6.76M Beat $5.03M Estimate", "summary": "", "symbols": ["ZSPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419968/zspace-q1-sales-6-76m-beat-5-03m-estimate", "tags": []}
{"id": 45419999, "time": "2025-05-14 16:08:25", "headline": "NEXTracker Q4 Adj. EPS $1.29 Beats $0.98 Estimate, Sales $924.00M Beat $828.84M Estimate", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45419999/nextracker-q4-adj-eps-1-29-beats-0-98-estimate-sales-924-00m-beat-828-84m-estimate", "tags": ["earnings"]}
{"id": 45420004, "time": "2025-05-14 16:08:29", "headline": "Cisco Systems Sees Q4 GAAP EPS $0.62-$0.67 vs $0.63 Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420004/cisco-systems-sees-q4-gaap-eps-0-62-0-67-vs-0-63-est", "tags": ["earnings"]}
{"id": 45420010, "time": "2025-05-14 16:08:37", "headline": "Cisco Systems Raises FY2025 GAAP EPS Guidance from $2.40-$2.52 to $2.53-$2.58 vs $2.57 Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420010/cisco-systems-raises-fy2025-gaap-eps-guidance-from-2-40-2-52-to-2-53-2-58-vs-2-57-est", "tags": ["earnings", "guidance"]}
{"id": 45420022, "time": "2025-05-14 16:08:45", "headline": "Cisco Systems Raises FY2025 Adj EPS Guidance from $3.68-$3.74 to $3.77-$3.79 vs $3.73 Est; Raises FY2025 Sales Guidance from $56.00B-$56.50B to $56.50B-$56.70B vs $56.47B Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420022/cisco-systems-raises-fy2025-adj-eps-guidance-from-3-68-3-74-to-3-77-3-79-vs-3-73-est-raises-fy2025-s", "tags": ["earnings", "guidance"]}
{"id": 45420028, "time": "2025-05-14 16:08:49", "headline": "Snail Q1 GAAP EPS $(0.06) Beats $(0.10) Estimate, Sales $20.11M Beat $18.00M Estimate", "summary": "", "symbols": ["SNAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420028/snail-q1-gaap-eps-0-06-beats-0-10-estimate-sales-20-11m-beat-18-00m-estimate", "tags": ["earnings"]}
{"id": 45420033, "time": "2025-05-14 16:08:52", "headline": "Earnings Outlook For Air Industries", "summary": " ", "symbols": ["AIRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45420033/earnings-outlook-for-air-industries", "tags": ["earnings", "guidance"]}
{"id": 45420035, "time": "2025-05-14 16:08:55", "headline": "Cisco Systems Sees Q4 Adj EPS $0.96-$0.98 vs $0.95 Est; Sees Sales $14.500B-$14.700B vs $14.58B Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420035/cisco-systems-sees-q4-adj-eps-0-96-0-98-vs-0-95-est-sees-sales-14-500b-14-700b-vs-14-58b-est", "tags": ["earnings"]}
{"id": 45420042, "time": "2025-05-14 16:09:01", "headline": "Spruce Power Holding Q1 EPS $(0.84) Down From $(0.13) YoY, Sales $23.82M Beat $23.00M Estimate", "summary": "", "symbols": ["SPRU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420042/spruce-power-holding-q1-eps-0-84-down-from-0-13-yoy-sales-23-82m-beat-23-00m-estimate", "tags": ["earnings"]}
{"id": 45420060, "time": "2025-05-14 16:09:26", "headline": "Penske Automotive Group Increases Quarterly Dividend From $1.22 To $1.26 Per Share", "summary": "", "symbols": ["PAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420060/penske-automotive-group-increases-quarterly-dividend-from-1-22-to-1-26-per-share", "tags": ["dividend"]}
{"id": 45420062, "time": "2025-05-14 16:09:27", "headline": "Star Bulk Carriers Q1 Adj. EPS $(0.07) Beats $(0.28) Estimate, Sales $230.65M Beat $173.06M Estimate", "summary": "", "symbols": ["SBLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420062/star-bulk-carriers-q1-adj-eps-0-07-beats-0-28-estimate-sales-230-65m-beat-173-06m-estimate", "tags": ["earnings"]}
{"id": 45420082, "time": "2025-05-14 16:09:42", "headline": "Clearside Biomedical Q1 EPS $(0.11), Inline, Sales $2.33M Beat $170.00K Estimate", "summary": "", "symbols": ["CLSD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420082/clearside-biomedical-q1-eps-0-11-inline-sales-2-33m-beat-170-00k-estimate", "tags": ["earnings"]}
{"id": 45420094, "time": "2025-05-14 16:09:50", "headline": "Penske Automotive Group Increases Securities Repurchase Authorization By Additional $250M", "summary": "", "symbols": ["PAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420094/penske-automotive-group-increases-securities-repurchase-authorization-by-additional-250m", "tags": ["buyback"]}
{"id": 45420100, "time": "2025-05-14 16:09:56", "headline": "Strata Skin Sciences Q1 EPS $(0.58) Misses $(0.52) Estimate, Sales $6.81M Miss $7.28M Estimate", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420100/strata-skin-sciences-q1-eps-0-58-misses-0-52-estimate-sales-6-81m-miss-7-28m-estimate", "tags": ["earnings"]}
{"id": 45420110, "time": "2025-05-14 16:10:02", "headline": "Aytu BioPharma Q3 EPS $0.21 Beats $(0.17) Estimate, Sales $18.45M Beat $13.74M Estimate", "summary": "", "symbols": ["AYTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420110/aytu-biopharma-q3-eps-0-21-beats-0-17-estimate-sales-18-45m-beat-13-74m-estimate", "tags": ["earnings"]}
{"id": 45420142, "time": "2025-05-14 16:10:23", "headline": "Marpai Q1 EPS $(0.21) Up From $(0.46) YoY, Sales $5.42M Down From $7.38M YoY", "summary": "", "symbols": ["MRAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420142/marpai-q1-eps-0-21-up-from-0-46-yoy-sales-5-42m-down-from-7-38m-yoy", "tags": ["earnings"]}
{"id": 45420152, "time": "2025-05-14 16:10:29", "headline": "Spire Global Q1 Adj. EPS $(0.77) Misses $(0.67) Estimate, Sales $23.90M Beat $22.68M Estimate", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420152/spire-global-q1-adj-eps-0-77-misses-0-67-estimate-sales-23-90m-beat-22-68m-estimate", "tags": ["earnings"]}
{"id": 45420167, "time": "2025-05-14 16:10:39", "headline": "Spire Global Wins 10-Year U.S. Space Force Contract With $237M Ceiling", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420167/spire-global-wins-10-year-u-s-space-force-contract-with-237m-ceiling", "tags": ["contract"]}
{"id": 45420187, "time": "2025-05-14 16:10:58", "headline": "SeaStar Medical Holding Q1 EPS $(0.44) Beats $(0.52) Estimate, Sales $293.00K Beat $150.00K Estimate", "summary": "", "symbols": ["ICU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420187/seastar-medical-holding-q1-eps-0-44-beats-0-52-estimate-sales-293-00k-beat-150-00k-estimate", "tags": ["earnings"]}
{"id": 45420188, "time": "2025-05-14 16:10:58", "headline": "Fossil Group Q1 Adj. EPS $(0.10) Up From $(0.30) YoY, Sales $233.30M Down From $254.90M YoY", "summary": "", "symbols": ["FOSL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420188/fossil-group-q1-adj-eps-0-10-up-from-0-30-yoy-sales-233-30m-down-from-254-90m-yoy", "tags": ["earnings"]}
{"id": 45420208, "time": "2025-05-14 16:11:14", "headline": "Spire Global Sees Q2 Adj EPS $(0.49)-$(0.42) vs $(0.47) Est; Sees Sales $18.000M-$20.000M vs $22.97M Est", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420208/spire-global-sees-q2-adj-eps-0-49-0-42-vs-0-47-est-sees-sales-18-000m-20-000m-vs-22-97m-est", "tags": ["earnings"]}
{"id": 45420215, "time": "2025-05-14 16:11:35", "headline": "Azitra To Present Phase 1/2 Study Of ATR04-484 For EGFR Inhibitor-Associated Rash", "summary": "", "symbols": ["AZTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45420215/azitra-to-present-phase-12-study-of-atr04-484-for-egfr-inhibitor-associated-rash", "tags": ["fda"]}
{"id": 45420219, "time": "2025-05-14 16:11:39", "headline": "Hawkins Q4 EPS $0.78 Beats $0.73 Estimate, Sales $245.32M Beat $230.69M Estimate", "summary": "", "symbols": ["HWKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420219/hawkins-q4-eps-0-78-beats-0-73-estimate-sales-245-32m-beat-230-69m-estimate", "tags": ["earnings"]}
{"id": 45420228, "time": "2025-05-14 16:11:48", "headline": "Aterian Q1 EPS $(0.52) Beats $(0.69) Estimate, Sales $15.36M Beat $14.95M Estimate", "summary": "", "symbols": ["ATER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420228/aterian-q1-eps-0-52-beats-0-69-estimate-sales-15-36m-beat-14-95m-estimate", "tags": ["earnings"]}
{"id": 45420232, "time": "2025-05-14 16:11:50", "headline": "Shimmick Q1 Adj. EPS $(0.22) Beats $(0.25) Estimate, Sales $122.00M Beat $94.35M Estimate", "summary": "", "symbols": ["SHIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420232/shimmick-q1-adj-eps-0-22-beats-0-25-estimate-sales-122-00m-beat-94-35m-estimate", "tags": ["earnings"]}
{"id": 45420240, "time": "2025-05-14 16:11:59", "headline": "Journey Medical Q1 EPS $(0.18) Beats $(0.24) Estimate, Sales $13.14M Beat $12.05M Estimate", "summary": "", "symbols": ["DERM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420240/journey-medical-q1-eps-0-18-beats-0-24-estimate-sales-13-14m-beat-12-05m-estimate", "tags": ["earnings"]}
{"id": 45420292, "time": "2025-05-14 16:12:33", "headline": "The Beachbody Company, Inc. Class A Common Stock Q1 EPS $(0.84) Beats $(1.44) Estimate, Sales $72.40M Beat $64.18M Estimate", "summary": "", "symbols": ["BODI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420292/the-beachbody-company-inc-class-a-common-stock-q1-eps-0-84-beats-1-44-estimate-sales-72-40m-beat-64", "tags": ["earnings"]}
{"id": 45420293, "time": "2025-05-14 16:12:38", "headline": "Talphera Q1 EPS $(0.10) Beats $(0.14) Estimate, Sales $27.00K", "summary": "", "symbols": ["TLPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420293/talphera-q1-eps-0-10-beats-0-14-estimate-sales-27-00k", "tags": ["earnings"]}
{"id": 45420295, "time": "2025-05-14 16:12:41", "headline": "Crescent Capital BDC Q1 Net investment income per share $0.45 Misses $0.52 Estimate, Total investment income $42.13M Miss $45.08M Estimate", "summary": "", "symbols": ["CCAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420295/crescent-capital-bdc-q1-net-investment-income-per-share-0-45-misses-0-52-estimate-total-investment-", "tags": []}
{"id": 45420322, "time": "2025-05-14 16:12:57", "headline": "Tenax Therapeutics Q1 EPS $(0.28) Misses $(0.19) Estimate", "summary": "", "symbols": ["TENX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420322/tenax-therapeutics-q1-eps-0-28-misses-0-19-estimate", "tags": ["earnings"]}
{"id": 45420325, "time": "2025-05-14 16:13:00", "headline": "Beachbody Co Sees Q2 Sales $51.000M-$61.000M vs $60.44M Est", "summary": "", "symbols": ["BODI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420325/beachbody-co-sees-q2-sales-51-000m-61-000m-vs-60-44m-est", "tags": []}
{"id": 45420321, "time": "2025-05-14 16:12:57", "headline": "10x Genomics Reaches Patent Litigation Settlement With Bruker; Bruker To Pay $68M In Equal Quarterly Installments Between Q3 2025 And Q2 2026 As Well As Ongoing Royalties On Sales Of Spatial Biology Products Through Life Of Licensed Patents", "summary": "", "symbols": ["BRKR", "TXG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420321/10x-genomics-reaches-patent-litigation-settlement-with-bruker-bruker-to-pay-68m-in-equal-quarterly-i", "tags": ["legal"]}
{"id": 45420341, "time": "2025-05-14 16:13:09", "headline": "Shimmick Affirms FY2025 Sales Guidance of $528.26M-$552.27M vs $448.10M Est", "summary": "", "symbols": ["SHIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420341/shimmick-affirms-fy2025-sales-guidance-of-528-26m-552-27m-vs-448-10m-est", "tags": ["guidance"]}
{"id": 45420342, "time": "2025-05-14 16:13:09", "headline": "SKYX Platforms Q1 EPS $(0.09) Beats $(0.10) Estimate, Sales $20.11M Miss $20.25M Estimate", "summary": "", "symbols": ["SKYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420342/skyx-platforms-q1-eps-0-09-beats-0-10-estimate-sales-20-11m-miss-20-25m-estimate", "tags": ["earnings"]}
{"id": 45420374, "time": "2025-05-14 16:13:20", "headline": "Grove Collaborative Hldgs Q1 EPS $(0.10) Misses $(0.04) Estimate, Sales $43.55M Miss $47.00M Estimate", "summary": "", "symbols": ["GROV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420374/grove-collaborative-hldgs-q1-eps-0-10-misses-0-04-estimate-sales-43-55m-miss-47-00m-estimate", "tags": ["earnings"]}
{"id": 45420382, "time": "2025-05-14 16:13:34", "headline": "Lulus Fashion Lounge Q1 EPS $(0.19) Misses $(0.10) Estimate, Sales $64.16M Miss $69.50M Estimate", "summary": "", "symbols": ["LVLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420382/lulus-fashion-lounge-q1-eps-0-19-misses-0-10-estimate-sales-64-16m-miss-69-50m-estimate", "tags": ["earnings"]}
{"id": 45420402, "time": "2025-05-14 16:14:04", "headline": "NEXTracker Sees FY2026 Adj EPS $3.65-$4.03 vs $3.86 Est; Sees Sales $3.200B-$3.400B vs $3.18B Est", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420402/nextracker-sees-fy2026-adj-eps-3-65-4-03-vs-3-86-est-sees-sales-3-200b-3-400b-vs-3-18b-est", "tags": ["earnings"]}
{"id": 45420413, "time": "2025-05-14 16:14:09", "headline": "Bionano Genomics Q1 EPS $(1.15) Beats $(3.02) Estimate, Sales $6.50M Beat $6.23M Estimate", "summary": "", "symbols": ["BNGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420413/bionano-genomics-q1-eps-1-15-beats-3-02-estimate-sales-6-50m-beat-6-23m-estimate", "tags": ["earnings"]}
{"id": 45420419, "time": "2025-05-14 16:14:21", "headline": "The Oncology Institute Q1 GAAP EPS $(0.21) Up From $(0.22) YoY, Sales $104.41M Up From $94.67M YoY", "summary": "", "symbols": ["TOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420419/the-oncology-institute-q1-gaap-eps-0-21-up-from-0-22-yoy-sales-104-41m-up-from-94-67m-yoy", "tags": ["earnings"]}
{"id": 45420426, "time": "2025-05-14 16:14:35", "headline": "Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?", "summary": "The drug could could offer a pharmacological alternative to CPAP devices.", "symbols": ["IXHL"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/general/biotech/25/05/45420426/incannex-healthcare-ixhl-stock-soars-over-800-whats-going-on", "tags": ["why_moving"]}
{"id": 45420428, "time": "2025-05-14 16:14:43", "headline": "Nortech Systems Q1 EPS $(0.48) Down From $0.26 YoY, Sales $26.89M Down From $34.22M YoY", "summary": "", "symbols": ["NSYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420428/nortech-systems-q1-eps-0-48-down-from-0-26-yoy-sales-26-89m-down-from-34-22m-yoy", "tags": ["earnings"]}
{"id": 45420448, "time": "2025-05-14 16:14:56", "headline": "Neurocrine Biosciences Presents Study Showing Relationship Between Higher Glucocorticoid Dose And Adverse Clinical Outcomes", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45420448/neurocrine-biosciences-presents-study-showing-relationship-between-higher-glucocorticoid-dose-and", "tags": ["fda"]}
{"id": 45420495, "time": "2025-05-14 16:15:15", "headline": "Oncology Institute Affirms FY2025 Sales Guidance of $460.00M-$480.00M vs $482.80M Est", "summary": "", "symbols": ["TOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420495/oncology-institute-affirms-fy2025-sales-guidance-of-460-00m-480-00m-vs-482-80m-est", "tags": ["guidance"]}
{"id": 45420506, "time": "2025-05-14 16:15:20", "headline": "$1000 Invested In Encompass Health 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["EHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45420506/1000-invested-in-encompass-health-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45420516, "time": "2025-05-14 16:15:31", "headline": "Fidelis Insurance Hldgs Q1 Adj. EPS $(0.41), Inline, Sales $658.40M Miss $927.63M Estimate", "summary": "", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420516/fidelis-insurance-hldgs-q1-adj-eps-0-41-inline-sales-658-40m-miss-927-63m-estimate", "tags": ["earnings"]}
{"id": 45420517, "time": "2025-05-14 16:15:32", "headline": "Navigator Holdings Q1 Adj. EPS $0.36 Beats $0.31 Estimate, Sales $151.41M Beat $146.30M Estimate", "summary": "", "symbols": ["NVGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420517/navigator-holdings-q1-adj-eps-0-36-beats-0-31-estimate-sales-151-41m-beat-146-30m-estimate", "tags": ["earnings"]}
{"id": 45420523, "time": "2025-05-14 16:15:35", "headline": "Nextracker Acquires Bentek Corporation For $78M In Cash Including Future Contingent Earnout Consideration", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45420523/nextracker-acquires-bentek-corporation-for-78m-in-cash-including-future-contingent-earnout-considera", "tags": ["merger"]}
{"id": 45420531, "time": "2025-05-14 16:15:42", "headline": "Boot Barn Authorized $200M Repurchase Program", "summary": "", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420531/boot-barn-authorized-200m-repurchase-program", "tags": ["buyback"]}
{"id": 45420552, "time": "2025-05-14 16:15:58", "headline": "Contineum Therapeutics Q1 EPS $(0.62) Misses $(0.58) Estimate", "summary": "", "symbols": ["CTNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420552/contineum-therapeutics-q1-eps-0-62-misses-0-58-estimate", "tags": ["earnings"]}
{"id": 45420584, "time": "2025-05-14 16:16:23", "headline": "Iris Energy Q3 Sales $141.20M Miss $159.37M Estimate", "summary": "", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420584/iris-energy-q3-sales-141-20m-miss-159-37m-estimate", "tags": []}
{"id": 45420586, "time": "2025-05-14 16:16:28", "headline": "RH Faces Margin Pressure Despite Tariff Relief, Analyst Flags Weaker Housing Demand Ahead", "summary": "B of A Securities analyst Nagle downgraded RH to Underperform, raised price target from $144 to $172 &amp; maintained Wayfair with Neutral.", "symbols": ["RH", "W"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/05/45420586/rh-faces-margin-pressure-despite-tariff-relief-analyst-flags-weaker-housing-demand-ahead", "tags": ["analyst_down"]}
{"id": 45420596, "time": "2025-05-14 16:16:35", "headline": "AGM Group Holdings Announces 50 For 1 Share Consolidation", "summary": "", "symbols": ["AGMH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420596/agm-group-holdings-announces-50-for-1-share-consolidation", "tags": []}
{"id": 45420606, "time": "2025-05-14 16:16:45", "headline": "Boot Barn Holdings Q4 GAAP EPS $1.22 Misses $1.24 Estimate, Sales $453.75M Miss $458.42M Estimate", "summary": "", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420606/boot-barn-holdings-q4-gaap-eps-1-22-misses-1-24-estimate-sales-453-75m-miss-458-42m-estimate", "tags": ["earnings"]}
{"id": 45420671, "time": "2025-05-14 16:17:29", "headline": "Vaxart Publishes Complete Data From Phase 2b Challenge Study Of First-Generation Oral Pill Norovirus Vaccine Candidate In Science Translational Medicine", "summary": "", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45420671/vaxart-publishes-complete-data-from-phase-2b-challenge-study-of-first-generation-oral-pill-norovi", "tags": []}
{"id": 45420696, "time": "2025-05-14 16:17:45", "headline": "Pony AI Stock Is Sliding Wednesday: What's Going On?", "summary": "CNBC reports one of the Pony AI&#39;s robotaxis caught on fire.", "symbols": ["PONY"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/05/45420696/pony-ai-stock-is-sliding-wednesday-whats-going-on", "tags": ["why_moving"]}
{"id": 45420720, "time": "2025-05-14 16:18:00", "headline": "Acuren Uplists To NYSE", "summary": "", "symbols": ["TIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420720/acuren-uplists-to-nyse", "tags": []}
{"id": 45420733, "time": "2025-05-14 16:18:16", "headline": "Maze Therapeutics Q1 EPS $(1.15) Up From $(13.91) YoY", "summary": "", "symbols": ["MAZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420733/maze-therapeutics-q1-eps-1-15-up-from-13-91-yoy", "tags": ["earnings"]}
{"id": 45420780, "time": "2025-05-14 16:18:49", "headline": "Silo Pharma Engages Veloxity Labs For Bioanalytical IND-Enabling Study For Novel Intranasal PTSD Therapy, SPC-15", "summary": "", "symbols": ["SILO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45420780/silo-pharma-engages-veloxity-labs-for-bioanalytical-ind-enabling-study-for-novel-intranasal-ptsd-", "tags": []}
{"id": 45420784, "time": "2025-05-14 16:18:53", "headline": "Electrovaya Q2 EPS $0.02 Misses $0.03 Estimate, Sales $15.02M Miss $15.95M Estimate", "summary": "", "symbols": ["ELVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420784/electrovaya-q2-eps-0-02-misses-0-03-estimate-sales-15-02m-miss-15-95m-estimate", "tags": ["earnings"]}
{"id": 45420787, "time": "2025-05-14 16:18:56", "headline": "Boot Barn Holdings Sees FY2026 GAAP EPS $5.50-$6.40 vs $6.24 Est; Sees Sales $2.070B-$2.150B vs $2.17B Est", "summary": "", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420787/boot-barn-holdings-sees-fy2026-gaap-eps-5-50-6-40-vs-6-24-est-sees-sales-2-070b-2-150b-vs-2-17b-est", "tags": ["earnings"]}
{"id": 45420791, "time": "2025-05-14 16:19:06", "headline": "Boot Barn Holdings Sees Q1 GAAP EPS $1.44-$1.52 vs $1.44 Est; Sees Sales $483.000M-$491.000M vs $486.49M Est", "summary": "", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420791/boot-barn-holdings-sees-q1-gaap-eps-1-44-1-52-vs-1-44-est-sees-sales-483-000m-491-000m-vs-486-49m-es", "tags": ["earnings"]}
{"id": 45420793, "time": "2025-05-14 16:19:09", "headline": "GCT Semiconductor Hldgs Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $496.00K Miss $1.87M Estimate", "summary": "", "symbols": ["GCTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420793/gct-semiconductor-hldgs-q1-eps-0-15-misses-0-10-estimate-sales-496-00k-miss-1-87m-estimate", "tags": ["earnings"]}
{"id": 45420799, "time": "2025-05-14 16:19:31", "headline": "Electrovaya FY2025  Revenue expected to be more than $60.00M vs $67.92M Est", "summary": "", "symbols": ["ELVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420799/electrovaya-fy2025-revenue-expected-to-be-more-than-60-00m-vs-67-92m-est", "tags": ["earnings"]}
{"id": 45420817, "time": "2025-05-14 16:19:53", "headline": "CoreWeave Q1 Adj. EPS $(0.599) May Not Compare To $(0.12) Estimate", "summary": "", "symbols": ["CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420817/coreweave-q1-adj-eps-0-599-may-not-compare-to-0-12-estimate", "tags": ["earnings"]}
{"id": 45420822, "time": "2025-05-14 16:20:05", "headline": "DXC Technology Q4 Adj. EPS $0.84 Beats $0.77 Estimate, Sales $3.17B Beat $3.13B Estimate", "summary": "", "symbols": ["DXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420822/dxc-technology-q4-adj-eps-0-84-beats-0-77-estimate-sales-3-17b-beat-3-13b-estimate", "tags": ["earnings"]}
{"id": 45420823, "time": "2025-05-14 16:20:09", "headline": "Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate", "summary": "", "symbols": ["ZNTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420823/zentalis-pharma-q1-eps-0-67-misses-0-63-estimate", "tags": ["earnings"]}
{"id": 45420828, "time": "2025-05-14 16:20:32", "headline": "Canaan For April Mined 87 Bitcoins", "summary": "", "symbols": ["CAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45420828/canaan-for-april-mined-87-bitcoins", "tags": []}
{"id": 45420829, "time": "2025-05-14 16:20:33", "headline": "Conifer Holdings Q1 Adj. EPS $(0.30) Down From $0.11 YoY, Sales $10.31M Down From $16.89M YoY", "summary": "", "symbols": ["CNFR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420829/conifer-holdings-q1-adj-eps-0-30-down-from-0-11-yoy-sales-10-31m-down-from-16-89m-yoy", "tags": ["earnings"]}
{"id": 45420849, "time": "2025-05-14 16:20:53", "headline": "BioCardia Q1 EPS $(0.59) Misses $(0.39) Estimate", "summary": "", "symbols": ["BCDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420849/biocardia-q1-eps-0-59-misses-0-39-estimate", "tags": ["earnings"]}
{"id": 45420871, "time": "2025-05-14 16:21:31", "headline": "Gold Miners Slammed By US-China Trade Truce: Is It Time To Take Profit?", "summary": "Gold miners plunged as the U.S.-China trade truce hit safe-haven demand. GDX suffered its worst 3-day drop since 2022. Is it time to take profits?", "symbols": ["AEM", "GDX", "GOLD", "NEM"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45420871/gold-miners-slammed-by-us-china-trade-truce-is-it-time-to-take-profit", "tags": []}
{"id": 45420889, "time": "2025-05-14 16:22:02", "headline": "Eledon Pharma Q1 EPS $(0.08) Beats $(0.30) Estimate", "summary": "", "symbols": ["ELDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420889/eledon-pharma-q1-eps-0-08-beats-0-30-estimate", "tags": ["earnings"]}
{"id": 45420908, "time": "2025-05-14 16:22:18", "headline": "Inhibikase Therapeutics Q1 EPS $(0.15) Misses $(0.12) Estimate", "summary": "", "symbols": ["IKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420908/inhibikase-therapeutics-q1-eps-0-15-misses-0-12-estimate", "tags": ["earnings"]}
{"id": 45420937, "time": "2025-05-14 16:22:28", "headline": "GEE Group Q2 Adj. EPS $(0.30), Sales $24.50M Down From $28.05M YoY", "summary": "", "symbols": ["JOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420937/gee-group-q2-adj-eps-0-30-sales-24-50m-down-from-28-05m-yoy", "tags": ["earnings"]}
{"id": 45420948, "time": "2025-05-14 16:22:44", "headline": "Cisco Says EPS Guidance Includes Estimated Impact Of Tariffs Based On Current Trade Policy; AI Infrastructure Orders Surpassing Our $1B Target One Quarter Early", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420948/cisco-says-eps-guidance-includes-estimated-impact-of-tariffs-based-on-current-trade-policy-ai-infras", "tags": ["earnings", "guidance"]}
{"id": 45420950, "time": "2025-05-14 16:22:53", "headline": "Okeanis Eco Tankers Q1 Adj. EPS $0.36 Beats $0.24 Estimate, Sales $80.15M Beat $74.56M Estimate", "summary": "", "symbols": ["ECO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420950/okeanis-eco-tankers-q1-adj-eps-0-36-beats-0-24-estimate-sales-80-15m-beat-74-56m-estimate", "tags": ["earnings"]}
{"id": 45420955, "time": "2025-05-14 16:23:03", "headline": "NASA Selects Rocket Lab To Launch Aspera Mission To Study Galaxy Evolution", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420955/nasa-selects-rocket-lab-to-launch-aspera-mission-to-study-galaxy-evolution", "tags": []}
{"id": 45420961, "time": "2025-05-14 16:23:22", "headline": "DXC Technology Sees Q1 Adj EPS $0.55-$0.65 vs $0.77 Est; Sees Sales $3.040B-$3.090B vs $3.12B Est", "summary": "", "symbols": ["DXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420961/dxc-technology-sees-q1-adj-eps-0-55-0-65-vs-0-77-est-sees-sales-3-040b-3-090b-vs-3-12b-est", "tags": ["earnings"]}
{"id": 45420965, "time": "2025-05-14 16:23:35", "headline": "DXC Technology Sees FY2026 Adj EPS $2.75-$3.25 vs $3.41 Est; Sees Sales $12.180B-$12.440B vs $12.41B Est", "summary": "", "symbols": ["DXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45420965/dxc-technology-sees-fy2026-adj-eps-2-75-3-25-vs-3-41-est-sees-sales-12-180b-12-440b-vs-12-41b-est", "tags": ["earnings"]}
{"id": 45420970, "time": "2025-05-14 16:23:45", "headline": "Armata Pharmaceuticals Q1 EPS $(0.20) Beats $(0.38) Estimate, Sales $491.00K Miss $1.38M Estimate", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45420970/armata-pharmaceuticals-q1-eps-0-20-beats-0-38-estimate-sales-491-00k-miss-1-38m-estimate", "tags": ["earnings"]}
{"id": 45421033, "time": "2025-05-14 16:25:23", "headline": "Inhibrx Q1 EPS $(2.80) Beats $(2.84) Estimate", "summary": "", "symbols": ["INBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421033/inhibrx-q1-eps-2-80-beats-2-84-estimate", "tags": ["earnings"]}
{"id": 45421041, "time": "2025-05-14 16:25:56", "headline": "Nvidia-Backed CoreWeave Reports Q1 Earnings: Revenue Jumps 420%, Backlog Grows To $25.9 Billion Following OpenAI Deal, Shares Hit All-Time Highs", "summary": "CoreWeave reports financial results for the first quarter after the market close on Wednesday. Here&#39;s a rundown of the report.", "symbols": ["CRWV"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/25/05/45421041/nvidia-backed-coreweave-reports-q1-earnings-revenue-jumps-420-backlog-grows-to-25-9-billion-following-openai-deal-shares-hit-all-time-highs", "tags": ["earnings", "contract"]}
{"id": 45421050, "time": "2025-05-14 16:25:57", "headline": "Alto Neuroscience Q1 EPS $(0.56) Beats $(0.61) Estimate", "summary": "", "symbols": ["ANRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421050/alto-neuroscience-q1-eps-0-56-beats-0-61-estimate", "tags": ["earnings"]}
{"id": 45421066, "time": "2025-05-14 16:26:20", "headline": "Sypris Solutions Q1 EPS $(0.04) Up From $(0.10) YoY, Sales $29.51M Down From $35.55M YoY", "summary": "", "symbols": ["SYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421066/sypris-solutions-q1-eps-0-04-up-from-0-10-yoy-sales-29-51m-down-from-35-55m-yoy", "tags": ["earnings"]}
{"id": 45421073, "time": "2025-05-14 16:26:29", "headline": "Co-Founder, CEO And CFO Aiden Lee Ping Wei Reports 48.9% Stake In Graphjet Technology", "summary": "", "symbols": ["GTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421073/co-founder-ceo-and-cfo-aiden-lee-ping-wei-reports-48-9-stake-in-graphjet-technology", "tags": ["management"]}
{"id": 45421201, "time": "2025-05-14 16:27:46", "headline": "Harte-Hanks Q1 Adj. EPS $(0.05) Down From $(0.02) YoY, Sales $41.56M Down From $45.45M YoY", "summary": "", "symbols": ["HHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421201/harte-hanks-q1-adj-eps-0-05-down-from-0-02-yoy-sales-41-56m-down-from-45-45m-yoy", "tags": ["earnings"]}
{"id": 45421212, "time": "2025-05-14 16:28:13", "headline": "Acrivon Therapeutics Q1 EPS $(0.51) Beats $(0.66) Estimate", "summary": "", "symbols": ["ACRV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421212/acrivon-therapeutics-q1-eps-0-51-beats-0-66-estimate", "tags": ["earnings"]}
{"id": 45421234, "time": "2025-05-14 16:29:21", "headline": "Alumis Q1 Sales $17.39M", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421234/alumis-q1-sales-17-39m", "tags": []}
{"id": 45421244, "time": "2025-05-14 16:29:25", "headline": "Precigen Q1 EPS $(0.18) Misses $(0.08) Estimate, Sales $1.34M Beat $500.00K Estimate", "summary": "", "symbols": ["PGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421244/precigen-q1-eps-0-18-misses-0-08-estimate-sales-1-34m-beat-500-00k-estimate", "tags": ["earnings"]}
{"id": 45421248, "time": "2025-05-14 16:29:32", "headline": "Boston Omaha Q1 EPS $(0.02) Up From $(0.09) YoY, Sales $27.73M Beat $27.10M Estimate", "summary": "", "symbols": ["BOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421248/boston-omaha-q1-eps-0-02-up-from-0-09-yoy-sales-27-73m-beat-27-10m-estimate", "tags": ["earnings"]}
{"id": 45421292, "time": "2025-05-14 16:30:09", "headline": "Marijuana Stock Movers For May 14, 2025", "summary": " ", "symbols": ["BBRRF", "BLOZF", "CBWTF", "CGC", "CNBX", "CNTMF", "CPHRF", "CURR", "CVSI", "CWBHF", "CXXIF", "ELLXF", "ESE", "FLOOF", "FUAPF", "GNLN", "LBUY", "NWVCF", "RMHB", "SOLCF", "TGIFF", "UGRO", "VFF", "ZDPY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cannabis/25/05/45421292/marijuana-stock-movers-for-may-14-2025", "tags": ["why_moving"]}
{"id": 45421359, "time": "2025-05-14 16:30:15", "headline": "Vornado 55% Owned JV To Office Building For $205M", "summary": "", "symbols": ["VNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421359/vornado-55-owned-jv-to-office-building-for-205m", "tags": []}
{"id": 45421362, "time": "2025-05-14 16:30:16", "headline": "$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["HIG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45421362/100-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45421454, "time": "2025-05-14 16:30:53", "headline": "Kodiak Sciences Q1 EPS $(1.09) Misses $(0.87) Estimate", "summary": "", "symbols": ["KOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421454/kodiak-sciences-q1-eps-1-09-misses-0-87-estimate", "tags": ["earnings"]}
{"id": 45421457, "time": "2025-05-14 16:30:55", "headline": "Logistic Properties Q1 Sales $11.84M Up From $10.48M YoY", "summary": "", "symbols": ["LPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421457/logistic-properties-q1-sales-11-84m-up-from-10-48m-yoy", "tags": []}
{"id": 45421459, "time": "2025-05-14 16:30:57", "headline": "Innovative Solns Q2 EPS $0.30 Beats $0.12 Estimate, Sales $21.90M Beat $14.23M Estimate", "summary": "", "symbols": ["ISSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421459/innovative-solns-q2-eps-0-30-beats-0-12-estimate-sales-21-90m-beat-14-23m-estimate", "tags": ["earnings"]}
{"id": 45421461, "time": "2025-05-14 16:30:57", "headline": "Capital Southwest Q4 EPS $0.61 Misses $0.62 Estimate, Sales $52.40M Miss $52.71M Estimate", "summary": "", "symbols": ["CSWC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421461/capital-southwest-q4-eps-0-61-misses-0-62-estimate-sales-52-40m-miss-52-71m-estimate", "tags": ["earnings"]}
{"id": 45421522, "time": "2025-05-14 16:32:03", "headline": "Independence Realty Trust Increases Quarterly Dividend From $0.16 To $0.17", "summary": "", "symbols": ["IRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421522/independence-realty-trust-increases-quarterly-dividend-from-0-16-to-0-17", "tags": ["dividend"]}
{"id": 45421532, "time": "2025-05-14 16:32:11", "headline": "Steris Q4 Adj. EPS $2.74 Beats $2.59 Estimate, Sales $1.48B Beat $1.47B Estimate", "summary": "", "symbols": ["STE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421532/steris-q4-adj-eps-2-74-beats-2-59-estimate-sales-1-48b-beat-1-47b-estimate", "tags": ["earnings"]}
{"id": 45421572, "time": "2025-05-14 16:32:42", "headline": "Avient Board of Directors Appoints Ashish K. Khandpur As Chairman Effective May 14", "summary": "", "symbols": ["AVNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421572/avient-board-of-directors-appoints-ashish-k-khandpur-as-chairman-effective-may-14", "tags": ["management"]}
{"id": 45421597, "time": "2025-05-14 16:33:11", "headline": "Biomea Fusion's BMF-500 Selected For Poster Presentation At EHA 2025 Highlighting Phase I Data In Relapsed/Refractory Acute Leukemia", "summary": "", "symbols": ["BMEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45421597/biomea-fusions-bmf-500-selected-for-poster-presentation-at-eha-2025-highlighting-phase-i-data-in-", "tags": ["fda"]}
{"id": 45421624, "time": "2025-05-14 16:33:35", "headline": "Verde Clean Fuels Q1 EPS $(0.08) Up From $(0.13) YoY", "summary": "", "symbols": ["VGAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421624/verde-clean-fuels-q1-eps-0-08-up-from-0-13-yoy", "tags": ["earnings"]}
{"id": 45421655, "time": "2025-05-14 16:34:05", "headline": "Steris Sees FY2026 Adj EPS $9.90-$10.15 vs $9.87 Est", "summary": "", "symbols": ["STE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421655/steris-sees-fy2026-adj-eps-9-90-10-15-vs-9-87-est", "tags": ["earnings"]}
{"id": 45421662, "time": "2025-05-14 16:34:16", "headline": "Steris Sees FY2026 GAAP EPS $7.82-$8.07 vs $7.87 Est", "summary": "", "symbols": ["STE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421662/steris-sees-fy2026-gaap-eps-7-82-8-07-vs-7-87-est", "tags": ["earnings"]}
{"id": 45421685, "time": "2025-05-14 16:34:40", "headline": "AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY", "summary": "", "symbols": ["AEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421685/aeon-biopharma-q1-eps-2-28-up-from-227-87-yoy", "tags": ["earnings"]}
{"id": 45421699, "time": "2025-05-14 16:35:26", "headline": "Enliven Therapeutics Q1 EPS $(0.57) Misses $(0.49) Estimate", "summary": "", "symbols": ["ELVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421699/enliven-therapeutics-q1-eps-0-57-misses-0-49-estimate", "tags": ["earnings"]}
{"id": 45421717, "time": "2025-05-14 16:35:44", "headline": "Edesa Biotech Q2 EPS $(0.30) Misses $(0.29) Estimate", "summary": "", "symbols": ["EDSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421717/edesa-biotech-q2-eps-0-30-misses-0-29-estimate", "tags": ["earnings"]}
{"id": 45421747, "time": "2025-05-14 16:36:36", "headline": "Red Cat Holdings Q1 Earnings: Revenue, EPS Miss Estimates, Drone Maker Affirms FY25 Guidance, Highlights Palantir Partnership, Shares Slide", "summary": "Red Cat reports first-quarter revenue of $1.63 million, missing\u00a0analyst estimates\u00a0of $3.85 million.", "symbols": ["RCAT"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/25/05/45421747/red-cat-holdings-q1-earnings-revenue-eps-miss-estimates-drone-maker-affirms-fy25-guidance-highlights-palantir-partnership-shares-slide", "tags": ["earnings", "guidance", "contract"]}
{"id": 45421781, "time": "2025-05-14 16:37:02", "headline": "Castor Maritime Q4 EPS $(1.24) Down From $1.10 YoY, Sales $16.16M Down From $26.36M YoY", "summary": "", "symbols": ["CTRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421781/castor-maritime-q4-eps-1-24-down-from-1-10-yoy-sales-16-16m-down-from-26-36m-yoy", "tags": ["earnings"]}
{"id": 45421787, "time": "2025-05-14 16:37:14", "headline": "Steris Sees FY2026 expects reported revenue from continuing operations to increase 6-7%.", "summary": "", "symbols": ["STE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421787/steris-sees-fy2026-expects-reported-revenue-from-continuing-operations-to-increase-6-7", "tags": ["earnings"]}
{"id": 45421812, "time": "2025-05-14 16:37:55", "headline": "CORRECTION: Capital Southwest Q4 EPS $0.54 Misses $0.62 Estimate, Sales $52.41M Miss $52.71M Estimate", "summary": "", "symbols": ["CSWC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421812/correction-capital-southwest-q4-eps-0-54-misses-0-62-estimate-sales-52-41m-miss-52-71m-estimate", "tags": ["earnings"]}
{"id": 45421819, "time": "2025-05-14 16:38:13", "headline": "Vroom Q1 EPS $(1.23) Up From $(37.68) YoY, Sales $36.20M Up From $34.88M YoY", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421819/vroom-q1-eps-1-23-up-from-37-68-yoy-sales-36-20m-up-from-34-88m-yoy", "tags": ["earnings"]}
{"id": 45421821, "time": "2025-05-14 16:38:21", "headline": "Boxlight Q1 EPS $(1.41) Up From $(3.80) YoY, Sales $22.40M Down From $37.09M YoY", "summary": "", "symbols": ["BOXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421821/boxlight-q1-eps-1-41-up-from-3-80-yoy-sales-22-40m-down-from-37-09m-yoy", "tags": ["earnings"]}
{"id": 45421823, "time": "2025-05-14 16:38:54", "headline": "MetaVia Q1 EPS $(0.36) Beats $(0.51) Estimate", "summary": "", "symbols": ["MTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421823/metavia-q1-eps-0-36-beats-0-51-estimate", "tags": ["earnings"]}
{"id": 45421827, "time": "2025-05-14 16:39:33", "headline": "Blaize Holdings Affirms FY2025 Sales Guidance of $19.00M-$50.00M", "summary": "", "symbols": ["BZAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421827/blaize-holdings-affirms-fy2025-sales-guidance-of-19-00m-50-00m", "tags": ["guidance"]}
{"id": 45421828, "time": "2025-05-14 16:39:41", "headline": "Blaize Holdings Sees Q2 Sales $1.500M-$1.700M vs $1.52M Est", "summary": "", "symbols": ["BZAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421828/blaize-holdings-sees-q2-sales-1-500m-1-700m-vs-1-52m-est", "tags": []}
{"id": 45421833, "time": "2025-05-14 16:39:54", "headline": "Empire Petroleum Q1 Adj. EPS $(0.13) Up From $(0.15) YoY, Sales $9.00M Down From $9.39M YoY", "summary": "", "symbols": ["EP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421833/empire-petroleum-q1-adj-eps-0-13-up-from-0-15-yoy-sales-9-00m-down-from-9-39m-yoy", "tags": ["earnings"]}
{"id": 45421877, "time": "2025-05-14 16:40:36", "headline": "Enveric Biosciences Q1 EPS $(1.22) Up From $(9.21) YoY", "summary": "", "symbols": ["ENVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421877/enveric-biosciences-q1-eps-1-22-up-from-9-21-yoy", "tags": ["earnings"]}
{"id": 45421886, "time": "2025-05-14 16:41:05", "headline": "Enpro Inc. Prices Offering Of $450M 6.125% Senior Notes Due 2033", "summary": "", "symbols": ["NPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45421886/enpro-inc-prices-offering-of-450m-6-125-senior-notes-due-2033", "tags": ["offering"]}
{"id": 45421912, "time": "2025-05-14 16:42:03", "headline": "Aardvark Therapeutics Q1 EPS $(0.71) Down From $(0.55) YoY", "summary": "", "symbols": ["AARD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421912/aardvark-therapeutics-q1-eps-0-71-down-from-0-55-yoy", "tags": ["earnings"]}
{"id": 45421914, "time": "2025-05-14 16:42:11", "headline": "Contango Ore Q1 EPS $(1.88) Misses $(0.21) Estimate", "summary": "", "symbols": ["CTGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421914/contango-ore-q1-eps-1-88-misses-0-21-estimate", "tags": ["earnings"]}
{"id": 45421947, "time": "2025-05-14 16:42:56", "headline": "Jade Biosciences Q1 EPS $(12.10) Misses $(1.74) Estimate", "summary": "", "symbols": ["JBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45421947/jade-biosciences-q1-eps-12-10-misses-1-74-estimate", "tags": ["earnings"]}
{"id": 45422083, "time": "2025-05-14 16:43:34", "headline": "Oruka Therapeutics Q1 EPS $(0.40) Beats $(0.52) Estimate", "summary": "", "symbols": ["ORKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422083/oruka-therapeutics-q1-eps-0-40-beats-0-52-estimate", "tags": ["earnings"]}
{"id": 45422094, "time": "2025-05-14 16:44:27", "headline": "Blaize Holdings Q1 EPS $(1.61), Sales $1.01M", "summary": "", "symbols": ["BZAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422094/blaize-holdings-q1-eps-1-61-sales-1-01m", "tags": ["earnings"]}
{"id": 45422104, "time": "2025-05-14 16:44:48", "headline": "Battalion Oil Q1 EPS $(0.35) Up From $(2.24) YoY, Sales $47.48M Down From $49.87M YoY", "summary": "", "symbols": ["BATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422104/battalion-oil-q1-eps-0-35-up-from-2-24-yoy-sales-47-48m-down-from-49-87m-yoy", "tags": ["earnings"]}
{"id": 45422127, "time": "2025-05-14 16:45:20", "headline": "Here's How Much $100 Invested In First Citizens BancShares 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["FCNCA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45422127/heres-how-much-100-invested-in-first-citizens-bancshares-15-years-ago-would-be-worth-today", "tags": []}
{"id": 45422161, "time": "2025-05-14 16:46:11", "headline": "Cisco Systems CFO Scott Herren To Retire Effective July 26, 2025; Mark Patterson To Succeed", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45422161/cisco-systems-cfo-scott-herren-to-retire-effective-july-26-2025-mark-patterson-to-succeed", "tags": ["management"]}
{"id": 45422166, "time": "2025-05-14 16:46:27", "headline": "Global Water Resources Q1 EPS $0.02 Beats $0.01 Estimate, Sales $12.46M Beat $12.00M Estimate", "summary": "", "symbols": ["GWRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422166/global-water-resources-q1-eps-0-02-beats-0-01-estimate-sales-12-46m-beat-12-00m-estimate", "tags": ["earnings"]}
{"id": 45422176, "time": "2025-05-14 16:46:50", "headline": "Precision BioSciences Accelerates Development Of First-in-Class In Vivo Gene Editing Therapy PBGENE-DMD For Duchenne Muscular Dystrophy Targeting Exons 45\u201355 Hot Spot, IND/CTA Submission Planned For 2025 And Clinical Data Expected In 2026", "summary": "", "symbols": ["DTIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45422176/precision-biosciences-accelerates-development-of-first-in-class-in-vivo-gene-editing-therapy-pbge", "tags": ["fda"]}
{"id": 45422181, "time": "2025-05-14 16:46:57", "headline": "Presidio Property Trust Announces 1-For-10 Reverse Stock Split", "summary": "", "symbols": ["SQFT", "SQFTP", "SQFTW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45422181/presidio-property-trust-announces-1-for-10-reverse-stock-split", "tags": []}
{"id": 45422183, "time": "2025-05-14 16:47:04", "headline": "Calidi Biotherapeutics Q1 EPS $(0.18) Misses $(0.15) Estimate", "summary": "", "symbols": ["CLDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422183/calidi-biotherapeutics-q1-eps-0-18-misses-0-15-estimate", "tags": ["earnings"]}
{"id": 45422220, "time": "2025-05-14 16:48:44", "headline": "Nauticus Robotics Q1 EPS $(0.28) Up From $(3.96) YoY, Sales $165.26K Down From $464.35M YoY", "summary": "", "symbols": ["KITT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422220/nauticus-robotics-q1-eps-0-28-up-from-3-96-yoy-sales-165-26k-down-from-464-35m-yoy", "tags": ["earnings"]}
{"id": 45422223, "time": "2025-05-14 16:49:01", "headline": "SS Innovations Q1 EPS $(0.03), Sales $5.10M", "summary": "", "symbols": ["SSII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422223/ss-innovations-q1-eps-0-03-sales-5-10m", "tags": ["earnings"]}
{"id": 45422224, "time": "2025-05-14 16:49:10", "headline": "Citius Oncology Q2 EPS $(0.11) Misses $(0.09) Estimate", "summary": "", "symbols": ["CTOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422224/citius-oncology-q2-eps-0-11-misses-0-09-estimate", "tags": ["earnings"]}
{"id": 45422257, "time": "2025-05-14 16:50:50", "headline": "Nvidia Rises 2.2% After Key Signal, Reversing Early Weakness", "summary": "A significant trading signal occurred for Nvidia stock, as it demonstrated a power inflow at $132.50, after which NVDA rose up to 2.2%.", "symbols": [], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/markets/equities/25/05/45422257/nvidia-rises-2-2-after-key-signal-reversing-early-weakness", "tags": []}
{"id": 45422260, "time": "2025-05-14 16:50:59", "headline": "SREIT Appoints Nora Creedon As President And CEO; Succeeds SREIT Appoints Nora Creedon Chief Executive Officer", "summary": "", "symbols": ["STWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45422260/sreit-appoints-nora-creedon-as-president-and-ceo-succeeds-sreit-appoints-nora-creedon-chief-executiv", "tags": ["management"]}
{"id": 45422271, "time": "2025-05-14 16:51:13", "headline": "Walmart Q1 Earnings Preview: Why Retailer Will Have 'One Of The Most Telling' Reports On Tariff Impact", "summary": "Walmart&#39;s Q1 financial results, to be released Thursday, may provide a better picture of the impact of tariffs on consumers.", "symbols": ["WMT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45422271/walmart-faces-tariff-test-this-quarter-preview", "tags": ["earnings"]}
{"id": 45422296, "time": "2025-05-14 16:52:06", "headline": "Citius Pharma Q2 EPS $(1.27) Misses $0.33 Estimate", "summary": "", "symbols": ["CTXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422296/citius-pharma-q2-eps-1-27-misses-0-33-estimate", "tags": ["earnings"]}
{"id": 45422297, "time": "2025-05-14 16:52:08", "headline": "FrontView REIT Q1 FFO $0.30 Beats $0.28 Estimate, Sales $16.24M Miss $16.33M Estimate", "summary": "", "symbols": ["FVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422297/frontview-reit-q1-ffo-0-30-beats-0-28-estimate-sales-16-24m-miss-16-33m-estimate", "tags": []}
{"id": 45422303, "time": "2025-05-14 16:52:25", "headline": "Cisco Shares Climb After Q3 EPS, Revenue Beat Estimates: Details", "summary": "Cisco releases its third-quarter earnings report. Here&#39;s a look at the details.", "symbols": ["CSCO"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/05/45422303/cisco-shares-climb-after-q3-eps-revenue-beat-estimates-details", "tags": ["earnings"]}
{"id": 45422323, "time": "2025-05-14 16:52:45", "headline": "Lithium Argentina Q1 EPS $(0.04) Misses $(0.01) Estimate", "summary": "", "symbols": ["LAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422323/lithium-argentina-q1-eps-0-04-misses-0-01-estimate", "tags": ["earnings"]}
{"id": 45422352, "time": "2025-05-14 16:53:32", "headline": "Presidio Property Trust Q1 FFO $(0.076) Down From $(0.035) YoY, Sales $4.13M Down From $4.79M YoY", "summary": "", "symbols": ["SQFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422352/presidio-property-trust-q1-ffo-0-076-down-from-0-035-yoy-sales-4-13m-down-from-4-79m-yoy", "tags": []}
{"id": 45422370, "time": "2025-05-14 16:54:24", "headline": "H&R REIT Q1 FFO $0.30 Beats $0.29 Estimate, Sales $205.64M Miss $236.60M Estimate", "summary": "", "symbols": ["TSX:HR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422370/h-r-reit-q1-ffo-0-30-beats-0-29-estimate-sales-205-64m-miss-236-60m-estimate", "tags": []}
{"id": 45422409, "time": "2025-05-14 16:55:01", "headline": "FibroBiologics, Inc. - Common Stock Q1 EPS $(0.14) Misses $(0.11) Estimate", "summary": "", "symbols": ["FBLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422409/fibrobiologics-inc-common-stock-q1-eps-0-14-misses-0-11-estimate", "tags": ["earnings"]}
{"id": 45422413, "time": "2025-05-14 16:55:08", "headline": "ZSPACE Q1 EPS $(0.26) Misses $(0.16) Estimate, Sales $6.76M Beat $5.03M Estimate", "summary": "", "symbols": ["ZSPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422413/zspace-q1-eps-0-26-misses-0-16-estimate-sales-6-76m-beat-5-03m-estimate", "tags": ["earnings"]}
{"id": 45422580, "time": "2025-05-14 16:57:30", "headline": "IREN Q3 EPS $0.11 Misses $0.14 Estimate, Sales $148.10M Miss $159.37M Estimate", "summary": "", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422580/iren-q3-eps-0-11-misses-0-14-estimate-sales-148-10m-miss-159-37m-estimate", "tags": ["earnings"]}
{"id": 45422590, "time": "2025-05-14 16:58:37", "headline": "Barnwell Industries Shareholders Reject Attempt By Ned Sherwood To Remove And Replace Board", "summary": "", "symbols": ["BRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45422590/barnwell-industries-shareholders-reject-attempt-by-ned-sherwood-to-remove-and-replace-board", "tags": []}
{"id": 45422591, "time": "2025-05-14 16:58:43", "headline": "Catheter Precision, Inc. Common Stock Q1 EPS $(0.36) Misses $(0.20) Estimate, Sales $143.00K Miss $300.00K Estimate", "summary": "", "symbols": ["VTAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422591/catheter-precision-inc-common-stock-q1-eps-0-36-misses-0-20-estimate-sales-143-00k-miss-300-00k-est", "tags": ["earnings"]}
{"id": 45422606, "time": "2025-05-14 16:59:27", "headline": "USA Rare Earth Q1 Adj. EPS $(0.19) Misses $(0.04) Estimate", "summary": "", "symbols": ["USAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422606/usa-rare-earth-q1-adj-eps-0-19-misses-0-04-estimate", "tags": ["earnings"]}
{"id": 45422633, "time": "2025-05-14 17:00:21", "headline": "$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MORN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45422633/1000-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45422635, "time": "2025-05-14 17:00:26", "headline": "Forecasting The Future: 6 Analyst Projections For PaySign", "summary": " ", "symbols": ["PAYS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422635/forecasting-the-future-6-analyst-projections-for-paysign", "tags": []}
{"id": 45422644, "time": "2025-05-14 17:00:34", "headline": "A Look Into Lennar Inc's Price Over Earnings", "summary": " ", "symbols": ["LEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45422644/a-look-into-lennar-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 45422645, "time": "2025-05-14 17:00:34", "headline": "Forecasting The Future: 6 Analyst Projections For Adaptimmune Therapeutics", "summary": " ", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422645/forecasting-the-future-6-analyst-projections-for-adaptimmune-therapeutics", "tags": []}
{"id": 45422665, "time": "2025-05-14 17:00:43", "headline": "The Analyst Verdict: Ulta Beauty In The Eyes Of 18 Experts", "summary": " ", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422665/the-analyst-verdict-ulta-beauty-in-the-eyes-of-18-experts", "tags": []}
{"id": 45422674, "time": "2025-05-14 17:00:53", "headline": "5 Analysts Assess SLM: What You Need To Know", "summary": " ", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422674/5-analysts-assess-slm-what-you-need-to-know", "tags": []}
{"id": 45422684, "time": "2025-05-14 17:01:01", "headline": "Assessing SoundThinking: Insights From 6 Financial Analysts", "summary": " ", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422684/assessing-soundthinking-insights-from-6-financial-analysts", "tags": []}
{"id": 45422702, "time": "2025-05-14 17:01:14", "headline": "AbCellera Receives Health Canada Authorization To Initiate Phase 1 Clinical Trial Of ABCL635 For Vasomotor Symptoms Due To Menopause", "summary": "", "symbols": ["ABCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45422702/abcellera-receives-health-canada-authorization-to-initiate-phase-1-clinical-trial-of-abcl635-for-", "tags": ["fda"]}
{"id": 45422703, "time": "2025-05-14 17:01:15", "headline": "Demystifying Tenet Healthcare: Insights From 10 Analyst Reviews", "summary": " ", "symbols": ["THC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45422703/demystifying-tenet-healthcare-insights-from-10-analyst-reviews", "tags": []}
{"id": 45422709, "time": "2025-05-14 17:01:20", "headline": "Waste Management Appoints John Morris As President", "summary": "", "symbols": ["WM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45422709/waste-management-appoints-john-morris-as-president", "tags": ["management"]}
{"id": 45422725, "time": "2025-05-14 17:01:34", "headline": "An Overview of Mersana Therapeutics's Earnings", "summary": " ", "symbols": ["MRSN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422725/an-overview-of-mersana-therapeuticss-earnings", "tags": ["earnings"]}
{"id": 45422729, "time": "2025-05-14 17:01:43", "headline": "Duos Technologies Group Earnings Preview", "summary": " ", "symbols": ["DUOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422729/duos-technologies-group-earnings-preview", "tags": ["earnings"]}
{"id": 45422741, "time": "2025-05-14 17:02:00", "headline": "A Peek at Super League Enterprise's Future Earnings", "summary": " ", "symbols": ["SLE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422741/a-peek-at-super-league-enterprises-future-earnings", "tags": ["earnings"]}
{"id": 45422751, "time": "2025-05-14 17:02:06", "headline": "Examining the Future: Rewalk Robotics's Earnings Outlook", "summary": " ", "symbols": ["LFWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422751/examining-the-future-rewalk-roboticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45422757, "time": "2025-05-14 17:02:25", "headline": "Lantern Pharma's Earnings Outlook", "summary": " ", "symbols": ["LTRN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422757/lantern-pharmas-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45422759, "time": "2025-05-14 17:02:26", "headline": "Cango Q1 GAAP EPS $(0.28) Down From $0.12 YoY, Sales $145.23M Up From $8.92M YoY", "summary": "", "symbols": ["CANG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422759/cango-q1-gaap-eps-0-28-down-from-0-12-yoy-sales-145-23m-up-from-8-92m-yoy", "tags": ["earnings"]}
{"id": 45422770, "time": "2025-05-14 17:02:29", "headline": "Carbon Revolution FY EPS $(77.90), Sales $47.34M Up From $25.30M YoY", "summary": "", "symbols": ["CREV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422770/carbon-revolution-fy-eps-77-90-sales-47-34m-up-from-25-30m-yoy", "tags": ["earnings"]}
{"id": 45422774, "time": "2025-05-14 17:02:36", "headline": "What to Expect from P3 Health Partners's Earnings", "summary": " ", "symbols": ["PIII"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422774/what-to-expect-from-p3-health-partnerss-earnings", "tags": ["earnings"]}
{"id": 45422797, "time": "2025-05-14 17:03:05", "headline": "VolitionRX Earnings Preview", "summary": " ", "symbols": ["VNRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422797/volitionrx-earnings-preview", "tags": ["earnings"]}
{"id": 45422800, "time": "2025-05-14 17:03:18", "headline": "Uncovering Potential: Fluent's Earnings Preview", "summary": " ", "symbols": ["FLNT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422800/uncovering-potential-fluents-earnings-preview", "tags": ["earnings"]}
{"id": 45422801, "time": "2025-05-14 17:03:20", "headline": "Precipio Q1 EPS $(0.59) Up From $(1.46) YoY, Sales $4.93M Up From $3.43M YoY", "summary": "", "symbols": ["PRPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422801/precipio-q1-eps-0-59-up-from-1-46-yoy-sales-4-93m-up-from-3-43m-yoy", "tags": ["earnings"]}
{"id": 45422806, "time": "2025-05-14 17:03:28", "headline": "Examining the Future: Bridgeline Digital's Earnings Outlook", "summary": " ", "symbols": ["BLIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422806/examining-the-future-bridgeline-digitals-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45422811, "time": "2025-05-14 17:03:32", "headline": "DXC Technology Stock Drops After Q4 Results, Q1 Guidance Below Estimates", "summary": "DXC Technology reports its fourth-quarter results. Here&#39;s a look at the report.", "symbols": ["DXC"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/05/45422811/dxc-technology-stock-drops-after-q4-results-q1-guidance-below-estimates", "tags": ["earnings", "guidance"]}
{"id": 45422815, "time": "2025-05-14 17:03:37", "headline": "Examining the Future: American Shared Hospital's Earnings Outlook", "summary": " ", "symbols": ["AMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422815/examining-the-future-american-shared-hospitals-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45422816, "time": "2025-05-14 17:03:38", "headline": "Reliance Global Group Q1 EPS $(0.66) Up From $(13.77) YoY, Sales $4.24M Up From $4.08M YoY", "summary": "", "symbols": ["RELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422816/reliance-global-group-q1-eps-0-66-up-from-13-77-yoy-sales-4-24m-up-from-4-08m-yoy", "tags": ["earnings"]}
{"id": 45422821, "time": "2025-05-14 17:03:51", "headline": "A Look Ahead: GameSquare Holdings's Earnings Forecast", "summary": " ", "symbols": ["GAME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/05/45422821/a-look-ahead-gamesquare-holdingss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 45422842, "time": "2025-05-14 17:04:24", "headline": "Takeda Pharmaceutical Data From Phase 2b Trial Of Oveporexton In People With Narcolepsy Type 1 Published In New England Journal Of Medicine", "summary": "", "symbols": ["TAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/05/45422842/takeda-pharmaceutical-data-from-phase-2b-trial-of-oveporexton-in-people-with-narcolepsy-type-1-pu", "tags": ["fda"]}
{"id": 45422844, "time": "2025-05-14 17:04:31", "headline": "Blaize Holdings Q1 EPS $(1.61) Down From $(1.23) YoY, Sales $1.01M Up From $549.00K YoY", "summary": "", "symbols": ["BZAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422844/blaize-holdings-q1-eps-1-61-down-from-1-23-yoy-sales-1-01m-up-from-549-00k-yoy", "tags": ["earnings"]}
{"id": 45422901, "time": "2025-05-14 17:05:35", "headline": "12 Information Technology Stocks Moving In Wednesday's After-Market Session", "summary": " ", "symbols": ["BOXL", "BZAI", "CRWV", "DXC", "GCTS", "KARO", "LWLG", "MASS", "RCAT", "REKR", "SLNH", "SVRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45422901/12-information-technology-stocks-moving-in-wednesdays-after-market-session", "tags": ["why_moving"]}
{"id": 45422905, "time": "2025-05-14 17:05:41", "headline": "12 Industrials Stocks Moving In Wednesday's After-Market Session", "summary": " ", "symbols": ["CLIR", "DFLI", "GTI", "HKPD", "HTCO", "ISSC", "LICN", "ORN", "PAMT", "PGHL", "SHLS", "ZJK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45422905/12-industrials-stocks-moving-in-wednesdays-after-market-session", "tags": ["why_moving"]}
{"id": 45422908, "time": "2025-05-14 17:05:46", "headline": "12 Health Care Stocks Moving In Wednesday's After-Market Session", "summary": " ", "symbols": ["AVTX", "AXDX", "AYTU", "BNGO", "CARM", "CDXS", "CHRO", "CTXR", "ICCC", "KLTO", "ONCO", "TNFA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45422908/12-health-care-stocks-moving-in-wednesdays-after-market-session", "tags": ["why_moving"]}
{"id": 45422913, "time": "2025-05-14 17:05:52", "headline": "12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session", "summary": " ", "symbols": ["BGI", "BODI", "BOOT", "CTNT", "DXLG", "ECDA", "GORV", "LVLU", "MTEN", "RYET", "TOPW", "XWEL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/05/45422913/12-consumer-discretionary-stocks-moving-in-wednesdays-after-market-session", "tags": ["why_moving"]}
{"id": 45422963, "time": "2025-05-14 17:07:01", "headline": "Stardust Power Q1 EPS $(0.07) Misses $(0.06) Estimate", "summary": "", "symbols": ["SDST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422963/stardust-power-q1-eps-0-07-misses-0-06-estimate", "tags": ["earnings"]}
{"id": 45422969, "time": "2025-05-14 17:07:09", "headline": "PRO REIT Q1 FFO $0.12 Down From $0.12 YoY, Sales $25.74M Up From $25.70M YoY", "summary": "", "symbols": ["TSX:PRV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422969/pro-reit-q1-ffo-0-12-down-from-0-12-yoy-sales-25-74m-up-from-25-70m-yoy", "tags": []}
{"id": 45422970, "time": "2025-05-14 17:07:13", "headline": "IREN Reports Q3 Earnings: Bitcoin Mining Revenue Jumps 24%, Company Targeting 50 EH/s By End Of June, Shares Move Higher", "summary": "IREN Ltd (NASDAQ:IREN) reported financial results for the third quarter of fiscal 2025 on Wednesday after the bell. Here\u2019s a look at the key details from the report.", "symbols": ["BTCUSD", "IREN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/25/05/45422970/iren-reports-q3-earnings-bitcoin-mining-revenue-jumps-24-company-targeting-50-ehs-by-end-of-june-shares-move-higher", "tags": ["earnings"]}
{"id": 45422998, "time": "2025-05-14 17:07:36", "headline": "Luminar Technologies Q1 Adj. EPS $(1.50) Beats $(1.78) Estimate, Sales $18.89M Beat $15.98M Estimate", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45422998/luminar-technologies-q1-adj-eps-1-50-beats-1-78-estimate-sales-18-89m-beat-15-98m-estimate", "tags": ["earnings"]}
{"id": 45423018, "time": "2025-05-14 17:08:04", "headline": "De-Escalating Trade Tensions In Asia-Pacific Will Reinforce Regional AI Opportunities", "summary": " ", "symbols": [], "source": "benzinga", "author": "Dmytro Spilka", "url": "https://www.benzinga.com/markets/equities/25/05/45423018/de-escalating-trade-tensions-in-asia-pacific-will-reinforce-regional-ai-opportunities", "tags": []}
{"id": 45423047, "time": "2025-05-14 17:08:44", "headline": "ATA Creativity Global Receives Nasdaq Notice Regarding Minimum Bid Price Deficiency", "summary": "", "symbols": ["AACG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423047/ata-creativity-global-receives-nasdaq-notice-regarding-minimum-bid-price-deficiency", "tags": []}
{"id": 45423139, "time": "2025-05-14 17:11:48", "headline": "Luminar Technologies Affirms FY2025 Sales Guidance of $82.94M-$90.47M", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423139/luminar-technologies-affirms-fy2025-sales-guidance-of-82-94m-90-47m", "tags": ["guidance"]}
{"id": 45423142, "time": "2025-05-14 17:11:57", "headline": "Logistic Properties Q1 EPS $(0.02) Up From $(1.67) YoY, Sales $11.84M Up From $10.48M YoY", "summary": "", "symbols": ["LPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423142/logistic-properties-q1-eps-0-02-up-from-1-67-yoy-sales-11-84m-up-from-10-48m-yoy", "tags": ["earnings"]}
{"id": 45423164, "time": "2025-05-14 17:12:44", "headline": "Ceres Global Ag Q3 Adj. EPS $0.05 Up From $0.03 YoY, Sales $214.98M Up From $212.32M YoY", "summary": "", "symbols": ["TSX:CRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423164/ceres-global-ag-q3-adj-eps-0-05-up-from-0-03-yoy-sales-214-98m-up-from-212-32m-yoy", "tags": ["earnings"]}
{"id": 45423182, "time": "2025-05-14 17:13:14", "headline": "CleanCore Solutions Q3 EPS $(0.10) Up From $(0.11) YoY, Sales $557.91K Up From $313.92K YoY", "summary": "", "symbols": ["ZONE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423182/cleancore-solutions-q3-eps-0-10-up-from-0-11-yoy-sales-557-91k-up-from-313-92k-yoy", "tags": ["earnings"]}
{"id": 45423290, "time": "2025-05-14 17:14:11", "headline": "Bird Construction Q1 Adj. EPS $0.23 Beats $0.18 Estimate, Sales $717.55M Miss $742.56M Estimate", "summary": "", "symbols": ["TSX:BDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423290/bird-construction-q1-adj-eps-0-23-beats-0-18-estimate-sales-717-55m-miss-742-56m-estimate", "tags": ["earnings"]}
{"id": 45423311, "time": "2025-05-14 17:15:19", "headline": "$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45423311/1000-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45423315, "time": "2025-05-14 17:15:30", "headline": "GlucoTrack Q1 EPS $(0.67) Up From $(11.73) YoY", "summary": "", "symbols": ["GCTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423315/glucotrack-q1-eps-0-67-up-from-11-73-yoy", "tags": ["earnings"]}
{"id": 45423332, "time": "2025-05-14 17:16:12", "headline": "Stantec Q1 Adj. EPS $1.16 Beats $1.10 Estimate, Sales $1.55B Beat $1.54B Estimate", "summary": "", "symbols": ["TSX:STN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423332/stantec-q1-adj-eps-1-16-beats-1-10-estimate-sales-1-55b-beat-1-54b-estimate", "tags": ["earnings"]}
{"id": 45423333, "time": "2025-05-14 17:16:12", "headline": "AutoCanada Q1 GAAP EPS $0.37 Beats $0.02 Estimate, Sales $1.24B Beat $1.17B Estimate", "summary": "", "symbols": ["TSX:ACQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423333/autocanada-q1-gaap-eps-0-37-beats-0-02-estimate-sales-1-24b-beat-1-17b-estimate", "tags": ["earnings"]}
{"id": 45423335, "time": "2025-05-14 17:16:15", "headline": "Boot Barn Stock Steps Higher Despite Q4 Miss: Here's Why", "summary": "Boot Barn issues Q1 guidance with its midpoint above estimates and announces a $200 million share repurchase program.", "symbols": ["BOOT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/05/45423335/boot-barn-stock-steps-higher-despite-q4-miss-heres-why", "tags": ["guidance", "buyback"]}
{"id": 45423358, "time": "2025-05-14 17:16:53", "headline": "Africa Oil Q1 EPS $0.11 Up From $0.01 YoY, Sales $76.40M", "summary": "", "symbols": ["TSX:AOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423358/africa-oil-q1-eps-0-11-up-from-0-01-yoy-sales-76-40m", "tags": ["earnings"]}
{"id": 45423368, "time": "2025-05-14 17:17:10", "headline": "Tungray Technologies FY EPS $(0.03) Down From $0.06 YoY, Sales $12.81M Down From $14.36M YoY", "summary": "", "symbols": ["TRSG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423368/tungray-technologies-fy-eps-0-03-down-from-0-06-yoy-sales-12-81m-down-from-14-36m-yoy", "tags": ["earnings"]}
{"id": 45423372, "time": "2025-05-14 17:17:50", "headline": "Sadot Group Q1 EPS $0.16 Misses $0.20 Estimate, Sales $132.17M Miss $145.70M Estimate", "summary": "", "symbols": ["SDOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423372/sadot-group-q1-eps-0-16-misses-0-20-estimate-sales-132-17m-miss-145-70m-estimate", "tags": ["earnings"]}
{"id": 45423376, "time": "2025-05-14 17:18:13", "headline": "Professional Diversity Q1 EPS $(0.39) Up From $(0.70) YoY, Sales $1.50M Down From $1.73M YoY", "summary": "", "symbols": ["IPDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423376/professional-diversity-q1-eps-0-39-up-from-0-70-yoy-sales-1-50m-down-from-1-73m-yoy", "tags": ["earnings"]}
{"id": 45423381, "time": "2025-05-14 17:18:36", "headline": "Integra Resources Q1 Adj. EPS $0.03 Misses $0.08 Estimate, Sales $57.02M", "summary": "", "symbols": ["ITRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423381/integra-resources-q1-adj-eps-0-03-misses-0-08-estimate-sales-57-02m", "tags": ["earnings"]}
{"id": 45423392, "time": "2025-05-14 17:18:47", "headline": "Edible Garden Acquires Patented Water Treatment Technology And Operational Shrimp Facility From NaturalShrimp In $15.5M Preferred Stock Deal, Adding $3M In Cash, Enhancing Balance Sheet, Advancing Zero-Waste Inspired Mission, And Expanding Cross-Platform Applications In Sustainable Agriculture", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45423392/edible-garden-acquires-patented-water-treatment-technology-and-operational-shrimp-facility-from-natu", "tags": ["merger", "contract"]}
{"id": 45423406, "time": "2025-05-14 17:19:59", "headline": "'Dick's Sporting Goods Nears Deal to Buy Foot Locker'- Wall Street Journal", "summary": "", "symbols": ["DKS", "FL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/05/45423406/dicks-sporting-goods-nears-deal-to-buy-foot-locker-wall-street-journal", "tags": ["contract"]}
{"id": 45423464, "time": "2025-05-14 17:22:31", "headline": "Bionano Genomics Sees Q2 Sales $6.300M-$6.800M vs $7.02M Est", "summary": "", "symbols": ["BNGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423464/bionano-genomics-sees-q2-sales-6-300m-6-800m-vs-7-02m-est", "tags": []}
{"id": 45423469, "time": "2025-05-14 17:22:46", "headline": "Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est", "summary": "", "symbols": ["BNGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423469/bionano-genomics-lowers-fy2025-sales-guidance-from-29-00m-32-00m-to-26-00m-30-00m-vs-33-43m-est", "tags": ["guidance"]}
{"id": 45423511, "time": "2025-05-14 17:24:23", "headline": "Luminar Technologies Shares Slip After Q1 Results, New Operating Plan", "summary": "Luminar Technologies releases its first-quarter earnings report. Here&#39;s a look at the details.", "symbols": ["LAZR"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/05/45423511/luminar-technologies-shares-slip-after-q1-results-new-operating-plan", "tags": ["earnings"]}
{"id": 45423567, "time": "2025-05-14 17:25:52", "headline": "Luminar Technologies Appoints Paul Ricci As CEO, Effective On Or About May 21, 2025", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423567/luminar-technologies-appoints-paul-ricci-as-ceo-effective-on-or-about-may-21-2025", "tags": ["management"]}
{"id": 45423570, "time": "2025-05-14 17:25:54", "headline": "Stantec Affirms FY2025 Adj EPS Guidance of $5.13-$5.26 vs $5.24 Est; Affirms FY2025 Sales Guidance of $6.28B-$6.45B vs $6.53B Est", "summary": "", "symbols": ["TSX:STN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423570/stantec-affirms-fy2025-adj-eps-guidance-of-5-13-5-26-vs-5-24-est-affirms-fy2025-sales-guidance-of-6", "tags": ["earnings", "guidance"]}
{"id": 45423580, "time": "2025-05-14 17:26:22", "headline": "Natural Alternatives Intl Q3 EPS $(0.37) Down From $(0.27) YoY, Sales $28.77M Up From $25.14M YoY", "summary": "", "symbols": ["NAII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423580/natural-alternatives-intl-q3-eps-0-37-down-from-0-27-yoy-sales-28-77m-up-from-25-14m-yoy", "tags": ["earnings"]}
{"id": 45423718, "time": "2025-05-14 17:28:34", "headline": "California Water Service Group Files For Common Stock Offering Of Up To $350M", "summary": "", "symbols": ["CWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423718/california-water-service-group-files-for-common-stock-offering-of-up-to-350m", "tags": ["offering"]}
{"id": 45423732, "time": "2025-05-14 17:28:48", "headline": "Knightscope Q1 EPS $(1.28) Beats $(1.40) Estimate, Sales $2.92M Beat $2.49M Estimate", "summary": "", "symbols": ["KSCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423732/knightscope-q1-eps-1-28-beats-1-40-estimate-sales-2-92m-beat-2-49m-estimate", "tags": ["earnings"]}
{"id": 45423744, "time": "2025-05-14 17:29:56", "headline": "Stantec Lowers FY2025 Adj EPS Guidance from $3.67-$3.76 to $3.57-$3.67 vs $5.23 Est; Lowers FY2025 Sales Guidance from $4.49B-$4.61B to $4.37B-$4.50B vs $6.50B Est", "summary": "", "symbols": ["STN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423744/stantec-lowers-fy2025-adj-eps-guidance-from-3-67-3-76-to-3-57-3-67-vs-5-23-est-lowers-fy2025-sales-g", "tags": ["earnings", "guidance"]}
{"id": 45423754, "time": "2025-05-14 17:30:24", "headline": "Here's How Much $1000 Invested In Fair Isaac 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["FICO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45423754/heres-how-much-1000-invested-in-fair-isaac-5-years-ago-would-be-worth-today", "tags": []}
{"id": 45423871, "time": "2025-05-14 17:30:58", "headline": "Patriot National Bancorp Files For Mixed Shelf Offering Up To $250M", "summary": "", "symbols": ["PNBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423871/patriot-national-bancorp-files-for-mixed-shelf-offering-up-to-250m", "tags": ["offering"]}
{"id": 45423892, "time": "2025-05-14 17:33:18", "headline": "North American Q1 Adj. EPS $0.36 Misses $0.77 Estimate, Sales $237.43M Miss $310.16M Estimate", "summary": "", "symbols": ["NOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423892/north-american-q1-adj-eps-0-36-misses-0-77-estimate-sales-237-43m-miss-310-16m-estimate", "tags": ["earnings"]}
{"id": 45423907, "time": "2025-05-14 17:35:44", "headline": "Galiano Gold Q1 Adj. EPS $0.01 Misses $0.04 Estimate, Sales $76.59M Beat $71.00M Estimate", "summary": "", "symbols": ["GAU", "TSX:GAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423907/galiano-gold-q1-adj-eps-0-01-misses-0-04-estimate-sales-76-59m-beat-71-00m-estimate", "tags": ["earnings"]}
{"id": 45423911, "time": "2025-05-14 17:35:59", "headline": "Galiano Gold Q1 Adj. EPS $0.01 Misses $0.02 Estimate, Sales $76.59M Beat $71.00M Estimate", "summary": "", "symbols": ["TSX:GAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45423911/galiano-gold-q1-adj-eps-0-01-misses-0-02-estimate-sales-76-59m-beat-71-00m-estimate", "tags": ["earnings"]}
{"id": 45423915, "time": "2025-05-14 17:36:34", "headline": "Spire Global Sees FY2025 Adj EPS $(1.80)-$(1.51) vs $(1.58) Est; Sees Sales $85.000M-$95.000M vs $90.30M Est", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423915/spire-global-sees-fy2025-adj-eps-1-80-1-51-vs-1-58-est-sees-sales-85-000m-95-000m-vs-90-30m-est", "tags": ["earnings"]}
{"id": 45423985, "time": "2025-05-14 17:37:46", "headline": "FrontView REIT Affirms FY2025 FFO Guidance of $1.20-$1.26 vs $1.16 Est", "summary": "", "symbols": ["FVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423985/frontview-reit-affirms-fy2025-ffo-guidance-of-1-20-1-26-vs-1-16-est", "tags": ["guidance"]}
{"id": 45423997, "time": "2025-05-14 17:40:43", "headline": "North American Const Gr Lowers FY2025 Adj EPS Guidance from $2.65-$2.86 to $2.58-$2.79 vs $3.80 Est; Lowers FY2025 Sales Guidance from $1.00B-$1.14B to $975.27M-$1.11B vs $1.29B Est", "summary": "", "symbols": ["NOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45423997/north-american-const-gr-lowers-fy2025-adj-eps-guidance-from-2-65-2-86-to-2-58-2-79-vs-3-80-est-lower", "tags": ["earnings", "guidance"]}
{"id": 45424003, "time": "2025-05-14 17:42:06", "headline": "Seacoast Obtains Regulatory Approvals For The Acquisition Of Heartland Bancshares", "summary": "", "symbols": ["SBCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45424003/seacoast-obtains-regulatory-approvals-for-the-acquisition-of-heartland-bancshares", "tags": []}
{"id": 45424004, "time": "2025-05-14 17:42:16", "headline": "Datasea Q3 EPS $(0.24) Up From $(1.55) YoY, Sales $10.35M Up From $1.38M YoY", "summary": "", "symbols": ["DTSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424004/datasea-q3-eps-0-24-up-from-1-55-yoy-sales-10-35m-up-from-1-38m-yoy", "tags": ["earnings"]}
{"id": 45424057, "time": "2025-05-14 17:43:22", "headline": "Adverum Biotechnologies Q1 EPS $(2.25) Misses $(1.94) Estimate", "summary": "", "symbols": ["ADVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424057/adverum-biotechnologies-q1-eps-2-25-misses-1-94-estimate", "tags": ["earnings"]}
{"id": 45424181, "time": "2025-05-14 17:47:09", "headline": "Forward Industries Q2 EPS $(1.32) Down From $(0.50) YoY, Sales $3.12M Down From $7.83M YoY", "summary": "", "symbols": ["FORD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424181/forward-industries-q2-eps-1-32-down-from-0-50-yoy-sales-3-12m-down-from-7-83m-yoy", "tags": ["earnings"]}
{"id": 45424189, "time": "2025-05-14 17:48:30", "headline": "Nvidia, Amazon, Tesla, Palantir Among Top Beneficiaries Of $1 Trillion Saudi Arabia AI Push, Analyst Says", "summary": "AI Revolution taking off in Saudi Arabia, creating major opportunities for US tech stocks. Trump&#39;s visit &amp; trade deal with China add to bullish outlook.", "symbols": ["AMD", "AMZN", "GOOG", "GOOGL", "IBM", "MSFT", "NVDA", "PLTR", "TSLA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45424189/nvidia-amazon-tesla-palantir-among-top-beneficiaries-of-1-trillion-saudi-arabia-ai-push-analyst-says", "tags": ["guidance", "contract"]}
{"id": 45424211, "time": "2025-05-14 17:49:57", "headline": "PermRock Royalty Trust Q1 EPS $0.12 Up From $0.09 YoY, Sales $1.72M Up From $1.31M YoY", "summary": "", "symbols": ["PRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424211/permrock-royalty-trust-q1-eps-0-12-up-from-0-09-yoy-sales-1-72m-up-from-1-31m-yoy", "tags": ["earnings"]}
{"id": 45424218, "time": "2025-05-14 17:50:58", "headline": "'Amazon trims jobs in devices and services unit'- Reuters", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/05/45424218/amazon-trims-jobs-in-devices-and-services-unit-reuters", "tags": []}
{"id": 45424252, "time": "2025-05-14 17:55:20", "headline": "Fed's Daly Says Monetary Policy Well-Positioned, Moderately Restrictive; Says Businesses Are Cautious Amid Uncertainty, But Not Stalling Out; Says Solid Growth, Solid Labor Market, Declining Inflation; Says That's Where We Want To Be; Says Fed Policy Can Respond To Whatever Comes In The Economy; Says Patience Is The Word Of The Day", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/05/45424252/feds-daly-says-monetary-policy-well-positioned-moderately-restrictive-says-busine", "tags": []}
{"id": 45424361, "time": "2025-05-14 17:57:18", "headline": "CORRECTION: North American Q1 Adj. EPS $0.36 Misses $0.52 Estimate, Sales $237.43M Beat $212.74M Estimate", "summary": "", "symbols": ["NOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424361/correction-north-american-q1-adj-eps-0-36-misses-0-52-estimate-sales-237-43m-beat-212-74m-estimate", "tags": ["earnings"]}
{"id": 45424391, "time": "2025-05-14 18:00:18", "headline": "Here's How Much You Would Have Made Owning Wix.com Stock In The Last 10 Years", "summary": " ", "symbols": ["WIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45424391/heres-how-much-you-would-have-made-owning-wix-com-stock-in-the-last-10-years", "tags": []}
{"id": 45424395, "time": "2025-05-14 18:00:26", "headline": "Price Over Earnings Overview: Kennametal", "summary": " ", "symbols": ["KMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45424395/price-over-earnings-overview-kennametal", "tags": ["earnings"]}
{"id": 45424406, "time": "2025-05-14 18:00:32", "headline": "Expert Outlook: Corteva Through The Eyes Of 10 Analysts", "summary": " ", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424406/expert-outlook-corteva-through-the-eyes-of-10-analysts", "tags": ["guidance"]}
{"id": 45424423, "time": "2025-05-14 18:00:41", "headline": "Demystifying KKR: Insights From 14 Analyst Reviews", "summary": " ", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424423/demystifying-kkr-insights-from-14-analyst-reviews", "tags": []}
{"id": 45424426, "time": "2025-05-14 18:00:51", "headline": "Where BioNTech Stands With Analysts", "summary": " ", "symbols": ["BNTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424426/where-biontech-stands-with-analysts", "tags": []}
{"id": 45424427, "time": "2025-05-14 18:01:06", "headline": "Breaking Down Ralph Lauren: 7 Analysts Share Their Views", "summary": " ", "symbols": ["RL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424427/breaking-down-ralph-lauren-7-analysts-share-their-views", "tags": []}
{"id": 45424428, "time": "2025-05-14 18:01:14", "headline": "Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["BDSX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424428/biodesix-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 45424436, "time": "2025-05-14 18:01:21", "headline": "Breaking Down OneStream: 14 Analysts Share Their Views", "summary": " ", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/05/45424436/breaking-down-onestream-14-analysts-share-their-views", "tags": []}
{"id": 45424440, "time": "2025-05-14 18:01:40", "headline": "CORRECTION: Spire Global Q1 Adj. EPS $(0.63) Beats $(0.67) Estimate, Sales $23.90M Beat $22.70M Estimate", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424440/correction-spire-global-q1-adj-eps-0-63-beats-0-67-estimate-sales-23-90m-beat-22-70m-estimate", "tags": ["earnings"]}
{"id": 45424442, "time": "2025-05-14 18:01:51", "headline": "Fury Gold Mines Q1 GAAP EPS $(0.02) Down From $(0.01) YoY", "summary": "", "symbols": ["FURY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424442/fury-gold-mines-q1-gaap-eps-0-02-down-from-0-01-yoy", "tags": ["earnings"]}
{"id": 45424475, "time": "2025-05-14 18:03:31", "headline": "Foot Locker Stock Soars On Potential Dick's Sporting Goods Deal: Report", "summary": "Foot Locker shares are running after the market close on Wednesday following reports that Dick&#39;s Sporting Goods is nearing a deal to buy the footwear and apparel retailer.", "symbols": ["DKS", "FL"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/sports/25/05/45424475/foot-locker-stock-soars-on-potential-dicks-sporting-goods-deal-report", "tags": ["contract"]}
{"id": 45424502, "time": "2025-05-14 18:04:59", "headline": "UPDATE: Battalion Oil Q1 Adj. EPS $(1.00) Up From $(2.24) YoY, Sales $47.48M Down From $49.87M YoY", "summary": "", "symbols": ["BATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45424502/update-battalion-oil-q1-adj-eps-1-00-up-from-2-24-yoy-sales-47-48m-down-from-49-87m-yoy", "tags": ["earnings"]}
{"id": 45424636, "time": "2025-05-14 18:15:21", "headline": "$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["FI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45424636/1000-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45424674, "time": "2025-05-14 18:20:34", "headline": "ESPN To Launch 'Ultimate Sports Destination' Streaming App In Fall: Why Analyst Says Disney Can 'Have A Direct Relationship With Their Viewers'", "summary": "Disney will target its huge sports fan base of the ESPN brand with a new standalone streaming app. One analyst says this could be a &#34;big win&#34; for Disney.", "symbols": ["DIS"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/25/05/45424674/espn-to-launch-ultimate-sports-destination-streaming-app-in-fall-why-analyst-says-disney-can-have-a-direct-relationship-with-their-viewers", "tags": []}
{"id": 45424880, "time": "2025-05-14 18:45:20", "headline": "$100 Invested In Linde 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["LIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45424880/100-invested-in-linde-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45424904, "time": "2025-05-14 18:51:07", "headline": "UnitedHealth Stock Caught In A Perfect Storm, Falls Nearly 50% Since April", "summary": "BofA Securities analyst Kevin Fischbeck downgrades UnitedHealth Group from Buy to Neutral.", "symbols": ["UNH"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/health-care/25/05/45424904/unitedhealth-stock-caught-in-a-perfect-storm-falls-nearly-50-since-april", "tags": ["analyst_down"]}
{"id": 45424976, "time": "2025-05-14 19:00:35", "headline": "Here's How Much $100 Invested In Ameriprise Finl 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["AMP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45424976/heres-how-much-100-invested-in-ameriprise-finl-15-years-ago-would-be-worth-today", "tags": []}
{"id": 45425124, "time": "2025-05-14 19:15:19", "headline": "Here's How Much You Would Have Made Owning Arch Capital Group Stock In The Last 20 Years", "summary": " ", "symbols": ["ACGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45425124/heres-how-much-you-would-have-made-owning-arch-capital-group-stock-in-the-last-20-years", "tags": []}
{"id": 45425225, "time": "2025-05-14 19:30:18", "headline": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["SPGI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45425225/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45425243, "time": "2025-05-14 19:30:37", "headline": "UPDATE: Harte-Hanks Q1 EPS $(0.05) Down From $(0.02) YoY, Sales $41.56M Down From $45.45M YoY", "summary": "", "symbols": ["HHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/05/45425243/update-harte-hanks-q1-eps-0-05-down-from-0-02-yoy-sales-41-56m-down-from-45-45m-yoy", "tags": ["earnings"]}
{"id": 45425369, "time": "2025-05-14 19:45:20", "headline": "$100 Invested In Cadence Design Systems 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["CDNS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/05/45425369/100-invested-in-cadence-design-systems-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45425393, "time": "2025-05-14 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["RNAZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/05/45425393/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45426247, "time": "2025-05-14 21:29:19", "headline": "Jeff Bezos Once Watched Amazon's Stock Collapse From $113 To $6, But Held On To The Belief That 'The Stock Is Not The Company' \u2014 Here's How He Weathered That Storm", "summary": "Jeff Bezos weathered Amazon&#39;s 94% stock crash during the dot-com bust by focusing on business fundamentals, not market panic \u2014 a strategy that helped turn the company into a $2.2 trillion giant.", "symbols": ["AMZN"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/25/05/45426247/jeff-bezos-once-watched-amazons-stock-collapse-from-113-to-6-but-held-on-to-the-belief-that-the-stock-is-not-the-company-heres-how-he-weathered-that-st", "tags": []}
{"id": 45426516, "time": "2025-05-14 22:13:01", "headline": "Chuck Schumer Says Trump Is 'Letting Cartel Members' Into The US, Asks How Much 'Memecoin' Did They Pay", "summary": "Senate Minority Leader Sen.\u00a0Chuck Schumer (D-N.Y.) attacked President Donald Trump\u2019s reported decision to parole\u00a0family members of Mexican cartel leaders\u00a0into the United States on Wednesday, implying a potential connection to the Official Trump (CRYPTO: TRUMP) meme coin.", "symbols": ["TRUMPUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-they-pay", "tags": []}
{"id": 45426626, "time": "2025-05-14 22:14:43", "headline": "Cathie Wood's Wednesday Wisdom? Bets On Airbnb's Platform Expansion, Dumps Palantir At Peak", "summary": "On Wednesday,\u00a0Cathie Wood-led\u00a0Ark Invest\u00a0executed significant trades, including a notable purchase of\u00a0Airbnb Inc. (NASDAQ:ABNB), a sell-off of\u00a0Palantir Technologies Inc. (NASDAQ:PLTR)\u00a0,", "symbols": ["ABNB", "ARKB", "ARKF", "ARKK", "ARKW", "BTCUSD", "PLTR", "SOL", "SOLUSD"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/25/05/45426626/cathie-woods-wednesday-wisdom-bets-on-airbnbs-platform-expansion-dumps-palantir-at-peak", "tags": []}
{"id": 45426637, "time": "2025-05-14 22:21:33", "headline": "Nvidia CEO Jensen Huang Expected To Unveil New AI Alliances At Computex 2025 As Geopolitical Pressures Persist Over Tech Sector", "summary": "Computex 2025 will spotlight Nvidia CEO Jensen Huang as he returns to headline the first major Asian tech gathering since Trump&#39;s tariff threats, with expected announcements on new AI partnerships amid rising geopolitical and industry shifts.", "symbols": ["AMD", "INTC", "NVDA", "QCOM"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/25/05/45426637/nvidia-ceo-jensen-huang-expected-to-unveil-new-ai-alliances-at-computex-2025-as-geopolitical-pressures-persist-over-tech-sector", "tags": ["management"]}
{"id": 45426769, "time": "2025-05-14 22:37:44", "headline": "UnitedHealth Stock Plunges Over 8% In After-Hours Trading As DOJ Criminal Probe Adds To Turmoil After CEO Shake-Up", "summary": "The crisis at UnitedHealth Group Inc. (NYSE: UNH) continues to deepen, with a new criminal investigation by federal authorities, following the abrupt departure of its CEO, and a steep decline in stock prices.", "symbols": ["AET", "UNH"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up", "tags": ["legal", "management"]}
{"id": 45427077, "time": "2025-05-14 23:16:26", "headline": "Bitcoin Flat, Ethereum, Dogecoin Slip: Analyst Firm Sees 'Significant Recovery' In Retail Interest But A Pullback Might Be Imminent", "summary": "Leading cryptocurrencies dipped on Wednesday as investors took profits on the recent advances.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD", "NVDA"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/05/45427077/bitcoin-flat-ethereum-dogecoin-slip-analytics-firm-highlights-resurgence-in-btc-retail-interest-but-a-brief-pullback-might-be-close-by", "tags": []}
{"id": 45427103, "time": "2025-05-14 23:23:23", "headline": "Reddit, Rocket Lab, Tesla, Alibaba, And Unitedhealth: Why These 5 Stocks Are On Investors' Radars Today", "summary": "U.S. stock markets saw a positive shift on Wednesday, with the S&amp;P 500 and Nasdaq 100 indices turning green for the year.", "symbols": ["BABA", "RDDT", "RKLB", "TSLA", "UNH"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/markets/equities/25/05/45427103/reddit-rocket-lab-tesla-alibaba-and-unitedhealth-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 45427189, "time": "2025-05-14 23:32:18", "headline": "After Trump Administration's Ban On Huawei AI Chips Goes Global, Tencent Says It Has Enough High-End AI Chips To Train Models For 'Generations'", "summary": "Despite a global U.S. ban on Huawei AI chips, Tencent says it has enough high-end inventory\u2014like Nvidia&#39;s H20\u2014to continue training its AI models for &#34;generations,&#34; while optimizing usage to stay competitive amid rising geopolitical pressure.", "symbols": ["BABA", "NVDA", "TCEHY"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/25/05/45427189/tencent-says-it-has-enough-high-end-ai-chips-to-train-models-for-generations-after-trump-administration-bans-huawei-tech-anywhere-in-the-world", "tags": []}
{"id": 45403511, "time": "2025-05-14 07:55:04", "headline": "Bill Gates Once Warned That Computers Might Eventually Think On Their Own\u2014But Admitted It Was A 'Scary Thought' And 'No One Knows When That Will Happen'", "summary": "Bill Gates appeared on The Late Show in 1995, predicting AI&#39;s emergence. He now warns of its potential dangers and the need for regulation.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/general/entertainment/25/05/45403511/bill-gates-once-warned-that-computers-might-eventually-think-on-their-own-but-admitted-it-was-a-scary-thought-that-no-one-knows-when-that-will-happen", "tags": []}
